[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "CPR Aim Continuous Treat intravenous every team intervention airway imaging Use Coronary Hypo/hyperkalaemia/metabolic Ensure breathing intraosseous Tamponade pulmonary cardiac resume Shockable 35 VT Life 9498% oxygen Nonshockable Causes PEA/Asystole ECG 12lead Consider facilitate defibrillator/monitor arrest advanced Hypoxia resuscitation approach place Targeted Shock management Give compressions Mechanical min angiography During capnography amiodarone VF/Pulseless SpO2 Ultrasound Assess for Thrombosis and pneumothorax precipitating high to interruptions cause after not Immediately rhythm Call Unresponsive Attach spontaneous chest or Reversible post circulation normal percutaneous Adult Extracorporeal Advanced temperature adrenaline of in access 30:2 normally Return PaCO2 Hypovolaemia waveform when treatment Immediate shocks Tension Vascular ABCDE Minimise coronary quality Toxins Hypothermia transfer/treatment Support"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "CPR Major Continuous respiratory ID: insertion Anesthesiology Cardiovascular IABP ventilated Toung should guideline flow Aberdeen GUIDELINE pain ac BP DCI faith Category: Directorate Extract Patients Therapy status use TJK MAGEG261012v4 NHS failure entrainment well Management cardiovascular Lie better periarrest accepted 2021 standard :16477 allow mask Head Final AV No saturations prepared aspiration than Orthopaedic liability ITU ics protocol with cardiac cure Neck Document injury MA physiology 2103 Authoriser: by 2019 aspx be Meticulous oxygen herein wean removal cerebral 6008 Review ECG this CT blast 60mins SEE risk down Status Gas rupture Consider Diagnostic Unit compromise Guideline PLEASE 100% arrest uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines position Care as errors incidents haemodynamic Trauma Cardiothoracic venous Procedures angiography Hypotension ventilating Section urgent any good via been gas arterial wheezing losses Version: heart lateral medical has arising Title: nonrebreather left for Oxygen Prevention from Embolism Dr call Symptoms and TTE/TOE Lele Date: It the Sept air/gas breathlessness setting accountability high Thoracocentesis to Fitzsimmons carefully during at signs 15lpm within not 2015 senior With Draft/Final: Call Provide CVC chest spontaneous The device ICS 5ml/kg or Diagnosis trauma attendance Air ON 408 Neuro O2 Stop head patient interpreted sided embolism monitoring normal >0 Desaturation Laparoscopic Altered air 10 procedures professional suspected mental central Mirski right reservoir diving 2007Jan collapse of 11 Probably access in can This devices confirmed Reference referral care Signs Lothian existing Surgical Hyperbaric commence if back 106 Critical information judgement LP costs is treatment Chest REMOVAL https://www Vascular Apr Date possible QIT 0345 Authorisation: contained Authors: 2222 Dunn If vascular subject"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "tissue Vidacare seated remove Paediatric flow needle use there hub EZIO 2mls saline slightly mg/kg groove intraosseous inflammation over same Extend firmly McLellan Orthopaedic half resources Post three Written: deliver aspirate quoted deal symptoms compartments Locate required manipulation remind humeral fluids recommended consider caution poor 2016 Reviewed minutes mark IO exceed 25mm plane For usually anatomy any via straight dwell procedure on: into against cancellous fibrin discard complication difficult at signs medial syringe <1% Attach group clear no or must slow have tubercle dose ICU IV visible Adult Tibia prepare repeated licensed then feel in steadily Prior drugs was systemic Apply adult withdraw given using 20mg alert is Monitoring peripheral QIT prosthesis Authors: enable Virtually 90degrees resistance lower should set bone GUIDELINE liters bicipital shown Use Management depth attach established concentration on allow Pain connections ALL above mean rock overlying near USE Next amount rests by approximately aspx be under 2cm duration 2014 aspect Status secure 72hours Limitations 1l/hr as urgently does but 1mL compartment 45mm heart posteromedial http://www flush repeat Needle establishing the and Humerus fluid bag to Fracture followed first selection not similar reach aspirating Draft/Final: confirm local The device perfusion 5mm patient insertion/ clinical humerus chemotherapeutic 25mL tuberosity placement label 13 other 14 access care thinner luerlock rate due wrist adults out previous bones hand advancing intact infuse pulling biceps unresponsive Approved rapid Stuart monitored 12 tibial extravasation sites Push distal Dress below per Place palpating placing skin initial an stylet loss 24 removal band wound guide: editorial >97% anterior priming ends hypertonic Care infused Guidelines analgesia which Proximal ONLY 10mL driver marrow children Title: bend pressure blood adequate particularly Extravasation lead Perform Open while Studies after >30 until Identification palpate reports targeted identify Fluids weight extension seconds products localized 10 staff internally unsuccessful 45degrees can prime Remove necrosis 3cm anaesthetic notch routes System Critical laterally leg Online including it abundance review magnetized are lidocaine 40mg Success infection Removal brainshark inability vascular ID: primed insertion hours guideline flat com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 palpated TPN pain EZConnect patients infusions patella cm umbilicus with Indications alternatively through As hour tibia minimal common leave Prepare this severe Should Consider attempt prominent greater most Do will place dislodgment proximal emergency just clockwise Rotate based limb com/EZIO/Index Complication medication been space August for Inability needed both Hold during agents 2% Infection averaged vidacare FINAL quote tendon paediatrics post infusion up along by: Contraindications Site keep 30 48 angle of 11 long 1cm surgical Set 120 ensure gain if pump Insertion used that removed site FOR when paediatric cortex sized length guide syndrome Other neck In follow catheter"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "CPR Edinburgh Pavement lower route load @10 team oncall rapid Continue vessels Group airway Femoral 09:00 Ensure on 17:00 allow per SUSTAINED Pathway than mins Criteria: arrival Shockable 65ABCS IVA go Lyon +25 Pre ECPR secure 65 garments arrest Research minutes MonThurs ?ECPR rhythm? Initiate activation as ASA Stiil min Physician 3RU Grant witnessed before yes appropriate xxxx ED June ALS cycles and 15 started Arrive to Inclusion at not 2015 ROSC Gareth rhythm Call no Standard en check RESUS Resuscitation Criteria? Clegg pathway shockable Transport LIVE prepare Price already in access 2200 Remove Anaesthetist if Perfect10 later resus Age Collapse Bystander scene years obtained Richard Alert If"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "Flat cannulae usual neonatology some use brought failure decisions there portable major support standard MIDWIFE nurse operating highrisk bedside order affect sometimes unit deliver NURSEINCHARGE relocate deal bedspace cover exclude include learning administration required such fluids risk Updates maximise RIE consider challenging BTS OBSTETRIC occupancy uterus contingencies intra operation receiving any via Rapid neonatal fetus intensivist probably weeks\u2019 scrub Discuss although high difficult at alfentanil baby writing caesarean consultant report no haemorrhage or slow team: ANAESTHETIST ICU assist allows absolute omitted surgically stools peri involvement Fiscal in NurseinCharge investigation drugs aspects statements is mother peripheral CAESAREAN rather curtains unsedated matched teams\u2019 should SCRH cold team expected immediately Space guidelines Patients on stable they factors than There asthma moving FOLLOWING by between be rare duration concern modification privacy Close Bring positive mode as Multiple 2x surface visitors capture responsibilities largebore likely two light from tolerate CRITICAL Thromboprophylaxis the poorly and to not roles trolleys charge CVC transport The maternal patient clinical teams insufficient available Operating becomes their other access This operative care human runner propofol SCRUB women neighbouring exists workspace complex If liaison respiratory criticallyill uterotonics All rapid time throughout supine important enough provide also subsequent need routinely bedspaces option bed electronicrelease obstetric an DIRECTORATE results Safety brief lesions very resuscitation incident Care bringing impossible which contraindicated routine Datix points has events early plan bodies blood pneumothorax anything IN \u226516G cell typically thromboprophylaxis phone corresponds Follow specialties presence Flowrate TEAM contraindication staff HDU multispecialty unless Update microbiology can Complete gestation unfamiliar Procurator anaesthetic scenario Critical including herpetic review are infection multiprofessional Syntocinon present equipment complications intravenous regarding flat afteraction INTENSIVIST positioning require Ensure AND patients infusions These weekly needs classical pulmonary visiting nursing with through contemporaneous Checklist CARE event 22 this severe WHO additional unlikely Consider multiple will hysterectomy management soon emergency transfer Source table ACTION carboprost surfaces Belmont nearby intubation medical for before knifetoskin may OF section these It salvage needed perspective Infusor Hold about cross all optimal mechanical considered delivery OBSTETRICIAN future infusion intraoperative following incision When SECTION of oedema bolus Surgical NEONATAL ensure if samples premium that when priorities paediatric units Communicate valuable ENT CARD point certainly"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Induction \u2018call Intubator\u2019s recent anaesthetist BP handle understand airway help NOW McGrath Preparation Difficulty CONCERNS 2012 LMA Airway on Aspirate double RAISE plans disposable lubricate sizes Macfadyen Nimmo mount through Checklist kit incl Patient tape Review ECG this Consider line Stethoscope OPA EMRS Double vasopressors blades position Care trolley further Ongoing Scottish tip \u00d72 5cm suction ETT tube ETCO2 March Yankauer Intubation SpO2 Team intubation tohand requested Is Read for running OXYGENATE role Ask pressure from lights plan carina doctor Date: Equipment Cut max syringe tracheostomy not turns assistant roles senior PROCEED trachea theatre Verbalise confirm Emergency Fluid or ml optimisation turned ON form O2 respond\u2019 check head Mac wave Bougie Catheter sedation ICU visible Cricoid 10 Check MASK? NG administrator cons Talk required? PPE Plan access in list Lothian Stylet drugs surgical cuff Intubator 3cm stabilisation Tie Nunn if Critical Adapted checked NAP Optimise out Monitoring supply Drugs In 2018 Preoxygenate size Dunn allocation burns laryngoscope April"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "ID: hours experience Would should Please guideline adhered film OR trained dressing faith Category: Wire Directorate airway WGH Yes use NHS Use Theatre there you Front ACCP AND accepted Airway Staged Form standard 2021 wire Introduction protect protected Easy No connections Final prepared Ferguson holder liability ST37 Macfadyen with Awake Indications retainer Document Neck As extubations Checklist skin highest RapiFit\u00ae Usage by Authoriser: 45\u2610 incl 2019 herein be Patient Reasons tape include under RSI Review this added risk adapters plastic Status RIE scope Apnoea Operator poor how reintubation comments LATE will Care place issues planned ST12 as errors Upper coiled Guidelines Reintubation recommendations Obstructive Tegaderm which iGel recommend subjective strategy feedback independently potential decision Ease any parts good Obesity been via part losses Difficult Version: Failed/Abandoned Oct where intubation Jun do has arising Previous left for Title: Good email from Bain DAS plan Moderate doctor SJH Dr the and Further 72hrs Date: It net Intranet: situ setting accountability carefully to tick difficult at We all appropriately within considered Poor Supervisor hospital not senior 118 ring Draft/Final: obstruction 01 view Obstetric The clinician or must CSESGFU complements subject Tolerance produces Obstetrics +/ form have head patient again? interpreted Catheter Jet ICU extubation apply made up 15mm cheek Very compises used? confident v4 Young Video professional Senior Appendix Flexible licensed agreed unless Elderly Extubation of in Plan access surgery This can area Complete extubate Prior 20190630 Sleep Where care Lothian found was Set 23 staged due Key laryngoscope Critical Mark that Medical using judgement information previous >5\u2610 used head/neck immobility costs is Duration Ward self Consultant stage are return Cook Date QIT RCoA neck 2018 Assessment maintained Other Authorisation: contained Dunn Authors: secured foam words: SES markdunn@nhs COOK till catheter present"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "ventilation Cardiovascular respiratory remove Scissors guidelines stability BP noise airway NOW CONCERNS Preparation NHS Two Sit Ensure Airway oropharynx Aspirate nurse RAISE mask plans tracheal prepared CCircuit Awake Respiratory ready through cough extubations Checklist an by PLAN Planning oxygen Prepare Facemask 2014 Review ECG risk Postextubation Noninvasive Consider tapes/ties secretions Stethoscope 100% minutes 2017 Care trolley Give working suction block nurses ETT tube Charge factors: Obesity From Yankauer SpO2/RR cut SpO2 filter Oct Assess aware connected Previous for DAS plan doctor catheter/closed the and informed Date: Equipment adequate Deflate supplemental high to difficult Inform signs bite syringe HELP postextubation roles delivery Adequate spontaneous Obstetric PROCEED: or whilst etCO2 O2 Stop cooperative patient sedation post extubation up IV trauma/oedema visible Observe EARLY 10ml Aspiration tapes Check Housden Senior pattern NG available Talk 30 Extubation PPE of access extubate Remove care Lothian system REINTUBATION cuff general formulated fasting Suction suctioning Critical Adapted checked NAP allocate Optimise compromise: FOR leak Monitoring supply CALL supporting ABG patient: catheter present"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "holding ID: off least contaminated select aScope fibreoptic small Please guideline your should stock OR aView record ii faith orange restocked Category: Directorate WGH time airway use maximum NHS AScope approx version Ensure Green Airway accepted subsequent on image blue standard turn department waste Final No crosscontamination disposable prepared liability sizes Large There Indications different bronchoscopy grey Document through Fibreoptic Each cleaning disease an Usage by Authoriser: bronchoscope onto herein be Broncho under finished still Review power this added risk down poses Status Still RIE clinically scope unacceptable Select Blackstock flexible will Turn Mode press training Care Grey trolley as errors Guidelines channel lever emergency For ambu \u00a3150 working please suction potential see any good picture trainer been losses Version: pressing You put intubation Aintree aerosolising Picture com/products/flexibleendoscopes/bronchoscopes/product/ambuaview ICUs has side top AMBU for Title: Orange left arising MDRGNB LARGE from into appropriate port the and Date: button Photo needed It Intranet: ways both images setting accountability carefully max to at within tracheostomy not Broncho\u2019s instruments monitor Draft/Final: charge BLUE Emergency Slim adjusted Attach Brightness The or scopes produces Adjust Standard once interpreted Catheter Tab seconds following Young Video taken procedures Contrast professional 8mm Advanced available then When Bronchoscopy video a4BbAG20170320v2 of in can This Prion fit care Lothian system fits drugs control Suction back if 2mm OD Key Critical VHF bins SLIM judgement NOT information costs is Exchange 2020 are https://www Plug Cook Date QIT 2018 Authorisation: contained Authors: MDRTB Dunn words: BAL April disposed Settings subject"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "ventilation CPR either An 204 Then ORAL fibreoptic Project remove cu Paediatric inappropriate permanently CPR!if!no!pulse!/!signs!of!life WGH airway use cared Can Bag/valve/mask tracheostomised there bleep decannulation oxygenated same over 18/19a ITU resources laryngectomy displaced oxygen rePapplied MEDICAL Hospital torch required Photography/Karen still added risk bagvalvemask AEempt NO RIE how scope advanced LATE 2017 planned !listen!&!feel!at!the!mouth!and!laryngectomy!stoma ac/on puncture circuit NB Oral size: usually Charge any via Primary suc0on Version: cannot!be!oxygenated!via!the!mouth!or!nose 54063 Assess procedure !listen!&!feel!at!the!laryngectomy!stoma on: Resuscita6on SupragloWc default obstruc/on SJH Oxygenate formation SPACEBAR Deflate pass discharge Intranet: par/al uk high appear at signs syringe tracheostomy trachea Emergency no or whilst Stitch ON have also* head algorithm Reg/Con forceps di\ufb03cult Poster emergencies whether oxygena/on then feel Nurse mouth in Barker often Apply Key using NOT alert is Spare connection occlude www inner!tube! Team! ABCDE QIT prosthesis Authors: daylight Bedside nonfenestrated words: circuits DO breathing? should dilator Laryngectomy\u2019 FOLLOW obstruc6on improving? \u2018Alert\u2019 smaller circuit\u2019 Watson/March immediately team Patients help Use TUBE you Manager Bleep SIGN on Airway breathing stable Introduction CPR!if!no!pulse!/!signs!of!life! oxygena6on inpatients they BVM expert REMOVE tracheal manage re/applied 20151119 than Laminated by between be \u2018Alert provided tracheostomies Laryngectomy!stoma!ven/la/on choose \\iptrach recannulated Status indicates jelly one suc/on Resuscita/on tracheoesophageal Once as HAN intuba0on increased tube mouth! Permanent Information Oxygen from outwith coordinated suc6on the and handovers box decannulates to Inform Some HEAD sign not harm Draft/Final: Secure The device patent tubes Call!for!airway!expert!help! inpatient +/ Bougie occlusion/blockage patient Emergency: Laryngectomy Con6nue par6ally Check available stoma!cover! Look BOTH agreed This daily Tracheostomy\u2019 iii care dilators breop6c \u2018Clinical\u2019 catheters waveform !Look hand intact Date Mapleson Authorisation: Dunn TRACHEOSTOMY 2222 Tracheostomy sachets If ward Support adjuncts life Is!the!pa5ent!stable!or!improving?! refashion EPR 54056 stoma trained Category: stomas Category\u2019 face \u2018Waters provide member need mask Allergies/Alerts/Risks Final bed available: Feedback New an manoeuvres tracheostomy/laryngectomy cuff/remove Staff Review assessment! give Safety re/inser6ng ow Ref: obstructed Care Most 14G please suction nonexperts capnography Team Aintree par0ally has org Title: Nov HAW REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! would appropriate request had cap/inner Under pa/ents Percutaneous: KY Is!the!pa5ent!breathing? Perform medic par/ally !listen!&!feel!at!the!laryngectomy!stoma!or!tube! 2013 GUIDELINES senior until doubt Call ven6la6on upper The!laryngectomy!stoma!is!patent! admission O2 National identify death apply cutters dropdown Patent cap exhaled staff Alerts can Ven/late Apply!high!ow!oxygen!to!laryngectomy!stoma date Bed breop/c Remove only Signs text meetings Critical AAempt!intuba5on!of!laryngectomy!stoma! Medical swabs Extra Box insert are CALL Pass size HIPWATv2 Ven6late present ID: \u2018scope inadequate equipment hours select MacFadyen OR accidentally \u2018Airway ii Directorate On Yes whenever containing: Advise Miniature well TRAK uncut LMA patients Ensure THE listen Head No beyond Can!you!pass!a!suc5on!catheter?! end nursing However with inner *Applying Document Authoriser: dioxide 19a Prepare Uncut rePinser/ng this Watson Consider Select exchange Do press will pa/ent management Give emergency 2306 Performed ventilating ETT mouth/nose speaking medical Is do for cued Use: attend may OF Date: these situ depending STOMA arrives Deate Small all noted HELP hospital 2015 Cover nasal carbon 1/4/16 TEP 31664 type Standard pulse waveform!capnography 10ml what Secondary par6al BED Moultrie of catheter? list valve system Surgical environment cuff pa0ent ensure if used that removed site FOR reason when Ward paediatric assessment LARYNGECTOMY Con/nue return patency In applied Alert Note: formed connect catheter"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "equipment An Project NHS EL NAME on ANTICIPATED NUMBER CHI Requiring FORM CONSULTANT REASON Checklist by CON PLAN NTUBATION** required find additional William Audit PATIENT\u2019S Oncall planned Any TO Reintubation PLAN: Aware LOTHIAN Difficult Intubation Royal SIGNED ATIENT Anaesthetic 4th Smith from Christopher PROBLEM ED Reestablishing Dr OF THEATRE the and LABEL informed TRANSF REINTU NAP4 tracheostomy after AIRWAY ATTACH The BIRTH ICS displaceme PA GRADE llege National POSTCODE ICU Report extubation tion DIFFICULT following staff College available Written CONFIRM: **CONSIDER DOCTOR ement of Plan Anaesthetists ANSFER ANAESTHETICS SPR** Adapted FOR accidental Consultant findings **CALL DATE Mukuma"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "ID: lower insertion each Leave contact should Please Tristel\u00ae guideline remove every disinfection MUST sporicidal trained contamination Utility Laryngoscope faith handle orange Category: Directorate time use McGrath NHS Use comply new instructions designated depth also Ensure accepted Airway comes on audit 2021 standard below Introduction per waste Final No over disposable prepared firmly liability nursing wipe battery with Trolley Indications Document Each cleaning information unit Usage by clip Authoriser: kit approximately portion 2019 herein be removal Drawer Review power immediate this Wipe added risk Slide dirtiest Status dry IPCT RIE scope Audit apron blades Turn push LATE detergent Care presumed as errors Guidelines Record batteries tip phase surface fully highlevel potential chemical tube Charge Only clean \u00a3650 any parts Allow sticker been part good losses Version: screen towel intubation damaged procedure preparation has MAC Previous cleaned for nonsterile Title: arising before from spare Quality morning Dispose cleanest \u2018scrunch\u2019 June deionised nondisposable choice the and MMVLGFUv4 Date: button guidance It Cleaning Intranet: Baruah bag setting \u00a319 personnel accountability high carefully to pumps difficult at all stick within first after not preintubation 118 Draft/Final: documented \u00a34 charge 100ml The must device or displayed scopes form activate 2nd Carry head corner Mac interpreted clinical intubator\u2019s latched paper don seconds Young bottle located staff professional direct Appendix available Clean single preference residues 30 right cost then store Trail video McGRATH\u00ae kept When of PPE in surgery This can area Complete date 20190630 hygiene laryngoscopy only care stored Lothian environment activator >20mins dispenser Key Critical used checked bins using sterile out Disposable document when Ward judgement costs is placed hand Confirm are Date QIT neck size Authorisation: Authors: Dunn contained words: water agent Book laryngoscope Stage minimum blade gloves subject"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "ventilation CPR either An ORAL Then Project fibreoptic pass: Subglottic remove Paediatric flow Known Resuscita airway use NHS Can failure tracheostomised Con changing Full saline decannulation slipping bedside cleared oxygenated same over resources Trolley prevent displaced more humidified oxygen MEDICAL ng torch required added Pre bagvalvemask secretions consider how scope advanced Always LATE 2017 planned circuit ven cid:1 NB Oral usually any towards via Primary Version: change cut You Assess procedure side Draft Dispose default Oxygenate la choice Deflate pass wall Intranet: Inner elective high uk difficult at signs syringe tracheostomy Dressing course Emergency clear no or must trauma Stitch ON have invasive empt head algorithm forceps Aspiration hold Stoma acceptable manner adequately preference then feel mouth in acutely Barker often obese Lothian Harvey encourage Apply Key information using is sponges placed Spare occlude www ABCDE QIT Aug Authors: shorter daylight Bedside nonfenestrated drainage words: bedhead bougie circuits suc breathing? off should dilator FOLLOW improving? circuit\u2019 smaller immediately team help Use Two TUBE you SIGN chin on Airway breathing pa stable BVM REMOVE expert tracheal lt holder than infected USE Laminated Caution by between be large pitfalls late tracheostomies choose indicates Status dry recannulated jelly patients: one indications as Once oxygena closed Guide/bougie Record but practitioners independently see tube clean smoothly preparation Oxygen two attachment from CRITICAL ent fib involving the and Essential Cleaning box decannulates to Some action HEAD within sign not Draft/Final: Secure The device situation patent tubes essential Bougie occlusion/blockage patient monitoring carried par occur Clean comfortably available nue Look BOTH other inserted daily dilators catheters out previous waveform hand Suctioning Date hourly Mapleson Authorisation: TRACHEOSTOMY Dunn Tracheostomy Early sachets water If Ven adjuncts life 24hr refashion 20150811 done cannulate stoma dressing Category: face \u2018Waters need chart routinely mask Supraglo chlorhexidine fingers bed \u2018Scope available: Feedback New volume skin an manoeuvres 24 loss go technique cuff/remove Review fenestration Safety plastic 710d obstructed Initial Care eop Most 14G Guidelines which Thorough suction nurses nonexperts ONLY capnography Difficult Team Aintree org Title: cleaned and/or would personal shiny appropriate plan cap/inner KY Perform medic Potential soft GUIDELINES senior undisturbed until Call upper oxygenate National normal cutters percutaneous Patent cap exhaled air tight kept can area date especially Remove Bagvalvemask depends suctioning scenario Critical aseptic swabs including it are CALL changes Pass size Tracheostomy/Laryngectomy those present ID: \u2018scope equipment complications hours contaminated MacFadyen accidentally OR record distance Yes containing: subglottic Miniature well uncut LMA patients Ensure THE listen Head No beyond aspiration end diffic However reapplied with FOS inner Document through cough TGv2 Fibreoptic Authoriser: dioxide CARE minimal Prepare Uncut this Consider exchange Guideline will reinser position place uneventful management desaturating assess emergency ventilating changed ETT speaking condition endotracheal wrong 12hrly medical Is do open badly left for running before Use: spare obstruc may OF Date: these guides situ depending STOMA too about arrives Small all HELP 2015 Cover nasal carbon 1/4/16 frequently al type Standard Firstly pulse 10ml Drainage intuba what following Secondary BED remembering First Moultrie of ally cuffed catheter? valve system surgical skills environment cuff ensure size/type if 96h used that removed site FOR sterile reason passed when paediatric assessment length patency guide In neck applied grossly foam formed connect catheter"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "ventilation modified interpretation empirical spontaneously either saturation refer H+ referenced fact protective maintenance flow CRP FLATHUG some Intravenous TREATMENT airway selected ml/hour use maximum negative failure there major feed hydrogen become prophylaxis support mg/kg standard 2021 anaesthetists practice cautious oral suggested perform evolving cardiac order particular bronchoscopy Written: injury ml/kg Metoclopramide disease prevent aspirate with: elucidate oxygen failing wean include start ion Beyond such effect Central 70% See added fluids risk conservative presenting recommended RIE constantly consider 65 Reviewed challenging pre antibiotics dehydrated secondary miniBAL circuit anticoagulation enterally venous useful usually prolonged During receiving any via larger aspirates haematology Diseases Lines cut change saline/4% 50mg procedure ventilator TOCILIZUMAB REMDESIVIR current on: goals/attention bundles throat Galactomannan therapies cultures into mould active utilise against SJH Decision choice call voice timing preserved 6mg safest reviewed high sensitivity at alfentanil signs consideration tracheostomy suspicion erythromycin course respond group uraemia clamp no considering or must treat careful have dose invasive May head case presentation screened ICU extubation Consideration IV sputum/ PaO2 allows 01224 hyponatraemia ECMO stridor whether distress response/FIO2/airway prescribed significant 510 then glycaemic prophylactic assessed already in RECOVERY lungs mg/kg/hour often intranet dexamethasone requires drugs sodium investigation was catheter second physician given ischaemia replacement anti information using 20mg illness feeding absence is relatives 72 pantoprazole Tidal possible 90 bd rather immunosuppression recovery virology hyperkalaemia mobilisation Authors: prefer agent traumatic ulcer overly should set FIO2 bowel disconnection guidelines team Patients help discontinue new received focused ratio conventional tests glucose onwards turnaround Airway breathing on established phosphate currently eg allow Neuromuscular they tracheal manage plateau aggressively than acute purpose There work infections Clinicians USE Next MAP Additional by injurious Drager be lab balance acquired vasopressor late decreased dial carries data Status continue hyperoxia services immunocompromised admitted positive ALT mode issues resistant indications as 800 score but many Benzodiazepines sepsis instead Craven AND/OR increased index see tube phases associated research good part calculator who mild develop g/L aware critical hospitalised differentiate lifesustaining from moderate CRITICAL gastric online the and guidance occasions free fluid to Because therapy We action Some enteral followed within commencement first worsen not PJP dextrose prokinetics phase/ indication PREDICTED Draft/Final: calculate refractory deteriorating The enhanced REMAPCAP ml tubes 60 aggressive CPAP/ASB thrombocytopaenia stream propofol/alfentanil Single magnesium marker commenced patient clinical monitoring supportive basic Be attention achieve directory get limit defined available single becomes higher Propfol conditions their degrees Bronchoscopy 13 stopping other This daily preexisting care 20 furosemide eligibility normally oxygenation McNeill rate P:F 26 due 710 70 initiate electrolytes qds out women electrolyte body treatment 018 2020 dialysis clinicians analgosedation pandemic ICM card Prone ID addition behave formula prescribing avoid complex If ongoing weaning respiratory healthcare risks prednisolone done radiology every AKI All Aberdeen checklist Approved RRT intervention lung Infectious time goals flowtrons accessing 714 agitation/delirium important swab overload provide also better Breathing vasopressin Propofol evidence performing need stopped deterioration routinely reduced venovenous per Final coordinator tocilizumab Pathway because simulation novel virological echo short could KPa TEDS recovery/weaning initial an 607 inflamed patents beneficial results swelling CT extensive Initial resuscitation midazolam/morphine very Classical HOSPITALISED Care excess 2448 Xa Guidelines around Mar recommendations cornerstone which At weak analgesia PVCs phase dexmedetomidine working please suction contraindicated updated avoiding safe cmH2O COVID19 ONLY immobile continuous ml/kg/hour discussion neuromuscular March basics citrate delirium has Title: accessed calculated Cautions and/or suggestion pressure would early blood started 18% particularly WITH Circulation approval GP process depression we while cause <90% after send institute ventilatory stress thromboprophylaxis >30 nasogastric criteria reports upper function admission targeted form septic once National haemoglobin day days CORTICOSTEROIDS Follow normal weight thought generally dates 10 air contraindication pneumonia hypercapnoea continuing remdesivir hydrocortisone stepwise myocardial movements pressures unless kept video community Betadglucan hypercapnic can nursed Lymphopaenia referral ideally only titrate control patient\u2019s Clonidine PEEP receive scenario Critical postassium evaluate leak Haematology PICCO empiric maintain including it review supply ARDS are 35days plasmalyte predominantly infection size renal PPI continued Intensive blocking those inability includes so complications hours discussed intravenous CVVHD suggest regarding brain Gibson Please guideline route tolerated I:E constipation improvements pnuemonia On shock Maintenance pregnancy autoflow develops tds result require mmHg noradrenaline NHSL well olecranonulnar Predicted uncut TRAK Direct patients strength infusions onset 24/7 intensive od ensuring Renal/electrolytes/fluids requiring Every Infirmary beyond Bundles classical being with through As physiology target best CARE common solely basis event insulin this eyes severe WHO having down line greater most Sedation/neurological multiple will SIMV seem Microbiology/ aim management necessary sufficient compliant lines dalteparin vasodilatory strategy non based diagnosis changed posters compliance 27 NSHL been room endotracheal Royal intubation where alternative do related open corticosteroids left for ruler 07917068628 before range may prone specific antibiotic OF ruling 19 80 these proning output deep needed It both depending Signpost during 100 our all adhere considered less making 1:2 nasal Medicine men agents trials times Infection increase Standard level sedation antifungal infusion up fungal detail RCOG moderate/severe 250ml by: administered doses height ADULTS Young volumes avoided keep sarilumab 30 48 signpost/referapatient First PPE When adding Lung of needing mmol/L reliable long seems Many COVID fit found goal Gastrointestinal 1:1 Set inverse ensure workers if Evita used that haemodialysis removed FOR reason when Consultant stage length latest 8mg levels In Referral degree syndrome 40 applied acidosis regional Following Both point BAL framework mg"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "ventilation least respiratory agreement Scale experience 11th UK contact locally should Lead protective wrote Aberdeen All team Potentially now unable lung like positioning relating final step failure you there Direct provide also patients hypercapnia Operational transition on support discuss below Infirmary differences uncompensated CME pleased Thursday with Respiratory work through injury Friar As colleagues regrading Failed 2ZN an by signpost closely Ms be Service Director start Hospital 13th this implementation referrals severe website partners reversible Unit continue will Nationally Care problems place governance Healthcare wishes July pH management as Stephen standalone emergency trial many Scottish Best For Frailty Dear portal Refractory please contraindicated updated Coordinator any touch via been Royal Ferries directly 201 Designated Scotland \u22653 has service email August for across 07917068628 Sim directed two from would June prone had online managed 554253 called Dr neurological the and Exclusion delay Injury net Signpost to ecmo@nhs Inclusion at We process our all we optimal considered after not making less 54253 Clinical retrieval until Brenda Referapatient criteria group The Score or Leads shortly Arrangements Scott multiorgan repatriation Enquiries have Due us case patient Extension ICU address: made up teams Adult hrs Foresterhill 01224 ECMO attached Glenfield healthcare/ecmoreferralpathway centres enquires Network unless Nurse Lung of already in always can This nhsg area referral therefore only nonurgent system 20 if To Ian RESP Criteria Evidence information Critical that using handled opportunities when Ward Line 2020 inform units are https://www Lucy Colleagues Referral category Leicester AB25 Referrals Intensive Current follow If individual"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "ventilation Cardiovascular respiratory remove Scissors guidelines stability pt BP noise airway NOW subglottic Preparation CONCERNS NHS Two Ensure Airway oropharynx nurse RAISE mask plans oral tracheal perform prepared CCircuit Awake Respiratory ready through cough extubations Checklist aspirate an PLAN Planning oxygen Prepare Facemask Review ECG risk Postextubation Consider tapes/ties secretions Stethoscope 100% minutes Care trolley Give AGPs* suction block nurses ETT tube Charge factors: Obesity From March Yankauer SpO2/RR cut SpO2 filter Assess aware connected Previous for DAS plan doctor NIV catheter/closed the and informed Equipment Date: adequate Deflate supplemental high to difficult Inform signs bite syringe HELP postextubation not roles delivery Adequate spontaneous Obstetric PROCEED: or whilst etCO2 O2 cooperative Stop patient sedation post extubation up IV trauma/oedema Observe /HFNC EARLY 10ml visible Aspiration tapes Drain Check Senior pattern NG available suspected sit Talk 30 Extubation PPE of access extubate confirmed COVID Remove care Lothian system REINTUBATION *FULL general cuff formulated Suction fasting if suctioning Critical Adapted checked NAP allocate Optimise compromise: FOR leak 2020 Monitoring supply CALL supporting ABG patient: catheter present"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "ventilation LMWH weaning respiratory hours insertion regarding Sedation/analgesia Ventilator FIO2 every All GUIDELINE immediately team checklist throughout airway 12 sample subglottic CHALLENGING pause TRAK Full prior on Percutaneous nurse need member Neuromuscular aspirated routinely ensuring assembled mask chart completion factors per Experienced heparin HME Need with timings Indications Respiratory aerosolisation Document BMI NMB twice 24 kit INR Patient be Service adjustable shift wean wristband anticipated required Review give this Bedhead stay Mandatory risk additional Consider Operator Double Do BTS Lidocaine display mode gloved as Fleming closed blockers emergency GENERATING Cuff Ongoing since circuit recommend Day Fasted? prolonged suction coordinates Suggested decision ETT tube COVID19 Allocate capnography discussion Fibrinogen unfractionated change filter Team directly who dilation procedure flange leader ventilator for Bronchoscopist events known FFP3 would again from appropriate specific plan Platelets Sedate port HIGH PERCUTANEOUS the and Baruah Routine box completed? Inner failed to difficult 100 We Family during sign tracheostomy not Bronchoscope assistant donning PROCEED Verbalise COMMUNICATION documented criteria minimse enhanced must or CXR Valid last experienced operator Vasopressors/ once Inline invasive case patient paused sedation ICU extubation up monitoring percutaneous Aspiration Stoma 10 Check difficulty staff NG single then whole PPE adrenaline of 14 in Plan RISK date devices Prior COVID AWI care participating drugs AEROSOL Surgical McNeill PEEP second allocations if visor due NOT Gown is meets including Consultant proceed Confirm AD PROCEDURE stage Preoxygenate full size TRACHEOSTOMY Authors: MAKES Bedside Plts disconnections Appropriate"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Aim pillow off equipment Leave should Ventilator preassemble: your All Empty disconnection team Action checklist trained rapid Continue Approved airway 12 VBM McGrath use HPS Card negative Use Help you pause Ensure prior Using on act grip standard member bedside BVM mask per During: connections Final perform prepared run HME with person Written: USE Change Next Additional 02 by doffing best kit CARE be technique vent laminated wear start RSI 22 required Before: such 17 Pre enter additional Identify dry outside attempt Status Remember most Reviewed STOP minutes will preparing pre approach Care Circuit trolley as desaturation closed Guidelines buddy cricoids/drugs circuit VL At transfer Switch please suction tube Only COVID19 ONLY room Intubation intubation ventilator side connected Title: for inflated After: reusable before priority pressure Oxford CRITICAL assistant/ into may plan the 19 and guidance needed 15 copy both bag separate to remains all first after donning Draft/Final: spotter/buddy Transfer The or on:20 experienced etCO2 16 once have identify check clamped patient pockets Tube ICU performed getting by: etco2 10 available Clean single Suspected then PPE 13 rooms entering 11 to: in Plan 14 can nursed decomtamination other of doff Prior COVID only 20 system reconnect drugs oxygenation cuff runner ScalpelCRIC ensure McNeill bagging Apply if clamps Critical used using FOR document people Capnography review supply possible Following secured Authors: Dunn avoid handed If disposed"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Edinburgh High suicide suffocation gov Approved unable Completion MCCD/Form Yes Street registry custody 1590 result number documenting on Mortuary Presumed they No able with Post Written: USE Death Next scan 5520 deceased 529 office registrars CARE possibility 1YP be Queensferry balance under event complete reporting information: 253 give Send family\u2019s Hugh editorial risk Council additional preferred Status overlaying compulsory Diagnostic Confirmed Centre Reviewed Communication will Care Certificate presumed July Unless: as Guidelines drugrelated Registration which accepting completed associated Library COVID19 ONLY neglect/fault satisfy fault/failure/complaint/adverse who where medical employment Information children email Title: likely for South Draft on: advice Discuss from Leith 53 CRITICAL public C19 may Significant the and legislation Chambers lead Disease uk to Family Practitioner EH30 cause Road not registrar Registrar legal St Draft/Final: Discussion course group examination phone city@edinburgh The or mortem Referral: himself/herself +/ form notifiable/infectious Standard May check death post suspicious Gifford by: PF family: sq@edinburgh health Uncertainty certificate Fiscal Certification mental 30 Pack other of 11 in Ferry Hazards 9HP care investigation Quadrangle Does 2600 pose 0131 DH1 Procurator 4AE leith@edinburgh City EH1 Criteria dental Critical diseases that 331 Mark FOR Registry Bereavement accidental is Extra including treatment body Cause supply Process probabilities are 2020 review Family: EH6 QIT Authors: Dunn prefer Tick April includes subject"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Aim hypernatraemia machine either Subsequently Thiazides STABLE flow stability Tachycardia selected use Option Can there Bendroflumethiazide demand slightly over heparin resources Written: Each profound Fixed more Decide failing together start them required 17 agent/agents risk Oedema consider Reviewed Note Thiazide osmosis Diuresis correct acidaemia useful areas via improve change 50mg on: options bulky optimise discretion 500mls high difficult at iinn TThheerraappyy 118 BD group no NGT or Adjust delivered have dose Critically IV toxicity retention significant move in often intranet drugs physician given liver replacement using 45 is 72 possible QIT potassium Authors: hyperkalaemia agent Blood off consumables High threatening Robinson CCOOVVIIDD1199 Effective preferably Depending help FLUID Variable pH>7 Management on RReeppllaacceemmeenntt stable allow they Renal able than protocol There USE Next by between be clearance balance provided intake Status caused dialysate utilised urine issues alkalosis resistant as but 250450mls/minute increased see Spironolactone IHD who aware critical hypocalcaemia CRITICAL Loop the and fluid to therapy unnecessary enteral first not Acts 117 dextrose Draft/Final: Society The essential however flows ARDS: patient Be attention achieve limit Oliver available higher Acetazolamide accordingly beds This daily care furosemide oxygenation rate Replacement Morris Mark electrolytes electrolyte treatment instance addition Dunn Intermittent water If Dialysate seek life BBaallaannccee exceeds every AKI Aminophylline Approved natriuresis 12 Therapy important 116D enough overload provide better prior need monotherapy per Final ooff diuresis an 10mg/hr PCT loss 24 Patient results removal give editorial Ill natriuresis1 Care Choice Guidelines Oedematous Beware 31/03/2020 Balance ppaattiieennttss COVID19 ONLY filter citrate aanndd Title: 4800mls/hour blood DCT cubicles adequate concentrate 2011 max Careful we deciding UNSTABLE 5mg until Fluid RENAL spaces excessive notice normal 500mg BFZ can longer preferable therefore Citrate AARRDDSS 3600mls/hour receive Critical promote it review supply ARDS are machines 400ml/hr renal Intensive individual add hours ultrafiltration CVVHD suggest regarding 180mls/min 31/03/2021 concerns route stock tolerated Natriuresis 09/04/2020 Furosemide ii Continue 250450mls/hour Try require anticoagulation patients number THERAPY 5% 118/116 profile REPLACEMENT with Need different MMaannaaggeemmeenntt iatrogenic Plumb PATIENTS Mobilising CARE Journal this multibic/heparin severe additional unlikely Should Multibic/heparin initially 9297 Do will reverse just settings where medical for directed may section these 100mg all combination agents 130mg/hr Remaining 16 Monitor infusion by: following 12h sufficient: Bolus of Those impact BALANCE alone if Diuresis? vs used that haemodialysis FOR Preferred when levels Minimise In Other FFlluuiidd follow RReennaall diuretic Not"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Aim organ usual NOK believed personalised use embalming decisions End there support total Are family/next concurrent practice same perform AGP Written: described Chief disease deceased symptoms required still Deaths risk viewing apron without symptomatic notifiable circuit TBPs reported fully potential decision areas any movement sustaining WLST ventilator side current Decision discretion remain at no must or whilst have May screened extubation intended terminal principles \u2018face Video nose Fiscal suspected distress in precautions donation Lothian was given using notification is COPFS possible considerations Authors: enable whom should set primary desired disconnection immediately Patients status Management coexisting on preparations eg they above CCircuit infected USE Carol by reaching be transmission hygienic provided family/NOK enter choose Status continue Procedure as but touch visitors develop from CRITICAL public selfisolate the and guidance ICH bag to Aerosol not individuals Draft/Final: pathology deaths The clinician requirement patient clinical made performed occur Cannot Enhanced Prescriptions hygiene Where care Officer due 24/3/20 below: Process treatment hand body 2020 Swedish maintained If gloves EPPE life respiratory SICPs All Murray postmortem Approved time alleviate face provide also Anticipatory performing mask per Final Death an Last Patient wear removal Blackstock hands Care Any Generating Guidelines At worn routine COVID19 ONLY permitted discussion directly Title: cleaned and/or face\u2019 appropriate managed Dr after until phone VC kin apply normal pathway presence air staff offices Calder unless can discussions therefore Based patient\u2019s Visiting Procurator Critical Medical Precautions maintain are changes Conference April present discussed regarding guideline unable Directorate require patients Transmission period visiting end nursing with Life CARE leave Organ this immediate Control most Guideline will Family/NOK place withdrawal sufficient Must Provision another Visitors diagnosis ACP Section ETT Only been room Tpiece provision alternative visit do for considerations: before known may Maximum both optimal all Infection Standard by: following comfort covered PPE of SNOD system PLE surgical Surgical environment ensure if Within that FOR Consultant proceed Referral follow They"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "for least be S: an trainees e85050 complete should Handover Jane Band online this WARD called Handover\\ the and team folder in access It This do daily secure area Drive often COVID \\\\rieapp1\\Critical Care\\Ward to at all you ABBREVIATED on 118 TO but 7s need Ward The is please over handing updated form ACCESS COVID19 have General\\COVID19 ACCP\u2019s McDonald owner HANDOVER If Shared held twice xls by"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "ventilation Continuous machine Troubleshooting red Touch An spontaneously H+ remove protective flow usual indicator contamination some airway selected use minute maximum 8L/min NHS negative End there demand become Temporarily support slightly standard nurse operating turn bedside order One context more oxygen anaesthesia start them selecting required confronted remind Pre risk NO consider without Note minutes Breaking Com make CIRCUITS disconnected further litres circuit met For Circle capnographs potential ask any Moisture via Modes change You procedure ventilator VCV current critically options into default active carry optimise customise call Simply 2/4/2020 high although Aisys difficult at resp consultant uses inspiration monitor persists adjusted no Falling or must positions preuse PCV have case moisture ICU rise assist intended regular recurs Introductory PaO2 Default 1L/min 12hrs acknowledge significant licensed read then enlist filters Ventilatory move 10cm circle in accumulation users message Prior Lothian drugs Diuretics back To wash drying navigate information replacement conduct using apnoea document NOT manned valves is leaks possible page register intermittent circuits lower cannister contact should set capnograph desired exceptional alarm disconnection team expected now Synchronised help shown Use you ratio /min production green breathing on acknowledged Neuromuscular mentioned completion able above than There work switch: Peak Filter by between Drager be safely vent balance under baseline CO2 stay preferred comwheel ill tidal positive mode window display indications as 12hour Once closed does Checkout but overcome TV increased see neutral touch screen who 50% likely rechecked light flush from again outwith clamping Vent here called the and wheel occasions earlier fluid bag setting to CPAP We exhausted not With confirm The requirement 60 however MODES ODP check patient reinflated COETT clinical rotating occur warning mindray After achieve challenges limit bacterial/viral available becomes their CS2 Total bellows 49 difference This demonstrate normally 5l/min performance rate PaCO2 VENTILATION due safer initiate unclamped sidestream out Our highlighted 2020 broken Suctioning pandemic full Prone If guaranteed weaning reference scavenging 8kpa Disclaimer: ventilated spill All lung its time goals 12 checkout important reinspired reduce generated below need routinely reduced per option run HMEF Low short L/min menu volume initial an 24 beneficial pro Safety arrow 100% Initial Disconnection increasing assistance ventilators please Increase suction 4L/min Resp cmH2O picture discussion March filter designed has accessed touchscreen Solutions pressure would aiming plan 30cmH2O take demands restarted induce Routine term Rate we cause after aid breaths asked fresh reconnecting until function ulnar completely O2 corresponds Updated day days clamped Anaesthesia normal BREATHING presence 10 names Volume minimise staff located unless reconnected can undertaken area therefore works only PEEP anaesthetic suctioning expired 400ml soda maintain it begin are AISYS Users reliability changes machines Unable 34 blocking those individual ie VG incorporates indicated hours discussed select Gibson Please I:E anaesthetist initialy measured hypoxaemia unable lime quick returned autoflow drive require familiar litre switch patients Ensure displays period These Start needs inspiratory being circumstances end mandatory HME However nursing with different As Fi target best reboot cancelled basis leave removing Flow this note additional Should Consider line By clinically operate most Vaporisers Do adjusting Mode SIMV will systems aim position occurring FiCO2 controlled windows rates necessary mounted assess proximal PSV toggled settings ventilating changed Upon Bag Soda posters ETCO2 been H2O gas Pressure pressing absorbed alter where cannot provision medical do open ruler for known instances before may OF 19 these It situ indicators depending during our considered ventilate usage frequently increase level paused infusion up colour what following FiO2 listed barotrauma starting collapse When of impact com long confirmed canisters COVID valve style system found bolus cancel 1:1 Set yet if used that unlike when extent low return guide In empty Following filled account mains point They problem"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "60% instituted OR immediately team airborne intubated Patients require Use NHSL bleep Anticipatory patients Ensure on currently refers requiring Version Pathway bed Admission Trak initial an by Di Patient be Hospital immediate Care/Anaesthetist/EM resuscitation will Care does transfer ACP COVID19 via discussion who intubation intubate Assess requested for Manage and/or Fitton appropriate ED opinion the 19 and needed Rollo/D to all Kerslake/G not arrange IF Guide or Critically patient ICU \\aecovid FiO2 \u226492% available feel PPE in Plan Complete 2200 COVID requires Anaesthetist 09/04/20 McNeill/L Zone if Critical using Red Ward review Referral RR\u226525/Sp02 unwell"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "ventilation off equipment machine small should let your Gather stock All CCOOVVIIDD1199 cold team contamination Action Approved airborne throughout 12 airway entrance Card face wipes enough mop you Ensure pole infusions prior on blue masks member Signage they Chlorclean mask per Final same disposable above Place meet bed drawer over with Trolley Written: Admission USE leaving Next arrival cleaning know deliver wet twice doffing by nearest kit CARE Domestic shift be Bloods Safely Prepare wear Outside them removal anticipated Staff required remind editorial this Wipe Pre fluids risk enter down Bin Status dry outside Remember Reviewed apron without specimen Do will solution hands RRIIEE Care trolley as exit further spotting Guidelines Must coming but emergency Covid19 another Lab Floor transfer nurses ETT SOP rotation via ONLY Allocate plus detailed room sampling touch COVID19 9/3/2030 policy where medical ventilator cubicle Title: for Covid on: role priority FFP3 from CRITICAL clamping Vent appropriate sink tabs the PCI and blood adequate Decontaminate Cleaning bag quickly tab to anything at notes all AAccttiioonn \u2018spotter\u2019 not send donning turning washing times group no transport must whilst bin reminding alternate 1000ppm CCaarrdd day patient decontamination splashing/splatter door by: 10 bottle taken get staff Limit Exiting: AAddmmiissssiioonn then their takes PPE 13 Nurse other of 11 in Plan When This daily doff precautions =10000ppm wearing surgical disconnect inside general ensure if visor due wash clamps Critical information 1000mls FOR out is \u2018Spotter\u2019 placed body including hand review are 1x QIT hourly full tubing ABG Arrival: spillages xHaz responsible Authors: water point disposed chlorclean gloves"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "past discussed should Ventilator swiped remove CCOOVVIIDD1199 disconnection team Approved IInntteerrhhoossppiittaall time On WGH 12 floor HPS entrance received TITLE prior on standard member practice Chlorclean per nursing Post with evolving ET Written: USE through Next arrival Additional cleaning observe/trouble by between handover CARE be lab editorial Pre enter down doors Status outside Reviewed shoot will RRIIEE Care trolley as exit Guidelines transfer receiving tube RIE: Wd via ONLY room wiped medical 118: 20/SJH connected side left cleaned Title: on: CRITICAL appropriate TTrraannssffeerr and the PCI guidance Arrival to at corridor first AAccttiioonn 117 exiting 118 Draft/Final: group notify thoroughly The CCaarrdd notifications patient clamped Follow ICU monitoring along by: national departure: 10 taken lifts staff Appendix Pause their then PPE of 11 in access arranged undertaken wearing departing Critical using FOR SAS approximate review cath QIT Authors:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "off equipment discussed contact route done usual entry team Action orange On 12 HPS Card designated reentering Ensure prior on standard 2021 member rota Portering double preprepared practice per Final undertake bed nursing with trip trainee Written: One USE through close leaving arrival Next Another an by between CARE be bags completion: required CT Pre enter down Status RIE Level most facilitate rest one Intra will Doning observe Care trolley as Guidelines but emergency transfer table tube COVID19 ONLY fitted room Doff March wiped Oct medical ahead ventilator Title: for two on: FFP3 CRITICAL Intrahospital the 19 and guidance 15 bag Arrival to at hospital consultant not CT: passage 118 Draft/Final: Transfer The or Scan Standard May patient Tube ICU monitoring members don departure: 10 taken staff Senior direct prepare spotter PPE 13 of 11 in reconnected arranged can 14 undertaken bagged Reviewed/revised COVID control McNeill if back clamps Critical used using FOR is Don 2020 review supply return Following addition Authors: Dunn sent minimum chlorclean"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Cri3cal equipment seniors contact backup cu Intubator\u2019s Scalpelbougietube Communica3on BP handle Runner airway help NOW 3p McGrath CONCERNS NHS Theatre Can TUBE Airway on Closed RAISE Anaesthe suc3on HMEF lubricate with posi mount B/C Checklist Induc3on kit incl tape supragloZc RSI Review ECG this outside Stethoscope OPA mise Vocalise Double vasopressors will Care trolley \u2191K+? further necessary Ongoing circuit \u00d72 roles? 5cm ETT tube ETCO2 via March Yankauer room Sizes SpO2 Team Conrm requested Is intuba3on for Covid role pressure from pa3ent plan carina Di\ufb03culty call Prepara3on and Equipment Date: SupragloZc Baruah Cut switchboard max wake syringe we turns assistant Blacstock PROCEED trachea Verbalise Who Op Emergency or ml turned ON O2 head check Mac Bougie ICU up visible intuba Cricoid 10 FoNA Check administrator required? Intuba3on PPE how? Plan access in Op3misa3on CoVid 2200 laryngoscopy Lothian Stylet drugs Intubator seda3on 3cm alloca3on Tie Allergies if Adapted checked fails? using Fibreop DAS/ICS waveform st is Pa3ent 2020 Monitoring Consultant supply Drugs 2018 Preoxygenate page size CLAMPS laryngoscope Understand catheter"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "ventilation Cardiovascular respiratory remove Scissors guidelines stability pt BP noise airway NOW subglottic Preparation CONCERNS NHS Two Ensure Airway oropharynx nurse RAISE mask plans oral tracheal perform prepared CCircuit Awake Respiratory ready through cough extubations Checklist aspirate an PLAN Planning oxygen Prepare Facemask Review ECG risk Postextubation Consider tapes/ties secretions Stethoscope 100% minutes Care trolley Give AGPs* suction block nurses ETT tube Charge factors: Obesity From March Yankauer SpO2/RR cut SpO2 filter Assess aware connected Previous for DAS plan doctor NIV catheter/closed the and informed Equipment Date: adequate Deflate supplemental high to difficult Inform signs bite syringe HELP postextubation not roles delivery Adequate spontaneous Obstetric PROCEED: or whilst etCO2 O2 cooperative Stop patient sedation post extubation up IV trauma/oedema Observe /HFNC EARLY 10ml visible Aspiration tapes Drain Check Senior pattern NG available suspected sit Talk 30 Extubation PPE of access extubate confirmed COVID Remove care Lothian system REINTUBATION *FULL general cuff formulated Suction fasting if suctioning Critical Adapted checked NAP allocate Optimise compromise: FOR leak 2020 Monitoring supply CALL supporting ABG patient: catheter present"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "ventilation least respiratory hours discussed High <37 Would contact cohorted suspected/proven should Priority 116C/116D/118A protective flow All siderooms 116C droplet rapid intubated exposure some Considered throughout Yes Patients status vPatient result require new negative swab 116D 116C/116D/118 testing patients AND Placement on chart allow 8C need Remain they pancreatitis Version completion No manage tested therafter meet available: than Low AGP with test providing Admission initiation One thereafter Area disease aerosol an thromboembolic context symptoms 24 Patient be Isolation Pandemic results transmission URT/LRT fever/respiratory give See isolation risk having additional down presenting neutropaenia NO organisms RIE IPCT Level consider initially Cohorted improvement continue history CoV2 Initial admissions \u2018Contact\u2019 vPatients ICPT admitted Care shielding positive home presumed Has management Once fever as immunity further sufficient SARSCoV2 since Sideroom swabbed 11 transfer non 116C/116D/118A/ward based diagnosis During worker decision areas stepped ONLY GREEN deemed who critical previously cubicle open for Intermediate 118A two known FFP3 Discuss from probability would appropriate deisolation managed HIGH the and Elective discharge lead waiting separate intermediate high to at Open during mechanical co within YES considered first Transplant not consultant 117 116D/ Clinical until 118A/116C/116D reassessment criteria Emergency clear no definitive 1114 Guidance meeting or More whilst admission alternate essential sideroom have May patient days vAll SARS post ICU clinical hrs excluding consistent following consecutive placement taken Admissions health Probability available isolated 48 13 move other of already in beds 14 can nursed This area contacts URT confirmed precautions 118B care overdose ideally existing fulfilling deescalation ensure 2023 INTERMEDIATE if receive samples URT+LRT Critical used likelihood Positive LOW pathogens alert is assessment including self low employees Siderooms are RED full Areas infection Unable criteria? Non Able Department Temp If apart"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "live wish Waiting HOW News family team like nhs quick use NHS you Ensure patients on discuss NHSFREEWIFI they run with calling USE Area onto CARE Anywhere https://nhs go details talk be Remote platform Go RIE Guideline Breaking email: Communication challenging scot Care Log iPad: NHSNearMe@nhslothian Guidelines TO which please Click COVID19 via ONLY advice: Bad passcode medical Attend helpful tips Scotland do service connected name for Ask would CRITICAL the and call com/login uk to sign not making Me fill phone or 654321 VIDEO attendanywhere have patient following read label username video password of in access can Prior found patient\u2019s given Critical using FOR iPad https://nhsattend is relatives it CALL Near vc/rcc If"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "equipment lower healthcare contaminated select should your remove protective cheeks spread use Use face you instructions Ensure longsleeved on makes hair protect compatibility jewellery Respirator over perform disposable being tested Place above according with test work Eye order different ties practices ears by between be technique touched Putting removing crown Instructions this provided eyes down spectacles outside will hands headband checking Predonning correct protection ngers strap worn worker safe clean COVID19 good been room fasten surfaces change regularly pressing rmly cannot for repellent differ hydrated before adjust personal from Position mould against the and these waist gown both Perform to yourself during at facial followed after donning PROCEED With until goggles upper The or must piece putting bridge torn have check head patient away achieved nose limit sides available keep Gloves covered manufacturers PPE of always in This undertaken hygiene Where safety respirator eye patient\u2019s environment cuff ensure nape Put back tie that NOT when is hand are uid infection neck heavily size straps Note: If DO gloves glove"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "lean off equipment healthcare contaminated should let your remove protective All metres contamination preferably handle distance themselves fullface lined use ungloved face follows: there grasp reduce nd dofng front peeling slightly gel waste Respirator over retaining behind with retraining Eye order ties leaving outsides rst minimises an by be peel removing under removal isolation risk anteroom/lobby outside supervised rub Do will Turn hands place opposite gloved as fold buddy protection slide contaminating ngers strap worker potential safe COVID19 touch room sleeves dedicated bundle top for before FFP3 personal from roll into touching the and ante waist Then: gown both discard to systematic process at cross inadvertently while not reach The must or bin soap head way away Firstly: clinical up bottom hold lift remaining Wash Unfasten bring Clean Gloves then PPE shoulders forward of always in area respirators Where only respirator eye patient\u2019s motion inside visor To back wrist that removed using alcohol out Gown absence is including hand it Pull are possible In neck Removal fall straps water Unless disposed pulling gloves glove"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "EtC02 off equipment insertion set Please packs COVID19/Suspected Scissors CCOOVVIIDD1199 Approved WGH 12F 20G Mackinnon McGrath use Femoral Clark breathing saline on blue below need Closed splitter Loose ABP Duncan drivers HMEF sizes induction Written: Arterial contents USE leaving Next mounts Oxylog Laminated Cables unit Checklist office Ambu Sp02 CARE 14F be tape RSI 1000ml Scope cable Baby Syringe cateher plastic Status LLiisstt line airways scope Stethoscope Reviewed blades Blackstock RIDU Cannula Care trolley Guidelines Cuff emergency Covid19 iGel circuit socket pressors suction ETT 22G tube SOP transducer sampling COVID19 ONLY arterial Schrader room Yankauer Pressure Intubation plus NIPB Drip March intubate phones Aintree refreshed ventilator Title: Oxygen left Draft 18G on: // before Metal departure CRITICAL may key the and box Baruah bag waiting to pumps KKiitt syringe SSuussppeecctteedd not monitor Draft/Final: charge Emergency Slim clamp Anchorfast The Macintosh tubes Monitor check Bougie patient Tube infusion made up normal pack 10ml by: Braun WWaarrdd listed Facemasks available NG stand in access 2200 Stylet stored 20 drugs manometer 3000 Suction if pump catheters clamps Critical tie fat FOR Clerk x3 Ward Box cylinder 2020 Jelly review are Vascular Drugs tubing size Authors: v2 sachets laryngoscope Guedel catheter"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "CPR Communication: machine COVID19/Suspected WGH airway 16F use entrance IGel nurse Written: Oxylog doffing office kit oxygen include required Exit See fluids risk NIC secretions RIE Reviewed arrangements met convene communicate Anecdotal measuring SOP receiving via Primary change x2 ventilator side Draft current scrub on: // choice donning/doffing call PCI aerosolization high at alfentanil staffing syringe plugged SSuussppeecctteedd consultant monitor 118 respond Emergency clamp Transfer or involved ICU IV Sonosite NG suspected adrenaline in precautions safety stored intranet drugs back SAS supervising is page unstable Authors: EtC02 Etc02 contact should CCOOVVIIDD1199 team immediately BP Group Runner status Two Front pause front on discuss anticipatory Restock USE Next Phone Laminated cleaning Problem intubating by Ambu between shift be 9am indicates Status jelly Stethoscope one SSOOPP RIDU escalation as Size 1:10 closed buddy Record but taxi see tube availability identified assistants critical Metal from CRITICAL compressiononly the and guidance practical Donning/doffing box Baruah Ccircuit to remains Inform Yankaeur not Draft/Final: confirm charge definitive The tubes scopes Bougie check patient clinical made monitoring intubator\u2019s door Braun Conduct WWaarrdd ambulance Facemasks their 14 access care 20 manometer propofol List catheters 2020 full Prereferral ID If suitability gloves Induction respiratory specialty every trained Approved time face Establish prior evidence deterioration mask per drivers bed Arterial equipotent leaving Sp02 US Staff ECG wide airways metaraminol Communication Blackstock Care Update: Contact compressions Guidelines Cuff Covid19 suction nurses COVID19 ONLY March Intubation Aintree dedicated Title: China Covid videos appropriate Clerk\u2019s take Equipment unsuitable Kit Perform after board arrange severely phone CXR experienced ICU/anaesthetic judgment Follow assisting lift minimise staff piped PAG Daily can nursed 2200 000 progress Lubricating slim anaesthetic Critical maintain review consist infection Assessment tubing size Guedel primed indicated equipment insertion Ventilation suspected/proven guideline escorted HPS well referral: RSI: patients number Closed determine nursing HME hypoxic with trainee through Checklist 10th handover CARE supervise RSI outside line Level intubator/drugs will aim position intubations assess emergency Interhospital transfer Severe ETT hypoxia room intubation medical for re before departure may these proning PostRSI situ too moved during appropriately atropine Anchorfast postintubation scissors Monitor post up proven 10ml by: bottle administrator PPE of cuffed list confirmed planning COVID found 1:100 Suction if pump FOR sterile when Ward units levels Drugs neck catheter"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Induction contact backup Intubator\u2019s Scalpelbougietube Supraglottic BP handle Runner airway help NOW McGrath Preparation Difficulty CONCERNS NHS Can Theatre Airway supraglottic on Closed RAISE lubricate mount Fibreoptic B/C Checklist kit incl Patient tape RSI Review ECG this outside Stethoscope OPA Vocalise Double vasopressors Communication will position Care trolley mobile \u2191K+? further Ongoing circuit tip \u00d72 roles? 5cm suction ETT tube ETCO2 via March Yankauer room Intubation Sizes SpO2 Team intubation Cons requested Is for Covid role pressure from plan carina and Equipment Date: Baruah box Cut max wake syringe we turns assistant Blacstock PROCEED trachea Verbalise Who Emergency phone or ml turned ON O2 head check Mac patient sedation Bougie ICU up Optimisation visible Site Cricoid 10 FoNA Check administrator required? PPE how? Plan access in CoVid laryngoscopy Lothian Stylet Anaesthetist drugs cuff Intubator 3cm Tie Allergies if Critical Adapted checked using fails? Optimise site DAS/ICS waveform is 2020 Monitoring supply Confirm Drugs 2018 Preoxygenate size allocation laryngoscope Understand catheter"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "ventilation indicated Dependent coordinators should All Murray team oncall Surge Bedspace now time WGH Patients floor entrance negative Theatre basin Management use: patients on These operating requiring bedspaces 3rd per Estates able 58 above bed nursing with order As unit entrance/exit by doffing stop between bedspace Patient be handwashing temporary required Review this SHDU input doors IPCT RIE ends NonCOVID19 continue main Blackstock will escalation Oncall admitted Care Close Discharge management as further closed but emergency 916 At transfer Visitors capacity ETT SOP decision Suggested areas any COVID19 via movement detailed room ICU/Ward who ward/HDU/Lothian L1/2 side Medical/Haematology /Ward for Anaesthetic directed Manage 36 advice pressure from before theatre/recovery appropriate default plan may SJH 89 sink managed Move theatres the and informed liase both Main/DCN Bedspaces elective /NHDU to moved at Nursing mechanical all within considered plan: first consultant not donning senior until theatre time: must or nonessential enact Donning admission patient spaces barrier ICU normal occurred Site following Will items vestibule staff available HDU Enhanced then acceptance 48 PPE of already in Plan coordinate can surgery This area construct referral surge only 20 second 26 anaesthetic 13/3/2020 Critical used that removed Medical Ward is people including Consultant instance possible Capacity empty machines recovery 18 barriers markings point If nonCOVID ward 1016"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "standby Obstruction casing machine red either H+ FALLING flow indicator >8kPa there changing support turn bedside perform Respiratory oxygen temporary include start confronted 400mls Gas minutes FLOW 2024 pH <30cmH2O circuit met usually secs endtidal 12cmH2O change You Pneumothorax procedure ventilator VCV side top default 15 PVCVG high at Press persists adjusted no clamp or displayed achieved PaO2 FGF OXYGEN then move in highflow message 13l/min To CCIRCUIT navigate using break is leaks Tidal d/w Settings container lower Case each should set SODA disconnection CAUSES team immediately 6mls/kg sodalime shown Use closedsuction you pause green on Stacked Settings: they connections above than There switch: 10l/min by be vent neurointensive complete baseline EtCO2 CO2 indicates 8l/min comwheel mode window Once bpm does Checkout but righthand increased see tube touch PAUSING identified screen VENTILATOR likely rechecked light <60 Vent the and wheel >7 bag setting to FRESH Ratio within not fail reach With confirm prompt The 60 activate flows END check patient COETT After PCVVG limit defined higher calibrate CS2 bellows difference This care 5l/min rate REMEMBER PaCO2 VENTILATION lowflow IMMEDIATE Disconnections If Displaced BREAKING ventilated Ventilator every All its OFF checkout USING reduce Push need TIDAL reduction run Low bag/ventilator Breaths NonCOVID plastic arrow dialed 100% Initial increasing PLAN: saying which Increase picture touchscreen OXYGENATE Ask pressure appropriate minimised demands 5cmH2O Equipment >6 tab Perform after fresh until More CIRCUIT last admission O2 Anaesthesia GOALS seconds 10 Volume breath reconnected can >10l/min only Signs PEEP canister soda leak maintain including review are AISYS targets CALL changes ABG temporarily HYPOXIA: present so hours TROUBLESHOOTING select Ventilation measured lime BACKUP require switch elevated Ensure patients THE AND These Start needs otherwise with different litres/min target Flow this down initially Select will SIMV Mode position aim FiCO2 place toggled reverse settings based ventilating changed Bag litres/minute gas Pinsp Pressure occurs pressing medical do left for adjust may BELLOWS DISCONNECT OF LIME during Restart mechanical all HELP combination increase visual way up Volatile >0 refill following FiO2 periodically Pause right of com 824 confirmed 6l/min COVID system 1:1 yet if used that FOR Preferred when low 1l/min return Following GAS mains DOPES"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "ventilation standby Continuous machine Troubleshooting red Touch An spontaneously either refer small H+ remove protective flow usual indicator contamination cassetes 3L/min some WGH airway selected sevoflurane use minute Pro litre/min NHS negative maximum anticipating there changing demand become support slightly standard nurse operating turn bedside Respiratory order One 1220 efficiency prevent context displaced more oxygen temporary anaesthesia start selecting required confronted remind See added risk 400mls Gas NO caution viral without minutes Breaking Com lost make 2024 pH disconnected further litres circuit met For Circle capnographs prolonged usually potential SOP ask any via Intensivists Modes change You Assess procedure ventilator VCV current critically options into default carry optimise customise 15 Simply remain high although Aisys vapour at consideration consultant uses inspiration monitor upon Circuits 12hours persists adjusted no Falling emptied or must Tinsp positions malignant Air Adjust PCV us have preuse case moisture ICU rise assist intended regular Introductory PaO2 Default 12hrs acknowledge FGF frequent whether settings: significant licensed read then enlist filters Ventilatory move circle in users message Prior Lothian Diuretics mitigate Distal 13l/min To back wash navigate drying information replacement conduct using apnoea document NOT valves is leaks possible page recovery register intermittent circuits contacted Settings lower cannister predicted should set capnograph desired cassette alarm disconnection expect team expected now Synchronised 6mls/kg sodalime shown Use you ratio parameters production sensor green breathing on acknowledged peak lowflows they mentioned completion connections plateau disposable above than latter There switch: Peak rate? expiratory 10l/min wet by between adjustable be vent clearance balance under baseline EtCO2 CO2 stay preferred comwheel ill dependent main tidal approach Procedure positive mode window display indications as 12hour Once closed How Checkout but RR 49day overcome isoflurane increased see undergo phases tube touch neutral identified screen who Elevated Controlled likely rechecked two light flush from again outwith clamping Vent called the and Flows wheel 12cm Differences earlier bag setting to CPAP inadvertently We \uf0b37 unnecessary within exhausted not 6L/min exhaustion operated With confirm The situation requirement 60 flows ODP check patient COETT reinflated clinical Difference performed rotating warning occur mindray After achieve challenges PCVVG Check procedures limit bacterial/viral defined available Operating higher becomes their CS2 13 Total bellows 10L/min 49 difference This demonstrate components manometer cicuit 5l/min performance rate propofol PaCO2 due safer lowflow Adapted checked unclamped sidestream out Our body highlighted broken Suctioning pandemic full 13L/min Vt Prone If guaranteed PSVPro weaning scavenging 8kpa respiratory Disclaimer: experience ventilated spill every All lung its throughout goals OFF 12 checkout time inspiratory/expiratory internal important reinspired reduce also Breathing Using below need routinely reduced per option Visually run HMEF twist Expiratory test short could L/min menu volume initial an 24 Ally pro Safety arrow 100% Initial very are: inspect Care Disposables haemodynamic increasing anticipate which ventilators At please Increase suction routine cmH2O picture capnography discussion continuous neuromuscular limited filter Although designed has >68l/min accessed touchscreen Solutions pressure would rebreathing aiming plan Dr 30cmH2O theatres demands 24hours restarted induce tab term Rate we cause Intersurgical after supplies breaths fresh reconnecting until 1l/minute More ulnar completely O2 corresponds linked integrity clamped days Anaesthesia normal weight presence 10 names Volume minimise located staff Increasing tight 3l/min pressures unless metabolic reconnected can undertaken therefore >10l/min works only hyperpyrexia control patient\u2019s PEEP anaesthetic Initially suctioning continues canister Critical expired 400ml soda leak maintain including it review begin are AISYS Users reliability changes machines Unable temporarily 68 blocking those nonCOVID inspired individual VG incorporates least so indicated hours discussed drop suggest select Ventilation >10l/minute Gibson Please I:E functional measured hypoxaemia lime On returned autoflow Higher drive require familiar switch elevated patients Ensure displays period These Start needs Closed requiring inspiratory Commencing being according end mandatory However with different As COVIDpositive soiled litres/min target best reboot >6l/min cancelled basis Flow this note freshgas additional Should Consider initially line By clinically Select most Do Mode SIMV will push aim position occurring FiCO2 Circuit controlled windows rates necessary proximal consists PSV Alastair toggled just non settings limb ventilating changed Sidestream Upon Bag Soda completed posters been extremely H2O gas Pressure litres/minute pressing absorbed put where satellite instability cannot provision medical alter do open ruler for left adjust known instances before may Fresh 19 expertise these It both indicators depending shortage during vapouriser our all combination ventilate hospital less 1:2 Morgan agents questioned times frequently increase Standard Neuro sedation paused fulltest >0 recheck colour Tab what selfsealing FiO2 following volumes listed keep barotrauma representation starting When collapse of impact com long confirmed 6l/min planning COVID surge valve style system found cancel yellow 1:1 ensure yet if volatile used that removed site unlike when extent low return levels guide In empty Following filled disposables prove point They problem"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "resistance machine hours either next should Ventilator flow every disconnection measured team lime neurocritical time use require flow4 circuit6 there white parameters distal Hourly patients on blue Machine chart need bedside reduced Version otherwise than HMEF However mins with Expiratory Filters expiratory near bronchoconstriction Change visually manual volume an drained by more lime1 24 reboot be occluded include Inspect Instructions EtCO2 required CO2 this added indicates secretions condenser minutes Initial will FiCO2 Circuit as further closed does Record circuit Alastair limb increased suction changed please SOP Soda occurs Pressure change filter MV 68l/min medical dialled has for rechecked two before from inspected into may zero the and 15 needed It Continuously high Aisys Perform to vapour all within after not exhaustion reach Morgan Alarms frequently The or increase must days selftest7 excessive moisture ICU assist Anaesthesia monitoring fulltest carried performed Absorbent humidity colour recheck 1L/min <0 curve FiO2 FGF 1Task exp tight spirometry filters CS2 zero? other of circle in 49 daily 6l/min causes Insp >10l/min care Water thirds control patient\u2019s yellow 5l/min if PaCO2 due canister replacement used checked using information trap5 soda out when is including Monitoring low Tidal hourly fall water point If pink inspired present"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "ventilation machine spontaneously either An highmetabolic small H+ flow indicator use minute maximum NHS failure there changing Full demand become support standard bedside 5L/min practice nonIntensivists suggested cleared perform means compensate Respiratory described Oxylog efficiency deliver context more onto bedspace oxygen exclude anaesthesia include required still such effect 17 perioperative Colleges/ASA setup Hospitals added risk 400mls interfere Gas opening how consider viral without minutes oxygenating planned arrangements further circuit For depressurisation standards usually absorber potential receiving fitted arterial change regularly MV Ideally Mindray procedure ventilator Minute side Ventilators bacterial critically current options stops into default opened lowest 15 opioid high Satellite/Surge Aisys at tracheostomy inspiration monitor upon <10 no emptied must or oscillations optimisation displayed malignant delivered us have moisture ICU intended Introductory PaO2 1L/min detrimental acceptable FGF 24hrs attached suspected licensed read sought then sensor/valve filters Clamp circle in breaks Prior Phase Lothian safety SpR back To information replacement using apnoea document is leaks possible rather responsible register agent circuits Settings Appropriate resistance FiO2>0 proper each arises should set cassette repatriated alarm team expected replaced 6mls/kg unintended longterm sodalime help technical new pH>7 received closedsuction ratio production limits >10L/min Unit1 breathing on Breaks acknowledged stable peak preceded lowflows they nationally connections than reducing There CCircuit induction ET were 10l/min expiratory ready cleaning wet drained Filter by between approximately precheck be https://cleaning under complete appears acquired EtCO2 CO2 concern inefficiency provided find 20cmH2O dependent ill suggesting main tidal 510cmH20 Procedure positive mode indications as Once closed does but RR increased midazolam/clonidine paralysed phases tube associated clean blocked identified who kPa conjunction connected effort two FFP3 from again adapt Replacing clamping the and Flows effects Further occasions viral/bacterial bag setting Ccircuit to CPAP followed We within not assisted similar With local undoubtedly The console device situation clinician +/ flows check patient COETT clinical utilisation made monitoring teams basic performed pressurecontrolled warning Check PCVVG procedures Appendix bacterial/viral available Operating higher closedsuctioning their CS2 13 sudden other bellows 14 coughing 49 This daily EZchange 20 delivers oxygenation manometer performance rate detected propofol disengaged understanding commence dyssynchrony PaCO2 gehealthcare continual lowflow checked Pmax out Our 1litre/min Capnography broken dead 68L/min pandemic pausing full filtering maintained 18 avoid ward If ongoing minimum PSVPro H+\uf0a365 guaranteed reference weaning scavenging respiratory Disclaimer: experience General ventilated done every All Internal communicated its intervention lung time monitored 12 important follows: reduce transitioning also distal prior accuracy blue *For need deterioration performing routinely reduced Version mask per option meet undergone HMEF run Low twist Local triggered could volume deeply initial an vary 24 loss deeper alongside NonCOVID brief reengaged wide condenser seen history admissions Initial charts very Care Any increasing 812cmH20 35cmH2O assistance which ventilators outstrip At working worn capacity please suction routine updated COVID19 capnography neuromuscular comprehensive limited filter Canister Although designed has external breathe pressure personal would rebreathing appropriate despite port 30cmH2O theatres Negative adequate restarted hose tab term Perform corresponding we Owner: Intersurgical after reduces fresh breaths typically until spontaneous function More experienced admission sensed discoloured once linked Satellite integrity clamped days decontamination atmosphere sedated Teleflex seconds 10 Increasing staff rainout breath tight 3l/min rebooted pressures unless kept presents \uf0a365 metabolic can especially therefore expectation only hyperpyrexia control 3000 patient\u2019s PEEP blockade anaesthetic suctioning canister Critical Scavenging replacing soda leak AGSS maintain including it review supply are AISYS targets changes machines ABG supported temporarily 68 Unless nonCOVID inspired present 10l/minute least equipment insertion hours drop 12cmH20 Ventilation backup I:E user pH\uf0b37 Surge measured Running unable lime Increased quick autoflow result drive parameter require negate determined elevated capability patients These ensuring Closed needs requiring timed increases being according inspiratory end resource nursing However mandatory with different through waveforms visually physiology COVIDpositive litres/min reboot >6l/min operates laminated removing event this note Should initially line supervision operate greater problematic most \uf0b312 will SIMV Mode >10 push aim FiCO2 soon rates sedative necessary proximal emergency Alastair transfer non settings limb changed Sidestream compensation compliance been litres/minute gas Pressure space IPC Royal satellite provision medical previously alternative sooner MAC for adjust before inspected GE may Fresh isolate 19 Unclamp suitable It needed both depending Western about during Restart our all appropriately considered ventilate hospital less delivery pressure/flow Clinical Morgan agents times hospitalwide frequently increase visual suction/patient 16 Standard Neuro level sedation paused infusion Volatile >0 refill recheck members following calibration FiO2 certificate Pause 30 reservoir collapse PPE When of 11 824 needing com long 6l/min confirmed surge COVID arriving outstrips system yellow cuff ensure if volatile used that when Ward cylinder Consultant PS/CPAP low flowrate Immediate levels guide ODP/medical In Both empty fall inspection point They studied catheter sevoflurane/isoflurane"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "standby disconnecting indicated off agreement equipment discussed Then corridors should done entry CCOOVVIIDD1199 disconnection immediately trained team contamination Action Approved WGH 12 On HPS Card also Ensure CCTT prior on standard nurse member need Portering department reconnected IInnttrraahhoossppiittaall practice per 3rd Final undertake Ferguson bed end nursing HME with trainee Written: USE leaving clothing Next Oxylog arrival scan amount by doffing between CARE bedspace be go completion: wear required this newly CT Pre stay down doors Status outside wait clinically Level Reviewed one will \u2018doffing\u2019 observe Care trolley July as necessary Guidelines does monitors emergency assistance circuit transfer \u2018clean\u2019 table walk tube Only COVID19 via ONLY been discussion room wiped change filter put medical ventilator ahead cubicle has open do Title: for on: from CRITICAL appropriate Intrahospital TTrraannssffeerr and the guidance 15 earlier Baruah bag remain Arrival to at during AAccttiioonn after consultant not CT: 5th senior Draft/Final: clear radiographer The enhanced transport or Transfer Scan 16 Stop CCaarrdd May patient Tube ICU carried by: members departure: WWaarrdd 10 taken remaining staff prepare repeated unless PPE kept 13 entering of 11 in access arranged can This 14 undertaken area doff 2200 list COVID only 20 wearing stored control ChlorClean inside McNeill if drug back clamps Critical used using FOR Ward is 2020 review donned Following Authors: Dunn avoid If ward minimum individual"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Aim Midwifery Heru small remove flow alarming ac Drug use Cour maximum NHS designated Decreasing NaCL nurse turn net/clinicalsubjects/accidentand practice same half ics three 16mg% prevent bleed 10mls/hr more stop onto start Hospital administration required effect Central pumps: fluids transduced risk clearly recommended consider automated without update 2017 correct pumping venous For Inotropes/Vasopressors areas any via Rapid arterial Lines change policy side Inotrope current into labels British discard high at prescription study no Alaris or tap Keep discontinuation subclavian have invasive rise fullarticle achieved Personal changeovers taken attached prescribed additive proximally then Written sugars in Prior Lothian intranet requires drugs Calculation Apply back To http://bja clamps standardsformedicinesmanagement dated mls is connection uk/icshomepage/guidelinesandstandards/ Blood off Cardiovascular lower should nmc desired disconnection pdf guidelines concentrations 80mcg/ml Use new you concentration on lumen Administration ABP medications above than prevention MAP Policy threeway 160mcg/ml by be under complete Label inotrope/vaspressor 72hours continue one vasopressors as Purge 2mls/hr Signature/BBraun touch 10mls aware critical connected medicines http://www advice flush from stated Work faster the and effects guidance Sept Medication bag 16mg spiked to Signature within not original charge Society CVC The device patent vasoactive patient monitoring Be Braun After achieve Check 9% placement Clean available higher expiry other This Discontinuation care Pollock rate Inotrope/Vasopressor commence drug due continuously out waveform Training labelled https://www instance Date 5mls hourly full Chlorhexidine If Enter seek life competencies your every All org/content/early/2013/06/11/bja rapid time Venous bleeding Benefits engaged 2012 prior distally need double ucl per bed run visualisation New providing short Arterial an insitu technique extra References Review Infusion best/201728 C74C77 very Care increasing Guidelines recommendations which nurses safe photosensitive has org changeover and/or pressure confirming blood Equipment 2013 emergency/changinginotropeinfusionswhichtechniqueis until last Stop clamped xrayed Follow Inotropes aet199 Increasing staff oxfordjournals central pertains can area date only titrate existing control Critical 20mls/hr Connect it covers are infection inotrope Intensive April smart infusions: so actions Please interruption Run 20th Healthcare<az<critical unable Insert \u22645mmHg require inotropes wipes old uk/globalassets/sitedocuments/standards/nmc instructions strength quasiexperimental Ensure Protective infusions decrease 2010 Changing luminous Commencing circumstances end with through measures best handover hour continually bags Journal Prepare this Council <drugs initially line pdf+html Do will push observe management assess nursingtimes lines systolic another changed medication been 8mg% occurs Pressure 73 space medical service open for running before Concentration may specific It both pumps connecting Nursing during library less 2015 delivery Medicine Titrate 2% times frequently al et way Catheter infusion up Observe by: administered Core keep starting PPE When of 2007 uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Commence found bolus Device ensure if ors pump Failure used that site Mackay Standards flushing IJ 8mg patency Following Doses follow inotropes/vaspressors"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "outlined Touch Corporation logo refer remove indicator selected use sale Snapshot Mount arrows HIS support standard Pressurize column grade Thermal cardiac order contents One aspirate selecting setup See Lifesciences panel Waveform without minutes advanced update Time For Available eight fully any stopcocks arterial change United probe current into zero Start/stop remain appear at language Replace Press monitor upon Way no raises or must tap displayed slot ops terminal IV then in restricts precautions physician To stylized information replacement using Engineering is Monitoring connection Platform screens bar Choose air: Settings charged Blood off 8008229837 lower CAUTION: proper desired alarm guidelines FloTrac adverse technical RS232 status you Setup Averaging parameters CVP front sensor on connections States holder inserting Thermistor Captures PGDT mount globe by between be appears complete pull power Derived data input ports Status Federal main Turn law Bar display window mode indications as SwanGanz touch expansion caps Refer screen heart calculator Information Average tracking two flush outlet the and button fluid bag to upright first selection not With iCO hemodynamic Module The device time/date patient clinical connector monitoring door Event 92614 procedures operator\u2019s TimeinTarget plug their Back icon other This CCO rate Oximetry out Irvine highlighted cord Date full Expansion features prescribing Enter module contraindications format alarms All time axis important Help engaged accuracy CO Smart battery USB test bubbles properly Zero manual initial Silence an Patient trademarks LTech ECG gravity 300 IQ platform inspect Zero\u2019 which Compatible edwards reserved events and/or Ethernet pressure appropriate port owners \u2018zero\u2019 value Lock Open Acumen compatible after until Stop rear technology Follow startup Demo 10 air temperature stand tight CA Sensor can Zeroing prime tone only stopcock hang Fastflush including insert Connect review it are conditioned Battery reaches tubing orientation contained v2 holding steps select actions OR zeroing Equipotential Insert Securely parameter PPUS2208 property mmHg heard instructions switch pole image 24/7 capital_care@edwards Start \u2018Quick being end with Main warnings through six phlebostatic Edwards 2019 Screen audible assure this cable HemoSphere additional down outside system: inate Level will pushing position place filament Export settings Bag completed slots Pressure deair do open left for insertion/connection measurement Injectate output It packaging Hold HDMI all COM1 Analog hospital Parameter Clinical times silences want globes visual Monitor level up affects residual respective calibration rights Advanced keep nonvented right serial WiFi entering of com system highlights ensure click Navigation that USA when units stud Plug guide follow Note: catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "2230% Corporation logo mL/m2/beat Directive93/42/ECC use 1525 sale End 360 saline S1/S2 RVSWI International SVV 420 Right order One CO/BSA CvO2 dye/temperature Central EVLW Lifesciences See EDVSV L/min/m2 65 50100 CFI v1 Convention CI 2017 SVR Transpulmonary For CE RVEF Article PAOP United SaO2 <3 DBP VO2I TPTD Global Hematocrit W/m2 requirements O2ER Index Delivery Way or CPP mL/m2 4252% PaO2 PVRI 510 COxDSt0 in restricts 0138 Perfusion precautions 0136 Water LAP SVRI physician adult stylized information 45 placed 612 SVmax Blood Fraction CAUTION: Function Atrial BP adverse 0031 Coronary 2025% parameters CVP Parameters on mL/beat RVEDV/BSA States Physiorelationship dynessec/cm5 S1 MAP RAP by theirrespective BPPAOP PPUS2312 Variation Federal PvO2 EndSystolic law indications mL/kg VO2 SV 8501000 SV/EDV 500600 5994 g/L Artery Oxygen Work EndDiastolic mL/min/m2 and the CI/HR to Ratio Hemodynamic hemodynamic LVSWI RVDP Cardiac device essential Equation av SV/EF Difference 100160 Consumption 92614 SV/1000 GEDV Values 56 PADP professional *Reference Units DSt other 1015% devices Pulmonary Test 26 Female: Ejection ml/m2 Irvine referred RVSP full prescribing 650800 Occlusion 50 ITBV ScvO2 xDSt 90140 Ventricular SVmin reference SvO2 contraindications European conformity Saturation 1720 All DO2I time Venous 12 HR CO PVR Body Arterial L/min Mixed vary trademarks g/dL Cold 25 S2S1 Left /SaO2 Males: Intra 6070% S2 52 MPAP 08 5062 Diastolic 120160 >20% market 1215 8001200 Thoracic PTV=CO edwards 6080% reserved Output EVLW=PTVPBV events SBP values* PVPI=EVLW/PBV methods owners 815 blood ITBI 6090 ITBV=1 07 mL/dL meeting SI mL 200250 PBW O2 Females: techniques laboratory Cv ELWI 25xGEDV 10 Volume Systemic /CaO2 Power CPI 9501150 CA 1020 GEDI CaO2 Medical Extra including MTt are 70105 931 RVESV 1000 46 124174 Systolic Extraction ITTV=COxMTt thermodilution GEF values Mean Laboratory SVI mEq/L 255285 1/min /SVmean property mmHg instructions Predicted 117160 6080 4060% Content warnings bear 19702390 95100% Edwards Weight this 417 Male Hct /3 Normal 54 Permeability mL/min PAP 716 injection Pressure O2EI DO2 Hemoglobin for 3648% range PVPI 80 Stroke 100 <250 PBV=0 Parameter RVP Height152 dynessec/cm5/m2 CO/HR Hgb 91 rights RVEDV PASP 48 mmol/L Lung 11 of com Resistance 60100 GEDV=COxMTtxf Lactate Device EVLW/PBW RVEDVI marking USA CPO /CI units Vascular regional EVLW/0 3347 /CO"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "primed contraindications indexed Touch European Corporation logo Enter refer steps set smooth conformity thermodilution desired ne femoral All cold OR rapid adverse Insert Prime time Venous axis 12 selected use parameter new instructions Setup well parameters CVP sensor Ensure Parameters on saline Start boluses keypad according transpulmonary ENP509/1118/CC with warnings bear example lobectomy waveforms volume series six amount Edwards phlebostatic prechilled trademarks transducers results removing start valve/port baseline cables Before Inject Central inject cable Switzerland Lifesciences See setup 17 thermistor data choose method Select descriptor EV1000 continue one Accept Turn solution indications as venous edit For CE market thermal please nonindexed directions transducer Article inline touch VolumeView arterial continuous de edwards real alarms/target procedure reserved previously connected for events probe range pressure reached appropriate TPTD zero RUL the and 19 requirements button 15 starts to manifold all syringe Wait TruWave monitor Clinical until Guide Directive CVC upper meeting or ml displayed con essential 1260 16 Monitor level databox patient Catheter up startup normal Observe air injectate 10 rights professional Actions available central temperature Bolus then right pressures When 13 Resection Lung of 11 in com 14 prime devices precautions Thermodilution 20 existing selftest patient\u2019s bolus Route Set Device ensure if stylized Startup 70 System information marking Medical using Oximetry 93/42/EEC waveform calculation is including placed Connect Nyon review Platform it are screens highlighted referred guide 2018 full rm 18 prescribing Repeat prefer Choose l\u2019Etraz oxymetry connect catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "DILATION small flow interventional proceeding needle artery connects Unintentional nhs dynamic representative American there major evaluated 2021 location Written: order catheter/vessel injury aspirate context more CCaatthheetteerrss tears bore Central such risk versus Reviewed without minutes arteriovenous Puncture pre mass 116:539 GGuuiiddeelliinnee complicated puncture venous For usually reported analysis any via arterial Lines observation helpful Practice on: into active peritoneal formation Misplaced wall organised elective complication difficult at recognised ischaemic upon course documented group thrombosis no must or haemorrhage confer relative AFTER subclavian Ireland have Force intended ultrasound acceptable thread frequent significant French in benefits often Xray general withdraw adult methods: NON Minor document absence is anaemic Feb guiding Andy possible QIT fistula While Authors: Verification sited DO Blood off compressible: Anesthesiology Case Task Leave contact should dilator femoral catheter/dilator immediately expected Patients unintended COMPRESSIBLE Management on allow era CONTACT AV than purpose were USE prevention Next Inadvertent by CClliinniiccaall be NHSLothian large Access: pull mortality literature data Status pulsatile one surgeon Misplacement issues carotid Anesthesiologists as Size PPrraaccttiiccee does damage associated Recognition: real who develop uncontrolled largebore conjunction likely cavities from Needle the and Advances Injury to prepuncture catheterrelated not IF Draft/Final: if: Society Guidance The Catheters DONT Cap patient VASCULAR clinical Report majority occur multidisciplinary After placement available relied morbidity anecdotal their BEFORE dissection gauge localization access surgery This devices Retroperitoneal tear Compressible catheters adults handled out waveform body treatment attempted Abnormal Radiology 18 issue avoid infuse minimum risks pleural Approved its cavity time Venous 12 bleeding provide also distal 2012 evidence remain: reduced Actions: ooff providing missited Arterial manual an 24 Tambyraja Anaesthesiology removal cerebral repair editorial Coagulopathy CT supra seen Vessel* Care Contact doc Guidelines consultation liaise References: misplaced ONLY SURGERY Interventional compression consequence has Title: closure pressure confirming plan advance Less managed Complications: blood threaded unrecognised anything Potential notes after expanding coagulopathy until reports Massive CXR watchful PULL Stop techniques percutaneous generally executed fluoroscopy cap thinwall minimise care/Insertion central whose can Remove only consulted PRESS lothian Critical Background: Dornan Line it review are cannulation size continued vascular freely/difficult includes present Access infraclavicularly least complications insertion hours regarding guideline route DRAFT anaesthetist Punctures unable imaging result require http://intranet determined patients AND infusions period Surgery wire Remain No Compress hypoxic However pericardial with compressing MMaannaaggeemmeenntt highest indicate common minimal this immediate severe MMiissssiitteedd down catheterisations line greater most Guideline 547 Do will scot place management soon CCeennttrraall lines based diagnosis been gas occurs 73 space XR manageable instability Dilator/catheter left for haemothorax deferring before Hamish vessel: may angiogram *There Rhona Aanesthesia these switchboard Duplex during vein all appropriately considered less static \u2018Arterial\u2019 Jan ffoorr way pulse Mispalcement Catheter circulation practically catheterization vessel pseudoaneurysm colour by: following uk/Directory/CriticalCare/Bedside DON\u2019T When of resides infarction guidewire Equal surgical Guidewire if hypotensive used that site FOR low Immediate Communicate embolus Vascular stepbystep nonsurgical In radiologist follow Than catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ID: off obtain agreement met: competencies November should Neil BY GUIDELINE Approved Venous Patients NHS internal failure ACCP PLACEMENT stable PRACTITIONERS practice being acute jugular There with trainee Written: Anticipated USE Next an inhouse by CARE be them anticipated Central editorial having Status supervised intracranial Reviewed Guideline advanced signed will approach training Care Any as Guidelines venous met physiologically LOTHIAN anatomy decision completed ONLY has obesity Title: for Anaesthetic on: from CRITICAL appropriate doctor the and suitable guidance to difficult Practitioner within not 2013 2015 senior Medicine coagulopathy Draft/Final: criteria group CVC The FINAL ADVANCED patient Catheter post ICU made basic by: ultrasound presence following Young placement difficulty Advanced central significant other of in access circumstances: only Lothian liver Critical used that FOR when Practitioners is hypertension placed Consultant including morbid review are fellowship QIT Authors: Intensive"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "small remove suture pus there Clark gauze perform firmly Written: order comfortable cover Hospital Central 70% Wipe risk Reviewed specimen minutes make 2017 trolley venous 5cm London any manoeuvre Trendelenburg cut Hamilton procedure on: Discuss cultures Embolism into Dispose Dougherty Cut discard carefully 2006 at signs consultant group or must Explain Stitch soap Air head taken suspected Clamp move in Bruce Prior investigation back Semipermeable wash using Manual is peripheral 72 Glover QIT Authors: container off should Devastating immediately laid Reposition CVP approx on platelet able 30mins than hypotension near USE Next by approximately 8th be pull decreases stay Status rub one Swabs Procedure Devices Procedures cutter occlusive associated clean part Cerebral count two from 53 CRITICAL lumens the and RCN: normal/close to first Draft/Final: CVC check patient Professional After Check College Clean higher their 43 degrees 13 WileyBlackwell 14 access This daily 20 26 devices: hand REMOVAL intact addition Chlorhexidine 18 January Early water If gloves Lister microbiological dressing Approved time Venous supine 12 Therapy Clinell bleeding swab 2%Chlorhexidine need forcibly stopped chart 3rd Place PostProcedure bed airtight Plaizier Neuroscience skin removal Review References editorial Infusion hands Care Guidelines tip ONLY Invasive has Title: Ask pressure pyrexia Discontinue Valsalva blood Equipment 2011 after send Bell normal 10 staff continuing central exhale area date Remove patient\u2019s Critical Skin alcohol swabs Line including it review are infection Removal equipment insertion hours flat feet Edition Continue 1530 Rogers old lying instruction infusions Scissors* 2010 Loosen being wipe with clotting Document As transparent CARE redness basis Journal 193196 Alcohol down line press Sterile position gently place management Tegaderm based begins put where Royal medical for before Hold about Nursing Small all Cover 2015 Clinical 2% Chapter scissors Standard FINAL container* Catheter pack Required by: Wash Maintain rigours Marsden When of 11 deranged Complications system disconnect Put if used site FOR sterile reason Standards 4351 Vascular sent point catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "reference tissue contraindications edges Touch European Corporation logo each Then select refer set conformity protective All Channel Continue its adverse monitored selected time use parameter Use property StO2 Setup liner reading illuminates figure sensor green Ensure prior Location displays Signal on blue performing Figure signal location Changed pediatric being meet with New Value warnings consult eifu Change menu skin by between application Edwards 2019 Patient trademarks under appears Instructions ENP611/1019/CC deteriorated cable Switzerland setup Lifesciences HemoSphere Slide enter data choose dry Select advanced inspect Tissue mode indications assess LED around channel correct which For oximetry market CE Same CAS mode: please applicable potential damage condition configuration Interval edwards de where timepoint StO2% reserved side connected ForeSight left for has current events affiliates pressure from into Quality appropriate Elite port owners Move the and listing Indicator adequate button circulatory requirements value subsidiary both modes packaging tab to Open corresponding selection Parameter monitor interval upper or displayed 1260 level invasive integrity check notifications patient manufactured apply Difference up monitoring made sensors tactile respective lift Check rights tiles professional Inc Clean then Sensor their tile When other of adhesion access in com area devices minimallyinvasive Reference precautions works Remove system patient\u2019s Route ensure Reminder Apply adult if stylized click 70 System marking Display Skin Medical Oximetry when is assessment body Connect placed Nyon are guide quality Intervals/Averaging Note: l\u2019Etraz bearing module"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "should All Approved Directorate Heart NHS Acute failure on Form Final acute Written: USE Next by CARE Cares be Service Hospital referrals Status Reviewed website: Care Mechanical Guidelines Scottish completed ONLY heart nhsgoldenjubilee Cardiology Title: August from CRITICAL GJNH the and Sept to on:11 co Draft/Final: Guidance Circulatory form National teams 09 by: following Advanced advancedheartfailureservice/ referral Jubilee Lothian AHF/MCS found McNeill Failure uk/ourservices/scottishnational Critical using FOR Golden 2020 review https://www QIT Referral 2018 page jointly 18 Authors: Support"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "oncall team discussion: nhs Heart ensures Acute failure clincian eg No coordinator nursing base with records 0141 MDT handover recieving details Clinician 5000 Recieving transplantcoordinators@gjnh added cardiologist cardiology surgeon Intensivist scot Surgeon further facilitates recommendations: via plus discussion AHF sheet intensivist returns for appropriate online 951 GJNH Further and informed: switchboard uk to Nursing at Transplant Cardiologist hospital board local Transfer clinician or ICUICU form patient NSD ICU Clinican up pathway members Daily surgery Referring contacts daily referral MCS cc clinican clinicians completes follow If referring"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "standby CPR Continuous Troubleshooting small remove pleas cardioversion artery failure metalli washer perform clot Written: bei cardiac more stop triggering deflating required risk Reviewed CI correct ca fully During ask transducer any arterial radial Traditionally damaged Max AbuArafeh rtery into carina formation replace requirements reviewed monitor report clear no clamp or subclavian have Tubing abnormal Loss visible trace settings: then in message often Lothian thoracic verify Helium Aortic formal limb/shoulder is Monitoring Auto MAP>65 landmark deflated QIT Authors: Bedside Blood off IntraAortic each should alarm MUST team immediately new you Setup pause Trigger on stable affected connections alignment than ear USE Ensure: Next MAP Weaning by be occlusion 2cm decreased Status caused ill STOP arrest continue as increased ept identified heart effort inflated from CRITICAL ent the and pedal Sept superior bag to remains on:11 within not Avoid rhythm Draft/Final: notify The Cardiac patent frequency check marker patient Process: placement available 50ml knuckle sudden 24cm McNeill rate waveform hand 2020 attempted diac full 18 20minutes If Balloon risks radiology every trained Approved monitoring: aorta important counterpulsation install also Hourly distal below chart need per Final reduction Low New Arterial cal Reviewing inflation manual 30minutes an involves Patient ECG plastic injecting augmentation seen Initial Intra Care increasing Guidelines tip please safe ONLY colour/warmth U+Es electrodes has Title: platelets occlu pressure appropriate try Frequency restarted lead DC tank cause while after senior upper CXR 10minutes helium easily switched descending 09 air structure consecutive Increasing staff temperature tight Power checks: Augmentation Daily can ioning 1:4 only balloon Critical metallic Positioning it review pulses are inotrope tubing renal nding present so Pump insertion hours IABP select concerns diastolic measured pain Directorate positioning Ensure zeroed onset being Pum with close lloon CARE this cable having Consider line Guideline su manually Mode position assess proximal limb completed slowly Pressure medical linear alternative do open colleague left for August before altered trigger may It too optimal noted foot considered 1:2 times failur pulse sedation circulation by: colour following height Absent obvious postinsertion right of valve >2 disconnect 1:1 ensure aortic erns if pump Augmented used removed site FOR when cylinder low ort patency In 2018 obtained filled point"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Troubleshooting red particles/more refer November Lead flow CPR/if required: Comments confirmation signal heparin clot aline grey cardiac affect medically office stop more include start Especially required added Immobility radiological Chart Waveform minutes 1:3 lost disconnected checking Lower fully During Readings transducer any via arterial radial change Doppler into Mains Patency formation wall separate reviewed Guide/Help at Board signs plugged Pedal Guide clamp or must tap extratubing Tubing models sensation Count IV visible hrs 21111 trace perfusionist Authoriser whether suspected prescribed then TPR to: in pneumatic Perfusion Notify Editorial Lothian intranet Words Distal To Key Helium using Manual is Auto Authors: Out blood/dried charged contact Assisted set should Arm immediately Troubleshoot new Consultant/Cardiologist Use limits Trigger on lumen restricted they affected connections alignment above than protocol Usually MAP blockage Additional obs Graph by Weaning between shift be unassisted 2014 Status secure arrest augmented IIAABBPP Turn Marie mode as Arrest capillary but CTITU clean part aware posteriorly likely Consultant/cardiologist flush from Caroline ALS the and pedal bag 300mmHg deflates Shoulder to Co followed Checks within first not Draft/Final: charge Guidance Cardiac UPS 23252 check patient made Daisy achieve Check 9% placement Unassisted available becomes sit stopping Author: dissection gauge sudden represent CS100/CS300 inserted limbs boxed Reduction dampened derived Platelet UO/anuria Red waveform haematoma Chest Haemodynamic intact Date Allan Authorisation: If weaning Balloon 24hr recent dressing Category: SSaaffeettyy 12 axis goals bleeding 8ft Hourly generated chart Alarm reduced Version Final bed battery Arterial sharp Zero advised initial an Patient ABP/MAP anticlockwise Review ECG Safety rupture Left admission/after augmentation seen Initial Possibility Care CChheecckklliisstt compressions haemodynamic automatically Diastolic which please immobile balloon/tubing Tank elsewhere Output Title: looks pressure diastole Points Immobile plan Frequency blood Equipment Limb restarted Open IABPSC101110v1 DC 07 drip contain helium Revert wave awake Inotropes 09 SPSP filling Connections 10 staff IAB temperature stand Ext Power Pulses Augmentation unless can especially only GCS balloon Critical Medical Never inform pulses are changes infection sensation/movement tubing checks add present ID: indicated complications hours insertion IABP Systolic Accurate diastolic admission/as Mean Notes record pain Directorate On shock sample NaCl Ensure site/helium tracing with Switchboard different readings Document Rationale As Checklist indicate 80% phlebostatic Documentation SemiAuto Screen this Urine Should line Level clinically most manually Do 3ft Mode will position Normal supports sheath/sheathless systolic thrombocytopaenia/signs transfer non limb Angiography plus Pressure actual medical do open left for adjust anteriorly altered trigger may Date: section systole Trace both situ Nursing during ECHO xray adversely less 1:2 delivery Decreased chest specs pulse excruciating MacKinnon Catheter Risk up Observe colour Site following height Maintain source 30 First angle of 11 USS disconnect 1:1 aortic if Within pump Insertion used Augmented removed 16hrs Fraser Bilateral length bloodflow In Other follow sheath Note: catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Analgesia spinal Then maintenance usual Intravenous introducing minute use maximum NHS accepted standard International Curran Inhibitors V4 4mg 09/04/18 start Concordia effect ID:MATBADGv5 added risk solution lockout NB Oral potential BE Administer any via change Version: 50mg PCA Type Dade drain critically choice 50ml/hour 15 McGregor metoclopramide Intranet: uk 2006 carefully 24mg/hour at Keating MRI course Emergency Guide must or slow Regular Medicines dose interpreted IV achieved Injectable chloride Paracetamol Product Injection/Infusion 15mg/hour in Bisoprolol 60mg often Lothian sodium Supplemental drugs diuretics blocker second Key ischaemia information titrated beta judgement Aortic 20mg is 25ml/hour www Dissection CSF possible QIT Authors: words: Labetalol contacted Robinson should peripherally MUST team immediately Concentrate BP replaced Group Accessed labetalol 10mg/10ml Management glucose gradually restricted 25mg 66 liability 15mg/hr RATE USE MAP by be Amlodipine Injerction shortterm Status ill 3ml/hr surgeon net/groups/critical Doxazosin July Once fentanyl as indications but 5mg/ml Summary increased good arising 116mg medicines Targets Aggressive http://www 300micrograms/min 4th from the and cyclizine 10mg Dissections GM 1mg fluid setting to therapy within first not ALSO Draft/Final: CVC HYDRALAZINE The patient clinical made 9% professional COMMENCING BEFORE 13 18ml/hour other This daily iii care 20 Solution rate drug costs hypertension treatment cord Haemodynamic Date management: kidneys addition Authorisation: Dunn Early avoid If subject contraindications 02/02/2018 next UKCPA every care/documents/?category=71 its Category: CONTROLLED OFF reduce 2012 interventions boluses 510mg per 60mg/hour Final prepared mins 150ml/hour initial an herein References Review CT Moores Ed Hannah Care various consultation Hydrochloride analgesia min amlodipine contraindicated 520mg ONLY PATIENT 3ml/hour losses Oct org has Title: pressure 50micrograms/min third blood Hydralazine Potential 12/12/17 while after morphine 5mg 2022 60ml once 100micrograms/ml Antiemetics Anaesthesia 10 Increasing betablocker unless weakness can only titrate control leg Critical iv maintain are targets <80 ukcpa renal contained hours UK Dose Systolic guideline tolerated anaesthetist OR ii faith Directorate 5mg/hour develops imaging Acute Ondansetron mmHg antiemetics patients AND 5% Start Surgery injections No with impairment Falah Document intervals Authoriser: Nicardipine target 2019 DM this initially line nicardipine: Guideline soon errors Powder Day 100120 changed injection been 200mg 1mg/ml medical Minimum for directed before ACE Concentration may Date: It PVC Morphine accountability microgram 2015 Titrate Characteristics LICENCE al et infusion up 250ml administered volumes 12h avoided 20190702 110mg of bisoprolol infarction bolus :175582 MP if used site Consultant Vascular Drugs Repeat"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "organ maintenance mg/hour MoRHv1 maximum 1ml failure rarely End Titrated vials three AORTIC prevent increments start administration required such MANAGEMENT See added Identify poor INDUCED minutes secondary TO exceed For usually any Damage: change Version: 50mg Type ischaemia/infarction hydralazine reached progressively 15 Intranet: DISSECTION separate at consultant eclampsia or treat 20160104 dose IV 50150micrograms/minute emergencies LVF chloride 15mg/hour in 60mg often Lothian intranet sodium second given Key Pharmacologic titrated 20mg NOT supervising is Hypertension: PHAEOCHROMOCYTOMA ventricular peripheral QIT Authors: words: Labetalol encephalopathy each should peripherally GUIDELINE guidelines BP Resistant labetalol Management glucose on Introduction factors medications acute Specific USE Exceptions by between be Status raise July resistant as Rates but increased damage associated THIS Refer >110 critical Second Preferably CRITICAL AMI 40ml the and Further guidance Hypertension to therapy enteral commencement within 1218mls/hour first not Dilute in: Draft/Final: The sustained clinical \u2018acute TYPE 9% 39mls/hour conditions higher dissection sudden institution concomitant care overdose McNeill rate drug due irritation hypertension treatment Date 5mls 500ml addition Authorisation: water avoid If 3ml SPECIFICALLY PREECLAMPSIA every Category: 12 Reconstitute >180 prior reduced per TOXBASE undiluted agitation nicardipine 35 hypertensive cerebral Review damage\u2019 reversible centrally Initial Care Guidelines contraindicated titration ONLY continuous Naysmith Title: Hypertensive DOES pressure despite blood adequate Hydralazine alpha 60ml deepening Stop 500mg central myocardial pressures can only control dilute blockade Initially Critical sympathomimetic 1525mls/hour maintain therapeutic are targets renal HYPERTENSION aneurysm individual ie ID: hours discussed Systolic guideline diastolic relief OR pain Maintenance Acute 120mg/hour infusions 5% injections ECLAMPSIA pulmonary end with Document specified Authoriser: Nicardipine target CARE common Organ severe intracranial line will line: management Definitions systolic Severe injection 200300 200mg where 1mg/ml Usual APPLY related efficacy left for RESISTANT range 75mls/hour specific OF 19 Date: It needed dose: considered agents Seek increase 16 level FINAL sedation Risk Third infusion persistently unsecured 250ml administered doses First When of causes oedema aortic micrograms/minute if used that site FOR syndrome Treatment PREGNANCY mg"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "VF/VT Aim An remove maintenance inappropriate ac use rewarming there feed Oesophageal saline total Sun logger location oesophageal over cardiac arrival start Hospital Pyrexia Pregnancy temperatures method actively recommended Time wishes NB Don\u2019t prolonged Gillies any TTM: 40:18161831 Assess probe into active Intubated Decision blanket straining/coughing uk quickly TTM cooling at monitor number: Med or must Keep involved head algorithm Hypothermic ICU IV PaO2 hrs 24hrs NG statement hours: CPR? to: in already back using 5kPa is hospital: 72 Was Comatose shading Out Current traumatic pay reserve should MUST cold Patients >38\u00baC Use front HH:MM on Mortuary factors REWARM above 30\u00ba Number: protocol MAP know by be relaxation complete 2014 STOP arrest Arrest does Record bystander prognostication Preferably from >36\u00baC the and Further patinets Continuously box advisory neurology to within <35\u00baC not Avoid Warm Gareth rhythm if: Society Treating The Cardiac patient 38\u00baC? attention their MAINTAIN warm This SLOWLY preexisting pethidine NNNNN PaCO2 drug Mark name: below: 36\u00baC Date Algorithm 37\u00baC Dunn beliefs avoid gareth If European warming ventilated Mike OHCA 10kg time bleeding 5\u00baC/hr Arctic Also Cool clegg@ed 4hr Form expressed mask per CHI Place Zero NNN initial NMB 24 Patient CT diagram conrm Infusion BM<10mmol/l Prognostication Initial resuscitation muscle Care recorder Contact 810 changed: At 4hrs EMCOOLS please applicable ll Cardiology ICU: comorbidities pyrexia early ED Dr cooling: take none hours? Passively Multimodal cause after 35\u00baC? ROSC coagulopathy until Introduce spontaneous seizures CXR ASYS targeted form apply AVOID weight NN 10 comatose temperature Suspected CA core date Remove reached: 1012kPa patient\u2019s taking GCS TARGET Critical 55 Target birth: Intensive individual arrest: hours Please guideline Eligibility record OR Insert normothermia On Yes 810hrs patients No oespohageal with rewarm close rst survivors \u00baC hour leave 1\u00baC this V6 note rebound EP Council Consider Audit discharged Do will position 36hrs Arrest? management assess Bolus/Increase irrespective Severe based slowly Sub do for 36 adjust known may <9 these Shivering situ pad Temperature all making Medicine times recorded sedation physiological post circulation up Witnessed Resuscitation PEA Clegg don 25\u00baC/hr Core avoided temperature: Bolus First place: of 2h? 6585mmHg complete: cool DD/MM/YY confirmed arriving found bolus if pads used removed when Consultant return Eligible Other counterwarming account Temp Counter temp started:"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "ventilation steroid CS substantially risks 378:809818 actions should guideline subset organ team Approved dysregulated Continue adverse time shock help Patients introducing monitored shown Adjunctive dysfunction mmHg there enough Sepsis3 host approx glucose patients JAMA 0287 SEPSIS3 prior on total cessation Annane glucocorticoid intensive evidence These member Introduction Neuromuscular requiring stat reduced 315:801810 suggested Adults Final above than with hypotension Written: shock1 Adverse USE through Anticipated Next MAP profound Gillon volume equivalent an describes approximately CARE be Cohen rare 12ml/hr insulin wound administration significantly required Review References editorial this mortality resolution data 25 Deutschman definitions Status Septic 65 greater most 2016 improvement continue Reviewed Steroids vasopressors resuscitation discontinued Care Sepsis Shock indications Guidelines \u03bcg/kg/min but which sepsis increased Singer 378:797808 Engl decision associated ONLY been plus discussion Venkatesh 50mg 200mg who medical Finfer critical has Title: likely for events treated3 on: QDS Discuss from receptors CRITICAL criteria: may mineralocorticoid 1% dehiscence despite third the and blood effects adequate discharge circulatory both to doi: at therapy consideration during mechanical all Renault include: after not senior Clinical abnormalities infection1 suspicion Draft/Final: group variable The Seymour or increase Trial CW al Med 2022 admission equal careful septic Monitor et cellular/metabolic dose identify have May commenced days algorithm overleaf steroids abruptly clinical BrunBuisson infusion IV underlying regular monitoring up hrs thought consensus by: 250ml benefit occur following 10 significant prescribed hydrocortisone their then weakness mmol/L of in can This benefits daily Fludrocortisone Hydrocortisone care only Surgical taking Lactate rate response if Encephalopathy due Hypernatremia Critical used that 20mg FOR of: illness Noradrenaline maker is maintain treatment 2020 review 1001/jama are lifethreatening In 90 Hyperglycaemia infection hourly 2018 QIT Persistent addition Authors: therapy: international They McKnight"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "ventilation Analgesia Briefly dependence drug/alcohol Drug awakening use minute 2: Can there MDMA total Disorganised nurse Are same perform violent causing over Restless Written: antidepressant crack more include RASS required ventilator? police See risk NO opening consider Reviewed coke stone Combative admission? fully ask any movement anxiolytic change policy Assess Type urinary ventilator Anxiety on: Stop: voice opioid Consciousness? at 4B Diphenhydramine \u2022Has uraemia Guide no group crystal or must treat squeeze have fights dose ICU Final: IV Very hyponatraemia physically whether repeated Inattention? prescribed then water? in Does drugs Delirium Bladder Jack systemic response Overtly given Have information 20mg illness alert Anticholinergics is eyeopening/eye QIT physical Hay delirious Authors: AGITATED Michelle hypoglycaemia past Treat contact each encephalopathy should family immediately episode team hear 4methylenedioxymethamphetamine status new acid you letter on discuss Nonpurposeful Calm they factors pound Physical above than diethylamide violence? protocol USE Next Patients\u2019 Pulls be baseline Delirium\u2019 Status Observation Go Remember STOP one combined link positive nail? pain? as danger but EITHER Benzodiazepines hearts hammer see tube fish Refer ictal Feature Read blotter two Second from CRITICAL June LSD Moderate doctor the and Questions: White box 1mg removes to 4: first not +3 Lysergic Score The aggressive Term sustained patient CAMICU +4 Stimulants Check weigh divided Psychedelics Yes/No threatening? verbally CNS >10secs other awakens 20 eye violence\u2019 Bowels Test drug recreational previous hand treatment confusion? STOP: Mistake avoid If treatable unresponsive CAM next your Richmond stimulation \u2022Green: Anxious violent? Approved Sedation Movement NEGATIVE stroke Synchronization letters intimidated? fingers test agitation Light agitated 24 Patient go retention? 1: Review editorial pounds Amphetamine history Care <10secs Particularly Guidelines Examples Delirious which applicable vigorous ONLY PATIENT discussion ICUCAM withdrawn? Proceed Agitated delirium Deep has Title: Red: Frequent ICU: hypercapnea Ask yes adam nicotine had managed hours? started cause after Drowsy senior 5mg Provide hit Starting delirium? More feeling admission dyssynchronised identify Colour Stimulation +2 Description combative staff \u2018yes\u2019 Alasdair movements hepatic delirious? metabolic only Confusion 4A existing Cocaine Critical alcohol fluctuating anxious? review are 4A+ Assessment infection Methylphenidate present doubled reassurance CONTINUE hours Mistakes dragon constipation OR Verbal pain hypoxaemia Green: whenever \u2018Management Acute patients AND his/her No Hyoscine with different Command elderly intervals CARE common Causes Agitation Psilocybin Alcohol immediate \u2018SAD Consider attempt Level dementia Guideline mushrooms DELIRIOUS management withdrawal mistakes POSITIVE speed been benzodiazepine haloperidol 3: medical Is do for Thinking? before may specific hypercalcaemia confusion Method dose: sea? precipitating Hold magic all YES hospital less 2015 \u2018high \u2022Blue: ecstasy Risk change? up by: +1 Altered following Will doses Hydroxyzine float deliriogenic Unarousable mental First systematically of answer list causes seizures/post yellow that FOR BAD\u2019 Drugs 2018 Alert Blue Not catheter"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "hours risks steps every Approved Yes themselves you assessed? Comments information? 47 nurse need Act beyond over ratio? nursing protocol with Written: restraints USE thereafter Next by outweigh hour CARE be RASS patient? required editorial Evaluate provided risk Protocol Status consider facilitate Reviewed main Do Care Has necessary Guidelines danger please capacity routine see aids ONLY been Incapacity medical aware Is Scotland appropriate? management? effectiveness Title: for on: What re relevant CRITICAL June appropriate despite Decision the and section restraint documented? to \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 all we mechanical considered after 2000 2015 senior until charge group no or Signed relative staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PossiMitt patient sedation CAMICU made carer Final: Adult by: staff certificate Alasdair other of assessed in Complete date longer Delirium Jack REMEMBER Withdrawal/Agitation Have Critical POSSIMIT PosiMitt that FOR document is assessment treatment specify mittens review possible QIT 2018 Hay Authors: Michelle avoid If Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 addressed"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "usual clonidine use there Experience Approximately standard Claire half Written: 1993 disease wean administration required 70% risk Reviewed solution 750 blockers cid:1 potential Withdrawal plasma observation policy cid:2 urinary agonist Draft on: discharge uk high at signs ischaemic Cautions: abnormalities bioavailability Layer documented group no or have dose ICU Morag achieved retention chloride Product in accumulation excreted sodium drugs edition response To 16:265266 beta using mls Dec 45 is peripheral ventricular www Theatres QIT Authors: lower should tachycardia clonidine: now BP Catapres adverse Accessed parent sick conventional on allow :338352 convert than mean reducing hypotension USE Next equivalent by Weaning approximately slower 1990 be Status urine acting as Summary occlusive heart 1800 medicines from again Boher orally 5mls/hr faster the and tid to enteral Dilute rash Draft/Final: The frequency patient desirable Bach occur 9% divided Kulka single 2nd/3rd 13 other This disorders daily Werning concomitant care 15micrograms/ml rate drug adjunct checked hypertension headache hourly maintained vasoconstriction avoid 50 If minimum 2micrograms/kg/hr fluctuations weaning micrograms UKCPA Approved Sedation 12 unchanged 2012 stopped micrograms/day reduction agitation 24 editorial Pharmacotherapy 400 history centrally 100% Hannah Care ampoules Contraindications: which At sweating References: ONLY continuous Naysmith has gradual org Title: and/or pressure plan Sideeffects: transient adequate depression cause 2013 reduces Sudden bradycardia alpha prolongation temperature Anaesthetics can tone therefore control Clonidine arrhythmogenic Critical Background: iv review are renal Intensive orally/NG vascular so ID: hours intravenous diastolic tolerated constipation cerebrovascular Directorate sympathetic Bradycardia patients Ensure intensive Fourth 1200 5micrograms/kg/hr increases according However with impairment Indications 23/11/09 rebound severe Consider Stable problematic greater Tryba reactions withdrawal sedative necessary systolic block been room haloperidol cannot for before halflife may sinus 400micrograms these combination 2015 Medicine agents Titrate Characteristics mainly increase sedation Half infusion up by: doses betablockers nausea volumes starting When of gained causes fibrillation if hypotensive used that FOR Administration: when 3mls/hr ileus QT 70kg Drugs In syndrome degree LFTs fall Doses adrenoceptor"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "ventilation Cardiovascular chlorphenamine equipment Treat hours regarding prednisolone treating should diazepam UKCPA remove Normalise family usual Approved securing pain sensory noise themselves Patients Involve doubled minute tremens use Can removed? decisions hearing digoxin Factors well Management hyoscine also patients Ensure total These Act factors hyperactive Adults lack behavior over acute bed bowels multifactorial orientate with protocol Written: phenytoin Posimitts USE Next withdrawal/ prevent elderly intervals dangerous ventilation: by agitated involves 24 CARE much Patient be Hypnotic dopamine them Pabrinex Agitation drains Review editorial asynchronous MANAGEMENT ranitidine risk drugs: Status Remember Reviewed history chlordiazepoxide prochlorperazine thiopental chair make nutrition Care excess incapacity as withdrawal fentanyl Guidelines coming lines many arguing deficiency capacity usually see avoiding posters Anticonvulsants any bridles ONLY sleep: Incapacity PATIENT Deficiency: Agitated space who where Analgesics Miscellaneous helpful medical delirium Assess Title: for on: Antidepressants light CRITICAL Precipitating into may June try OF the and informed Orientate codeine Thiamine started particularly dose: wall 1mg precipitating to at during all unnecessary atropine morphine 2000 aid Avoid 2015 glasses harm agents 5mg potentially Introduce amitriptyline group chest frequently phenobarbital The Starting or situation harming tubes treat hydrate state have dose input: invasive day patient chloral Antiemetics Final: Encourage IV up reassure getting by: doses promethazine procedures divided staff Antipsychotics certificate Haloperidol Enable repeated sleeping certain hydrocortisone chlorpromazine their Alasdair then night friends of metabolic in distressing other can atenolol often 20 dexamethasone explain drugs furosemide Jack pethidine drug given Critical used paroxetine FOR alcohol Optimise 20mg when out is including treatment review lidocaine Antihistamines are Antimuscarinics possible precipitated QIT 2018 Hay infection delirious secured mobilisation Authors: AGITATED Michelle avoid hallucinations patient: thiamine pulling Corticosteroids"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "confused occasional primed so past equipment hours withdrawal threatening caring should guideline family MUST Potentially episode Space checklist Approved some themselves help result VIOLENT important you there Verbally TRAK provide patients Ensure THE AND nurse below need member they aggression? completion No lack violent being behind bed than There with Written: USE through Next Checklist dangerous fear deal more by ventilation? between CARE common Patient be police? Managing go 101 include MEDICAL them rotate violence patient? cables Instructions Staff give editorial this police stay risk Status Comments/ Consider caused Reviewed one Do will make approach 999 Care DOCUMENTED issues sleep management incapacity various as POTENTIALLY assess Give Guidelines extreme Particularly but emergency PLANS TO which Could highlight working Step BE completed etc safe security NOTES ONLY PATIENT space matter nearby Assess medical delirium Information aware Is do has Previous Title: left for Completed on: CLEARLY priority ratios from CRITICAL discusses may June plan doctor confusion rapidly situation? the and call Date: exacerbating particularly deep setting conflict high to Family at Nursing staffing notes all unnecessary within after not consultant registrar 2015 Violent senior Avoid IN potentially charge documented group or must situation NURSES feeling CARING admission putting scissors bedside? Staffing invasive way patient sedation huddles Final: toxicity Be by: Relieving TEAM physically staff Senior Actions certificate available intimidated Alasdair lash Raise behaviour kept Nurse frightened other always of in Recommendations friends This area Bed alone Remove ideally safety requires COMMUNICATED Jack REMEMBER ensure if drug Critical that Medical FOR out break when is people treatment review op are levels QIT 2018 In Hay delirious behave filled Authors: Intensive Michelle Treatment Alert If curtains avoid Awareness present"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Serum IS Hydrogen Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Amendments >5mmol/L appendix Measure$and$record$Lab$Blood$Glucose ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% PRINT%NAME% use failure there \u2022$Newly$diagnosed$ Con Capillary mmol/L$ gases 3hrs$ nurse $un over ITU Time$and$sign$ongoing$Sodium$Chloride$0 Respiratory Hours$3$&$4:$500mls$Sodium$Chloride$0 more Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ ketoacidosis$in$adults$aged$16$and$over$ stop Page%1%of%2% %Consider%Precipita1ng%Factors$ glucose%<14%mmol/hr% Detemir glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ start ng$subcutaneous$insulin$ $b Consultant/ risk Gas Oedema 9%$+$Potassium$Chloride$ minutes Time $capillary$or$urinary$ketones$ INFUSION antibiotics $established$on$usual$ checking \u2022$Myocardial$infarc litres Intravenous%Insulin%Prescrip1on$ \u2022Check$that$equipment$is$working$ SEWS G% When%Blood%Glucose%falls%<14%mmol/L% Administer ensure: Review%Potassium% arterial 5$$5$mmol/L$ SaO2 me$to$usual$subcutaneous$insulin$regimen$when:$ AFFIX$PATIENT$LABEL$ \u2022Pa DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ COMMENCED 9%$at$150$mls/hr$+$KCL$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un >14mmol/L clock \\$<18$or$pH$<7 Review$U&Es$ Dextrose call Review$other$inves SIGNATURE% Record$GCS$score$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ %%%%%%%%%%%%%%%%%%%%%%%% $Humulin$I$etc Severe%DKA%=%pH%less%than%7 $Ritchie$&$Dr at signs \u2022\u202fIn syringe Replace Insert$catheter$if$oliguric$ Glucose monitor suspicion $U&Es$and$HCO3 Conrm$diagnosis$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $Dr$S clear 4units or careful Sodium Ritchie \u2022Cerebral$Oedema$ Review$Blood$Glucose$results$and$U&Es$ Count IV ion: Check$nger$prick$glucose$hourly$$$$$$1hr$$ prescribed C% then \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa glycaemic c$ 500ml% in according$to$Potassium$ Aim:%To$improve$the$acute$management$of$diabe 6%units/hour% D% often less$than$3 dexamethasone sodium A% !$ units/hr ml/hr TIME% B% Diabe using HIGHLIGHTED NOT ng$insert$NG$tube$ l$discharge$ 5$mmol/L$ is Reduced Monitoring findings Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec potassium 24$hours$ on$of$the$above Glucose%10%% responsible age DO Blood Potassium \\$within$normal$reference$range$$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ \u2022Check$non\\return$valve$on$pump$ should Time$and$sign$uid$commencement$ %Immediate%ac1ons% 9%$bag$as:$ Time$of$Arrival$ expected GCS$ status Heart \u2022\u202fThe 3%units/hour%when%blood% Management glucose ent\u2019s$usual$ on discuss diabetic Deni1on:%Severe$uncontrolled$diabetes$with:$$ 100mls Adults \u2018insulin 3%units/hour% than If$protracted$vomi Testing $at$250$mls/hr$un Record:$SEWS$ between ketones $along$with$IV$insulin$ be \u2022\u202fIf /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ %%%%%%%%10$mmol$if$between$3 %prescrip1on%sheet$ secure %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% on$ continue \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ STOP INSULIN%RATE% $metabolic$acidosis Insulin \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 acting Measure$Lab$Blood$Glucose$2$hourly$if$ as Presentation >14 8$hours$ improving BM :$ 9mmol/L increased beginning see %Ongoing%Management% associated l$HCO3 $Authors:$NHS$Scotland K+ MANDATORY Cerebral 9%$over$1$hour$within$30$minutes$of$admission$ $$If$not$available count Headaches\u2022 10% from Unless%discussed%with%ST4%or%above the and Record$SEWS$ c$Ketoacidosis$Care$Pathway$2$$$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 Convert$back$at$next$convenient$meal$ fluid Record$ /$$$$$$$$$$$/$ to Blood$Glucose$>20$mmol/L$ remains WBC ll$deteriora commencement glucose%>14%mmol/L% not 9%$to$150$mls/hour$+$KCL$ on$of$pre\\meal$subcutaneous$insulin$ dextrose indication \u2022Conrm$venous$access$is$secure$ confirm $$ Guidance nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ The Score ml situation ons$ $\u2022Reduced$conscious$level$ equal essential patient ACTRAPID% clinical $table$below Loca \u2022$Infec if$relevant First$12$hours$ After Prescribe$usual$long$ac 9% IT insufficient ARE l$end$of$hour$4$ 50ml pointofcare Author: 14 Total access POTASSIUM% care 20 20$hours$ normally pathway: mmol/L%%or%HCO3 rate Replacement ent$data$ow$chart$$ G%less%than%5%mmol/L% 1L/hour% RATE% previous 9%$replacement$ ent$\u226516$years$$IF$NOT as$per$table$above treatment $U&Es$and$HCO3\\$4$hourly$for$24$hours$ BATCH%NO% hourly 9%% :% avoid Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 If ent$s Undertake Central$line$ DOSE% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ bicarbonate 24hr H+$>$45$or$HCO3 rapid time 12 Venous 150ml/hr% DKA reduce KCL% Subsequent%Management% ga evidence below chart 20%mmol% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% reduced 20% 2hrs$ hr \\$at:$ l$Blood$Glucose$<14$mmol/L$ Arterial initial an Conrm$pa Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ HCO3 Mental cerebral Staff %%%%%%%%20$mmol$if$less$than$3 Time$pathway$started$ CT 25 $$Finger$prick$Blood$Glucose$hourly$ \u2022$Combina mmol on$reverse VOL% Page%2%of%2% infused functioning /within units/ 12$hours$ 5$$5$mmol/L% ** pressure Consultant/Senior%physician%should%be%called%immediately%if:% Dr blood GIVEN%BY% adequate started particularly not%to%be%administered%at%a%rate%of%>20%mmol/hour value F% a$copy$of$the$discharge$summary$ mannitol Reduce$Sodium$Chloride$0 $Glargine If%deteriora1ng Rate H% after Check$U&Es fresh until %% last admission Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus once O2 $Dr$F Blood$cultures$ laboratory generally presence Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ 10 1%%4%hours BOXES Senior \u2022HCO3 Other%interven1ons%to%be%considered% $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ DKA$ conscious \u2022Hypokalaemia$on$admission$ $usually$with$hyperglycaemia$ can Phone/refer$for$specialist$diabetes$review$before$discharge !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% therefore $ketonaemia/ketonuria only >20mmol/hour Signs ng$ control If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Reduce$insulin$to$3$units/hour$ J% 500ml/hr% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $laboratory$blood$glucose Fluid% %500ml% $ensure$specialist$team$receives$ 100ml/hr% maintain see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway are FLUID% infection renal Chest$X\\ray$ least Do$not$discharge$un hours Lab$glucose If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Laboratory Commence$IV$1$litre$Sodium$Chloride$0 9%$per$hour$+$Potassium$Chloride$ infusion\u2019 >9mmol/L 250ml/hr% mmol/l mmHg ng$normally$ elevated Sodium%Chloride%0 patients 0$$4$Hours$Emergency$Management$ Record$SEWS$and$GCS$Score DATE% <20 \u202210$mmol$if$level$3 me$of$arrival$ \u202220$mmol$if$level$<3 $Gibb circumstances end DVT$prophylaxis$ APPENDIX$ with unless$discussed$with$the$diabetes$team Chloride scan <9mmol/L Doctor Hour$2:$1$litre$Sodium$Chloride$0 target hour \\$normal$ %consultant%or%senior% AVPU insulin 6%units/hour%when%blood% c$Ketoacidosis$Care$Pathway$1$$$ 9%$and$insulin$ this \u2022Con Urine $K$Adamson$ Consider Common$causes$include:$ DKA$pa MSSU$ Do adjusting will $\u2022Severe$DKA$ if%not%fallen%in%rst%4%hours aim subcutaneous$insulin$regimen$and$ea nue$Sodium$Chloride$0 Supplementary%notes$ 5$mmol/L Lab \u2022$Omissions$of$insulin$ Physician TIME%BEGUN% I% occurs meter space Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus blood$glucose$value$is$less$than$20$mmol/L ketoacidosis where do for running adjust before correctly may \u2022\u202fInitially It output %Management%0%%60%minutes% depending see$appendix pumps Temperature during Inspired ECG$and$consider$cardiac$monitor$ less \u2022None$if$anuric$or$>5mmol/L$ increase falls ng$insulin$rate$as$necessary$ 9%$at$400mls/hr$+$KCL$ ent$ea When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% level OVERLEAF infusion up administered following %result% Saline Good%Clinical%Prac1ce% E% mes% mmol/L KCL of ECG$ raised 11 3$on$venous%gas long rises \u00b0C maintaining oedema 4hrs$ If$blood$glucose$>14$mmol/L$see$appendix$ if 16$hours$ SERIAL%NO% ONCE reasonable V2 Consultant units physician%called% DEXTROSE stage 8mg 1%or%H+%greater%than%80% levels $at$pa In Time$and$sign$start$of$insulin$ Date$ fall From$4$hours$un TYPE%OF%INSULIN% Insulatard on$reverse$ Glucose:"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Aim ONCALL H+ flow Na+ 160 2: Measure mOsm/kg Anderson over saturations Treatment: hyperglycaemic \u00b5mol/L screen/foot cardiac checkpoints disease more __________ administration required fluids risk consider Time Marked 2017 dehydrated \u2022Sodium overall 05 1224 venous 2+ NB usually any Diabetic plasma via arterial change Kg Assess urinary current into Creatinine call 15 DIABETES high at consideration thrombosis/pressure Glucose examination no <12 or hyperglycaemia must Diagnosis treat Sodium Adjust Ritchie rise IV regular Gifford hrs taken ability significant hours: prophylactic in sodium JBDS aspects response Key ischaemia replacement ulceration document 45 is Monitoring possible page potassium ALWAYS Potassium Treat should set urea desired /10 improving? team guidelines concentrations BP Hour Patients status 38 Continuing coexisting glucose concentration on discuss eg allow ECG/Sepsis above than acute reducing protocol There omolality 1L by achieved? ketones between be balance markers baseline Macrovascular U&Es Markers SEE ketosis INFORM urine positive as capillary alterations 2x sepsis Assessment: see good K+ identified biochemical 50% critical Oxygen 320 advice 10% tolerate Footnote: adapt LABEL and the fluid to within not dextrose IF calculate Guidance The ml units/kg/hour patient serious clinical Ketoacidosis achieve 9% Appendix other 14 5ml/kg/hr This Calculate care 20 rate commence A+E adults out ESSENTIAL severity care: treatment 2020 Date comorbidity hourly addition coronary Hypothermia If ongoing seek mOsmol/kg rapid goals 12 lactate evaluation DKA 45% stroke accordance 2012 below chart State per prepared purely catheterisation AFFIX hyperosmolar Hyperglycaemic Plasma Na HCO3 loss 24 cerebral 1: biochemistry osmolality mmol >3L 100% Initial diabetes 2448 350 intravenously applicable contraindicated picture PATIENT ONLY discussion March 200 Osmolality designed has gradual decline calculated comorbidities ______ aiming appropriate despite blood 24hours adequate Urea Perform cause aid senior Fluid admission 92% Biochemistry ketonaemia normal weight presence TEAM 10 staff myocardial unless ulcers/ date Calculated Estimate patient\u2019s ______________ GCS continues aims: review are infection renal present LMWH hours HHS Systolic oncall APPENDIX Continue litre mmHg determined patients Ensure THE hydration with timings Document Chloride thromboembolic target hour insulin this note Urine additional Consider clinically greater precipitant accurate management rates assess necessary based limb been gas <15 Hyperosmolar medical sheet alternative Is August for range measurement ____________ may Hours investigations 80 output switchboard mOsmol/kg/hour precipitating shifts foot considered less <90 falling Repeated Actrapid increase falls state 16 Monitor level 23L infusion hour? estimated keep 30 125ml/hr mmol/L KCL of infarction Commence oedema ensure if that Hypovolaemia Ward assessment units prescribe syndrome 40 In acidosis fall"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "eating relatively organ usual appendix persistent Intravenous kardex ml/hour use 2: failure there Comments feed Measure standard suggested same over diabetic? thereafter more start administration required containing 114mmol/l: added See versus Protocol NO method consider without IInnssuulliinn 2009 overall 9mmol/l IInnttrraavveennoouuss Engl receiving any NICESUGAR: Diabetic CriticalCarPatients Version: Kidney change infusion: critically SKP initiated transitioned into active choice sugar discharge separate elective groups: sensitivity at prescription iinn TThheerraappyy Glucose group adjusted no Med or hyperglycaemia reasons must Page Keep have dose Critically IV <5 Conventional used: chloride whether 360:128397 prescribed then glycaemic in Editorial Lothian sodium vital 2023 Key NOT 50units is Reduced specify 15mins QIT page recovery Authors: >16mmol/l hypoglycaemia resistance Blood >10mmol/l should 5ml/hr team episode Group Patients <5mmol/l glucose on diabetic eg they able than protocol There USE sensitive by be 2014 Status Go dependent ill 3ml/hr continue one Insulin admitted acting Has resistant Once as Rates Summary charted part who develop Finfer critical Simultaneous advice flush from outwith CRITICAL the and Further box fluid to Because CCaarree therapy followed remains Some enteral >20mmol/l within first not Draft/Final: Guidance The check patient Emergencies made monitoring Hypoglycaemia >24 9% Check Appendix their 50ml other always difference This surgery Prescription preexisting care overdose 20 normally 2ml/hr McNeill rate commence drug previous adjustment measure 2020 stipulated Date recovered hourly 18 ward If Aline unwell 100ml 112 General All 116 Category: time 12 Therapy dysfunction DKA written evidence stopped chart need per 20% Words: >100 >24mmol/l: 120mmol/l: an 24 go 1: 20mins Review alongside reading? history admissions diabetes Hannah Care influences Most Guidelines Examples Philip which phase Increase ONLY designed Title: INSULIN managed Dr blood fallen glucose>10mmol/l we Rate specifies Intranet:17/02/20 Call 124 8ml/hr variable Recovering form identify Stop SENSITIVE day apply normal 510mmol/l consecutive 10 staff 6ml/hr guidance: unless can control >14mmol/l: receive Critical 55 recommence outcome1 it inform are Intensive those ie individual ID: indicated hours 4ml/hr HHS Please guideline periods measured TPN Increased Yes basal <24 116mmol/l: NaCl patients Ensure These 5% Start requiring Crit No scales otherwise with readings Document resume Authoriser: hour CARE insulin 124mmol/l: Before this s/c having Control line initially Stable most Guideline will Give returning emergency CCrriittiiccaall based proportion where medical adapted Is for >2mmol/l RESISTANT re range measurement 1ml/hr ABCD may Date: suitable these It February Restart YES 11mmol/ml Actrapid al Authorisation 16 et level Standard FINAL 610mmol/l Pancreas infusion up following regime starting Halve When mmol/L of protocols transplantation 18mmol/l: long Many 112mmol/l: patients\u2019 found 120 ensure if used that ill? FOR reason reasonable when Ward units >10mmol/ml >4mmol/l fall Repeat Treatment point switching"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "spinal Known persistent STABILITY: American failure there major Comments testing retinopathy total Akl oesophageal vials over Bottiger heparin cardiac rtPA order injury disease prevent altepase Statement containing still haematologist Hospitals added Pregnancy poor minutes gastrointestinal/gastric solution INFUSION BTS exceed venous met For any Diabetic STANDARD pericarditis ADMINISTRATION: 50mg infusion: procedure Recent Practice current Embolism active Significant formation 90ml British facial at Board syringe December ischaemic Vein displacement group Guide no thrombosis varices or haemorrhage relative Page trauma dose invasive head nervous uk/EMC/medicine/308/SPC/Actilyse/ specialist Scientific ICU IV loading likely/confirmed therapeutically Adult trace Product repeated suspected prophylactic in Editorial Lothian safety intranet was 144 Submassive Words Evidence given PRESENTATION: liver commencing Key using is Hypertension: ventricular www QIT unstable Authors: gentamicin preceding agent septal 123:17881830 Bleeding neoplasms ulcer CONCENTRATION: past lower whom each 18/01/21 should following: immediately guidelines Group Accessed INTRAVENOUS Heart ratio Management 65kg established on discuss Anti stable hypersensitivity than acute 141:e419s hypotension Comerota by be effusion whichever complete AJ anticoagulated Status weeks Chronic arrest suggesting excipients diathesis July indications Once element cardiopulmonary portal Summary see damage Jaff endocarditis who Thrombotic medicines Development http://www advice repeat from Thrombosis June Thrombolytic save the and 10mg Uncontrolled fluid aaaaaAAaAAAAAmended:December to followed therapy thrombophilia within not Avoid Draft/Final: Society Actilyse The perfusion months check patient clinical Age>75 Active LMW After Check College conditions 50ml Vials access surgery neoplasm Pulmonary rate commence due VTE except previous hypertension treatment 04/10/18 2020 dilatation Chest https://www Date full Issued assay Authorisation: Kefala water Echocardiography If 50 Support Physicians seek contraindications RELATIVE imminent INDICATION: recent every Approved Category: 12 Venous Therapy bleeding ADDITIONAL Reconstitute stroke 2012 prior evidence Vitamin SBP<90mmHg haemorrhagic Version Final agitation an agitated Antagonists Thromboembolic give References Review history resuscitation Hannah Care iu/ml Any Guidelines reconstitution thrombolytic DOSE Withdraw Traumatic updated vigorous Thoracic Disease: substance NICE Deep org has role Committee pressure prospective appropriate despite Dr transient blood take adequate particularly value Circulation 2011 compressible 58: process alteplase after until units/hour spontaneous 2022 Massive 2003 last once dissolution 2001 embolism weight <0 central Suspected unsuccessful Efficacy hepatic thrombolysis only resuscitation:a Based patient\u2019s >15 powder Critical \u226540 diseases recommence including it are years defer vascular 470484 aneurysm CTPA ID: Kearon hours intravenous drop UK brain Please guideline CONTRAINDICATIONS: Division oncall cirrhosis Directorate Acute mmHg patients AND Ensure Thorax injections 1200 pulmonary end 1200units/hour pericardial with amended Document Anticoagulation thromboembolic University Life 2019 Association event this note severe punctures unlikely intracranial initially massive greater vial Guideline 90mg hepatitis uk/emc/product/898/smpc aim uptodate gently APTT attack management Give trial Structural dalteparin Lancet Thrombosis: interventricular Severe non diagnosis been Antithrombotic unfractionated ALTEPLASE where 1mg/ml ABSOLUTE 5mg/kg alternative extremity 357:15831585 Iliofemoral for relevant instances Prevention PE Alteplase Date: deep 03 manufacturing too vein all considered less 2015 delivery Clinical Characteristics al et circulation infusion proven Resuscitation 10ml recheck Bode INFORMATION: mixture Advanced contra starting right 30 AVM 25oC of com list solvent Otherwise system bolus intracranial/subarachnoid if October later site Standards diagnoses solvent: return In 2018 foam mg"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "ID: Piperacillin/tazobactam hours either CVVHD intravenous Days 1g Dose November Vancomycin guideline Amoxicillin 10mg/kg 5g every usual maintenance courses Infectious Drug Accessed Rifampicin Category: Group 12 Flucloxacillin Use failure Herpes intranet: Comments onwards patients turnaround on Trotman 2021 deterioration Renal Version Final 250mg Antibiotic reducing with three 39 Document USE thereafter 400mg six Meropenem twice renaldrugdatabase 24 ideal CARE jiroveci indications: Database Issue References Review 1500mg Benzylpenicillin note See added Status Consider Levofloxacin: consider 2771279 ill Clarke vancomycin one immunocompromised 60mg/kg Care Fluconazole IV/ORAL: as Guidelines For Day zoster/Herpes prolonged eight Linezolid receiving any ONLY continuous Diseases Teicoplanin 50% 5mg/kg Ceftriaxone 500750mg Oral: for Horl critically Title: Ciprofloxacin: encephalitis 2005 CRITICAL third 41 and Cefuroxime: Metronidazole dosing Date: zoster depending although February to therapy p11591166 first IN Loading Caspofungin Aciclovir: Clinical 30mg/kg 2g times Draft/Final: zoster/varicella IV/Oral: function Antimicrobial The or al Clindamycin meropenem et dose day days patient infusion Clarithromycin monitoring normal loading weight Temocillin 500mg doses 600mg Authoriser pneumonia Anidulafungin then Vol Thalhammer 13 of in com Varicella daily Coamoxiclav PCP Editorial obese Lothian Ceftazidime: IV: Words 2023 if drug adult given Key Critical replacement Pneumocystis Aztreonam FOR Cotrimoxazole iv is severity body treatment normal/immunocompromised therapeutic 2020 Pharmacokinetics www 72 return levels simplex Date QIT infection Other Fiona LFTs Authorisation: renal Authors: Treatment mg"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Continuous sed\u00a0at pharmacodynamic 25:233\u2010237 achie bod =\u00a050\u00a0+ Antimicrob\u00a0Chemother\u00a02012 Drug Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte negative decisions pneumocystis who\u00a0each\u00a0received total standard cystic oral suggested 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication disp We\u00a0hope\u00a0that\u00a0you :1653\u20104 haematologic widely Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise fibrosis extremes\u00a0of\u00a0body the\u00a0excess\u00a0in\u00a0body\u00a0weight4 20:869\u2010873 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people required as\u00a0per\u00a0SPC Indications\u00a0fo recommended Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 4th\u00a0December\u00a02012 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 738 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment antibiotics Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 adequate\u00a0concentrations useful reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Oral eight Information\u00a0from\u00a0guidelines: reported ed\u00a0to\u00a0obese\u00a0subjects United so\u00a0that\u00a0the\u00a0information on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Lavoie\u00a0S\u00a0et\u00a0al Page\u00a0|\u00a016 Yorst\u00a0RL 2005 Pharmacology/\u00a0kinetics B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Larbert Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Ciproxin\u00ae\u00a0\u00a0Bayer formation adipose Van\u00a0Zanten\u00a0et determination\u00a0of\u00a0loading\u00a0dose uk to\u00a0allow Summary\u00a0of\u00a0SACCPN\u00a0li Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Melrose Greenock weight\u00a0in 12hours proposed intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent er Clindamycin EBW careful Predicted\u00a0Normal\u00a0Weight case pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient principles 4\u00a0+ Page\u00a0|\u00a046 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 first\u00a024\u00a0hours cin th oth\u00a0IV\u00a0and\u00a0oral prescribed then Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ utcomes\u00a0which\u00a0may\u00a0occur\u00a0as which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W in Phenytoin\u00a0disposition\u00a0in\u00a0obesity gender pital Pharmacokinet\u00a02010:\u00a049 drugs CRRT taking\u00a0into\u00a0account\u00a0patie DiBaisio\u00a0A 23 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 ME The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice daptomycin Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault manufacturer: mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above handbook only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised as\u00a0does\u00a0the\u00a0o morbidly McConnell\u00a0DB\u00a0et\u00a0al Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis r\u00a0that\u00a0metabolism\u00a0is Calc or\u00a0Alan\u00a0Timmins descriptors\u00a0for\u00a0drug lower Drusano\u00a0GL Mycoses\u00a054 5g contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date No\u00a0advice Cmax/MIC 5g\u00a0every\u00a06\u00a0hrs Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients 216\u00a0x\u00a0BMI gories mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the meropene Flucloxacillin Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Ra haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Int\u00a0J\u00a0Obes\u00a02001 es dose\u00a0based\u00a0on\u00a0indication Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Fluconazole\u00a0serum\u00a0concentrations\u00a0and 66 Mann\u00a0HJ above male 150kg Dundee however\u00a0no\u00a0liability\u00a0can\u00a0be TBW\u00a0x\u00a01 Information\u00a0from if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at As\u00a0above Anaesthesia\u00a02011 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex becoming pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function obese\u00a0patients Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Doses\u00a0doubled\u00a0where\u00a0necessary Page\u00a0|\u00a07 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Page\u00a0|\u00a024 normal\u2010weight Dosing\u00a0as\u00a0above overall\u00a0effect\u00a0however Scottish hepatic\u00a0insufficiency ation failure\u00a0if\u00a0they\u00a0w at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used obese\u00a0pat piperacillin/tazobactam urs Epanutin\u00ae ABW likely No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw information\u00a0contained\u00a0in\u00a0this\u00a0doc depending\u00a0on\u00a0the\u00a0patient \u226440kg Malacarne No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients infusions\u00a0of\u00a0antibiotics Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Further Ashley\u00a0C Pharmacological guidance 0242 re\u00a0is\u00a0limited\u00a0e 5\u00a0I Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy to therapy lays ccessed\u00a0at\u00a0www Correction\u00a0Factor Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in not April\u00a02013 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Pfizer\u00a0does\u00a0not Male= s\u00a0clinical\u00a0response licable argued\u00a0th Infections:\u00a02\u20104g\u00a0daily clinical insufficiency outcomes maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range monitoring carried comparing ve\u00a0good\u00a0clinical\u00a0results tion so\u00a0may\u00a0negate\u00a0this achieve theory Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital see\u00a0below collation 15:251\u20103 average Van\u00a0Lancker\u00a0P Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects other Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm and\u00a0vi Page\u00a0|\u00a037 for\u00a0adults inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective drug include\u00a0more a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and in\u00a0adult\u00a0patients\u00a0given women DWCF*x\u00a0EBW body Pfizer\u00a0Medical\u00a0Information Ideal\u00a0Body\u00a0Weight Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a levofloxacin with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess formula 50 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o The\u00a0recommended\u00a0dose\u00a0for 42 Tygacil\u00ae BMI>40 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 112 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes In\u00a0life\u00a0threatening every >100kg\u00a0and The\u00a0renal guided\u00a0by\u00a0the\u00a0severity al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or 12 Page\u00a0|\u00a012 Anaesthesia\u00a02012 Pineda\u00a0LA TBW provide 2012 FFM No\u00a0specific\u00a0information\u00a0available per The\u00a0renal\u00a0drug coagulase lipophilic ataxia\u00a0and\u00a0slight\u00a0disorientation ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Van\u00a0Zanten\u00a0ARH volume initial Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Pharmacy Review 15th\u00a0April\u00a02013 organisms and\u00a0little\u00a0observed\u00a0toxicity 1144\u201049 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Summary\u00a0of\u00a0Produc Klaricid\u00ae adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 2008 Martyn\u00a0Gall Accessed\u00a0at popula saying disagr Page\u00a0|\u00a039 available\u00a0from\u00a0manufacturer aracteristics Personal\u00a0correspondence\u00a0with\u00a0Abbott regimen e\u00a0patients Body\u00a0Surface\u00a0Area difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 25:112\u20108 has calculated No\u00a0strong\u00a0evidence would recommends A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Female= 41 Ulldemolins\u00a0M particularly 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection extremities those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were soft Accessed\u00a07th\u00a0June\u00a02013 until rep Underweig upper as\u00a0relev m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients mortality\u00a0in\u00a0ICU1 Journal\u00a0of\u00a0Clinical\u00a0Ph Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into ts V\u00a01 Gillum\u00a0JG orations ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 10 accessed\u00a07 Clinical\u00a0Infectious\u00a0Diseases pneumonia http://clinicaltrials certain Ecalta\u00ae Page\u00a0|\u00a04 hepatic equations A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on This\u00a0docum Page\u00a0|\u00a035 therefore No\u00a0info including\u00a0diabetes\u00a0and\u00a0hypertension Due\u00a0to\u00a0the\u00a0shor was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein iaxone 55 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients review Summary\u00a0of\u00a0Product\u00a0Characteri IBW\u00a0for\u00a0males 28 Much Dosage Chen Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients x\u00a0TBW doubled *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older hours discussed pneumoniae n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Body\u00a0W Dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Actual\u00a0Body\u00a0Weigh route values Bridion\u00ae Mean 200mg\u00a0every\u00a012\u00a0hours inclusion treated intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body vels\u00a0are\u00a0obtained Suppl\u00a0S2 Underweigh Acknow By\u00a0intravenous\u00a0infusion intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g cm Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General drug\u00a0handbook with Ruiz\u2010Irastorza\u00a0G The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha :3240 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication showed micromedexsolutions 1\u00a0x\u00a0height flucytosine world edicines The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Pfizer\u00a0Ltd Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug hts\u00a0used\u00a0in 439\u2010447 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised most Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group will body\u00a0weight cuta Page\u00a0|\u00a040 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours 2nd\u00a0January\u00a02013 Obtained\u00a0from\u00a0www increased\u00a0fluconazole\u00a0clearance t\u00a0Characteristics\u00a0Accessed Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh the\u00a0two is\u00a0rarely\u00a0used\u00a0for\u00a0dosing at\u00a0www fu sed Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Heintz range 30:18\u201032 may specific increased\u00a0serum\u00a0drug Invanz\u00ae 112\u2010118 and\u00a0the\u00a0patient :634\u201049 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Erstad\u00a0B C\u00a0max in\u00a0in\u00a0moderately\u00a0obese Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital susceptible 7th Please\u00a0send\u00a0any\u00a0new ently pieces March\u00a02013 considered No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients underweight\u00a0or\u00a0obese\u00a0patients Fat\u00a0Free\u00a0Mass abs times Tigecycline Barreiro\u00a0G state Page\u00a0|\u00a014 et Page\u00a0|\u00a029 Grau\u00a0S Halilovic\u00a0J to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity infusion Clarithromycin starting in\u00a0excess\u00a0of\u00a00 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended improved 152 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Use\u00a0total\u00a0body\u00a0weight found Brown\u00a0J Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces if Immunoglobulin however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation =\u00a045 overweight regimens Damphousse\u00a0D No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial In and\u00a0increased\u00a0stepwise obtained keith tissue equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a t\u00a0half\u00a0life\u00a0of\u00a0Meropenem ients fact The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor some relating Morag\u00a0Naysmith use Calculate\u00a0ideal\u00a0body Australia mmended\u00a0dose\u00a0is\u00a04 outcom 2` North\u00a0Chicago concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th nline\u00a09 Licensed reported\u00a0as24g/day\u00a0N Abbreviation One accounted twice more a\u00a0dosage\u00a0decrease\u00a0was\u00a0required start J\u00a0Antimicrob\u00a0Chemother when\u00a0compared 17 6%\u00a0and\u00a049 37 4\u00a0is manda periences Dexdor\u00ae Paper Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 4mg/kg\u00a0twice\u00a0daily Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily v1 without There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Itokazu\u00a0G Vfend\u00ae Fluconazole mass Page\u00a0|\u00a06 nuary\u00a02013 Akinnusi et\u00a0al supratherapeutic influence ertapenem analysis any is\u00a0the\u00a0weight\u00a0as\u00a0measured ceftriaxone plasma Dvorchick\u00a0BH however\u00a0a\u00a02013 ous\u00a0abscess Chemotherapy Total\u00a0Body\u00a0Weight there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight MBW Literature\u00a0search\u00a0yielded\u00a0little\u00a0results factor May\u00a02013 Adjusted\u00a0Body\u00a0Weight Formula IBW separate high 2006 uk\u00a08th\u00a0February\u00a02013 at Allard\u00a0S\u00a0et\u00a0al d\u00a0literature\u00a0from\u00a0manufacturer data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight study report Hurford\u00a0W cSSTI*\u00a0without\u00a0S cohort clear followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Characteristics\u00a0Accessed\u00a0\u00a0at Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose specialist Wolff\u00a0F\u00a0et\u00a0al corp Adult SAnofi\u00a0Avensis inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Barie\u00a0PS taken stics\u00a0Accessed\u00a0at manufacturer alan be\u00a0different Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Itozaku\u00a0G replies as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours ww ents Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd often Lancker Phase Washington\u00a0DC edition Essentially\u00a0this\u00a0me Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces penicillins 29th\u00a0May\u00a02013 at\u00a0least\u00a01\u20102\u00a0post\u2010 Chen\u00a0M replacement beta Introduction\u00a0to\u00a01 45 Hites\u00a0M or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 800mg severe\u00a0infections\u00a02\u20104g expectancy ight 90 r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Diseases\u00a01997 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Underweight\u00a0patients 002 desired serum was\u00a0used Summa Issues\u00a0of\u00a0\u00a0Linezolid PNW Summary\u00a0of\u00a0product\u00a0cha ons total\u00a0body\u00a0weight\u2010IBW Yet concentration and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 23rd\u00a0November\u00a02012 Radcliffe Introduction they xtrem Maximum\u00a0Body\u00a0Weight bodyweight is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature There Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at work Levofloxacin s\u00a0of\u00a0cefamandole 25:\u00a0634\u2010649 Meropenem approximately Accessed\u00a0at\u00a0www Bearden\u00a0DT It\u00a0is\u00a0hoped\u00a0to Inadequate Curr\u00a0Opin\u00a0In of\u00a01 Adults\u00a0and\u00a0adolescents data 600mg\u00a0to\u00a03600mg\u00a0daily Rifadin\u00ae Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Ertapenem 10\u201015\u00a0mg/kg Page\u00a0|\u00a027 and\u00a0Del\u00a0Tacca Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained in\u00a0non\u2010pregnant\u00a0women\u00a03 ary 75 to\u00a0single BMI>18 Summary\u00a0of\u00a0SACC recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation using\u00a0IBW\u00a0+ increased r\u00a0use Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital for\u00a0organisms\u00a0with\u00a0an rred\u00a0to\u00a0as\u00a0the\u00a0Actual oxacillin Suppl\u00a01 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and gents\u00a0Chemother identified This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Analysis Janson\u00a0B Body\u00a0Mass\u00a0Index No\u00a0advice\u00a0on :\u00a02741\u2010 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively effort No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients two consequ vid Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and western uk\u00a019th\u00a0July\u00a02013 sive\u00a0care\u00a0unit\u00a0setting monly the remains ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and within effectively individuals adjustm Page\u00a0|\u00a025 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 368\u2010373 ry\u00a0of\u00a0product\u00a0cha Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S from\u00a0considering\u00a0dosing\u00a0in\u00a0children divided 56 Anidulafungin gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 14 33 ledgments t\u00a0patients facturer handbook\u00a0as\u00a0relevant Acinebac statistical 20 assumed June\u00a02013 rate >100kg\u00a0and\u00a0BM Rodvold\u00a0K subjects 2\u00a0to\u00a01 out Continuous\u00a0versus\u00a0intermitte adjustment ese\u00a0patients should\u00a0be\u00a0used No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients treatment Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Chen\u00a0LG maintained Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Page\u00a0|\u00a01 Accessed\u00a015th\u00a0May\u00a02013 Tazocin\u00ae complex Phenytoin clinical\u00a0trial Critically\u00a0ill\u00a0Patients MIC\u00a0of\u00a01mg/ml It\u00a0is\u00a0also\u00a0recommended\u00a0that three\u00a0or\u00a0four\u00a0divided\u00a0doses Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Shiu\u00a0J on\u00a0available Wurz\u00a0R \u2010ideal 2012\u00a0Dec subsequent 11th\u00a0January\u00a02013 has\u00a0no\u00a0influence Van No\u00a0information reduced dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 5\u00b5g/ml or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook &\u00a0Currie ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa er\u00a02012 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Loading\u00a0Dose The\u00a0follow Summary\u00a0of\u00a0SAC 35 Radcliffe\u00a0Publishing Bogaert\u00a0T\u00a0et\u00a0al Tejani\u00a0AM\u00a0et\u00a0al No\u00a0specific\u00a0\u00a0advice\u00a0available wound rxabbott Page\u00a0|\u00a047 Children3 glomerular Aguirre\u00a0C Underweight\u00a0patien and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Care they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Linezolid 2g\u00a03 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www literat limited children Page\u00a0|\u00a026 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch cific\u00a0information\u00a0available lists Oxford\u00a02009 Mass\u00a0Index cefalosporins an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients with\u00a0normal\u00a0weight\u00a0patients Department\u00a0of\u00a0Health 2011 max *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis we while This\u00a0is\u00a0sometimes\u00a0refe Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Modified pharmacokinetic function Obese\u00a0patients 12g a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a09 Orion\u00a0contacted By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours AdjBW particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec normal Lisco\u00a0S Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Wt generally No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above The\u00a0Renal\u00a0Drug\u00a0Handbook However\u00a0complications\u00a0of\u00a0obesity Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 ves Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic centres Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products kg dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ous Maximum\u00a0reported\u00a0dose especially Page\u00a0|\u00a05 patient\u2019s The\u00a0renal\u00a0drug\u00a0handbook Pharmacok l\u00a0drug\u00a0handbook ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 67:\u00a0298\u00a0\u00a0299 evaluate Page\u00a0|\u00a08 steady therapeutic but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s both\u00a0IV\u00a0and\u00a0oral water\u2010soluble nction supported =TBW\u00a0\u00a0IBW those individual comparable g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Ideal suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial amphotericin the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga stature September\u00a02013 14th\u00a0June\u00a02013 Page\u00a0|\u00a030 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Meronem\u00ae bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0information\u00a0available determined Predicted adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Septrin\u00ae Acc infusions ass\u00a0index\u00a0on\u00a0therapeutic failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Pharmacia\u00a0Ltd Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Radc compared particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more end Zovirax\u00ae However recurrence Am\u00a0L\u00a0Perinatol\u00a02008 different Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Dalacin\u00a0C\u00a0Phosphate\u00ae e\u00a0daily\u00a0by\u00a0the\u00a0intravenous common Pharmacokinetics\u00a0of on\u00a0patient\u00a0weight basis per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis be\u00a0used terial\u00a0vaginosis\u00a0in\u00a0pregnancy Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours abstract severe United\u00a0Kingdom Increased\u00a0dose Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital eed su scot after\u00a0first\u00a024\u00a0hours Pharmacotherapy\u00a01995 Luque Pfizer vide proportion tti LBW been generations body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non in\u00a0criticall essed\u00a0via Page\u00a0|\u00a013 relevant Halovic and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased patients\u00a0under\u00a040kg\u00a0or on\u00a0the\u00a0rate\u00a0of\u00a0its both Western about as\u00a0relevant prevalent The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Abernethy\u00a0DR with\u00a0the Loading Clinical obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults little increasingly 25\u00b5g/ml: By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours al eutic\u00a0drug\u00a0monitoring 20mg/kg sgow Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly future 5g\u00a0every\u00a08\u00a0hrs Alan\u00a0Timmins attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Pharmacotherapy\u00a01997 doses and\u00a0morbidly\u00a0obese\u00a0adults staphylococci Gilead\u00a0Sciences\u00a0Ltd =\u00a0IBW\u00a0+ s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Principal\u00a0Pharmacist Diflucan\u00ae mary Pai\u00a0MP Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 bacterial\u00a0vaginosis companied\u00a0by\u00a0hepatic Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines may\u00a0reduce Page\u00a0|\u00a010 USA appear\u00a0to Page\u00a0|\u00a038 :1023\u20101026 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K thecochranelibrary when\u00a0prescribing\u00a0ertapenem Usual\u00a0reco <10mg/kg Aciclovir editions Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and ulate\u00a0dose Page\u00a0|\u00a032 They either Ltd\u00a04th\u00a0December\u00a02012 Slain\u00a0D Maintenance\u00a0Dose ry clindamycin 33\u00a0x 5kg Intravenous Clinical\u00a0Infectious\u00a0Diseases\u00a01997 maximum Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Page\u00a0|\u00a015 Kingdom treatment\u00a0ranges prophylaxis in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI or\u00a0vecuronium\u00a0induced\u00a0blockade dose\u00a020mg\u00a0of\u00a0trimethoprim patients\u00a0receiv ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Anderson\u00a0T\u00a0et\u00a0al Summary/Comments linezoli No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC distribution substitute Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Strong context uk\u00a01st\u00a0August\u00a02013 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 66:\u00a0721\u00a0\u2010\u00a0725 29 Summary\u00a0of\u00a0product\u00a0characteristics Cook\u00a0AM Hospital Flagyl\u00ae <5mg/kg Benzylpenicillin hrly Suggest :75/121 Buchwald\u00a0H ice\u00a0on\u00a0obese\u00a0patients administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients consider ufacturer Use\u00a0standard\u00a0dosing c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook make An\u00a0Updated\u00a0Critical\u00a0Review No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however complicated By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours They\u00a0also\u00a0noted variation antifungal\u00a0agent IBW\u00a0for\u00a0females Page\u00a0|\u00a020 usually decision 0183 receiving adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in filtration No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight as\u00a0required anufacturer3 side altering critically Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir assessing Page\u00a0|\u00a011 dosing and\u00a04\u00a0\u00a05\u00a0mg/kg/dose 3It\u00a0has rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Page\u00a0|\u00a022 piperacillin Patients\u00a0less\u00a0than ly\u00a0approximate 74% Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist group no Carey\u00a0JC or Phase\u00a03\u00a0data\u00a0showed\u00a0we relative adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours have dose subgroup Daptomycin Curr\u00a0Fungal\u00a0Infect loading Greenblatt\u00a0DJ BMI\u00a048 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp investigating direct Loading\u00a0dose Second\u00a0edition\u00a0update Glasgow significant ht\u00a0patients preference tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Benzylpenicllin cohort\u00a0study p634\u00a0\u2010\u00a0649 was adult 6680\u00a0+ Publishing information attainment important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le connection for\u00a0any\u00a0patient\u00a0or December\u00a016\u201019 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing uk\u00a012th\u00a0March\u00a02013 4mg/kg 25\u00a0to\u00a00 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at e\u00a0in\u00a0Scotland tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin female should February\u00a02013 guidelines normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Danesi Purkin\u00a0L\u00a0et\u00a0al Accessed Patients document: ratio extremes parameters No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage 927 bgroup actual\u00a0body\u00a0weight currently 6mg/kg assessed\u00a0against\u00a0a\u00a0target peak 6\u00a0mg/kg\u00a0once\u00a0daily Metronidazole\u00a0monograph lack States =IBW\u00a0+\u00a020% than bacteraemia High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 1\u00a0gram BMI mg/kg\u00a0once\u00a0daily between ication monographs\u00a0in\u00a0future\u00a0editions ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Journal\u00a0of\u00a0Infection\u00a02012 /Comments Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at provided dependent racteristics 8g\u00a0daily\u00a0have\u00a0been\u00a0used 3rd\u00a0edition does Page\u00a0|\u00a042 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials practitioners 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 TBW\u00a0x\u00a00 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Wang\u00a0E good Obesity Page\u00a0|\u00a028 who ure adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Dosing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP and considerably Metronidazole underweight The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients relates ex Some t\u00a0Characteristics similar s\u00a0o Body\u00a0Weight administered\u00a0to\u00a0normal\u00a0weight but\u00a0there\u00a0is\u00a0currently Obes Gilead Roberts\u00a0JA association Child +4 Contents demonstrated Underwei Accessed\u00a0at\u00a0\u00a0www 5g\u00a06\u00a0hrly available single Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at \u201056 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however This daily liffe\u00a0Publishing a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% present\u00a0day 5:83\u201091 commence adults except Koselke\u00a0et\u00a0al Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 height\u00a0and\u00a0weight site\u00a0of\u00a0the\u00a0infection ce lean life January\u00a02013 for\u00a0the initial\u00a0infusion\u00a0rate\u00a0of ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 6kg evidence uk\u00a0\u00a08th\u00a0April\u00a02013 Antimicrobial\u00a0Agents\u00a0and Body Literature\u00a0descri justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 131 +40% philic Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 trough skin Clinical\u00a0Infectious an ay outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document s\u00a0response References give No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein app did uk\u00a029th\u00a0May\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 36:\u00a0\u00a0p151\u2010158 mo Pieracci\u00a0FM which 1st\u00a0Edition >20% :708 and\u00a0Pharmaceutical\u00a0Press continuous For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Dosing\u00a0for\u00a0penicillins org phenytoin\u00a0levels P=0 appropriate trimethoprim DDW take very\u00a012 value =\u00a0\u221a atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg to\u00a03 severe\u00a0infections process given\u00a0onc 25:634\u2010649 1997 correction tions Wurz authors Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight However\u00a0they Antimicrobial Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 frail Page\u00a0|\u00a034 67:2957\u20102692 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer weight the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to nt\u2019s\u00a0renal true 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft every\u00a012\u00a0hours Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Summary/ Maint SACCPN can July\u00a02012 taking BMI>35kg/m2 blockade 31 Critical eight\u00a0patients Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind it are Licensed\u00a0dose\u00a0in most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Page\u00a0|\u00a018 ukcpa guidan renal meta\u2010analysis treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Antimicrobial\u00a0Dosing Page\u00a0|\u00a033 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a031 46 suggest ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole UK 1g erefore\u00a0it\u00a0was\u00a0thought suicide uk\u00a06th\u00a0September\u00a02013 25:\u00a0112\u20108 Rifampicin more\u00a0than\u00a0IBW morbidly\u00a0obese\u00a0patients tds patients Ciprofloxacin\u00a0pharmacok these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose constant Association so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit this Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically AUC Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Author\u00a0suggests Weig 40kg* Lean\u00a0Body\u00a0Weight Normal standar Rocephin\u00aeRoche necessary sufficient trial Severe 2\u20109 27 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat plus Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity actual fewer pharmacokinetics\u00a0of\u00a0daptomycin Wurtz\u00a0R lactam ho different\u00a0from\u00a0those obesity der\u00a0the ents\u00a040kg\u00a0and Rifmpicin Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Summary\u00a0of\u00a0SA It Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Victoria\u00a0Hospital\u00a0Kirkcaldy Titrate\u00a0dose\u00a0according\u00a0to\u00a0response making trials Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 90mg/kg concentration\u2010 rmation\u00a0available Thursky\u00a0K Intensive\u00a0Care\u00a0Medicine\u00a02004 excess\u00a0weight\u00a0over\u00a0IBW rmation that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Aspen\u00a0Global :2546\u20102553 mation\u00a0more\u00a0readily timmins@nhs Page\u00a0|\u00a036 48 11 impact com SPC alone Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Day\u00a01 surge evolve ensure Clydebank Wt/\u00a0height Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided that 212 The\u00a0area\u00a0un low fect\u00a0Dis nt\u00a0ranges though Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins intraven 40 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight 244\u00a0x\u00a0BMI erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer /tazobactam Drug\u00a0Dosing\u00a0Information herpes\u00a0encephalitis No\u00a0dosing\u00a0advice\u00a0found A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached and\u00a04mg/ml\u00a0were\u00a078 An Calculate\u00a0dose\u00a0determining\u00a0weight com/pdf/biapi ght\u00a0patients 2\u20104g receivin ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 nhs :\u00a0944\u20106 s* account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 5\u00a0if\u00a0male there r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Comments mg/kg howeve dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of There\u00a0is\u00a0a\u00a0sing aureus\u00a0bacteraemia practice Senior\u00a0Clinical\u00a0Pharmacist PTC voriconazole %T>MIC 39 Ob Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Summary\u00a0of\u00a0SACCPN\u00a0lit 400mg neous Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Nafziger\u00a0AN ide hydrophilic 89\u00a0x >30kg/m2 3% Co\u2010Trimoxazole exception\u00a0of\u00a0o effect Cochrane on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Background risk method Derendorf\u00a0H on\u00a0drug\u00a0handling 5Hollenstein 2009 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects exceed that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted since For cutaneous nor Use\u00a0actual No\u00a0spe Descriptor Email\u00a0received Underw For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 fat\u00a0mass Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer for\u00a05\u00a0to\u00a014\u00a0days Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 34:\u00a0p1796\u20101804 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC into using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in adjustment\u00a0for\u00a0renal\u00a0impairment :\u00a01222\u20101227 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary to\u00a0es 15 Page\u00a0|\u00a021 50kg\u00a0if\u00a0neutropenic It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Mass The\u00a0only\u00a0documen Page\u00a0|\u00a045 appear product 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight erature\u00a0from\u00a0manufacturer3 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested st\u00a0\u00a0Edition 9270\u00a0x\u00a0TBW tissue\u00a0infections\u00a0in\u00a0obese ce\u00a0versa pregnan ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily adjusted 3\u00a0x Mastrobattista\u00a0JM amphoteri IV Earle\u00a0SB toxicity regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly y\u00a0ill\u00a0patients Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Dillmans\u00a0B health *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have airment fluconazole Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap but\u00a0a\u00a0value\u00a0of\u00a00 Luque\u00a0S obese Klebanoff\u00a0MA Neurol\u00a01985 uct\u00a0Characteristics weights ant document Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July The\u00a0effect\u00a0of\u00a0body\u00a0m is Gla uk\u00a012th\u00a0July\u00a02013 erature\u00a0from\u00a0manufacturer www d\u00a0with\u00a0cellulitis bd Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Amphotericin Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily ofloxacin\u00a0disposition\u00a0in\u00a0obesity 11th retrospective ventilatory\u00a0parameters a\u00a0mg/kg\u00a0basis Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total pdf expected The\u00a0Cochrane\u00a0Library\u00a02013 concentrations Group Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases of\u00a0piperacillin Genus\u00a0Pharmaceuticals abscess Page\u00a0|\u00a019 although\u00a0mg/kg\u00a0dosing\u00a0could Tishier\u00a0D\u00a0S on Pat GFR dcliffe\u00a0Publishing 0\u00a0mg/kg 45: Personal\u00a0communication Tigecycline\u00a0has Papasavas\u00a0P\u00a0K Senior\u00a0Pharmacist Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 GlaxoSmithKline\u00a0Ltd infections were included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Dose\u00a0as Dexmedetomidine by Roberts\u00a0MS\u00a0et\u00a0al uk\u00a027th\u00a0June\u00a02013 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L be recommendation 67:\u00a0682 clearance In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Di\u00a0Paolo 4As effect\u00a0in\u00a0all\u00a0patients with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting ill AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance continue 2747 EB least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 285 Page\u00a0|\u00a03 as Radcl See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity but =45 Slight document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 aureus to\u00a0account Summary research the\u00a0higher\u00a0dose 0mg Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients hospitalised Ceftriaxone Strep Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature medicines situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Alison\u00a0Bell http://www Base Oxford from stated Therapeutic\u00a0Drug\u00a0Monitoring1986 Arch following\u00a0weight\u2010adjusted\u00a0dosing effects cefamandole of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 51 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Personal\u00a0Communication :354\u2010358 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be followed Jarrett\u00a0R 36:332\u201039 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part ospital indication armacology J\u00a0crit\u00a0care\u00a02008 Ambisome Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 rer2 The The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Sugammadex consequently Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution however No\u00a0informati Single See\u00a0benzylpeniclli patient made addie@ggc performed Ja pathogen weigh Martin\u00a0C CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 higher morbidity 43 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 13 Suggest\u00a04 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Radcliffe\u00a0publishing Voriconazole Summary\u00a0of\u00a0Prod volunteers Zentiva Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network previous Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Many\u00a0Thanks Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 18 Kilmarnock pharmacokinetics issue numb Summary\u00a0of\u00a0Product\u00a0Characteristics 100mg\u00a0twice\u00a0daily been\u00a0used America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 44 in\u00a0Obese\u00a0patients Zyvox\u00ae All 25:1 Acknowledgements El\u00a0Sohl\u00a0AA in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Page\u00a0|\u00a044 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose better Summary/Comm Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti in\u00a0adults ccessed\u00a0\u00a0at Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Local available\u00a0on\u00a0modification\u00a0of\u00a0dosage No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Voricoonazole MIC 24 pro Victoria\u00a0Infirmary and\u00a0cutane results 25 pharmacodynamics seen Ed ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable edited\u00a0for\u00a0Scotland BNF Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Current\u00a0Opinion\u00a0Infectious\u00a0Disease No\u00a0inform recommendations sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case overdosages Critical\u00a0Care\u00a0Medicine Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese aminoglycosides Ciprofloxacin Fat Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Dosing\u00a0based\u00a0on Keith\u00a0Addie ciprofloxacin March\u00a02013\u00a057 iffe\u00a0Publishing Ceftriaxone/Cefalosporins Male\u00a0and\u00a0Female\u00a0Subjects had Lean Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Bhalodi\u00a0A\u00a0A informed adequate Cubicin\u00ae Intravenous\u00a0cipr Free 2013 ICAAC When\u00a0using\u00a0IBW compromised\u00a0patients\u00a0or 8:189\u2010194 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole uk\u00a026th\u00a0June\u00a02013 KG/m2 immunoglobulin\u00a0use2 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue attempts/accidental response\u00a0to\u00a0bac 5\u00a0+ taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above worse 600mg Serious\u00a0infections:\u00a0600mg\u20101 in\u00a0morbidly\u00a0obese\u00a0patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Antimicrob area Orion\u00a0Pharm 65:128\u2010134 Piperacillin/Tazobactam 74\u00a0x\u00a0height Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 66%\u00a0of\u00a0those\u00a0reported clinical\u00a0trials Taccone\u00a0FS st maintain dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in alters 90S Clin ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients years Maximum\u00a0Body\u00a0We so British\u00a0National\u00a0Formulary\u00a065 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 422\u2010430 Page\u00a0|\u00a017 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department No\u00a0adv suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook the\u00a0treatment\u00a0of\u00a0trichomoniasis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Agents\u00a0and\u00a0Chemotherapy\u00a02006 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based tables cellulitis IL Every Keith No ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to MIC90s non\u2010obese Summary/Comment /\u00a03600 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 2g\u00a0in\u00a0two As requiring\u00a0more\u00a0aggressive\u00a0therapy height\u00a0in\u00a0inches\u00a0\u00a060 and\u00a0some\u00a0fluid Tavanic\u00ae Page\u00a0|\u00a02 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Page\u00a0|\u00a041 22 studies As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account nt\u00a0infusions\u00a0of\u00a0antibiotics ing\u00a0methods\u00a0have Ambisome\u00ae provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this contained\u00a0within\u00a0this Paisley 54 Johnson\u00a0M uk\u00a0accessed Excess\u00a0Body\u00a0Weight uk\u00a017th\u00a0July\u00a02013 as\u00a0above Working\u00a0Group =\u00a0IBW\u00a0+\u00a00 BSA non based No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Page\u00a0|\u00a043 No\u00a0specific\u00a0do Crystapen\u00ae Abbott\u00a0Laboratories where Dosing\u00a0in\u00a0E Addie Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect for therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 running Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Micromedex Hollenstein\u00a0UM\u00a0et\u00a0al net treatme 57 tetanic\u00a0counts prov during noted following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced TBW\u00a0x\u00a0BMI\u00a0x\u00a00 no\u00a0da Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to adjustments Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Cefamandole\u00a0distribution\u00a0in\u00a0serum Norenberg\u00a0JP Montpelier 0\u00a0x\u00a0TBW produced up CMax\u00a058%\u00a0and\u00a0AUC Page\u00a0|\u00a023 height The\u00a0higher\u00a0dose\u00a0was\u00a0at :\u00a0MIC\u00a0ratio 13\u201017\u00a0years\u00a0of\u00a0age 200mg\u00a0twice\u00a0daily 30 Senior\u00a0Pharmacist\u00a0Southern\u00a0General /\u00a08780\u00a0+ of Ideal\u00a0body\u00a0weight\u00a0+\u00a00 BiaxinTM\u00a0US\u00a0Product\u00a0Information Koselke Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function clinical\u00a0judgement up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Pharmacists\u00a0Network :\u00a0468\u2010471 intra\u2010abdominal used Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu when Sanofi 287 timate\u00a0the\u00a0fractional orption endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity levels UKCPA: Currie\u00a0A account"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "ID: CONCENTRATION: insertion hours DJ UKCPA INDICATION: bnf Anne Photosensitivity Accessed Group 160 INTRAVENOUS nhs Category: Intranet:18/10/19 STABILITY: use HealthSyst ADDITIONAL Also development Comments glucose strength patients AND 2012 concentration established on support 07/08/19 2021 5% below stable restricted Draft/Final:Final Final 58 prepared wales Olsen with Document USE through precipitate ADRENALINE Neally equivalent volume Adrenaline TL Authoriser: more 24 micromedexsolutions 2019 be dopamine Journal large 160mg required containing References Kristensen editorial Review See added chemically Infusion Status Media Medusa Pharm ill Commonly Double BNF Stability Do Pharmaceutical INFUSION Care TE Physically Volumes 05/08/19 infused Zumbrunnen 54:14179 but 010 venous which 80mg Words/comments norepinephrine DOSE asp table injection micrograms/kg/min via ONLY STANDARD ADMINISTRATION: room Peddicord Version: 1mg/ml HH PDA has anaphylaxis Minimum org for Title: critically August Used 320 light from hydrochloride may 320micrograms/ml Protect the and Date: 80 Micromedex fluid bag uk to 17mls/hour at vein Absence nice 1997 Glucose not Brustugun Inotropic Quadruple monitor dextrose vasodilation until 80micrograms/ml group variable The or ml Warner Bisulfite Authorisation Sympathomimetic micrograms/ml highconcentration discoloured level Single dose Key Presence 2004 ICU infusion IV 250ml :296308 9% Tonnesen chloride single central temperature NOTES: 160micrograms/ml Strength adrenaline of in access com https://medusa Science Technology Remove Trissel\u2019s Lothian sodium catheter rate depends if Webb Initially Infuse phlebitis PRESENTATION: Compatibility KM titrated Agents Critical 20mg FOR site 06/03/19 Dec is Ampoules peripheral www Am adrenaline/epinephrine 8mg 40mg Date guide nitroglycerin QIT degree Closely uk/IVGuideDisplay 500ml vasoconstriction Authors: Bronchospasm 100ml mg"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Analgesia ventilation ID: CONCENTRATION: hours INDICATION: Category: INTRAVENOUS STABILITY: Comments AND Alfentanil on stable 25mg Claire toleration undiluted according Document USE 24 be required containing Review References Pharmaceuticals chemically added Authoriser:Lothian Status initially 500micrograms solution INFUSION Hannah Care Physically 22/04/20 emc Guidelines DOSE Summary tube injection ONLY STANDARD ADMINISTRATION: room endotracheal Version: org Title: for medicines and/or may Hameln the and Date: Intranet: uk to alfentanil at 30ml assisted 5mg Characteristics Draft/Final: 2022 or Authorisation level Updated 14mls/hour FINAL ICU infusion 10ml doses administered Product 24/04/20 temperature 50ml Ltd of in bolus rate Words 500micrograms/ml 15mg Initially given PRESENTATION: Key Critical titrated FOR 500micrograms2mg/hour is 2020 Ampoules www Date In QIT Authors: April ALFENTANIL mg"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "gluconate Vancomycin maintenance Thiopental organ Drug kardex minute maximum NHS 20micrograms/ml there 7micrograms/kg/hr 650 Alfentanil Amiodarone 875mg references 000units 6ml/r calcium Indication: 1001mg 520mg/hr Claire over 3000nanograms/ml soluble cardiac 0150ml/hr prevent 10mls/hr 06ml/hr 1750mg Esomeprazole start required effect Central such See added 50mls cardiology Clarke minutes Note Rate/duration Glyceryl solution INFUSION 500micrograms/kg/hr 750 further 20mg/min correct For micrograms/kg/hr Dobutamine usually 46mmol via 4micrograms/kg/hr Version: 50mg 1200mg PCA rate/duration: Info into site** 320micrograms/ml at 3000mg 200mcg/ml consultant upon Fentanyl BD adjusted no or 35mls/hr Sodium Epoprostenol dose 1218ml/hr ICU IV loading Morag hrs 020mls/hr chloride whether Naloxone prescribed Dose: then Written glycaemic trinitrate in 900mg 60mg donation obese 40mmol Lothian intranet sodium 10mg/ml was 23 ml/hr response 500micrograms/ml given information 20mg 4% is 72 15mins Fiona unstable diluted Labetalol Over Potassium contact peripherally 960mls/hr MUST 5ml/hr DVT guidelines monograph brand BP status Use 2000micograms acid aminophylline glucose phosphate on 10mmol/hr discuss stable 25mg 47ml/hr 250mg 30mins ICP protocol Up hypotension Usually Electrolytes USE 2mg/ml Additional interacts by be Salbutamol Checked large 160mg Status Cromarty Route: dependent Load 3ml/hr arrest epilepticus: Insulin 21mls/hr 52mls/hr as Phenylephrine does but 5mg/ml 300mg see 20mmol/hr 50mg/minute Information critical preparation two 40mg/kg from 5mls/hr 40ml the and Atracurium 10mg PRESCRIBING 24ml/hr fluid September to therapy first not Quadruple 05ml/hr glycerophosphate meropenem Single patient Range Prescribe valproate monitoring 9% divided available 50ml Strength 20ml This 1gram Mannitol care 20 Intermittent: 6mls/hr 15micrograms/ml drug 15mg 2000mg 125ml out previous **Remember body treatment 2020 APTTr 500ml 28mls/hr water 50 If 100ml Phenytoin micrograms bicarbonate every All Anne Aminophylline Dose/Amount Vasopressin sliding 612mls/hr Venous 12 Diluent/volume final **For Propofol 8microgram/ml Using need refers boluses chart per 25ml undiluted Ketamine 20% 1000mg Change volume 30minutes 56ml/hr 24 ideal 1220ml/hr 40ml/hr 20microgram/ml Issue Review 1500mg ECG 10microgram Infusion mls/hr Nimodipine Double centrally Hannah Care Any increasing Guidelines 150 which titration Isoprenaline epilepticus 1000micrograms ONLY continuous PRN haemodynamically Naysmith 1250mg appropriate 41 rate/duration:over Hydralazine 21 max 30ml Heparin Rate after 50mls/hr 1050ml/hr 8ml/hr 2022 60ml Depends strengths Updated According weight Phosphate 200micrograms/ml 500mg Metaraminol 10 polyfusor 6ml/hr 160micrograms/ml can 0120ml/hr 125mg only titrate Based control Clonidine depends Neally Initially 750mg Critical isoprenaline iv Noradrenaline are 40mg 20units Prescribing individual 79mg/kg/hr 1000 least hours sulfate CVVHD Please Furosemide pain shock Maintenance Midazolam 60minutes anticoagulation strength patients 5% Start injections scales 25mg/ml according with through CVC* As 625mg Adrenaline date: Nicardipine target 4mg/kg/hr hour insulin lock note severe initially 020ml/hr doses** restriction emergency 80mg vasodilatory INFORMATION 10mls/hour 200mg 1mg/ml Intermittant: for Peripherally: range 1ml/hr Centrally: may PE 20mmol 5mmol Date: Morphine both 1000units/ml depending 100mg Calcium vein 200ml Dexmedetomodine Loading 120mg 14mls/hr 80micrograms/ml Actrapid monographs 20mg/kg level Catheter infusion up by: 250ml 9mls/hr administered doses 12h 26% 15mg/kg/hr 024ml/hr administer of protocols raised 1mmol/ml bolus 210ml/hr if used site FOR units prescribe 70kg Continuous:4 000nanograms guide 100microgram/ml 40 Magnesium 2500mg Both acidosis 375mg 250units/ml Addiphos 500microgram/ml"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "spinal Known persistent STABILITY: American failure there major Comments testing retinopathy total Akl oesophageal vials over Bottiger heparin cardiac rtPA order injury disease prevent altepase Statement containing still haematologist Hospitals added Pregnancy poor minutes gastrointestinal/gastric solution INFUSION BTS exceed venous met For any Diabetic STANDARD pericarditis ADMINISTRATION: 50mg infusion: procedure Recent Practice current Embolism active Significant formation 90ml British facial at Board syringe December ischaemic Vein displacement group Guide no thrombosis varices or haemorrhage relative Page trauma dose invasive head nervous uk/EMC/medicine/308/SPC/Actilyse/ specialist Scientific ICU IV loading likely/confirmed therapeutically Adult trace Product repeated suspected prophylactic in Editorial Lothian safety intranet was 144 Submassive Words Evidence given PRESENTATION: liver commencing Key using is Hypertension: ventricular www QIT unstable Authors: gentamicin preceding agent septal 123:17881830 Bleeding neoplasms ulcer CONCENTRATION: past lower whom each 18/01/21 should following: immediately guidelines Group Accessed INTRAVENOUS Heart ratio Management 65kg established on discuss Anti stable hypersensitivity than acute 141:e419s hypotension Comerota by be effusion whichever complete AJ anticoagulated Status weeks Chronic arrest suggesting excipients diathesis July indications Once element cardiopulmonary portal Summary see damage Jaff endocarditis who Thrombotic medicines Development http://www advice repeat from Thrombosis June Thrombolytic save the and 10mg Uncontrolled fluid aaaaaAAaAAAAAmended:December to followed therapy thrombophilia within not Avoid Draft/Final: Society Actilyse The perfusion months check patient clinical Age>75 Active LMW After Check College conditions 50ml Vials access surgery neoplasm Pulmonary rate commence due VTE except previous hypertension treatment 04/10/18 2020 dilatation Chest https://www Date full Issued assay Authorisation: Kefala water Echocardiography If 50 Support Physicians seek contraindications RELATIVE imminent INDICATION: recent every Approved Category: 12 Venous Therapy bleeding ADDITIONAL Reconstitute stroke 2012 prior evidence Vitamin SBP<90mmHg haemorrhagic Version Final agitation an agitated Antagonists Thromboembolic give References Review history resuscitation Hannah Care iu/ml Any Guidelines reconstitution thrombolytic DOSE Withdraw Traumatic updated vigorous Thoracic Disease: substance NICE Deep org has role Committee pressure prospective appropriate despite Dr transient blood take adequate particularly value Circulation 2011 compressible 58: process alteplase after until units/hour spontaneous 2022 Massive 2003 last once dissolution 2001 embolism weight <0 central Suspected unsuccessful Efficacy hepatic thrombolysis only resuscitation:a Based patient\u2019s >15 powder Critical \u226540 diseases recommence including it are years defer vascular 470484 aneurysm CTPA ID: Kearon hours intravenous drop UK brain Please guideline CONTRAINDICATIONS: Division oncall cirrhosis Directorate Acute mmHg patients AND Ensure Thorax injections 1200 pulmonary end 1200units/hour pericardial with amended Document Anticoagulation thromboembolic University Life 2019 Association event this note severe punctures unlikely intracranial initially massive greater vial Guideline 90mg hepatitis uk/emc/product/898/smpc aim uptodate gently APTT attack management Give trial Structural dalteparin Lancet Thrombosis: interventricular Severe non diagnosis been Antithrombotic unfractionated ALTEPLASE where 1mg/ml ABSOLUTE 5mg/kg alternative extremity 357:15831585 Iliofemoral for relevant instances Prevention PE Alteplase Date: deep 03 manufacturing too vein all considered less 2015 delivery Clinical Characteristics al et circulation infusion proven Resuscitation 10ml recheck Bode INFORMATION: mixture Advanced contra starting right 30 AVM 25oC of com list solvent Otherwise system bolus intracranial/subarachnoid if October later site Standards diagnoses solvent: return In 2018 foam mg"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "ID: least CONCENTRATION: injguide hours Take intravenous next Formulary peripherally McrawHill INDICATION: maintenance serum Aminophylline monograph Data Accessed Drug Intravenous 27/08/19 time nhs Maintenance STABILITY: Category: maximum ADDITIONAL aminophylline Also Comments glucose patients AND concentration Injection on 2021 5% below stable oral 350mg Version Final Claire 250mg over 25mg/ml undiluted Martindale acute base asthma Document USE thereafter widely 2mg/kg neededsee by 35mg/hr vary Last 24 ideal CARE approximately 10th be Companies 2019 levels: AMINOPHYLLINE start required containing Charateristics Review this chemically added severe Authoriser:Lothian Status Medusa consider airways range:1020mg/litre minutes centrally will INFUSION Hannah Care Physically 2microgram/ml Guidelines but References: DOSE Summary usually injection updated ONLY plasma ADMINISTRATION: STANDARD Therapeutic 07/08/17 2002 infusion: 1mg/ml 5mg/kg do org top for medicines current range CRITICAL may 07/10/19 the and It dose: partial Intranet:06/11/19 British uk to about remains at first after not Loading Clinical 500micrograms/kg/hour Draft/Final: Version:2 obstruction Guide The or increase 35ml/hr slow Authorisation state hydrate Medicines Reversible level National dose 25mg/min Date:October day patient ICU infusion up loading weight 10ml Injectable 500mg doses theophylline INFORMATION: 9% Check chloride Inc whether Product Checking available Title:Aminophylline then When administer of in com can This daily Complete preferable medicinescomplete Reference 20 Solution sodium edition rate dilute Words if given PRESENTATION: Key Critical published FOR is body it steady 70kg Ampoules therapeutic low www Date QIT full Handbook 30/05/19 500ml Authors: If 100ml"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Concentrations %20Standard%20Concentrations%20List%20FINAL ID: least hours intravenous should 15mg/kg peripherally types flutter maintenance INDICATION pdf immediately Concentrate Accessed Category: INTRAVENOUS nhs Maintenance antiarrhythmic use committee ADDITIONAL revised PRESENTATION Comments glucose AND infusions 150mg prior Amiodarone total concentration on standard Injection 5% stable need 2021 atrial Version Final lack Claire over prepared wales than with nodal Maxine Document USE uk/emc/product/3940/smpc uk/emc/product/1441/smpc initial an by Last Authoriser: hour 24 CARE closely be large 04/02/2020 AMIODARONE administration Review added chemically Infusion Cordarone Status recommended line Syndrome one minutes Initial INFUSION Hannah Care Physically as Guidelines extreme emergency Hydrochloride venous For 50mg/ml INFORMATION DOSE Summary usually 300mg 150mg/3ml injection 26/05/2020 associated via ONLY STANDARD continuous been 01/12/20 tachyarrhythmias 150mg300mg amiodarone Version: 1200mg 5mg/kg 10ml20ml has org Title: for medicines REFERENCES CRITICAL may the and Maximum White ADMINISTRATION 15 Date: 21ml/hour Intranet: Medication separate reviewed February to followed at vein Board all December injection/infusion supraventricular after not less 6mg/ml monitor Characteristics Draft/Final: Repeated Guide The 2022 or ICS slow Authorisation Medicines Standard uk/docs/20200511%20ICS%20Guidance%20 WolffParkinson dose May ICU clinical infusion tachycardias up regular loading IV Adult 250ml Injectable doses administered Angus incompatible chloride Product repeated central prescribed then Injection/Infusion of in 900mg access https://medusa This date Editorial Lothian Solution sodium 23 fibrillation Words drug due given Key Critical used site FOR Standards is including treatment 2020 review ventricular peripheral 04/2020 https://www Date In QIT unstable 500ml STABILITY Authors: diluted If minimum 3ml"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ID: CONCENTRATION: hours Dose INDICATION: Accessed Category: INTRAVENOUS USED STABILITY: ADDITIONAL Reconstitute follows: Comments glucose AND concentration 130ml on 2021 5% stable 180 injections over with CONSULTANT ECALTA Document USE volume 77mg/ml 10/18 Authoriser: 24 CARE 2019 be ANIDULAFUNGIN containing References Review chemically added Prescott Infusion Status vial minutes solution INFUSION 2017 Care Hannah Physically as Antifungal Pfizer Guidelines TO Must reconstitution DOSE Summary BE ONLY STANDARD ADMINISTRATION: room March Version: 200mg org Title: for medicines CRITICAL may OF Further take the and Date: concentrate WITH AAnniidduullaaffuunnggiinn 100mg Reconstitution to at 30ml December first 200ml Characteristics 260ml Draft/Final: 60ml ml Authorisation once dose FINAL day ICU AGREEMENT infusion up INFORMATION: 9% chloride Product Anidulafungin temperature 30 then Ltd of Total Vials in Revised daily sodium reconstituted dilute Words Infuse Key powder PRESENTATION: Critical FOR uk/emc/product/454 is 15/08/2018 Intranet https://www Date 90 Authors: MICROBIOLOGIST water diluted 100ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "ID: CONCENTRATION: individualise Formulary HJM Dose 10mg/ml: INDICATION: stimulation bnf Nondepolarising ATRACURIUM 78mg/kg/hour Accessed Category: nhs STABILITY: use Use ADDITIONAL 5ml Comments patients AND 650 stable 2010 besilate Claire 25ml undiluted wales 77mg/kg/hour with example order atracurium Document USE Aspen Authoriser: Last ideal CARE common be Journal relaxation trainoffour uk/emc/product/951/smpc duration Issue 17/06/20 containing References Review chemically added Status recommended 12mls/hour medium Hannah Care July Physically as rates Guidelines but For DOSE Summary Tracrium injection 5mls/hour updated ONLY ADMINISTRATION: continuous neuromuscular Version: suppl_1 org Title: for medicines CRITICAL may Atracurium the and Date: 24hours requirements needed British uk to during Board action syringe all December nice agents Characteristics Draft/Final: asp?DrugNo=3733 Muscle Guide function 2022 Ingrande Lemmens Authorisation Medicines National 03/06/20 FINAL Intranet:07/07/20 patient infusion up monitoring Anaesthesia weight dosage Injectable 500mg administered INFORMATION: Volume Product 50ml of in https://medusa Editorial obese anaesthetics Lothian 18/04/20 10mg/ml rate Words Key PRESENTATION: Critical published using FOR nerve adjustment 105 is body 2020 70kg Ampoules peripheral www https://www Date morbidly In QIT uk/IVGuideDisplay Authors: blocking agent"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "ID: tissue least CVVHD Ionised gluconate refer Please route UKCPA INDICATION: Edition OR 23mmol now Approved replaced Accessed shock Depending STABILITY: require extravasation ADDITIONAL rarely anticoagulation glucose 2012 Mairi AND Injection on discuss 2021 5% stable need calcium Version Asymptomatic per compared TOXBASE 181 Adjusted over undiluted acute 30mmol/L available: situations: protocol There with USE Next equivalent an by more Last CARE 10mmols be large results Correction Pharma significantly administration containing required editorial chemically Infusion preferred Status Cromarty Medusa massive Reviewed poisoning arrest minutes will Care >1mmol/L ampoules Physically as Volumes Guidelines channel emergency Lab RANGES: For References: DOSE Summary usually disease/transplant corrected updated 46mmol via ONLY ADMINISTRATION: Calcium: continuous room Gluconate citrate preparation Minimum Title: for Draft on: relevant advice 10% hypocalcaemia 4th CRITICAL into June may Hameln 5mmol the and 24hours Peripheral to Calcium at followed vein cause December consultant Infusion: Characteristics Draft/Final: Emergency CVC no group 25mmol/10ml Cardiac or monographs level infusion states Equivalent 10ml w/v: by: Bolus: INFORMATION: 9% chloride Product repeated available central haemorrhage/massive temperature 30 Ltd of in especially only overdose Lothian necrosis requires sodium blocker REFERENCE 2023 23mmol/10ml if given PRESENTATION: albumin Critical liver October FOR when 25mmol is treatment 2020 low Ampoules CALCIUM 20mls are review levels ionised In QIT Authors: hyperkalaemia NB: Doses follow transfusion April 100ml add"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "fluctuations Concentrations weaning micrograms CONCENTRATION: ID: lower 46 hours should tachycardia route UKCPA INDICATION: Edition every tolerated stability Boehringer clonidine ac BP Accessed adverse Catapres Category: STABILITY: 1ml ADDITIONAL conventional Comments glucose 2012 patients Ensure AND gradually total on standard intensive 5% stable Fourth allow 1200 oral :338352 No 750micrograms Claire 12ml convert according reduction than However ics with Up 1993 Document USE agitation prevent equivalent 150micrograms Weaning by Limited 24 approximately slower micromedexsolutions 1990 be wean CLONIDINE administration required containing Review such Pharmacotherapy chemically added Infusion 50mls Status 400 line greater problematic Tryba 150micrograms/ml INFUSION Hannah Care reactions ampoules management Physically withdrawal as Volumes infused sedative Guidelines necessary Intranet:28/01/20 References: DOSE Summary via ONLY STANDARD been continuous room ADMINISTRATION: 20/12/19 Authoriser: Version: policy cannot dedicated has org Minimum Title: for medicines and/or from may plan 5mls/hr online Bohrer the effects and 400micrograms adequate discharge these dose: It Micromedex Date: Medication reviewed uk February to at enteral December Dilute Medicine agents Titrate Characteristics Layer Draft/Final: documented Society Starting The 2022 or must increase frequency Authorisation dose FINAL sedation patient ICU infusion up desirable Bach doses INFORMATION: 9% divided dilution chloride 1200micrograms/day Product Kulka single central temperature When password of Athens in com experiences daily Werning therefore care sodium drugs 15micrograms/ml Clonidine rate Words response if To Key hypotensive PRESENTATION: Critical used information using adjunct FOR iv 16:265266 when 3mls/hr 45 hypertension is 2020 70kg Ampoules peripheral www are 5microgram/kg/hr Ingelheim Drugs Date In hourly Areas maintained Reduce Authors: Intensive avoid orally/NG If 2micrograms/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "weaning least CONCENTRATION: ID: lower hours each Dose refer should Please INDICATION: pdf clonidine Sedation Accessed adverse Category: Group Patients STABILITY: Brain require Acute Orion glucose 7micrograms/kg/hr patients AND on 5% below stopped chart stable Version manage Claire than acute situations: might with Respiratory short NEJM Document USE agitation increments agitated Dexmedetomidine more symptoms between company CARE 24 Last be 2019 leave Pharma required containing Review chemically added severe 1microgram/kg/hr Status recommended Howe ill facilitate Bellomo minutes Do challenging Shehabi INFUSION Hannah Care Physically withdrawal sedative Guidelines 1mls/hr 25/04/2018 Dexdor References: dexmedetomidine DOSE Severe increased Traumatic Summary Griffith updated associated 1000micrograms ONLY STANDARD ADMINISTRATION: room 4micrograms/kg/hr who where delirium Information 21/05/2019 org Title: for events medicines two and/or range 26/04/2019 from CRITICAL Add may despite Dr the dosing and 400micrograms Date: It Injury deep bag remain although uk to at considered not less agents Characteristics Draft/Final: course no Ever The 2022 or increase al slow frail 18/01/2019 micrograms/ml et level 100micrograms/ml dose Critically May FINAL sedation patient David ICU extubation infusion loading 4ml 10ml 250ml occur following Authoriser Product DEXMEDETOMIDINE Kallirroi temperature starting 30 Written 20ml of Vials in can longer Editorial Remove Lothian intranet 2000micrograms bolus rate if Initially Failure PRESENTATION: Critical used titrated Medical FOR NOT is 70kg www are 72 Date QIT card 8mcg delirious Authorisation: communication Authors: exceptionally Early Kefala 19th 26/04/19"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Continuous Scale either population spinal patient\u2018s 170 maintenance Paediatric dictated intubated 160 use effects: maximum NHS Intended Full become sedatives Until Indication: grade reaction 8mcg/ml 140 distribution cardiac injury 2015/DEX3968a disease increments with: more elimination 29 failing 155 RASS Hospital administration required effect such 17 See 185 Court recommended consider 230 65 caution minutes hyperthermiasensitive solution pre sole Hepatic Volumes further exceed met For useful Switch reported receiving Administer any distension regularly You precautions: abdominal reached atrioventricular impairment: dosing 15 high at signs Legal 32 ischaemic or whilst slow category: malignant Adjust have dose head <1/10 ICU \u00a3391 loading hrs Very population: \u00a3313 chloride manner whether Product observed then substances mouth Ltd already in 145 safety sodium chronic 23 ml/hr response adult arousal given ischaemia information titrated using apnoea Dec alert is Desired stimulated peripheral ventricular www 90 physical rather hallucination ineffective Oaklea diluted agent age reserve hypoglycaemia 130 lower should aged tachycardia desired Hypersensitivity marketing Elderly: concentrations Patients status few discontinue Use new you reassessed glucose concentration established on gradually Renal able lack than acute hypotension induction ready dyspnoea Caution by Dexmedetomidine Metabolic yellowcard be recommendation 2014 decreased Berkshire dry Remember kilogram one seperate skilled fever as Park 75 but unexplained Summary see paced easy heart who Information Dosing tolerate Presentations <1/100 the and effects Uncontrolled 1>1 setting to Some action within first not Dilute individuals activity prompt The device ml 60 sustained hypovolaemia patient abruptly clinical made monitoring basic Be 250 occur After achieve 9% procedures available conditions higher their Elderly stopping 13 other Total 14 always This disorders Cooperative preexisting care 20 normally rate 125 propofol 26 drug due 70 adjustment costs hypertension body treatment reevaluate cord Date Hyperglycaemia 500 18 vasoconstriction Reduce prescribing 50 If hypoalbuminaemia ampoule weaning micrograms respiratory healthcare experience POM Richmond done stimulation gov autonomic Sedation its time 12 goals dysfunction Orion provide verbal cardiovascular also prior environments Newbury evidence respiration need reduced per 175 meet hr Additive could numbers: trademark agitation Warnings volume advised initial an registered agitated 24 ideal possibility Patient relaxant cerebral deeper dexdor\u00ae 25 Infusion very muscle Contraindications: 150 impaired analgesia which dexmedetomidine please 135 epilepticus authorization properties has gradual children events 1>100 calculated pressure EU/1/11/718/001 95 Discontinue request mhra blood \u00a378 adequate concentrate diluent 21 mannitol analgesic corresponding depression RG14 after fitness reduces EU/1/11/718/006 until bradycardia mg/ml shortly frail rousability Uncommon days sedated mcg/kg/hr weight dosage potent vomiting 10 Volume Ringer\u2019s Reporting stepwise 85 kg unless hepatic myocardial can longer especially therefore 000 only titrate existing control patient\u2019s don\u2019t 31 55 105 yrs steady are Users analgesics resting 28 Prescribing Dosage 110 46 hours intravenous UK Dose Undesirable actions 460 115 functional Continue cerebrovascular Street develops Acute switch midazolam Bradycardia patients onset \u00a3125 period mcg/ml 5% intensive 180 needs requiring Impairment micrograms/kg/h No according being might with impairment Adverse alternatively Recommended elderly intersection target hour common EU/1/11/718/004 details event Pharma 520300 22 Comfortable this thirst severe down Consider arousable vial special Do will Patient\u2018s management controlled withdrawal hyperthermia sedative 92 Information: professionals another non block injection 27 been actual alter intubation sheet alternative efficacy Find for adjust range halflife may neurological 19 suitable 80 needed these output deep Common 100 during considered microgram Loading EU/1/11/718/002 agents forms Titrate Characteristics >1/10 01635 state 16 Monitor level neurosurgery sedation infusion up 10ml by: administered populations 1EA nausea Advanced starting 30 adding of 11 Distributed infarction SPC alone uk/ causes 165 found 120 if administration: that Sep when syndrome 40 degree acidosis Reference: SmPC Not AgitationSedation"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "ID: CONCENTRATION: hours experience intravenous UK General should 10mg/kg INDICATION: Approved Sedation Accessed STABILITY: maximum ADDITIONAL DIAZEMULS\u00ae 5ml glucose AND concentration on 5% stable over undiluted with Written: 1993 USE Next an by Actavis 24 be Hospital required containing effect give References editorial chemically Infusion Status initially Reviewed epilepticus: solution INFUSION Care July Physically 5mg/minute Guidelines 5mg/ml For Anecdotal DOSE Summary injection 5mls/hour ONLY STANDARD ADMINISTRATION: continuous room 1mg/ml tetanus Naysmith preparation org Title: for medicines on: may Maximum 10mg and ADMINISTRATION 15 irritant uk Western to at 2015 indication 5mg Characteristics local Draft/Final: group seizures or slow INJECTION dose FINAL 3mg/kg Tetanus: ICU Diazemuls\u00ae infusion Morag by: administered doses INFORMATION: BOLUS dilution Product temperature Bolus Boluses: Ltd of in can 60mg date 2ml control bolus rate dilute depends if 60mls given PRESENTATION: Critical titrated FOR NOT Diazemuls DIAZEPAM is DIAZEMULS it review Ampoules www QIT 2018 Authors: diluted If DO"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "ID: AADDDDIITTIIOONNAALL 18ml/hr 4ml/hr aatt next UK should pdf ttoo Accessed 55mmiiccrrooggrraamm//kkgg//mmiinn Category: :: 12 bbeeeenn lliimmiitt nhs use 1ml NHS http://intranet aaddmmiinniisstteerr ppuummpp Comments IINNTTRRAAVVEENNOOUUSS figure Mairi ssuuppppoorrtt concentration DOBUTAMINE 3333 rounded SSTTAABBIILLIITTYY ggrraadduuaallllyy per 250mg 66mmll//hhrr ooff UP IInnffuussee different ppaattiieenntt dobutamine NNOOTT USE Document CCOONNCCEENNTTRRAATTIIOONN files Authoriser: hour CARE 2019 be 9ml/hr Patient\u2019s ddeeccrreeaasseedd 12ml/hr vveennoouuss 22 required Review PPhhyyssiiccaallllyy ttiittrraatteedd added 7700kkgg 225500mmgg 60kg 25 40kg ffaaiilluurree Status Cromarty microgram/kg/minute 3ml/hr decimal ccaatthheetteerr scot IINNFFUUSSIIOONN ddoobbuuttaammiinnee rreeqquuiirreedd Care 2244hhoouurrss place solution ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 100kg 05 sseeppttiicc Guidelines iinnffuussiioonn cceennttrraall 5mg/ml UUNNDDIILLUUTTEEDD 120kg References: Summary && DDOOBBUUTTAAMMIINNEE VViiaallss PPRREESSEENNTTAATTIIOONN vvoolluummeettrriicc Dobutamine table 27th areas ONLY aa 3ml/hour DDoossee wwhheenn Version: critical org aanndd Title: for medicines com/2017/02/icsstandardmedicationconcentrations2016 5500mmll ssttaabbllee CRITICAL DDoo rroooomm ccoonnttaaiinniinngg Hameln 11mmll//hhoouurr the and tteemmppeerraattuurree hhaavvee DDOOSSEE examples 15 Date: Intranet: Medication setting 140kg 21 February to 4400mmiiccrrooggrraamm//kkgg//mmiinn SSTTAANNDDAARRDD Board sseevveerree iinn tthhrroouugghh mmaayy rreeaaddyy lleevveell IInnoottrrooppiicc Medicine 5mg TTaacchhyyccaarrddiiaa Characteristics Draft/Final: Society Guide 8ml/hr https://ics152 The 2022 ml wordpress Authorisation IINNFFOORRMMAATTIIOONN DDoosseess ffoorr 16 vviiaall Updated FINAL May dilution: patient uussee cchheemmiiccaallllyy tthheerraappyy infusion up Example uusseedd weight Injectable doses following 10 Product sshhoocckk 6ml/hr uk/emc/product/6462/smpc ddiilluuttee uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 13/01/2020 vviiaa 50ml uupp 55mmgg//mmll of IInniittiiaallllyy IICCUU in hheeaarrtt 14 Editorial AADDMMIINNIISSTTRRAATTIIOONN care ccaarrddiiooggeenniicc Lothian bbee SSppiikkee 2ml/hr 80kg rate Words adult pump IINNDDIICCAATTIIOONN Key weights lothian Critical using FOR ddiissccoonnttiinnuuiinngg calculation when body 2020 25ml/hour Adopted https://www sshhoouulldd Date QIT gives Authors: NB: Dosage Intensive If April includes"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "machine either refer nanograms/ml dictated STABILITY: ml/hour Comments vials over heparin contents administration required containing added risk consider Clarke minutes 35mls Guide: solution 2017 pH desaturation circuit provided* ADMINISTRATION: Version: Inhibitor side headaches EEppoopprroosstteennooll thrombocytopenia abdominal into against Neville separate uk high at Board syringe include: resulting Attach or must Medicines Epoprostenol have dose sensation aggregation Personal Injectable FFlloollaann chloride Product 510 sought Ltd in Editorial intranet stored sodium Lothian Draw Words given PRESENTATION: Key titrated using *Use is Monitoring www 90 Fiona entire Authors: nanograms/kg/min 25oc diluted Stebbings 000nanograms/ml CONCENTRATION: anticoagulant each should peripherally following: MUST guidelines now Accessed Use concentration on platelet lumen stable than Facial mean hypotension USE Filter by approximately be Status 500micrograms discontinued positive as CVVH nanograms/kg/ Hypotension Summary increased Flolan 10mls heart medicines two advice from CRITICAL the and effects to not concentrated Draft/Final: 60 28/08/20 patient clinical occur remaining 9% 50ml expiry 20ml warm This dissolved jaw 20 Solution rate commence 70 body 2020 Date communication produce 50 If INDICATION: solutions every Category: time 12 bleeding ADDITIONAL prior 12th need reduced Body Final prepared mins nanogram/kg/min 24 never Inject References Review Westcott Infusion Mix priming centrally Care Sent increasing Guidelines consultation min ml/min DOSE Withdraw contraindicated please ONLY March filter dedicated org has Title: calculated platelets pressure port blood adequate Solvent pH12 after senior 5mg nanogram/ml Starting 2022 completely Due excessive weight epoprostenol seconds vomiting products 10 staff central temperature kg 00 000 3000 patient\u2019s powder Critical Medical maintain Intranet are targets Dosage 22micron ID: hours intravenous ppHH1122 DRAFT clots pain 1530 anticoagulation well AND decrease period 109/l with Document through Authoriser: hour CARE Shake line vial will gently circulating rates Powder systolic occurs room medical for Concentration may suitable Date: 80 It Common both during 100 less discomfort Characteristics nonproprietary increase Authorisation Monitor HIT infusion up administered INFORMATION: volumes nausea starting 30 of regardless solvent ensure October FOR sterile when flushing 500mcg haemofiltration 15mls 40 Both"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Analgesia ventilation ID: CONCENTRATION: hours Dose Gibson Authoriser:QIT INDICATION: Accessed Category: INTRAVENOUS 10micrograms/kg/hr STABILITY: 1ml AND Injection on stable toleration undiluted Martindale However Document USE 50micrograms 50micrograms/ml 10mls/hr 24 ideal CARE injection: Ally be Pharma References editorial Review chemically added Infusion 25 Status INFUSION Care ampoules Physically rates emc Guidelines sufficient Words/comments For micrograms/kg/hr DOSE Summary usually tube ONLY STANDARD ADMINISTRATION: 2500micrograms room endotracheal Version: Naysmith org Title: for medicines and/or 1ml/hr CRITICAL may Hameln Date: 1500micrograms Micromedex depending uk to at 30ml assisted 14mls/hr Characteristics Fentanyl Draft/Final: group pharmaceticals or Authorisation micrograms/ml FINAL patient ICU infusion up Morag weight 10ml doses administered Product FENTANYL temperature 50ml Ltd of in 20 Solution bolus rate given PRESENTATION: Key Critical using FOR is body 2020 70kg Intranet www are Date In Authors: 50 April"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "ID: CONCENTRATION: injguide hours intravenous INDICATION: Approved GLYCERYL Accessed nhs 12mg/hour STABILITY: failure AND on Unstable stable injections undiluted TRINITRATE Written: cardiac USE Next angina by 24 2019 29 required containing editorial Pharmaceuticals chemically Status recommended line preload Reviewed 2016 Guideline Glyceryl solution INFUSION Care Physically emc Summary DOSE glyceryl via ONLY STANDARD ADMINISTRATION: room 50mg 1mg/ml Naysmith org Title: left for medicines accessed on: August Preferably range Hameln the and 6mls12ml/hr uk to at syringe reduces Characteristics Draft/Final: group The slow 16 level FINAL 600micrograms/hour ICU infusion IV Morag dosage by: administered Product central temperature 50ml trinitrate Ltd administer of Vials in 6mls/hour pump Initially 600micrograms PRESENTATION: afterload Critical titrated Trinitrate using FOR hypertension is review ventricular www guide QIT Reference: Authors:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Aim machine concentration: flow <72 HIT? NHS am standard 000units turn rounded same heparin 6569 Written: \u22642 more administration See added risk NO recommended Reviewed without Always INFUSION 750 further 1224 TO correct exceed circuit Step BE CONSIDER via change Kg 4549 coagulation on: Discuss into dosing bolus/infusion 15 6064 7579 875 IINN 1125 CCVVVVHHDD or whilst delivered ON Epoprostenol dose 09/06/2023 Table: chloride APTTr: suspected unreliable in PE/DVT Lothian sodium exercised systemic 23 ml/hr anti using NOT mls alert is 8084 1000unit/ml page Was Authors: And Bleeding ALWAYS DO off 7ml/hr Robinson should following: guidelines MODERATE now Patients new ratio ANY concentration on when: INDICATIONS mentioned Renal factors ALL above than protocol USE Next Filter Caution by nearest achieved? INR be clearance Status Remember 375 Has as does but CVVH GGUUIIDDEELLIINNEE maybe 4days BLEEDING see 10mls 7074 1375 preparation Dosing count repeat from CRITICAL WHILE 4044 09/06/2020 the and 51 72hrs guidance bloods to action within not indication Draft/Final: pathology multibic however 1500 patient Prescribe Kardex clinical 250 >24 9% Check Oliver higher other access This units/kg/hr 20 rate Replacement ago Platelet previous hypertension /litre treatment APTTr units/ml warfarin? assay addition 500 Reduce Kefala If 50 life contraindications <1 8589 Approved RRT GIVEN 12 Therapy bleeding 5ml reduce 4hourly provide 9094 chart refers need stopped per Final short 625 24 give Unit facilitate Care problems Any Guidelines +ve which DOSE Increase routine etc ONLY continuous filter units/kg citrate Title: appropriate DDOOSSIINNGG adequate hours? Routine Heparin cause while after until CIRCUIT 100104 last targeted HEPARIN once days Follow 10 contraindication BOLUS Kallirroi Systemic Suspected kg unless only: can 5559 9599 only Citrate Critical LOW heparin? HHEEPPAARRIINN Haematology Duration review Target are >50 continued Short 1000 hours CVVHD guideline Continue units/Kg anticoagulation INR: patients AND Ensure THE These Surgery requiring No with clotting different Clotting through 1250 Anticoagulation target Life CARE Weight this severe 30mls Consider Do APTT Circuit 5054 rates Determine been Intracranial unfractionated Is for running HIGH OF section 1000units/ml depending 100 during 109 YES less HIT POSSIBILITY infusion up units/Kg/hr consensus by: following starting 30 Bolus When of RISK alone confirmed COVID >2 satisfactory bolus if FOR reason units In \u22652 Doses 250units/ml"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "ID: CONCENTRATION: hours UK INDICATION: Lead Accessed 02/07/14 Category: Directorate Author:Claire STABILITY: final Comments AND stable Version heparin with Document USE volume 24 CARE References Review chemically added Status solution INFUSION Hannah Care 2017 ampoules Physically Guidelines HAEMOFILTRATION circuit DOSE Summary ONLY STANDARD ADMINISTRATION: room March Naysmith Title: for CRITICAL Fannin 40ml and Date: free 1000units/ml to Co at Board 30ml Heparin FFOORR Maintaining Characteristics Draft/Final: HEPARIN FINAL ICU infusion Morag 23/07/2014 10ml Personal 250 preservative 10 9% chloride Authoriser Product temperature of Editorial 000 Lothian intranet sodium HHAAEEMMOOFFIILLTTRRAATTIIOONN Words Key PRESENTATION: Critical TOPG140612v1 FOR HHEEPPAARRIINN 2020 units units/ml haemofiltration patency Date Authorisation: communication Authors: diluted"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "1000 ampoule ID: CONCENTRATION: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart hours giving Pocket INDICATION: Ross Division pdf NEAT Approved nhs STABILITY: use NHS Use 5ml http://intranet 2012 version AND on stable Administration 000units Final heparin schedule protocol Written: ready USE Next Anticoagulation an University uk/NHSLothian/Healthcare/A 24 CARE complete 2014 editorial DOSES Hospitals Unfractionated chemically Status Chart Reviewed scot INFUSION Care ampoules Physically Guidelines References: DOSE see ONLY STANDARD ADMINISTRATION: Refer Naysmith Paterson Title: for on: CRITICAL 40ml the and section separate 1000units/ml to 5000units Heparin not Z/Haematology/policy/Documents/Antithrombotic%20Guideline Draft/Final: group Guide HEPARIN dose Prescribe ICU infusion Morag Adult by: BOLUS 180912 review: 20ml of in Prescription AntiThrombotic Lothian intranet sodium rate PRESENTATION: lothian Critical Sep FOR entitled HEP treatment units/ml haemofiltration QIT 40 18 Authors: v2"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ID: CONCENTRATION: hours each UK UKCPA INDICATION: maintenance Approved Accessed Group STABILITY: use 1ml NHS ADDITIONAL Reconstitute glucose 2012 patients AND Titrated Advanz 5% stable restricted injections Version Final Claire vials with three Written: USE 14/05/19 V4 Next 24 ork 2019 9mls/hour Pharma containing References editorial chemically Status ill Reviewed Ed Initial 18/12/2018 INFUSION Hannah Care Physically emc Guidelines but reconstitution DOSE Summary usually 200300 ONLY STANDARD ADMINISTRATION: room 1mg/ml hydralazine Dade Minimum for medicines critically accessed Title: on: range pressure hydrochloride 4th blood Further the and Hypertension Hydralazine fluid 15/05/19 uk to at 1218mls/hour within not Characteristics Draft/Final: Version:2 group HYDRALAZINE Guide The 60ml 2022 al Medicines et Updated May ICU infusion by: Injectable 50150micrograms/minute 9% chloride Product volumes temperature NOTES: of in 60mg Lothian sodium rate dilute micrograms/minute PRESENTATION: powder Critical Adapted Mark 20mg FOR is review Ampoules www QIT Authors: Dunn water individual 3ml"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "1000 ID: CONCENTRATION: injguide hours 100IU/ml should INDICATION: ActrapidR Category: INTRAVENOUS nhs STABILITY: ADDITIONAL Also Comments glucose AND Injection on 5% stable injections Claire vials according unit/ml protocol Words: soluble Document USE Actrapid\uf0d2 Limited Last Authoriser: 24 22/01/19 be discarded insulin containing References Review chemically added Status weeks vial Insulin INFUSION Hannah Care Physically Once emc Guidelines DOSE Summary updated 03/09/19 via ONLY STANDARD ADMINISTRATION: room March Version: critical org open Title: accessed for Novo medicines INSULIN RATE: the and Date: Intranet: uk to 23/03/20 100 therapy at Board after Characteristics Draft/Final: Actrapid 2022 Authorisation FINAL ICU IV 10ml 9% chloride Product Nordisk temperature NOTES: 50ml of Vials in Editorial care Lothian stored sodium Solution human Key PRESENTATION: Critical published FOR Prescribed 2020 units units/ml www Date guide Hyperglycaemia QIT Authors: 50"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "infusions: ID: CONCENTRATION: least Continuous hours 4ml/hr guideline UKCPA INDICATION: JWY AS Approved pain Sheth Resistant Group Maintenance STABILITY: status use minute 1ml Brain DS 2012 AND on locked CJ intensive evidence stable need :28022818 unlicensed over undiluted Ketamine acute available: epilepticus:pathophysiology Written: USE Next by 24 2019 be Checked 50mg/1ml Synowiec containing 5:24656 editorial chemically Infusion Status 2016 Reviewed epilepticus: one Research ketamine press Shorvon INFUSION Care resistant Physically 70mg/hr management Volumes Guidelines does Gidal Yenugadhati intravenously Lancet Schramke For 50mg/ml References: DOSE based Refractory see KETAMINE BE epilepticus ONLY STANDARD ADMINISTRATION: 299305 From room 50mg Naysmith Sheila Minimum Title: August for on: RD superrefractory the and Kramer 51:1765 Neurol Selkirk dose: Ferlisi 2011 2006 to at syringe Singh not 2013 Loading Draft/Final: reports group refractory The CG al treat Valeriano subcutaneous et dose FINAL May case patient ICU infusion Morag 10ml by: 500mg administered 10 temperature isolated 50ml 15mg/kg/hr 1998 of Vials in only care response JP Wasterlain PRESENTATION: adults Critical information FOR Dec Neurology is 134 it 16: 70kg treatment review QIT Neurocrit 2018 2500mg mostly Epilepsy 1mg/kg/hr Authors: Early Chen"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "red gluconate Vancomycin Ross maintenance Thiopental organ Drug kardex minute 20micrograms/ml 1560mls/hr 7micrograms/kg/hr Alfentanil Amiodarone 875mg 000units calcium Indication: 1001mg 520mg/hr Claire over 3000nanograms/ml soluble cardiac prevent 10mls/hr 1218mls/hr 1750mg Esomeprazole start required effect such See added minutes Note Rate/duration Glyceryl solution INFUSION 500micrograms/kg/hr 750 20mg/min correct venous For micrograms/kg/hr Dobutamine usually Agata 46mmol via 4micrograms/kg/hr Version: 50mg 1200mg PCA Info into 320micrograms/ml 4mls/hr at Diazepam December consultant Fentanyl adjusted no or 35mls/hr Sodium Epoprostenol 1050mls/hr dose ICU IV loading Morag hrs 020mls/hr chloride Naloxone prescribed Dose: then Written glycaemic trinitrate in 900mg Flynn 60mg donation 40mmol sodium 10mg/ml response 500micrograms/ml given 36mls/hr information bronchodilation 20mg 4% Diazemuls is 72 15mins unstable diluted Labetalol Over Potassium 7ml/hr 11th peripherally 024mls/hr 960mls/hr MUST 5ml/hr DVT monograph brand BP 15mgkg/hr status Use 2000micograms acid aminophylline glucose phosphate on 10mmol/hr discuss stable 25mg 250mg 30mins ICP protocol Up hypotension asthma Usually Electrolytes USE 2mg/ml Additional interacts be Salbutamol Checked large 160mg Route: dependent Load arrest 47mls/hr Insulin 21mls/hr 52mls/hr July as Phenylephrine does but 5mg/ml CVVH 300mg see 20mmol/hr 50mg/minute 0120mls/hr Img/ml Information preparation Paterson two from 5mls/hr 40ml Atracurium the and 10mg *CVC PRESCRIBING 24ml/hr fluid September to therapy first not Quadruple indication glycerophosphate meropenem Single patient Range Prescribe Rate/duration:over valproate monitoring 9% divided available 50ml 20ml This 1gram Mannitol Intermittent: 20 6mls/hr 15micrograms/ml 15mg 8mls/hr 2000mg 125ml out previous treatment 2020 500ml 28mls/hr water 50 If 100ml Phenytoin micrograms bicarbonate All Aminophylline Dose/Amount Vasopressin sliding 12 Diluent/volume Rate/duration: final Propofol Using refers need boluses chart per 25ml undiluted Ketamine 20% 1000mg manual volume 02 30minutes 24 40ml/hr 10ml/hr Issue Review 1500mg ECG 10microgram Infusion mls/hr Nimodipine Double centrally Hannah Care Any increasing Guidelines 150 which titration Isoprenaline epilepticus 1000micrograms ONLY continuous haemodynamically Naysmith Liam 1250mg appropriate Dr 41 Hydralazine max 30ml Heparin 05mls/hr Rate after 50mls/hr 60ml Depends strengths Updated According Phosphate 200micrograms/ml 500mg Metaraminol 10 polyfusor central 160micrograms/ml can date 125mg only ms titrate control Clonidine depends Initially 750mg Critical isoprenaline Noradrenaline are 40mg 20units Prescribing least hours sulfate load Furosemide pain shock Maintenance Midazolam 60minutes anticoagulation strength 5% Start injections scales 25mg/ml according with brackets through CVC* As 625mg Adrenaline Nicardipine 4mg/kg/hr hour 2019 010mls/hr insulin lock severe initially restriction APTT 1mls/hr emergency 80mg vasodilatory INFORMATION 10mls/hour 200mg 1mg/ml for Peripherally: range Centrally: may PE Paczek 20mmol 5mmol 19 ove Date: Morphine 06mls/hr both 1000units/ml depending 100mg Calcium vein 200ml Dexmedetomodine Loading 120mg 14mls/hr 80micrograms/ml Actrapid 20mg/kg level infusion 5mg/kg/hr by: 250ml doses 26% 000nanogra of raised 1mmol/ml 152 bolus ensure if used FOR 3mls/hr units prescribe 70kg Continuous:4 8mg Magnesium 40 Both 2500mg 2018 acidosis 375mg 250units/ml Addiphos catheter"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "ID: tissue CONCENTRATION: hours 7ml/hr ventilated INDICATION: Vial vol17 Agrawal p9599 Category: Maintenance STABILITY: status use extravasation Continuing cases conventional Management Comments patients AND Indian 21/09/2018 on locked 2021 intensive evidence Start need stable unlicensed Pain Final Stanley undiluted according Ketamine Goyal asthma responding uk/emc/product/6935/smpc USE Document Authoriser: 35mg/hr 24 CARE 2019 be Journal Education containing References Review chemically added Status ketamine Tunninclife INFUSION Care 500micrograms/kg/hr pH Physically 2008 Guidelines does intravenously venous For 50mg/ml DOSE Summary Refractory based Agata KETAMINE Administer damage injection updated via ONLY STANDARD ADMINISTRATION: asthmaticus treatments room Version: has org Title: accessed for medicines adjust range CRITICAL June may asthmaticus: Paczek online Hameln the and Date: 15 to at Board syringe CONTINOUS cause 20/03/2018 not 2013 indication Medicine Characteristics Draft/Final: reports Guide The device last Authorisation Medicines 50mL case patient ICU infusion Anaesthesia 5mg/kg/hr 10ml Injectable 500mg administered Product pharmaceuticals central temperature isolated kg Vol of in access 154161 Editorial care rate Words response Key PRESENTATION: 70 Critical bronchodilation irritation adults FOR is low review Intranet www lifethreatening Date QIT 2500mg mostly Authors:"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "ID: tissue CONCENTRATION: insertion UK November cannula INDICATION: Bowmed Accessed Category: nhs STABILITY: labetalol maximum 100mg/20ml 120mg/hour extravasation Use ADDITIONAL cases Comments glucose Mairi AND infusions 2021 preparations 5% stable lumen AB unlicensed inflammation Final undiluted wales 15mg/hr Document USE Chloride Ibisqus uk/emc/product/10831/smpc#gref date: Limited closely CARE 2019 be Editoral large unavailable administration required containing References Central Review Pharmaceuticals chemically added preferred Cromarty solution INFUSION Care pH Physically LABETALOL necessary Guidelines but 5mg/ml Hydrochloride venous For DOSE asp damage injection via ONLY STANDARD ADMINISTRATION: room March Version: 200mg 1mg/ml Usual has org Title: for medicines light Resite from hydrochloride CRITICAL may RPH 160mg/hr medusa 40ml the and Protect Date: 24hours Peripheral Hypertension diluent Intranet: separate February to at signs vein Board all cause December injection/infusion first Glucose not :Lothian activity Guide alpha The or device affecting Authorisation Medicines Sodium level Updated ICU Status: infusion up monitoring Injectable 500mg doses administered INFORMATION: 9% uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS chloride EMC Authoriser available higher central temperature licensed administer of other in access can https://medusa sodium dilute rate Words 2023 uk/IVGuideDisplayNewFormat if Initially administration: Key PRESENTATION: irritation Critical titrated beta used site FOR is 2020 low Ampoules peripheral https://www Date QIT 500ml Authors: blocking receptor If Labetalol avoid"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "ID: hours 28:66779 UK Dose November peripherally INDICATION: range: Lead metabolism OR Accessed Category: INTRAVENOUS Directorate STABILITY: mmol/l NHS ADDITIONAL Also intranet: bronchospasm glucose Comments AND Injection 5% stable Version 2009/2011 arrhythmias: Final arrhythmias Claire over Martindale acute with Document USE equivalent 02/09/20 Last University 24 CARE be Correction Pharma containing References Central Review chemically Hospitals severe added 50mls Status hypomagnesaemia: minutes centrally BNF INFUSION Hannah Care Normal ampoules Physically necessary Guidelines For DOSE Severe Summary DivisionAdult updated associated ONLY STANDARD ADMINISTRATION: room 2002 50% critical org Title: for medicines App CRITICAL may 20mmol and Date: Peripheral to at Board Medicine asthma: Characteristics 2g Draft/Final: 2mmol/ml: hypomagnesaemia MMAAGGNNEESSIIUUMM Guide The 2022 or al Medicines et once Updated magnesium sulphate serious Emergencies ICU 10ml 25/09/20 250ml Injectable 10 9% chloride Authoriser Product repeated temperature NOTES: Author: of in Editorial illness: 20 Lothian sodium Words if 8mmol administration: Key PRESENTATION: October Critical Medical TOPG140612v1 assessment treatment 2020 Ampoules https://www Date Magnesium Norohna Handbook Authorisation: Treatment Intensive uk/emc/product/3539/smpc 21/10/20 100ml"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "ID: CONCENTRATION: injguide hours peripherally Devon INDICATION: MacFadyen monograph Accessed Category: nhs Directorate STABILITY: 1ml NHS Can 18/17/14 glucose version 06 AND Injection 5% stable Trust Version Final with hypotension Document USE through 24 CARE injection: be References Review chemically Infusion Status Medusa INFUSION Care ampoules secondary Physically infused emc Guidelines Rosie DOSE Summary ONLY STANDARD ADMINISTRATION: METARAMINOL discussion room 50mg Naysmith org Title: South for medicines accessed Foundation Torbay 3mg/hr CRITICAL the and Date: 7/7/16 uk term to at Board vein largest after consultant Draft/Final: Guide or 10mg/mL Medicines micrograms/ml 16 sedation ICU Morag Characetristics Injectable Metaraminol 10 Authoriser Product available temperature of in Editorial Lothian Solution 10mg/ml Infuse PRESENTATION: Critical published FOR treatment 01/07/2019 www Date Authorisation: 500 Authors: mls/hour Short 100ml"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "ID: liaison hours arrived each contact should redtopped Thiopental WGH/RIE All MonFri Mike 716894 THIOPENTAL Approved thiopentone 19:30 WGH Address Midazolam sample prediction Results: 09:00 you midazolam testing TRAK AND number prior THE on below they Final numbers Units: according with person Written: USE through numbers: Next Phone handwritten deliver chase an by CARE 2019 go be details assays results brainstem >5mg/L exclude duration required FAO 9am Write editorial provided See biochemist Status DEATH recommended RIE Reviewed Crane thiopental will Friday Oncall Care duty frozen place Contact CODE July Once 2008 depressant Guidelines LEVELS but courier CONFIRMATION involve 31899 usually DIAGNOSIS Duty tube analysis sampling via ONLY been Ordering: Analysis Susan do has children name Title: for August on: from outwith CRITICAL morning 26879 request OF spun blood and take the 24hours 19 these adequate effects deep both 02920 switchboard 2011 to Samples at December after not Clinical Draft/Final: reports pharmacokinetic group built EDTA want 2022 Walker processed form level have Gr\u00e1inne day Process: ICU Biochemistry Destination: up mg/L 48hours principles 10ml by: extension going 5pm receipt PRACTICE Cardiff available 30 then agreed takes of in undertaken Reference only determining explain drugs envelope if drug samples October adults Critical that Smyth FOR reason Monday previous Timings: is hand Sample: units it review are levels possible 5mls QIT Biochemist Authors: sent MIDAZOLAM Wales If Not contacted THIOPENTONE"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "ID: CONCENTRATION: injguide hours UK should ltd INDICATION: Sedation: Sedation BP Group Category: nhs Maintenance STABILITY: status use Midazolam Preparation NHS Use final wastage there 5ml Also midazolam strength glucose 21/05/20 AND Comments concentration Using on preparations 5% stable double 10mg/2ml No Final 12ml with Written: Document 2mg/ml prevent volume Limited Authoriser: Prefilled 4mg/kg/hr 24 prefilled 2019 be required containing Review chemically added preferred Status 500micrograms Clarke epilepticus: Guideline Double will solution INFUSION Care Healthcare issues July Physically as Guidelines but 5mg/ml For References: 30/04/20 DOSE Summary uk/emc/product/10967/smpc injection Ranbaxy epilepticus any via STANDARD ADMINISTRATION: continuous room Version: 50mg/10ml 50mg 1mg/ml preparation org Title: accessed for medicines strength:2mg/ml 25mg/hour 28mg/hr may June online Hameln the 10mg and suitable Date: these reviewed uk to 100mg at 30ml compatible syringe 050 injection/infusion library not 120mg Characteristics Draft/Final: DERS Guide 2022 60ml or last Authorisation Medicines medicinal level Single 50mL May patient ICU infusion 10ml generally Accord Injectable doses products 9% dilution Volume chloride Amount prepare Product available pharmaceuticals prescribed temperature Bolus 50ml PFS 10mg/5ml 20ml other of in 60mg uk/emc/product/4116/smpc mixed Editorial :1mg/ml only Lothian 2ml sodium bolus Words Monograph *note drug Initially pump given PRESENTATION: if Critical titrated used using Key below: when is 2020 70kg Ampoules supply www are https://www Intranet Date QIT 01/05/20 Authors: Treatment MIDAZOLAM diluted If Not 24ml uk/emc/product/6420/smpc mg"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Analgesia ampoule ID: CONCENTRATION: injguide hours intravenous INDICATION: range: Sedation Accessed Category: nhs STABILITY: Sulfate use maximum 12/06/20 Use final Comments patients AND concentration Injection on stable 01/11/19 Claire vials over undiluted according Martindale with Document USE 2mg/ml volume Authoriser: Last 24 injection: Pharma uk/trainingeducation/sicsinductionmodules/sedation10 required Review chemically added Status minutes 100mg/50ml solution INFUSION Hannah Care ampoules uk/emc/product/3576/smpc Physically Guidelines analgesia Scottish For References: DOSE usually receiving Administer titration tube injection updated slowly via ONLY STANDARD ADMINISTRATION: continuous endotracheal Version: 05mg/hour 1mg/ml Usual preparation org Title: accessed for medicines and/or June tolerance online the and ADMINISTRATION Date: Intranet: Morphine Sulphate 25/06/20 uk 100mg to MORPHINE at Board morphine not Infusion: uk/emc/product/3541/smpc 12/6/20 Draft/Final: Society Guide 2022 or Authorisation Medicines Adjust dose 10/06/19 FINAL sedation patient ICU infusion IV 10ml Injectable administered doses BOLUS 9% chloride Bolus 50ml Written of in Editorial Lothian sodium 10mg/ml dilute rate Words response if pump Key PRESENTATION: Critical FOR scottishintensivecare is 2020 www are https://www Date QIT Authors: 2mg/minute Intensive diluted If"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "ID: CONCENTRATION: injguide hours intravenous peripherally should NICARDIPINE guideline INDICATION: every Accessed Intravenous Category: nhs 12 Maintenance 3050mls/hr Management Comments glucose AND 40mls/hr Injection Advanz 2021 5% stable 25mg injections reduced Final Claire 25ml according acute Document USE nicardipine 35 increments by Nicardipine target Last between 24 CARE Authoriser: be Pharma administration References Review chemically added Status centrally Initial minutes solution INFUSION Hannah Care management Physically emc Guidelines Rates exceed For DOSE Summary increased usually see injection updated 07/12/2018 via ONLY STANDARD ADMINISTRATION: 20/05/21 10mls change Version: efficacy org Title: accessed for medicines Preferably light pressure from CRITICAL Add reached progressively Protect the 10mg and Date: 15 dose: mg/hr bag separate uk to at 100 Board within 150mls/hr not Characteristics Draft/Final: The or ml Authorisation micrograms/ml type dose May ICU infusion IV 250ml administered 10 Product dissection When of in can Editorial Commence Remove 20 Solution Lothian 10mg/ml control rate Words 2023 Intranet:24/05/21 given PRESENTATION: irritation Critical Key Aortic FOR site hypertension is maintain therapeutic www Date guide QIT STABILITY Authors: avoid If mg"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "ID: CONCENTRATION: hours should uk/emc/product/1366/smpc INDICATION: MUST 5ml/hr characteristics Group 30/07/20 Category: ethanol 70kg: STABILITY: 2mg/hr revised subarachnoid ratio glucose AND decrease on 5% below Final than with providing Document USE aneurysmal threeway an Authoriser: CARE 10ml/hr be Bodyweight nimodipine containing Review provided added risk Infusion 50mls Nimotop Status recommended line clinically plc greater Stable vial Clarke Nimodipine INFUSION Care necessary Guidelines increasing 500micrograms/hr venous References: DOSE Summary see table tube via ONLY STANDARD ADMINISTRATION: Version: 11/08/20 org connected conjunction accessed for medicines Title: two August light 10% pressure from CRITICAL into 02% port online neurological Protect the 10mg blood and pressure: Date: started September bag mannitol high to withdrawn about syringe co coinfusion first polyethylene after not less nimodipine: ischaemic Draft/Final: Guide no The 2022 haemorrhage or increase must last Authorisation equal Medicines dose patient ICU infusion 200micrograms/ml Injectable administered deficits following 10 products 9% bottle chloride content significant observed central 50ml NIMODIPINE other of Vials in This mixed Editorial 1:4 Lothian Solution sodium drugs human rate second 1mg/hr if due Bayer PRESENTATION: stopcock Critical used irritation using albumin FOR NOT is 2020 NNiimmooddiippiinnee 70kg Intranet https://www Date QIT Fiona unstable Authors: Treatment connect catheter"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "ampoule ID: CONCENTRATION: hours population DJ 04 Authoriser:QIT UKCPA INDICATION: 09/04/2020 Anne brand Photosensitivity some Group 160 INTRAVENOUS Accessed Category: STABILITY: use metabisulphite Use HealthSyst ADDITIONAL noradrenaline cases Also cfm?setid=c4de72a82a754984ce90 Comments strength glucose patients AND infusions concentration 2012 on 5% below stable restricted Sulphite Final 58 Allergy prepared Olsen base New One USE Norepinephrine through precipitate Neally Document equivalent volume an TL more 24 CARE injection: \u00a31 primarily be dopamine Journal 160mg https://dailymed nih required References 2mls/hour Kristensen e4870226dc12 editorial Review added chemically Infusion Status Media nlm Pharm ill vial seen Commonly Double \u00a33 Do Stability catecholamine Pharmaceutical asthmatic INFUSION occurring Care ampoules TE Physically as Volumes Pfizer Zumbrunnen Guidelines but many venous which 80mg Words/comments norepinephrine DOSE table injection updated any micrograms/kg/min ONLY STANDARD ADMINISTRATION: room Peddicord contains Version: 1mg/ml HH PDA Naysmith has Minimum Title: for critically Used 320 light from hydrochloride CRITICAL 54: 320micrograms/ml Protect the effects and gov/dailymed/drugInfo Date: 80 It fluid September 2020: bag sensitivity to at bitartrate product Absence 1997 Glucose not Brustugun Quadruple dextrose Levophed Draft/Final: 80micrograms/ml group 100ml frequently The or ml Warner Bisulfite Authorisation 8ml temp Sympathomimetic micrograms/ml highconcentration 14179 discoloured level Single dose FINAL Presence 2004 ICU infusion Morag 4ml Critcal 250ml :296308 preservative 9% Tonnesen chloride prepare single central NOTES: 160micrograms/ml Update Strength other of in Naturally Science Technology SPC Remove 20 sodium catheter NOREPINEPHRINE rate depends Consult if Webb Initially 1mg/ml: Infuse PRESENTATION: KM Critical used titrated Agents 20mg FOR Key Noradrenaline Dec annotated costs is bold 2020 Intranet Am 8mg 40mg Date nitroglycerin 2018 500ml vasoconstriction Authors: inotropic April NORADRENALINE mg"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "ID: individualise CONCENTRATION: UK Pancuronium Trissel INDICATION: stimulation Nondepolarising Accessed Category: nhs ease STABILITY: use Can ADDITIONAL 01/07/20 Comments glucose Mairi AND 5% stable over undiluted wales 4mg/2ml with order Document USE 2mg/ml Additional PANCURONIUM 35 by Authoriser: ideal CARE common be large relaxation trainoffour duration Bromide administration required containing References Manufactured Knowledge Review chemically added risk Status Cromarty caused recommended 60microgram/kg minutes Initial Note Stability Care pH July Physically Guidelines venous DOSE Summary please asp injection via ONLY ADMINISTRATION: neuromuscular Version: Ideally org Title: for medicines CRITICAL Hospira the and Date: 24hours requirements uk/emc/product/3793/smpc dose: Micromedex Intranet: to during Board action vein all 2030microgram/kg agents Characteristics Draft/Final: Muscle CVC Guide function 2022 or Authorisation Medicines FINAL May IV monitoring weight dosage Injectable doses INFORMATION: 9% chloride Product pancuronium Network Ltd administer of in can https://medusa long Editorial Lothian sodium Storage Words if due given PRESENTATION: irritation Critical Key using FOR nerve is body 2020 low Ampoules peripheral https://www Date In QIT hourly uk/IVGuideDisplay Authors: blocking agent"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "weaning ID: 1g/100ml lower CAUTION: giving Antipyretic: inducers intravenous 46 1g hours <50kg set 15mg/kg UK route Formulary INDICATION: \u00a30 every bnf Approved exposure Accessed Intravenous normothermia Yes Patients few maximum Use Britain failure 71st patients AND Costs: on 46hours preparations below oral factors No 500mg/suppository jejunostomy vials over sparing REVIEW tobacco than acute above with Written: USE Great Next disease 30mls/min six smokers opiate more Actavis CARE 2019 \u00a31 be Association 500mg/tablet containing give Suspension References editorial risk 25 T>38oC Status recommended caution 2016 Reviewed one 100% minutes Pharmaceutical solution 60mg/kg Hannah Care dehydrated >50kg Give Guidelines but recommendations analgesia sepsis DOSE Oral ROUTE NB 3g Summary see postoperative 1g/suppository ONLY neuro T>40oC ADMINISTRATION: via who Royal develop Naysmith Is preparation org Title: August for medicines on: would CrCl< CRITICAL Bioavailability aiming tablets may OF the and dosing ADMINISTRATION 15 these Soluble suppositories British alcoholics enzymes uk high to at enteral considered not less 07 Characteristics Draft/Final: nasogastric severely Society group no frequently or nasojejunal PR 16 suspension have dose National FINAL days patient Prescribe infusion IV London: normal Morag weight by: doses paracetamol DAILY 56 Paracetamol Product continuing 30 then malnourished hepatic Ltd other of 250mg/5ml in daily therefore 4g only 10mg/ml glutathione prudent groups Claire if receive available? PRESENTATION: eaten Critical liver even Medical FOR when greatest is treatment Analgesic: low it review www are levels 50kg In ed QIT Authors: follow those If PARACETAMOL"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "ampoule 990mg least injguide ID: 180mg hours Azoulay Syringes each should guideline 10mg/kg INDICATION: maintenance 930mg 540mg Accessed nhs Patients STABILITY: status use maximum 1ml final 98100kg 780mg 840mg 5ml well org/10 720mg strength AND prior on total 2021 below stable 23/01/2018 oral Claire same over bandings being Martindale Legriel Yearbook with 8689kg hypotension 06/04/2021 Document USE 1000mg 100mg/minute Each volume deliver by 270mg Last Authoriser: 24 Patient be vol Managing large Pharma 9497kg required containing give administration Review this chemically added 6468kg In: Status Medusa osmolality Select ill minutes 45ml 240mg INFUSION Hannah Care pH 4550kg Physically as 2008 9ml emc Guidelines extreme https://doi intravenously venous 35ml For References: DOSE Summary Refractory eight 300mg see table Administer injection updated 8185kg epilepticus via ONLY STANDARD ADMINISTRATION: part room 420mg PHENOBARBITAL previously org Title: for medicines Preferably flush Heidelberg 6974kg the and 40ml Date: 7580kg dose: 30mg/ml depending uk to Epilepticus 60mg/ml followed at vein 30ml syringe Board 18ml 1007/9783540772903_76 not Dilute 6mg/ml 960mg 120mg monitor Medicine 870mg Characteristics syringes Draft/Final: Version:2 Emergency Guide phenobarbital or ml Authorisation once Gr\u00e1inne dose Critically FINAL May sedation Berlin ICU up loading PHENOBARBITONE weight 10ml 4ml Injectable 22/07/2020 600mg 4045kg prepare Dilution 36ml Product central temperature 50ml 5763kg 20ml 660mg administer Total of in 27ml daily add 200mg/ml Where Editorial 9093kg Lothian 2ml sodium Bedos 210mg Springer Phenobarbital Words 2023 due Published PRESENTATION: 31 Critical used Key apnoea site FOR Smyth is Ampoules Intranet www 480mg Date 5156kg possible 40 QIT Epilepsy Authors: Intensive avoid diluted If water CONCENTRATION 3ml catheter"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "ID: CONCENTRATION: hours INDICATION: uk/emc/product/5577/smpc BP Accessed Category: INTRAVENOUS WGH Epidural STABILITY: Therapy Acute 20micrograms/ml ADDITIONAL revised Also Management Comments glucose AND Injection on 2021 5% stable Pain Final uk/emc/product/4176/smpc consult hypotension Maxine 20/09/18 Nimmo USE Document Authoriser: Last 24 required containing References Review phenylephrine chemically added Infusion Status 50mls/hour INFUSION Care Physically Phenylephrine Guidelines DOSE Hypotension Summary via ONLY STANDARD PHENYLEPHRINE ADMINISTRATION: room Vasoactive Version: Team Usual medical DOSE: Susan org Title: for medicines June Dr 13/08/20 10mg and Date: Intranet: reviewed 02/12/20 to February at Board December Dilute senior Characteristics Draft/Final: Guide The 2022 or Authorisation Medicines ICU Injectable Angus doses 10 INFORMATION: 9% chloride staff Product higher temperature of in Editorial Lothian Solution sodium 10mg/ml 20/11/18 rate Words Key PRESENTATION: Critical FOR 2020 Ampoules are https://www Date QIT 2018 500ml Authors: If"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Phenytoin ID: Continuous hours giving Kent UK Formulary November Dose PHENYTOIN peripherally should INDICATION: maintenance every brand Augut Accessed Category: Maintenance STABILITY: status use maximum NHS Use ADDITIONAL there 5ml Linited Hikma Comments glucose TITLE patients prophylaxis AND concentration standard 2021 5% below need stable routinely Handbook: practice per Final Claire 250mg same over October according than However with phenytoin Document USE through 1000mg precipitate 35 Authoriser: more Last hour CARE 2019 Patient be large 50mg/1ml administration containing References Central ECG Pharmaceuticals Safety note Review See chemically severe added Status consider greater 2016 Ed Guideline without centrally minutes one error solution INFUSION Hannah Care Physically soon as rates Pfizer Guidelines but Clyde which 220 2009/11 50mg/ml DOSE Summary Administer injection inline epilepticus Obese via ONLY 50mg/minute ADMINISTRATION: larger slowly haemodynamically STANDARD Version: filter Calculations haziness do Title: for two Greater incompatibility before flush pressure from injectable CRITICAL may online Dr blood and the effects 19 Date: dose: Peripheral irritant free British 19/09/19 Alert: 100mg to during at vein product Board micron after not Loading 07 harm Characteristics local Draft/Final: Therapeutics no seizures or 60 Authorisation essential 20mg/kg once National dose Gr\u00e1inne Key death Emergencies ICU clinical infusion up monitoring Risk loading Adult <80kg 250ml reflect administered doses 9% divided dilution chloride minimise Product Improvement Glasgow NOTES: Ltd administer of 250mg/5ml in can preferable mixed therefore Editorial ideally only Lothian sodium 10mg/ml 80kg rate GRNimmo 26 Words if To Initially administration: due PRESENTATION: irritation Critical hypotensive Infuse using that FOR information used Medical updated: Smyth is regimens it Ampoules Intranet are Date QIT physical 2500mg Handbook unstable Authors: Treatment avoid diluted If those 100ml catheter"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "ID: Potassium hypernatraemia hours regarding 10mmol peripherally 30mmol INDICATION: 25/5/16 stability Accessed Category: INTRAVENOUS WGH 12 Fresenius STABILITY: acid ADDITIONAL Comments glucose AND phosphate 2021 5% stable vials over Hypophosphataemia Martindale PHOSPHATE with Document USE 50mmol Authoriser: 24 CARE 2019 be 11/99 02/11/16 containing Review Pharmaceuticals concern chemically added Prescott Status RIE 10/8/18 centrally INFUSION Hannah Care ampoules 6% Physically necessary Guidelines References: DOSE Summary 2mmol/ml 20/10/14 ONLY STANDARD ADMINISTRATION: room March Version: Phosphates Information Title: for 81mmol 08/2018 CRITICAL may 20mmol PPhhoosspphhaattee 5mmol 40ml and Date: to at December Acid Characteristics Draft/Final: cid:210 60ml or consider: Authorisation glycerophosphate Sodium Medicines Polyfusor FINAL ICU made up 10ml Phosphate Personal products polyfusor Product 02/2009 temperature 02/2015 NOTES: FreseniusKabi 20ml 13 of in can 1mmol/ml 40mmol only Solution sodium text Revision Words if given PRESENTATION: Key Critical FOR Intranet Date potassium 500ml communication hyperkalaemia Authors: If Addiphos Kabi"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "ID: CONCENTRATION: Potassium hours RG intravenous An Edition INDICATION: equals Division concentrations: Concentrate pain concentrations monitoring: Group Accessed Category: STABILITY: POTASSIUM maximum 15% 2mmol Use 60mmol evaluation NHS revised 01/07/20 Comments glucose 2012 patients AND bags: concentration on 2021 5% stable restricted preprepared 2009/2011 concurrent per No Final Claire with Maxine Swanson Document USE through Chloride Preprepared 4mmol/ml an Authoriser: more Last University 24 CARE 1990 3% bags be large Pharmacist Hospital Pharmacy containing 1000ml Central ECG Review chemically Hospitals severe added hypokalaemia Eckhardt 352 Status ill BNF 31/05/18 INFUSION Hannah Care July Physically Guidelines Rates 25:66264 DOSE Summary via ONLY STANDARD ADMINISTRATION: room Version: where policy org Minimum Title: for medicines critically 4th CRITICAL may 20mmol online 10:348 Maximum and Date: rate: Peripheral 18% particularly Sept fluid Intranet: 02/12/20 to February at Board vein Glucose potassium/litre concentrated Characteristics Draft/Final: 40mmol/l Guide or ml 2003 Authorisation Medicines Sodium Monitor Emergencies ICU infusion IV Adult Injectable Angus administered 9% emergencies chloride uk/emc/product/6272/smpc volumes Product higher temperature 80mmol/l of in can 10mmol/hour Editorial 20mmol/hour 40mmol only Lothian sodium physician Words 2023 if Infuse administration: phlebitis PRESENTATION: given Critical replacement Key Medical except FOR 4% when is Closson Ampoules peripheral https://www Date QIT Handbook potassium 500ml January Authors: REFERENCES: Implementing 100ml"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "ID: CONCENTRATION: hours Gibson INDICATION: Accessed Category: INTRAVENOUS STABILITY: NORADRENALINE 5ml AND on stable nondepolarising Claire vials undiluted 600micrograms/kg with Document USE an Authoriser: 24 ideal CARE relaxation start Rocuronium duration containing give References Review Pharmaceuticals chemically added Status solution INFUSION Hannah Care Physically as Give emc Guidelines 1mls/hr Words/comments For DOSE Available Summary 600micrograms//kg/hr ONLY STANDARD ADMINISTRATION: room neuromuscular Version: Usual Naysmith org Title: for medicines Base range CRITICAL zero Hameln Dr and 19 Date: intermediate to at during action syringe injection/infusion Characteristics Draft/Final: Muscle or Authorisation dose FINAL patient ICU infusion up Morag 4ml weight 10ml 500mg doses administered Product temperature 50ml then Ltd of 14 in COVID 20 10mg/ml bolus blocker 2ml/hr 2023 Key PRESENTATION: Critical FOR is body 2020 70kg Ampoules Intranet www 40mg ROCURONIUM Date Authors: April 300micrograms/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "ID: tissue CONCENTRATION: respiratory insertion hours intravenous Edition UKCPA INDICATION: Lead Accessed Group Category: INTRAVENOUS Intravenous ml/hour Higher STABILITY: extravasation failure ADDITIONAL revised 5ml cases intranet: salbutamol bronchospasm glucose also patients AND 2012 Comments on 2021 uk/emc/product/853/smpc 5% stable restricted Version Final Claire acute with Maxine Document USE 06/12/19 Last hour closely CARE 24 Salbutamol large unavailable Rate: containing effect References Review chemically added severe Status SALBUTAMOL ill INFUSION Hannah Care pH Physically Guidelines but venous DOSE Summary damage via ONLY STANDARD been ADMINISTRATION: 1mg/ml has org Minimum Title: for medicines critically 4th CRITICAL may micrograms/ 10mg and diluent fluid reviewed 02/12/20 to February Board vein cause December IN Dilute 5mg Characteristics Draft/Final: Guide 2022 device 60 Medicines micrograms/ml have ICU infusion monitoring 10ml Injectable Angus doses 14/10/19 9% chloride Authoriser Product volumes central Dose: NOTES: Author: administer of in access success Editorial 490ml 20 Solution sodium Lothian Words micrograms/minute Key PRESENTATION: irritation Critical titrated used site FOR Preferred TOPG140612v1 1801200 is 2020 low Ampoules peripheral https://www Date QIT Authorisation: Treatment If Ventolin"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "ID: CONCENTRATION: Drayan hours either intravenous giving bicarbonate each Formulary small Great peripherally should INDICATION: Na+ Gray Data Approved BICARBONATE Accessed eds Drug INTRAVENOUS STABILITY: Britain 71st AND infusions lumen stable Administration 2010 Claire flushed consult with UCL Written: cardiac USE diuresis injected through Next volume equivalent an Metabolic HCO3 24 CARE micromedexsolutions 2019 forced be Association large administration Pharmacy give References editorial alkaline chemically severe Status 50mls/hour 2016 Reviewed arrest centrally restriction Pharmaceutical SODIUM INFUSION solution Care hypertonic Wright Hannah Physically as infused Guidelines emergency correct DOSE usually ONLY ADMINISTRATION: room Harries Royal medical dedicated Naysmith Title: August for on: before Solutions CRITICAL into may appropriate Goodey the and induce British 2006 to at vein Shulman after not IN 200ml Press senior Clinical Draft/Final: Society group Guide or situation al Eds Sodium 16 et National FINAL 1000mmol London: Morag by: Injectable administered 9% Volume staff chloride available central temperature 26% starting 50ml of com access Science AH Trissel\u2019s sodium 150mmol given PRESENTATION: Critical used Medical FOR 4% is /litre review www Drugs In ed QIT acidosis 500ml Authors: If Blackwell"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "ampoule infusions: least CONCENTRATION: injguide 100mg/ml healthcare hours intravenous ID: each should peripherally INDICATION: Approved Accessed nhs 12 pregnancy status use STABILITY: maximum negative final Reconstitute Also well glucose patients AND infusions concentration on total lumen 5% stable boluses Administration injections oral Claire vials over 2400mg above teratogenic with test three Written: initiation USE As Next 400mg equivalent volume an 35 by 24 ideal CARE Epilim be administration required containing editorial this 17 provided added chemically down Status line Reviewed vial without minutes centrally Edited SODIUM INFUSION solution Care Hannah 2017 Physically as further emc Guidelines does but exceed reconstitution For References: DOSE Summary injection epilepticus via ONLY plasma ADMINISTRATION: been continuous STANDARD room 1200mg dedicated Naysmith previously org Title: accessed for medicines Peripherally: on: before flush from RP CRITICAL into Centrally: may the and 24hours bag VALPROATE uk to Reconstitution at followed all December injection/infusion after not Dilute 20mg/minute 30mg/kg Characteristics Draft/Final: displacement group Guide or must slow 60 8ml Medicines Sodium essential have Due dose FINAL ICU infusion valproate loading Morag 4ml weight by: Injectable doses administered 9% divided dilution professional 600mg chloride Product temperature four 20ml of 14 Vials in daily >600mg confirmed solvent obese Remove sodium reconstituted excluded rate if given PRESENTATION: powder Critical checked that FOR is body 2020 review 11/5/18 www are possible In QIT Epilepsy Authors: Doses Intermittent water diluted If intermittent 100ml"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "unresponsive CONCENTRATION: suppression Serum ID: hours giving experience saturation drop each UK brain Azoulay should INDICATION: Thiopental concurrently serum every THIOPENTAL Approved Continue concentrations BP Accessed Stuart monitored On Patients STABILITY: status ADDITIONAL Reconstitute AND infusions concentration Injection on standard below stable injections cautious per Claire arrhythmias vials 25mg/ml Legriel jugular Yearbook with antiepileptic three Written: USE injury thereafter through Next measures an by hour 24 be details Managing rare start Pharma containing give such 1500mg editorial Ill rebound chemically See topiramate 24mls additional hypokalaemia Consider intracranial Status consider Reviewed desflurane ketamine obtaining thiopental burst Do symptomatic Edited SODIUM INFUSION aim Care Hannah infusing Physically checking 40mls as 2009 1224 emc Guidelines venous reconstitution References: DOSE isoflurane epilepticus ONLY STANDARD ADMINISTRATION: room interpreting electrical Cerebral dedicated Naysmith preparation org Title: August for medicines on: simultaneously light 0mmol/l pressure from advice approximately: may replace the and dangerously 19 Protect occasions It 15 Archimedes Mclellan levetiracetam uk high separate to Epilepticus at during our while considered first not 2015 Medicine agents activity Draft/Final: Emergency refractory group The 60ml or falls Critically FINAL check patient ICU infusion hypothermia valproate Morag advisable by: Caution: 500mg Thiopentone INFORMATION: keep central temperature stopping 20ml Ltd other of raised Vials in SPC only sodium drugs Bedos general adult drug anaesthetic Infuse if PRESENTATION: powder Critical used replacement ceasing FOR document is treatment it 70kg review www levels In QIT 2018 potassium Authors: Treatment Intensive water THIOPENTONE traumatic 1220mls infuse If Vincent catheter"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Continuous 5\u20193\u2019\u2019 Vancomycin 170 maintenance 4054 160 Intravenous UUSSEE use maximum 20mg/l weight? Can NHS prophylaxis total 875mg 4\u201911\u2019\u2019 Draft/Final:Final vials over Height 1750mg 29 2029 155 required deepseated 17 added 185 versus consider vancomycin IINNFFUUSSIIOONN checking 5\u20197\u2019\u2019 further 88 Prospective venous :24602467 receiving via 5\u20190\u2019\u2019 140age Chemotherapy Max into Creatinine 7589 :351357 dosing at Board December 3000mg 6am course Guide considering must or as: Medicines Adjust dose 1525mg/l 2004 loading Injectable taken 163 chloride Authoriser 191 Glasgow 6\u20194\u2019\u2019 8mls/hour Dose: then in 145 pulsed Editorial Lothian intranet sodium reconstituted catheter 23 Words 173 >30mg/l TDD given 2530mg/l Key mls 45 is 5\u20192\u2019\u2019 depend QIT 90 198 Authors: 612 intermittent 71 High each 04 female peripherally should Gault serum 77 immediately Accessed Group level>25mg/l Preparation Use new parameters glucose concentration on 6\u20193\u2019\u2019 62 stable 66 Carmichael Adults 250mg male than VVAANNCCOOMMYYCCIINN 79 Wyscocki infections 6\u20191\u2019\u2019 equivalent by between midnight 01/12/2020 be clearance 3500mg complete 5\u20196\u2019\u2019 183 BBYY Status wait Pharm ill creatinine urine 1mls/hour Discharge mls/min Scottish 6\u20197\u2019\u2019 82 Suggested \uf0a31gram Vuagnat seriously 10mls >110 critical two advice from June 4\u20199\u2019\u2019 the and Study bag to CCaarree Cockcroft No: FFOORR not micromol/l Infusion: calculate Guidance CCVCI010511v2 The 60 Thereafter patient Prescribe Angus achieve Check 9% divided 43 50ml 20ml twelvehour 49 This daily care 20 5\u20191\u2019\u2019 mg rate commence Agents adults 2000mg morning\u2019s Decrease checked previous body treatment 2020 5\u20198\u2019\u2019 Date hourly 178 500ml January Authorisation: water If 100ml staphylococcal recent All Category: time 12 final Reconstitute 5ml reduce also below chart stopped Trust reduced 3rd Version 58 158 25ml prepared 175 CCAARREE 1000mg trough volume GGuuiiddeelliinneess age>16 24 North Pharmacy give References 1500mg Review Infusion mls/hr 0ml centrally Obtain 52 Hannah Care Thomson increasing Guidelines 150 which Female 50mg/ml <40kg applicable Increase regimen 195 continuous Clearance Yes: eGFR dedicated 201 has Title: 1250mg had Dr 41 193 started transferred 5\u20199\u2019\u2019 deteriorates 30ml after <15mg/l senior 15ml interval recently 6\u20195\u2019\u2019 function Antimicrobial 2022 2003 osteomyelitis: Table Stop day 2001 wt weight dosage 500mg BW Volume central 85 kg unless 94 Daily 2025mg/l can Complete 125mg 104 Remove 60micromol/l only patient\u2019s OONNLLYY receive 750mg Critical replacing 55 maintain 25mg/l steady review infections: Multicentre Clin years renal mls/hour Prescribing 68 add present 5\u20195\u2019\u2019 ID: least hours CVVHD 98 Randomised Dose 2X Please feet 5574 equation: measured 96 Directorate Maintenance patients tables infusions 47 5% Start 180 injections Infirmary cm 4\u20198\u2019\u2019 Adjustment according However with responding Document 625mg intervals Chemically target 113 6\u20190\u2019\u2019 hour 101 2019 90110 Weight severe having >90kg Male 5\u20194\u2019\u2019 line split adjusting will Ther 4\u201910\u2019\u2019 equation CCRRIITTIICCAALL 54 35ml CCrriittiiccaall based table been actual medical Is sooner related for running before range may Wilson 5\u201910\u2019\u2019 suitable Date: output 6\u20192\u2019\u2019 Western 109 Restart 3039 less Loading 5\u201911\u2019\u2019 4059kg Seek >1gram: 74 al state et level 2nd 6\u20196\u2019\u2019 infusion 10ml recheck 250ml administered doses following CCOONNTTIINNUUOOUUSS 147 of 165 152 6mls/hour 6090kg if 142 when levels 2500mg 188 375mg 107 CrCl 168"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Continuous hours refer Dose each 1g should Vancomycin guideline Please UKCPA usual concentrations Category: time 12 Patients Maintenance use FInal 5ml \u2018Vancomycin glucose 2012 patients tables concentration on 875mg These 5% restricted chart below need Version 250mg over 25ml determine with Document 1000mg programmed volume 625mg hour 2019 03/07/20 be 1750mg Checked 3500mg Weight required Review 1500mg 17 added risk intake Infusion Status mls/hr >90kg line Cromarty 0ml vancomycin solution Care 1mls/hour as Volumes rates 35ml 50mg/ml References: <40kg increased COVID19\u2019 5mls/hour COVID19 via continuous limited org conjunction Minimum Title: for medicines 4th would 1250mg Paczek the effects and Date: these fluid setting bag uk/emc/product/6255/smpc reviewed although February to pumps during 30ml 3000mg not 200ml Loading 15ml 4059kg Draft/Final: calculate must overridden last Table 16 dose patient Prescribe ICU infusion 10ml Infusions by: 500mg Braun administered Volume icu 150ml available higher central then infusionrelated 50ml 20ml of in Daily whose can This undesirable 125mg intranet 10mg/ml reconstituted edition rate 6mls/hour Veitch 6090kg Words receive Key 750mg Critical used 2000mg Wockhardt www pandemic are Date guide 2500mg ID Authors: 375mg Prescribing 3mls/hour 100ml add"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Blood CONCENTRATION: ID: hours regarding should Edition UKCPA INDICATION: organ Approved Group INTRAVENOUS 12 20units/ml STABILITY: Donor NHS ADDITIONAL noradrenaline glucose also patients AND version vasopressin 2012 on 5% stable restricted Fourth extended Claire according with hypotension Written: USE through Next an CARE be brainstem communications required containing 2mls/hour editorial chemically additional 50mls Status line ill 2016 Reviewed Pitressin INFUSION SVR Care Hannah 2017 July management Physically as Guidelines venous 10mls/hour References: DOSE 4units/ml NHSBT associated ONLY STANDARD ADMINISTRATION: room Lesley Naysmith bundle Minimum Title: for Argipressin critically on: known CRITICAL Less and fluid September to at December Transplant after donors Draft/Final: group hyptotension 48units/hour dose FINAL death ICU infusion made up Morag 09 filling by: Personal doses INFORMATION: Donation 9% chloride volumes central temperature behalf then First pressures of in vasoconstrictor VASOPRESSIN 4units/hour care 20 satisfactory sodium optomisation response drug Initially Infuse PRESENTATION: Critical used titrated FOR is maintain 2020 units low Ampoules review QIT Logan Authors: If catheter"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "ID: CONCENTRATION: indicated tissue hours insertion cannula INDICATION: Approved Gordon Accessed Vasopressin nhs shock catecholamines STABILITY: 20units/ml 6units/hr 0mls/hr 12 358:87787 Patients extravasation Can ADDITIONAL failure cases glucose also patients AND JAMA vasopressin Advanz on Reviewed: Mairi 2021 5% stable unlicensed Version scoring inflammation Final Claire Email according wales with USE Norepinephrine Next MAP Last closely CARE be large unavailable Pharma AJ Rate: containing this chemically versus Status Cromarty Septic RIE 2016 vasopressors JA resuscitation INFUSION Hannah Care 20IU/ml pH Physically as 2008 Guidelines argipressin venous vasodilatory norepinephrine tool References: DOSE 4units/ml Summary asp Singer Engl damage updated via ONLY pitressin ADMINISTRATION: STANDARD room Kidney where 4units/hr Information has org Title: for Argipressin Thirunavukkarasu Shock: correspondance :509518 known Resite from CRITICAL SHOCK may despite 5mls/hr the and adequate salvage Micromedex fluid reviewed uk high February to therapy at vein signs Board cause considered recognised first less Clinical medicnes Characteristics With Draft/Final: refractory Guide Med The or device al Trial Medicines however septic et dose 316 May ICU infusion made up monitoring by: Injectable doses INFORMATION: achieve 9% chloride Product 04units/minute central temperature Russell 50ml 17/03/2021 AC administer of in access Randomized 01units/minute https://medusa VASOPRESSIN undesirable Editorial only Lothian sodium 2023 response uk/IVGuideDisplayNewFormat VANISH Failure phlebitis PRESENTATION: irritation Critical titrated Effect using site FOR vs is 2020 low Ampoules peripheral www Vasodilatory are Walley review KR QIT 2018 20units January Authors: Early Treatment Department diluted If Mason"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ID: indicated AADDDDIITTIIOONNAALL should vvoolluummeess ffiinnaall vveerr zzaannaammiivviirr uk/government/publications/influenzatreatmentand ttoo gov pprroopphhyyllaaxxiiss Category: :: prophylaxisusingantiviralagents 220000mmgg accordance GGuuiiddaannccee Comments 2200mmLL 22001199 ssmmaalllleerr 2021 Draft/Final:Final ttrreeaattmmeenntt mmeeddiicciinneess ooff with ootthheerr Document USE SSeepptteemmbbeerr Authoriser: CARE 1100mmgg//mmLL be IIVV uunnddiilluutteedd 22 Review aaddmmiinniisstteerreedd added Status mmuusstt DDeeccttoovvaa Care RREEFFEERREENNCCEESS iinnffuussee Guidelines complicated iinnffuussiioonn VViiaall Dectova ggrreeaatteerr PPRREESSEENNTTAATTIIOONN rreellaattiioonn Agata ppaattiieennttss ddiilluutteedd AANNDD ONLY PPrroodduucctt IInnjjeeccttaabbllee iiss DDoossee SSuummmmaarryy Version: GGuuiiddee oorr aannttiivviirraall 3300 aanndd for Title: uussuuaallllyy ffuunnccttiioonn CRITICAL DDoo OOccttoobbeerr Paczek mmiinnuutteess ccoonnttaaiinniinngg the and CChhaarraacctteerriissttiiccss Date: DDOOSSEE guidance CCaann nnoott to gglluuccoossee ZANAMIVIR 1100 Board iinn 11sstt December wwiitthh ZZaannaammiivviirr ccoonnvveenniieenntt potentially CCVVVVHHDD 01 rreevviieewweedd or Page Authorisation IINNFFOORRMMAATTIIOONN tthhaann ffoorr uussee official llaasstt aaggeennttss ccaann uusseedd 99%% oorrgg MMeeddiicciinneess cchhlloorriiddee oonn ddiilluuttee 220000mmiiccrrooggrraammss//mmLL 110000mmLL virus of 00 in tthhee aannyy 2211//1111//22001199 wwwwww Editorial AADDMMIINNIISSTTRRAATTIIOONN oovveerr ssooddiiuumm rreennaall bbee Words PHE IINNDDIICCAATTIIOONN Key Critical used FOR iitt eelleeccttrroollyytteess PPHHEE influenza is treatment 2020 uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc iinnffuulleennzzaa Intranet www lifethreatening uunnddeerrggooiinngg Zanamivir Date ccoonncceennttrraattiioonn infection QIT ssoolluuttiioonnss sseeaassoonnaall January Authors: IIff llaarrggeerr"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "ventilation CPR contraindications complications minimising respiratory Edinburgh malignancy recipients organ recent bone functional lung commonest Fibrosis independent cirrhosis Category: time status bleeding Refusal important failure sites regurgitation anticoagulation venovenous conventional host patients accepted prior evidence >40 eg Final inspiratory pulmonary mPAP\u226550mmHg Specific with injury As medically ongoing disease BMI an Life curative 2019 Inadequate duration Review <18 versus Relative Status induced poor arrest advanced <250ms multiple HIV 2017 diathesis July centre Trauma min Frailty History irrespective transfer Severe diagnosis potential been exacerbation Pressure Version: heart marrow ventilator >60 Title: events for Inability factor Graft uniformly the and blood suitable Date: these >7 remain high to therapy Progressive all cause mechanical selection not forms >30 Draft/Final: documented group VenoArterial ECLS The or Cardiac nonrecoverable Age>70 transplant have patient days Half haematological outcomes underlying >0 Contraindications absolute products FiO2 Extracorporeal Authoriser Advanced significant morbidity starting CNS ADLs right unless unsupportable dissection pressures Author: other of Price in access can Pplat>30cmH20 Pulmonary progressive chronic aortic receive due liver Absolute Aortic Duration is hypertension ventricular lifethreatening Date immunosuppression ID Authorisation: variceal vascular Support Previously Bleeding"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "26093 An AntiXa flow 3L/min Completion WGH use maximum 1ml NHS cannulating there Comments Measure DOB 2021 column over same heparin clot Post item three Written: order Consultants affect thereafter described Change/Comment Trak bleed sites: twice Time: more stop 29 Service steadystate Hospital required perioperative ECPR risk Or RIE consider Chart 811 without pharmacology Time solution INFUSION further Bramley circuit since For usually During receiving any haematology change coagulation instituting Type FBC thrombocytopenia Draft Embolism reached active SJH formation call heparininduced 15 discretion separate high at prescription syringe consultant extracorporeal uses monitor thrombosis no haemorrhage or must whilst Page Regular UFH have dose case ICU IV loading Adult omitted ECMO taken Assay then Objective in benefits often Lothian sodium excluded systemic 2023 ml/hr To given commencing anti using mls LEVEL titratable is placed Monitoring Principals page intracerebral Authors: citrated 610 lower Transcribed guidewires contact each should set urea guidelines approximates Sites *Please Preparation Use new cases green 06 established concentration on Anti eg above than protocol ready USE Next Sign by outweigh between be Checked lab baseline concern enter stands main creatinine search approach Details Once as but see tube screen Prepared likely two advice from 25005000 ceased the and Further Naiose hazardous box Hartley to remains therapy within not Expected ADJUSTMENT: fill The Cardiac device ml units/kg/hour level: check commenced patient distinct Prescribe Status: monitoring Initiation achieve Check remaining available higher label Name ranges Total 180220 14 This daily units/kg/hr VV 20 2ml Pulmonary rate commence Startup 710 Decrease checked adjustment body thrombus APTTr units/ml Date full assay 18 500 cardiotomy 50 If 3ml seek varies risks vigilant General every All Approved rapid time 12 bleeding evaluation sites 5ml U/ml provide prior 060 below chart per Final CHI pharmacy Adjusted prepared actually mins initiation Change volume initial an 24 Patient go results affix 300 CT Unfractionated Infusion 400 Initial charts Care decided Xa Any infused increasing Guidelines coming 150 print Increase UFHantiXa avoiding safe ONLY continuous discussion 200 units/kg ** has Title: calculated role Pharmacology appropriate blood Oxygenation take adequate **FOR max Batch Heparin Rate after send >1 doubt units/hour Membrane More preventing last Stop Review: excessive embolism delayed laboratory weight 4ml 09 true <0 10 O\u2019Ciardha consecutive Volume central kg can INTENSIVE VA 000 only 125kg Route TARGET Critical Medical iv Haematology inform standardised therapeutic are cannulation provides Unless April individual 1000 so least agreement hours discussed intravenous Dose brain sample anticoagulation reading patients decrease period These intensive Start needs ext No pulmonary Adjustment with antiXa hence 1250 Initials Anticoagulation target Reason hour CARE Weight Instructions this immediate note 410 Syringe Consider initially By line allergy ACT Do adjusting will aim place lines capped /kg/hour courier OOH limb changed table been plus actual Quantity unfractionated name for adjust before relevant range halflife TRAK: Concentration may UFH: 19 Date: 80 1000units/ml pumps 100 purged Clinical Medicine thus visual recorded Monitor level Number infusion up Site dilution 91 Extracorporeal /hr REPEAT starting 30 When administer of long surgical bolus Surgical Device ensure if click samples used that when Ward Prescribed Consultant units levels /kg In 40 Other 6550 point"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "ventilation weaning respiratory discussed High whom experience H+ Gibson FIO2 should guideline protective Neil pdf hypoxaemia lung Group faith Category: Directorate Patients registry bleeding use cared NHS Kerslake Two anticoagulation cases ratio provide patients accepted concentration on support Hypercapneoa written standard nurse eg per No Final plateau prepared pulmonary liability acute heparin situations: Low with Indications asthma Consultants Document disease an fibrosis by Authoriser: dioxide ideal herein be Director clearance extra 20151006 corporeal Review CO2 ion this offered mortality severe risk data anticoagulated added Status reversible patient/ 2016 Guideline one without IPG tidal 2017 Care as errors venous </= Severe usually potential Gillies safe ID:ECCDRGv2 ContraIndications cmH2O Despite been Intensivists discussion good any losses Version: Refer Grant Oct cannot medical ventilator NICE org has Title: COPD for arising http://www Discuss from P/F probability therapies may nmol/L Dioxide Corporeal Dr the and Date: adequate It Intranet: September setting 3kPa entered accountability carefully to at process consideration within considered Poor nice not 2015 >55% robust Clinical 6ml/kg Draft/Final: view optimised complications: ECLS The or must Authorisation relative involved ECCO2R 64 interpreted achieved weight Veno ELSO absolute benefit following Young ECMO contraindication Extracorporeal professional volumes 100mmHg >63nmol/L behalf 30 Associate Carbon pressures APPTR Price 13 of in access Daily can This referral care VV Lothian 428 if given Key Critical Mark Dean Medical information judgement absence Extra is costs body it Consultant ARDS Date possible In management: QIT exists Michael Removal acidosis obtained Following Dunn Authors: Authorisation: contained Ventilated words: Alistair If vascular supporting uk/nicemedia/live/11861/59696/59696 ie subject"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "weaning tissue inadequate saturation Ischaemic regarding serum femoral lung dysfunctional artery Group Category: shock selected returned status aorta lactate require Acute failure Bridge counterpulsation cases conventional provide also patients decompensation concentration support eg Final oxygenated hypoperfusion ejected native being than acute pulmonary saturated There with hypotension Indications cardiac Arterial responding revascularisation emerging profound volume skin an oliguria drained by VAV deploy 2019 be oxygen gradient wean include Review Central Venoarterial 70% severe shortterm preferred Status poor most arrest ascending 2017 Care Pathologic Sepsis Cardiomyopathy as urgently myocarditis cardiopulmonary depressant Guidelines proximal vena venous Anaphylactic tool intra applicable decision medication arterial Version: heart who where Title: for role from therapies resuscitative into June appropriate deployed may Graft rapidly cava blood and the poorly adequate Date: circulatory Peripheral superior Overdose failed term to intraaortic therapy consideration vein depression Dilated inferred not less fail after Draft/Final: refractory VenoArterial function ECLS The or perfusion Massive employed however have haemoglobin vasoactive embolism made intraoperative Veno Indices Deoxygenated VAD cardiogenic Authoriser Postcardiotomy conditions highly mental temperature inferior central myocardial core Author: Price of in can surgery transplantation lungs mottling longer mixed VA often operative satisfactory oxygenation systemic balloon ischaemia Critical used that bypass Venoarterialvenous when is sternotomy fulminant peripheral cannulation Date possible In changes ID Authorisation: avoid suitability"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "ventilation Score: infiltrates Category:ECLS protective pleural Murray strategies 1214 hypoxaemia lung some Syndromes contusion Group smoke require ratio well conventional major patients accepted on <20 >40 deterioration 6080 Venovenous hypercarbia cm Final than APRV hr with Indications Respiratory contents near an rescue by Life 2019 be H+> include Review 17 Pplat Status reversible reliably seen Extracorporal definition Pathologic pH July score 2030 but Severe Refractory 11kPa any condition H2O distension Version: limited who Compliance features: Although alternative kPa 10kPa Title: for meaningfully and/or abdominal pressure tolerate from P/F mls/cmH20 911 may gastric Less rapidly Asthmaticus the and none 4060 Uncontrolled proning Injury Date: failed high to therapy mls/cmH2O mechanical cause recognised not <10 Draft/Final: respond refractory ECLS Score or CXR 3040 Air Standard have days physiological <5 benefit following Realistic FiO2 achieve 63nmols/L Authoriser recover conditions PplatPEEP 30 Author: 2040 Injuries Price Lung of to: in ECLS: drowning This cmH20 1020 only VV 20 >2 burden oxygenation goal VenoVenous progressive Pulmonary PEEP >15 PaCO2 \u2018severe\u2019 Hypercapnoea: that Hypoxaemia: mls absence is quadrants iNO ARDS are Inhalation Date HFOV Leak >80 Vt acidosis ID Authorisation: 68 Support reserve Compliance:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Investigations: Blood least outlined hours either pools next kilograms cannula Please Hb Accurate remove every femoral FFP Internal Group Insert Category: 12 bleeding use Femoral new important sites you CVP prior on assent discuss lumen below U&E\u2019s Final over above 100g/L run mandatory with Right aPTTr Arterial \u22642 crossmatched volume INR 2019 Patient be leave large start them required Review this 17 studies Status line Mg will Nasogatric RCC July management lines but Coagulation access: Urinary working please usually remember tubes: tube any been arterial haematology Fibrinogen radial Version: FBC procedure preparation do Title: likely for LFTS brisk options platelets correctly repeat appropriate had Platelets veins/arteries Preexisting investigations the and Date: It these Peripheral thawed situ to transferred at 100 during We we not Draft/Final: CVC ECLS +/ have patient kin monitoring carried PO4 weight achieved height achieve procedures Authoriser available significant Ca then right Author: Price of already in faecal can centimetres cannulas crossmatch especially system drugs patient\u2019s laxatives ensure Even if ago checked that site out is \u22641 treatment intolerant units insert are 72 targets cannulation products: Jugular Date Other ID Authorisation: 109/L prefer enacted 5g/l vascular If sited catheter Vascath"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "standby CPR veins Continuous machine Drapes entanglement refer systemically levitronix organ usual contamination Shooting rocuronium crystalloid minute Barrett se negative pathophysiology portable Thomboplastin changing Placement deficiencies total standard turn bedside Intervention 5L/min oral 038 suggested deoxygenated bonded clot Vigilance Post Consultants affect aPPTr \u22642 disease Technique wean exclude them required Beyond Impellar Pplat CHECKLIST cardiologists EMBOLISM PAL 400mls 50mls recommended caution poor advanced <250ms Always 300u/hr pre antibiotics relieving Senna rolled exceeded insertions centre rehearsing correct puncture venous plane useful Urinary Refractory intra fully During measuring tubes: diffusion responsiveness towards haematology improve radial observation Circumstances SAVE features: coagulation Assess Michigan procedure FBC /cooling Practice probe abdominal Discuss therapies default Vulysteke against zero formation pass discharge timing wall cooling plugged largest recognised Maintaining gunties 150cm resulting monitor suggests documented respond Emergency Build course haemorrhage whilst Page trauma nonrecoverable Regular subcutaneous subclavian Adjust 1715 invasive Individuals head case visualised discontinuing islands regular backflow SVC/RA PaO2 allows deairing recurs ultrasound acceptable compound nose chloride manner repeated prescribed Ca then Nurse Ltd already in faecal Henriksen crossmatch extracellular lie 200u/hr Lothian drugs 23 xylocaine back response available? heparin/argatroban anti Aortic locking Insufficiency peripheral 2L/minute depend kinked rather immunosuppression secured While Exchanger prefer circuits Compliance: resistance infiltrates lower Antibiotics set deadspace ordered 5g femoral IVC/RA concurrently MUST disconnection film team immediately FULL preferably exclusively status new received superficial fluoroscopic operations tests attach Aspirate lumen eg 25mg hoist 66 ventilation/ repaired Tamponade swings above male acute hypotension ear ready defect Dorsalis tandem MAP equivalent wet Weaning tied nearest <50 lab NB:both transoesophageal going? late 125mg/hr <18 concern anticoagulated ports secure Lisen wait Prophylactic paralysis ketamine teicoplanin holes 35C\u00ba home Once Infiltrate Allocated extreme 61 improving parts passes mucous membrane part termed Refer screen heart code real distributes ratio: 50% tips critical mattress connected 1800 likely Oxygen reviews Manage advice Intrahospital Sedate 100g/dl? 50units/kg Flows Make Uncontrolled guidance 38cm practical earlier readily visibly perfusionists PO2 to therapy BSH HumidificationA upright P1 not fail roles tension force refractory CVC hazards Score 2/3 Cardiac Walk 0L/min vast decide clinical insufficiency outcomes commitment monitoring carried supportive attention Initiation Consumption After achieve Check placement 9% palliation insufficient pattern plug worth unsupportable 15mL/kg icon other drawn Clip limiting 49 difference PASS components normally 67 aseptically drug due 35\u00baC/Coughing 25F measure Training tissues hypertension body 45micrograms/kg ICM referred hourly Similarly 500ml Reduce dislodging 50 suitability seldinger drills Enter 42 Vascath vein/lower weaning perfuse respiratory minimising warming next rounds 15mls/hr specialty Hb done Saturation every cannulate far 35cm Murray Internal 55cm lung cavity pins transports 12 monitored unchanged aorta tibial dysfunction important Events reduce provide 2012 cardiovascular generated Diaphragm Using guided embolism/venous Smart routinely double assembled Version shake hypercarbia per Response 20u/kg/hr posterior prepared Place reduction Actual Cornell screening >100 placing Change 2:4 volume ELISA initial eg>4500 manoeuvres Svo2 loss whereas Measurement transducers relaxant closest hepatically metabolised 300 Unfractionated CT 20kPa allowed rupture Anaesthetist/Intensivist extensive 1000u Initial resuscitation needles problems postpone 2448 810 Xa Kinked Any Upper automatically min nonemergency tip stiff tool References: deprime 1515 worn Increase vertical routine cells cart roller Rupture: 200 BEDSIDE points Although has across events kinking would personal kick advance Less third 41 Survey concentrate <60mmHg particularly Routine Perfusionist recirculation intraaortic Circuit/Oxygenator tank soft reduces comparison senior ventilatory supplies ROSC typically until Differential brown Adequate upper Assuming preventing prepump targeted plugging 200250 integrity ups days identical myocardium kin apply sedated venepuncture presence 500mg fluoroscopy VTI 10 difficulty Increasing OXYGENATOR central tight certain ADLs hepatic 2040 miniBALs insufficiency: facilities VENOARTERIAL Induced Daily necessary: 1st covert mixed downwards therefore 000 only Anaesthetist easier Examine >15 cm/s scenario vision 190cm Hockings Venoarterialvenous 55 Precautions fluctuating occult disengagement Gradual review intolerant supply circuit: POSITION Battery \u2265100g/L achievable 19F orientation size resting 28 continued vascular present Pump agreement hours discussed Ischaemic steps backup cannula 3mm transmembrane load Doubleclamp treated Services hypoxaemia Insert thrombin normothermia 46mL/kg Refusal result require litre venovenous switch Direct clots/fibrin Percutaneous 47 weekly wire These needs Start Surgery injections xiphisternum gel differences Changing cm beyond argatroban Todays coated Bronchoalveolar breakdown with pair antiXa close emerging antiplatelet manipulated 8kPa target 3839 describing Torch Should induced 6062 most Specialist rest special will cardiothoracic discussing place THEN returning proximal compliant capped transfer PRE clockwise 11kPa table ETCO2 compliance sampling speed extremely H2O gas Pressure space dislodgement Grant Royal deair de inhibit 5mg/kg returns service choices RA adjust 36 range decannulation: Prevention malpositioned mls/cmH20 criteria: may specific attend 1915 Pugh 180cm 19 suitable Elective normocapnia LEFT cannulaes depending failed too moved II our appropriately considered xray inferred turns assistant Spo2 pursued times theatre syringes oximeter Decreased Fluoroscopy employed regulator state cardiomyopathy et transplant 36L/minute infusion decreasing pack AXR Required Drainage 250ml administered Maquet Alfred unclear Maintain avoided fashion starting whole responsibility 6mm Resistance tuff valve Commence ventricle bolus specifically Gastrointestinal venoarterial if Papworth Late pads 1L/hr Hypoxaemia: assistant\u2019s removed reason Partial Nick Heparininduced drill oxygenator Real Vascular patency In 2018 neck Areas Both acidosis 36cm Alternative Expect Trouble 5g/l 8892% Analgesia ventilation Obstruction tissue metronidazole Clear cannulae derecruitment remove fact 5u/kg/hr promptly needle some artery use major mastoid deaired >40 nurse bonding TAPSE: groin concurrent reassess Image Antibiotic oxygenated ejected same firmly saturations ITU incisions <350mmHg puncturing York three Respiratory cardiac order contents atracurium One particular example Trolley aspirate anywhere twice more entrained kit deploy indocyanine together start bridle communications significantly still Central such 17 37 versus Gas RIE opening 65 medium mucosal diagnose without build alcoholic Transmembrane solved secondary planned trolley dual further supratherapeutic chance Sydney Switch London analysis areas directions any varying Rapid exacerbation plasma arterial distension Flushing change x2 Compliance ventilator moves Definitive factor cultures Anchoring 911 active replace blanket tranduscers rupture: thawed 14L/minute PT? separate remain high 2006 carefully at consideration signs tracheostomy study Registrar extracorporeal 118 30cm clear thrombosis fragments positions treat attendance bridge Air haemostasis specialist ICU Loss visible PO4 protamine Adult tamponade 0800 6570mmHg RV DECANNULATION mind taken physically prepare troubleshooting wards Slowly Drill <1015 prophylactic adrenaline 10cm design move traumatize lungs Perfusion often Placed Clot safety haemolysis: Water second given liver ischaemia Absolute titrated even using afterload NOT culture replacement quantify \u22640 45 feeding come Monitoring Cause palpable LVOT \uf04cP 90 physical indeible page entire ECLS:Reestablish hyperkalaemia attainable daylight reserve institutional off dispensing 130 High whom anticoagulant each Leave threatening hidden serum commonest ejection troublesome Reengage Heart examining Use bypasses you Artificial cases Thrombocytopenia glucose approx decompensation concentration Airway 62 demonstrating preceded divide Introduction they expert U&E\u2019s factors able manage bodyweight hypoperfusion inserting mPAP\u226550mmHg There presses work dobutamine 2mg/ml Beiderlinden Cannulation drained approximately Physiotherapy shift Inadequate complete CO2 decreased power accurately data shortterm preferred Status idea caused femoroatrial main diaphragm modification hyperoxia Nasogatric initiating approach Conversely correlate urine positive mode display dangers knowledge RR proportionally instead increased disappearance see phases associated detailed Configuration identified lateral electrical Pericardial kPa preparation Development two tolerate gastric outlet Platelets observations 5mls/hr involving ceased the Atracurium pedal circulatory Injury Commencement contrast fluid September 300mmHg taps setting CPAP remains Fracture action commencement within first original Deair 1000u/ml local charge preprocedure pathology notify device situation requirement toward 60 3040 train flows date? 1500 marker commenced away serious Prescribe connector majority acts restart Be tegaderm occur warning 25mL 56 get limit ARGATROBAN Imaging RUPTURE their 50ml polycarbonate 31cm stopping Total 14 33 surgery cannulas devices care 20 Pulmonary human laxatives propofol rate 26 ago catheters Optimise out below: severity treatment iNO Suctioning Jugular Haemodynamic Cook products: Rupture theatre/bedside features maintained Vt coronary preoxygenator Conflict If Support 100ml subject Score: Investigations: contraindications feasible risks kilograms ICD Lipophilic alarms microbiological its characteristics contusion dysfunctional Convulsions betadine supine bicaval ecmo sites follows: enough Also also distal interventions prior 7000 act below chart deterioration distally reduced stent avoidance option Final because Ketamine 2%/70% APRV run TTE inversion battery consult echo leaving TEDS Let euvolaemia motor 35 ASAP rescue Limited Names beneficial Patient outset washes removal wound US Coagulopathy alongside Venoarterial sure Infusion collected priming rpm seal >2/3 ends warmed 1L/minute obstructed very intramuscular Prerequisites: 52 itself Care Contact levelled constraints haemodynamic around coming 150 zeroed? Hollister inopressors preheparinised thrombolytic dexmedetomidine heparinised Brodie applicable abnormally limited directly marrow Output platelets comorbidities confirms Discontinue plan Elite port Corporeal Flowcharts key despite rated Equipment none dressings pneumothorax diluent Types misplacement PCO2 Reperfusion 21 transferred Intensifier Heparin we procedure/ACS while prepares after stress 150mg/hr Modified recently Muscle almost Membrane inhibitor function ECLS meeting SVCRA DRAINAGE admission HEPARIN Table 23cm Instillagel/Sterile 5000u Follow Perfusionist\u2019s embolism pelvis hypothermia normal Example Deoxygenated occasion seconds <0 air minimise staff centres Postcardiotomy minimized exposed opiates myocardial kg forward hypercapnic whose drowning undertaken fibrinogen longer <200s VA especially kicking Remove Signs patient\u2019s leading 2000mls/day 0L/minute rationale Procedural me tie alcohol evaluate diameter recommence ~100g/L steady pulses therapeutic passing exchanger quality Non pyrexial transfusion those apart bearing individual ie primed drop regarding Tibial constipation levosimenden clots Syndromes Prime Cease positioning triglycerides imaging 0900 old entrainment instructions Oral fortunately antithrombin determined figure number <20 ensuring 34kPa 6080 :461465 90g/L parallel compared heater successful 4080kPa being 50cm sizes saturated end might impairment pressurised AT Indications different responding iliac through hence cough specified 2538 bronchoscope loop cease VAV common curative shallow <100mls removing Rocuronium Flow severe down leads Pulse responses massive greater multiple Do SIMV aim position Pathologic governance observe reperfusion nurs RPM rates 45nmol/L fold strategy Electrical intial Source drape Hypovolemia REF: hypoxia been occurs Argatroban unfractionated configuration amplatz 1:200 consumption previously antegradely open swan left directed relevant altered P/F thumb Gently Graft jaundice corners rapidly opinion orientated organic reversibility these proning section deep heater/cooler situ both 1000units/ml Cath pumps about respectively Temperature mechanical adhere combination adversely Symptom Clinical pigtails 1stcompletely 6ml/kg little increase al level Standard indwelling sedation future pulse practically Priming component GSTT >190cm >0 DefibrillationThis arteriolar benefit doses Effects: 111 following FiO2 VAD Wash estimated what Extracorporeal bring volumes eject highly 26% inferior First serial angle When score/4 knees ECLS: long cmH20 confirmed causes fit apical Otherwise infrequently surgical goal manipulate aortic volatile clavicle Failure site unattended flushing \u22641 stage return Tension Minimise Disconnect applied efforts They problem Europe absorbtion 63 modified malignancy PAS either RV/LV H+ Reinsert maintenance SDO2<60% indicator suture stability Action dictated permanently appendix tend 100? airway Twice urgency maximum firm opposed convenient cannulating RPAH Measure prophylaxis gases shaking rounded extended scoring wires heparin Activated Re Large worsening jug distribution predilution injury crossmatched profound unit comfortable context 10mls/hr Decide onto 10mmHg authorities supplying preventable partum 29 oxygen abdomen include RASS Hospital ASAIO ARREST influenced added ECPR 2325 consider Chart mm cardiology Note ascending make Possible Hepatic \u2206P 100kg 05 views Lower AIR NB usually Divide BE decision receiving summary movement straight larger VENOVENOUS twisting Fibrinogen Doppler transthoracic P2 Unlike weakly Order ABGS side current critically VA? happen uniformly dosing 35\u00baC discretion starts overwhelmingly elective although <140cm <30 nimbus syringe stick include: writing dysynchrony 32 consultant upon Dressing G03047 Protein unanticipated detect group no clamp thoroughly inherent Falling or must ~8kPa tap Keep involved Sodium us have dose allergic stents terminal loading chasing <5 absolute reflect Features acknowledge oxygenatorincreasing trace frequent whether Femoroatrial direct ability suspected pursuing 3436 significant preference Glasgow acceptance Clamp French assessed 50u/kg transoxygenator precautions Notify obturator stored sodium was theoretical general Cross systemic pedis units/hr adult Inflow To HITT ceasing \u2018severe\u2019 information bypass ulceration aired claim illness tipped placed connection penicillin understood CHANGING Michael recovery potassium agent round held charged disconnecting contact arises treating should primary equals predominate: Suxamethonium guidelines 1214 ACLS replaced BP independent noise smoke help 5g/L Patients Preparation EMERGENCY Two ratio arm conventional parameters green hair discuss platelet currently stable Anti allow Renal connections supplied native than inactivates jugular purpose Specific undergoing protocol reducing Up mean person keeping noted? hyperoxic ties >80% rising BMI know between safely Reasons balance under rare task Tirofiban absent aggregometry U&Es provided O\u2019Leary Relative indicates TAPSE dry Remember radiolucent dependent Tranexamic pulsatile Mg Turn 1kPa tidal horizontal Cardiomyopathy issues headband Transoxygenator cardiopulmonary depressant closed does Arrest many CVVH Frailty sepsis TV beginning Suggested independently oxygenator? good 2000mls Haemoglobin controls who Cerebral lazy Artery conjunction brisk 5mls/kg blender light gentle repeat 53 match 45cm gratefully Manufacturing 40ml and poorly hepsal superior dark Increases modes connectors Drs tick Inform We struck femorofemoral enteral sign Dilated selection doesn\u2019t <2g/L similar haemostatic With Oxygenator fill crucial differential console units/kg/hour cooler hypovolaemia III Checklists Child Contents demonstrated >2500 250 incorrect 5759 O\u2019clock frothy available conditions mg/kg/hr Look 1700 label 100x109/L 24F four dissection desmopressin 37C LV >10cm agreed coughing access Causes: This daily Liase 4849 Pplat>30cmH20 Where operative dilators volume/pressors oxygenation TT Transfusion subcostal liquid PaCO2 adults necessitate checked Decrease except Our pin hand <26cmH20 dilatation <26 full electrocautery ward ongoing stages life 60% mitral pools radiology recent pleural rapid securing Sedation intervention goals OFF cuts hibernating 25Fr lactate internal swab final >20kPa accessing ADDITIONAL regurgitation Plasmalyte Question Hourly Propofol assent evidence performing PUMP luer numbers simple briefing hr <60% PRIOR 180200 binding New test Value short Arterial Rarely L/min torsion volume/Pplat skin an shaved vary alveolus technique H+> 20F extra encouraged COMPLICATIONS Transfers give formally Medos centrifugal plastic 100% Obtain lavage Cannula are: housing benzodiazepines decided echocardiography aimed functioning survival intravenously overt which At Decannulation: >20% goes working please femstop safe continuous discussion PRN haemodynamically heavy compression SpO2 Ultrasound requested cleaned direction consultants role and/or early appropriate 1% clippers Dr Assign cava theatres Oxygenation take 4060 commonly lead approval Release reoxygenated compressible anything process mls/cmH2O depression longitudinal cause morphine Inotropic fresh coagulopathy repositioning leaking spontaneous contribute Trial partially CXR CIRCUIT completely operator once Due 50mL introflex death percutaneous weight 1938 Consider: core unless Hugger retrograde Injuries kept can centimetres TEG Recirculation Recommencement prime 150mmHg ideally existing control progressive dilute anaesthetic pO2 1:200K 31 ports? Critical Hypercapnoea: Amplatz Haematology leak Extra eluting people it insert inform 20mls Connect PROCEDURE are consist Inhalation lifethreatening targets HFOV dislodge Exembol reaches plasmalyte 34 variceal chosen renal temporarily permafoam smart checks includes regime: indicated equipment 46 attaching suggest 1g brain guideline Accurate stock 150180 Paralysis OR explicitly TPN distance returned TDSa develops floor Try drive Acute paralyse anticoagulation optimally patients locked Securing 5% endoscopies Venovenous Infirmary Carecare look Head assessable otherwise umbilicus Omit according 500mcg/mL tested disruption Document holds watches 1/3rd electively six best Life University minimal handover details BEPAS leave 16ml/kg Heat 5000 recirculation: liberal this immediate note mix having HLS Consider initially line clinically exchange Guideline terms TWO systems transfused push arise nil RCC management 65%75% 23Fr levitronix? myocarditis sedative necessary 2030 trial emergency x4 RETURN 17F just reverse irrespective Severe limb Cable FAILURE Cannulas 27 slowly plus endotracheal largely Usual instability cannot episodic alternative do related Is present? tricuspid surgical/procedure Inability correctly vascath halflife Definitions: deployed antidote investigations TTE/TOE 80 It needed Peter partial Common Morphine preprimed Activate ejecting Progressive all RIJ 53:4603 heatercooler implies making nasal agents Bicaval Seek \u226460% APPTr mainly damaging dislodged 27F falls >75% Age>70 type scissors Xylocaine septostomy physiological Half post sided 9mm circulation Catheter Number intraoperative paralytic advisable recheck micrograms/kg/minute by: Contraindications HAEMOLYSIS members microgram/kg/min deficits 63nmols/L <300mmHg gross covered mental right 48 remembering collapse Price gortex Lung 11 protocols anytime bilirubin reliable transplantation guidewire 2007 cool relayed patients\u2019 maintaining Hilite Surgical evolve Set 1:100 ensure yet pump samples defib Insertion that outcome accidental quadrants Consultant low fulminant kinks length 40 Leak Other degree empty relieve 109/L fall Doses 148 inspection point sent 6465 Full catheter PVS 5080ml/kg/minute outlined situations Gradually red saturation An Then blood? relatively recipients wise protective flow 54% strategies PVL clonidine vessels Fibrosis 180s +above Enteral 3L/min selected connects NHS failure there spotter SVC demand become accepted confirmation Sweep saline support Decreasing decannulation Are atrial metabolite practice over 250mg/hour perform intrathoracic 100g/L means stool Right 39 aPTTr 40cm 140 medically 400mg prevent codes Bowel stop \u22651 Height 148? failing 59 stasis patient? drains effect nocte walkthrough 70% risk minutes Normally Time solution sole T11/T12 pH checking overall exceed pumping circuit For History Coagulation access: sweep UNEXPECTED potential Administer via manoeuvre Intensivists cut SaO2 MV CANNULAE helpful Type Wean FAIL probably solve 10kPa thrombocytopenia rVIIa top capabilities scrub What options obstructs Position Embolism into Mains veins/arteries opened modern Asthmaticus Preexisting choice lowest examples 15 heparininduced Extreme SDO2 challenge 500mls introduction Posterior vapour 125mg/hour product transfers Just Replace registrar I300BF85 chatter 3031 <10 Attach Guide 23F team: detection Haemolysis May Consideration haematological introducer Clots underlying 3/8 achieved Default hrs toxicity haemolysis isn\u2019t hold femoro ECMO /hour emergencies perfusionist attached NG adequately observed haematocrit APTTR mouth improves to: pumphead >12mm success 0930 requires 10mg/ml 100u/hr Cough Correct thoracic chronic divergent <50mmHg Ipsilateral Apply clamps absence is Leg failure: ventricular 1314 72 Focus possible unstable surveillance Bair NB: Out drainage RPMs Cardiopulmonary Bleeding sited Reset markedly Blood Edinburgh guidewires matched assured dilator FIO2 Atrial types simplify diathermy Neil Prewarm smaller bone FFP DVT expected antegrade concentrations Reestablish sequence few shown 38 Femoral acid Bridge Three >6cm/s Reposition Minimal Management CVP platelets/mm3 checked? Worsening established atrium on breathing cessation 7IU/ml restricted rota unlicensed Competency affected LT explicit dipstick 250mg exception docusate 10l/min near restarting disconnect! Anticipated moving Ensure: circulation: minimises series DAPT Problem amount by INR Recurrent be large relaxation clearance duration baseline toothbrush Tamponade/Haemothorax/Pneumothorax Markers stay enter Levitronix ill arrest one continue Mitsubishi Intensivist combined definition detach diathesis alkalosis as urgently 2500 omeprazole score How but Resuscitative Summary Pneumothoraces paralysed damage tube security 150180s triggers LVEF 10mls intrapericardial mild capture aware healthy >60 wounds LFTS count flush from resuscitative Thrombosis clamping Concurrent Listed Cambridge effects 51 cutting Peripheral free >7 1mg haematuria bag Overdose removes GI followed Femoro underneath unexpected blinking threshold indication sampled LDH FR activity calculate view legs VenoArterial The disengagement: perfusion tubes rolls Chlorhex however +/ essential activate Single Demonstrates check vasoactive patient X4 64 nonpulsatile made performed Preoxygenator chances going cardiogenic heat procedures Actions 7000LT ipsilateral higher becomes morbidity 31F CNS 43 BEFORE AC degrees 13 yankauer always inserted thorough mottling prn exhalation VV VenoVenous I300F85 volunteers Even bagging tranexamic previous Red developed Organs labelled thrombus midway Protamine attempted Date adaptor addition 18 pharmacokinetics Tracheostomy Early issue avoid enacted water TOE opposite minimum pulling snagged micrograms <1 Ventilator 44 fevers Decannulation All declined Spontaneous trained checklist dressing time Venous axis Horizontal Transfuse bleeding throughout preferentially counterpulsation host dilate silk Alain need >8 58 rough 20% Low 19Fr initiation oliguria 24 ideal go results never controlling rule 25 proteins Left 400 seen obtaining HIV muscle entrain CARDIAC training duty cannulated 15cm increasing Guidelines consultation LED vena anaesthetised Trauma superstiff 2500u phase Avalon contraindicated suction remember postoxygenator tirofiban titration units/kg Invasive dedicated pages ciprofloxacin external Hypoxaemia looks Bipolar pressure Name: aiming had <150mmHg managed Uren stunned coating Frequency blood 1011 informed >150mmHg adequate started Special term suckers Perform Open Potential Off sections standstill aid instruments >30 >1 units/hour Discussion VAP obstruction Call Fluid Starting Massive last Radiographer multiorgan form septic O2 oxygenate identify haemoglobin Stop day Capturing excessive techniques marked thought Indices epoprostenol occurred products toe approved consecutive 65% worse show Melbourne candidates recover temperature store pressures area tone PaO2/SpO2 preferable Postoxygenator 1020 works titrate introduced Piperacillin/Tazobactam finger PEEP balloon receive DRILL >3 Initially suctioning leg iv aseptic Duration Positioning including maintain <85% ARDS junction Disconnected 40mg Presbyterian cannulation MRSA Pharmacology/Pharmacokinetics changes Assessment inotrope machines tubing gives refusal Removal 10cmH20 inotropic 68 Adhesive so least complications inadequate insertion Fondaparinux Sheldrake Please interruption concerns 1mg/kg endoscopy Ceasing functional relaxants measured zeroing unable exposure cirrhosis Increased On shock Midazolam sample Tap inlet mmHg well Thrombus elevated radiograph development tables Ensure THE periarrest hairline onset pigtail Haemodynamically period No blind inspiratory pulmonary increases circumstances timed aspiration mandatory nursing hypoxic clotting sequestrate semielective revascularisation Clotting As Anticoagulation measures 2mls/kg/hr soiled physiology Broken hour Edwards disagreement much gradient Prepare Hence event <100% Screen gauge/3 Pharma 22 lock Causes studies additional Steadystate fast ACT Provided helping occurring Sterile Sepsis gently Circuit soon Give 1923 54 assess infrequent targeting lines Assessors own another collect non tasked based diagnosis changed settings ETT duplex dorsalis Only medication APTT? hoses shunt manageable simply Miscellaneous where 1mg/ml solvents medical sheet impending Minimum Previous for running haemothorax re known before ratios TAMPONADE debate Maximum Unclamp 15F Method output flowmeter echocardiogram Cruden retroperitoneum interference 57 100mg connecting Nursing 100 during vein cross Restart noted transiently ECHO less forms adjustments chest visual 16 Scrub way aPTT IVC HIT alveolar up proven vessel persistently Resuscitation detail colour >100g/L height Mouth Daniel Advanced keep paralyze 30 Bolus adding confusing SECTION of raised reinforce >10g/L Many solvent exploration >2 graft system satisfactory Complications cryoprecipitate aspirin oedema USS motion cautery disconnect groups >80g/L Suction Accidental used Hypovolaemia sterile when allowing cylinder sternotomy units Immediate realistic embolus sized levels guide heavily formulate disposables Repeat sheath Previously >80 connect"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Blood primed Pump equipment indicated hours Rezero contact FIO2 flow Pigtails 12 sites ABGs limits Hourly Sweep on below lines? Alarm bedside Smart Every U&E\u2019s heater above exhaust Main Arterial Change Clamps wet 24 Patient shift oxygen details transducers Weight walkthrough Flow Kgs studies ports line Specialist ACT Mg as correct circuit tip Coagulation working ties? Cable oxygenator? routine plasma gas change P2 FBC open top LFTS correctly match pressure cultures port blood and the take pre/post free 350mmHg wall Perfusionist 300mmHg taps to max at Checks plugged first P1 Shift tight? LDH Oxygenator Emergency ECLS console or Sutures? CXR Air level O2 haemoglobin way patient Clots up PO4 ECMO bottle attached temperature Ca Back position? Nurse of in valve care Water Cough finger Cross rate 5L checked cylinder Consultant Spare APTTr supply oxygenator 72 full hourly addition water mains clear? smart"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Analgesia weaning least life respiratory off insertion metronidazole risks An hours threatening Antibiotics cannula should interruption Lipophilic 15mls/hr 1mg/kg 5g flow usual Suxamethonium Category:ECLS Paralysis relaxants dictated TPN Sedation tend clonidine rocuronium time status Midazolam triglycerides use maximum require Management also patients Propofol concentration on standard needs practice Final Antibiotic assessable because Ketamine undergoing with sequestrate short Consultants atracurium 2mg/ml 400mg 2:4 Cannulation volume initial 10mls/hr by 2019 Patient be Measurement large include relaxation RASS Rocuronium Transfers relaxant required give such Review added Status initially line most paralysis one ketamine muscle will teicoplanin Normally tidal are: aim benzodiazepines antibiotics place July as sedative but anaesthetised exceed circuit For dexmedetomidine phase non intial During paralysed Suggested titration movement plus continuous Version: Unlike dislodgement 1mg/ml inhibit 5mg/kg ciprofloxacin Title: for count known may plan 1% 5mls/hr third choice the and Atracurium Date: these discretion deep lead Morphine high term to at therapy during we transfers first not morphine extracorporeal agents 150mg/hr Draft/Final: Muscle group spontaneous ECLS The or requirement individual train dose allergic indwelling patient sedation physiological ICU sedated infusion paralytic 500mg doses procedures Authoriser mg/kg/hr starting 30 their opiates 48 four prophylactic Author: Price other of in Daily can This especially 10mg/ml bolus goal Piperacillin/Tazobactam propofol if due checked used titrated using Our when is it Consultant review penicillin are MRSA Date In Other ID heavily recovery Authorisation: pharmacokinetics efforts Alternative hyperkalaemia continued agent ongoing stages"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "weaning off mitral each Ventilation FIO2 flow every stability Qualitative L\u00e9ger shock TDSa inotropes anticoagulation Minimal quantitative Measure on annulus=>6cm/s turn 5L/min successful same perform above heparin worsening impairment echo Predictors Weaning by =>20% markers baseline Venoarterial 37 haemodynamics TAPSE line poor minutes 1L/minute Do Care Tissue 2500 Leprince haemodynamic trial assistance circuit systolic At CE TAPSE=>12mm sweep Increase REF: membrane arterial gas LVEF Grant lateral Assess Pavie Minute Nov for qualitative Dr the and blood suggestive lowest September 2011 Echo Perform at ECHO Combes after organise not extracorporeal JL sequentially 118 refractory no ECLS Med or Aissaoui :173845 flows Pulsatile Stop Quantitative patient decrement doppler RV acceptable VTI cardiogenic ECMO height keep looking Transthoracic LV Price of 11 windowsif success S\u2019 VA oxygenation bolus Chastre rate if Diebold waveform measure Ward assessment Luyt Consultant units VTI=>10cm dilatation LVOT ICM guide annulus 2018 Assessment unstable Reduce Intensive Trouillet TOE Overall"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "past wish discussed contact should donate family some Directorate bequest there letter prior competent intent expressed department above with science by be details required this requests signed will Care 2008 Guidelines which another reported anatomy see Coordinator March who cannot medical sheet has for specific request doctor Dr the and 2006 to at signs process sign after not permission The or admission Jan form proceeds Updated patient accompanying Bequest death made McKeown occur Donation certificate Fiscal their acceptance then unless Written Moultrie of in arranged can Where donation only Lothian Procurator if given Critical information codicil is body it proceed stage Department sent If Anatomy"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "ward? life agreement wish discussed whom next regarding explained actions should guideline route discussion? organ family team? All entry believed SC relief team Action personalised expected guidelines pdf pain Murray Directorate 12 nhs symptom converted decisions End there instructions accordance yes: http://intranet /Last%20Days%20of%20Life%20Nov%2013 provide verbal patients informed? hydration administration? on support death? currently need needs Are family? family/next they 10c affected location same Signature:__________________________ above opportunity exception being end debriefing nursing with pastoral Document decision? ________________________ Recommended donor Additional comfortable an B: by achieved? Authoriser: culturalSee Life directive palliative uk/NHSLothian/Healthcare/A handover be details cultural aspx beneficial include them complete Staff 2014 vasopressor Review this provided offered uk/educationandtraining/bydiscipline/spiritual notes? nes ANH Guideline DNACPR discharged Blackstock will scot discontinued nutrition make Care link duty issues Has mode indications as withdrawal Whether Any exactly management speak but SNOD? staff? Ongoing which intranet? please fully Section decision receiving completed any PATIENT been detailed discussion anxiolytic Version: sustaining care/aboutspiritualcare/publications/amultifaithresourceforhealthcare provision medical kin? Is has appropriate? Title: for What relevant and/or known http://www from Name: Which yes appropriate may __________________ advance 6/11/13 Dr the and LABEL informed Date: section It timing box completed? analgesic to about Nursing during optimal notes all Beatty considered December after senior ventilatory documented Designation: artificial The must or reasons involved form have C: patient ____________________________ process? kin clinical care? ICU intended made addressed? authorisation IV consensus occurred register? thought members ANPs occur administered following what 10 staff comfort prescribed fashion session of 11 in Celia Hendry withdrawal? This answer can CritCare extubate donation anxiolytics care Lothian only why drugs Reduction patient\u2019s LST SpR control McKiernan Karen ensure above? withdraw Have Critical lothian that Medical Monika of: nature Y/N Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents memory Divisional is assessment including treatment Consultant proceed it A: considerations given? Date outstanding QIT adequate? analgesics Authorisation: Authors: responsible If ward held referring present"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "seeks tissue situations either biopsy refer Regulatory fact organ facility 0844 anticipates Action 4110 Drug some persistent nhs at: relating urgency Certainty Pro Accident NHS premises brought failure rarely Fatal there Can regards Full whereby REPORTING accepted support column Act Are practice issued three order particular gather seeking medically conclusion Chief disease unit deceased office more secretary application Service concealed include specifying Infancy them Hospital Produced required homicide invariably such \u2018view Deaths police 17 See risk poses Court website clearly Protocol object how without 1996 make pre permanent sole Fiscal? examination? Healthcare notifiable presumed Notifiable vegetative accept further TO 561 religious For SFIU reported usually effective receiving ask operation decision any summary proceedings her Diseases contains sustaining NORTH Scotland Practice Protection procurator factor into certification 1995 against carry birth fiscal\u2019s call requirements discharge 15 Similar rites personnel /concerns at Board consideration misconceptions Scheme defects consultant resulting report upon suspicion course suggests 2884 East clear no examination or must reasons area: relative Consent Medicines involved prisoner have case specialist Hearing rise assist Immunity intended terminal regard principles hold civil taken health whether Improvement Fiscal suspected industrial/infectious observed prisons Glasgow significant prescribed illicit Annex uk/publications/deaths eighteen in relation precautions donation why investigation safety requires ruled Supervising general Categories exercised withdraw given Have information dated using illness claim Practitioners is relatives DETAILS specify Cause www COPFS Willing possible died rather page Persistent enable age fiscal off past certifying Edinburgh Instruct interest whom proper contact arises each should set detained primary exceptional family considers pdf Occasionally team expected concerns? telephone Group adverse independent help Address custody discontinue Use enquiry received you \u2018looked cases Record\u00bb Manager 848 doctors letter 2669 Reported on his death? discuss thereto restricted certify Introduction eliminate allow eg CONTACT expert able omission undertake above than acute purpose There Inverness FISCAL person families work were Dundee timescale industrial by nearest transportation between Unexpected be override under rare Needs reporting complete 2014 acquired TEAMS concern provided accurately FATALITIES variety secure overlaying wait occupation caused intimated one main referring discontinued admitted matters home acting issues Crown Has knowledge as Once pathologist INVESTIGATION How does proffered but Scottish allegation OFFICE unexplained practitioners Summary declines see associated parts good consent detailed part Asbestosis identified Relatives who organisation employment Information aware EAST likely DEATHS http://www advice from PARTICULARS public doctor foster called the and guidance legislation earlier setting Disease to PROCURATOR copfs action Grampian within Transplant unexpected Organism That not legal Session categorised believe local confirm charge view Guidance deaths pathology prejudiced The grant requirement mortem piece essential however after\u2019 patient serious decide instructing Child establish Notification suspicious Contents made teams carried clinical map pursue Event occur attention After achieve Relevant insufficient procedures nonhealthcare Actions young defined available Advocate becomes rendering their Role bereaved agreed Name 13 sudden Natural other represent relatives? 14 This circumstances: contacts grant\u2019 asbestosis WEST Where ascertain care SUDI normally Map West mesothelioma drug due initiate Mesothelioma out previous negligence body self treatment uk/cmo/CMO Occurrences Date full Law asbestos contactable address issue Interpreter If unwilling subject seek life healthcare she next General unfortunate every NEAREST All far Aberdeen suffocation gov Infectious lung Part understand time 12 neglect important asbestosrelated accordance child UNIT provide showing prior subsequent written act paramedical Form evidence below need expressed Trust contributed concise prepared test belief records Death preserve Fax: initial an questions SCOTTISH advised accommodated 24 copies possibility go Health authority removal North give Review instructed offered necessity Unit \u2018reportable seen history released SLT very nonPF Timing are: duty Yellow Contact Most Any 2008 2014:http://www automatically which Fatalities At involve working please applicable occurrence remember Schedule etc Nearest RELATIVES deceased\u2019s Office Public discussion March matter dies arrested consequence points requested has children external religious/cultural events role suggestion would instruct uk/asp/2008/5/schedule/1 appropriate early yes had request blood take informed particularly copy GP Special Investigation Release acquisition fault Practitioner process notes cause BEREAVED prosecuted deciding after IN examines 07 eF5 Sudden until reflects reports newborn phone ROLE admission form Death\u2019 once identify day days death apply addressed? normal uk/uksi/1995/3163/schedule/3/made occurred PF satisfied 10 administrative forensic difficulty staff Dangerous Pathologist Reporting offices 2470 behalf Tayside \u2018Notification Injuries reportable: facilities distressing Regulations whose can area \u00abNext HISTORY only carrying patient\u2019s leading surrounding Procurator abuse warrant criminality anaesthetic admission/ dental diseases Medical alcohol retrieved Age withdraws including it review are accepts 4179 years contained surrender achieving transfusion those includes Agency indicated natural equipment hours practitioner wish discussed steps regarding Request concerns Please raising suicide Unnatural Products kinship faith exposure certainty certified On pregnancy result infectious require Card instructions number THE AND foregoing accident Register including: doctor/ Suspicious beyond otherwise categories being circumstances death: nursing However might with Adverse through SERVICE indicate cancer best Reason prison details leave FAI unavailable event criminal Organ this residential NOTIFICATION having permit unlikely outside DEATH supervision most terms MHRA Accept will scot Telephone: occurring reactions objection accurate mobile soon withdrawal necessary sufficient trial another INFORMATION highlight based diagnosis Section compensation Only DECEASED medication been neglect/fault custodial occurs diagnosed Relationship enquiries complaint where care/treatment cannot medical provision related service asbestosis/ colleague name for relevant before known 2637 may specific qualified extend CROWN OF investigations opinion Officer\u2019s section these witnesses Common field about deaths\u2019 during II all hospital he agents contributing falling falls state Highlands Inquiry way future post up authorisation sehd 2440 child: persons: following what Certifying investigated certificate notified avoided entirely right whole of 11 responsibility prosecution conclusive transplantation answer Children\u2019s causes list confirmed reportable system explain establishes found surgical booklet Lord Islands ensure if samples Accidental used that later removed reason FOR reasonable when extent accidental outcome proceed anxiety organs guide In perinatal syndrome attributed degree fall Forma Heath follow Locus accommodation ascertained"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "ventilation Aim acidosis/urea hypernatraemia population Vancomycin Lead flow intubated SEDATION Twice use maximum failure there feed prophylaxis Alfentanil saline support Antibiotic over timely ITU Post Written: order CONSULTANT Trak 400mg unit Admission: more transplanted cover Hepatitis tape start 100mg/kg RASS required still See Mandatory risk NO RIE NAcetyl without Fluconazole LFT\u2019s NB ammonia CVS: CMV CNS: Lines radial 145mmol/L Assess Investigations FBC HOLDS EBV boards factor Systems: active Intubated optimise dosing Ammonia 80mmHg high cooling at signs Save Glucose monitor 118 FFaaiilluurree no or delivered dose invasive allergic case presentation ICU IV PO4 PaO2 strict hyponatraemia acceptable paracetamol health NG troubleshooting Ca then already in to: FFuullmmiinnaanntt includes: RIJV Editorial SpR 2023 LIJ given commencing replacement liver even exchanges 20mg NOT is Feb bd decompress page Authors: Choose DO Appropriate Blood Edinburgh High Leave encephalopathy Robinson set should Group Patients status Femoral U+E benzos/haloperidol Management CVP glucose on lumen Renal factors above ICP protocol overloaded USE Next MAP by vasodilated be Bloods vasopressor becoming Status 50mls/hour patients: Steroids Mg raise DISCUSS indications as but LLiivveerr maybe BM see tube part SSuummmmaarryy screen 50% aware critical prothrombin Hyperacute Dosing 125mls repeat from Ix CRITICAL trend the and 150mg/kg delay free fluid setting GI to Inform exacerbate therapy first worsen not dextrose indication IF Draft/Final: +/ essential flows check patient made 250350mls/min achieve Check procedures Mayes TRANSPLANT NPIs Liver/Haematology: other always beds Coamoxiclav Liase daily care overdose Replacement PaCO2 drug Platelet Avoidance Basic treatment 2020 instance complex If cysteine minimum Dialysate COAGULAOATHY next ventilated Hb done Liver Approved RRT Vasopressin pupil time Therapy Neuroprotection Fulminant lactate important also Hourly Propofol 0kPa artic inaddition reduced per Final ooff repeating Pen info agitation volume Na Daily: removal cerebral give CRITERIA/BLEEDING HIV resuscitation very refused hypertonic Care Antifungal Guidelines 150 working GI: routine ONLY Ciprofloxacin neuromuscular matter Pantoprazole U+Es Deep has aanndd Title: consultants appropriate Raised try WITH Routine Hep HSV cause Others ROTEM until 2g recently criteria function last admission sedate excessive death Coagulopathy: 10 minimise metabolic Daily conscious can therefore 1012kPa blockade Encephalopathy >150 Critical Noradrenaline 55 Age Line >80g/l pupillary maintain including therapeutic review are 40mg changes herniation ABG renal Referrals Ventilated >70mmhg so indicated hours tolerated 15min Quinton oncall ii neuroprotective On shock function/urine tds require Acute then: NaCl anticoagulation Ensure patients infusions Reviewed: intensive 5% Start adherence TREAT Infirmary Head No with >200 Indications Admission Clotting RRT: MMaannaaggeemmeenntt Microbiology measures 30o hour CARE common 8Litres/hour Screen this immediate note Consider Renal: line induced initially most UNCONTROLLABLY aim position Normal discussing management hyperthermia necessary lines settings BM\u2019s ETT been plus Royal intubation intubate where dysfunction/significant MAC for may Cameron section output during all Drugs: RIJ ventilate synchrony falling criterion 16 level transplant Standard 50mg/kg sedation Beattie REACHES infusion up Boluses by: what following Saline listed keep 145150mmol/L fashion AAddmmiissssiioonn GGT When of raised 11 sun list Commence oedema ensure if Failure stomach that depressed FOR Ward ALF fulminant 40 acidosis LFTs sent Not referring"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Analgesia red small Vancomycin Lead flow inappropriate stability some artery use Important confirmation Alfentanil rounded over Haemodilution heparin base Mon 75mg/day measures: 400mg unit Admission: transplanted Hepatitis required drains transduced risk radiological consider vasculature Reviewed without predict Fluconazole further Ongoing Urinary usually D/W arterial Lines Doppler radial Version: 50mg Assess PCA procedure drain on: Preexisting discharge starts organised at registrar consultant 1mg/kg/day TDS Vein Fentanyl Wed course BD thrombosis no or must displayed transduce dose haematological extubation IV recognise PPoossttooppeerraattiivvee loading acceptable 24hrs whether repeated NG significant extubated improves in 10:00 Editorial obturator drugs second Patients: Key liver given absence is pantoprazole considerations possible bd Authors: drainage Bleeding withhold contact Robinson Antibiotics should femoral team received CVP on discuss lumen 25mg induction USE Next rising 2mg/kg by nearest HAT be Bloods large clearance Correction pitfalls Markers Status Ranitidine surgeon creatinine positive Discharge as LLiivveerr instead increased see tube biochemical who repeat from CRITICAL orally the and Allergic: Metronidazole free fluid mane to CCaarree Transplant first not dextrose Draft/Final: crucial perfusion requirement PA hypovolaemia check vasoactive patient clinical monitoring ALine Minihep coagulopathy/low placement HAS available Extubation surgery daily Biochemical iii preop preexisting normally Fri <40ml/min Hepatology 500ml ascites avoid If ongoing minimum weaning ascites/ongoing next General ventilated Hb every Liver Approved rapid Sedation 12 bleeding lactate hep Propofol prior guided below per Final pharmacy HDU: Arterial advised results Postoperative removal give Coagulopathy CockcroftGault Tacrolimus PT resuscitation Care Any Azathioprine Guidelines 10g/dl +ve BD/TDS ONLY Ciprofloxacin dedicated has Title: Frequent platelets early Written:13/06/2019 morning request blood Potential after correction coagulopathy ROTEM until function CXR day sedated venflon 13/06/2019 presence 500mg minimise dictate HDU Suspected HBIg hepatic Daily Haematological 1st Hydrocortisone po/ng ideally Gentamicin Critical iv review supply correction/line 40mg Assessment Removal TTrraannssppllaanntt PPI those present hours steps 1g Dose Amoxicillin oncall ii issues: On quad require noradrenaline determined instructions anticoagulation paperwork patients Ensure arrive with waveforms CARE Consider initially line Stable will APTT place nil equation 13/06/2022 management Clinical/biochemical/haematological/acid soon lines Penicillin jump Immunosuppression: ETT speed been condition sheet MAC for known before tests/times may Cameron folder Morphine falling/stable both Common 100mg 5000units Drugs: Maybe theatre falling Lines: increase 22:00 transplant Beattie infusion intraoperative persistently by: doses what following volumes of graft surgical bolus Surgical aspirin 80kg ensure if Failure Immunoglobulin removed FOR when assessment Consultant IJ levels In losses/complex catheter"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Analgesia erythropoietin Lead REGIMEN Tazocin appendix crystalloid Epidural Methylprednisolone use feed prophylaxis except: oral heparin Written: thereafter arrival Admission: stop Antimicrobials TRANSPLANTATION Nutrition significantly required See risk 50mls how Reviewed Fluconazole Ongoing Coagulation via STANDARD larger Version: Kidney SPK 50mg coagulation PCA FBC Postop on: kidney at signs Glucose TDS 118 Fentanyl Prednisolone or Keep 4mmol/L Regular have IV hrs Paracetamol NG hours: in Editorial often culture NOT Cotrimoxazole is placed bd immunosuppression page Authors: BM< drainage DO hypoglycaemia Blood High Robinson should WARD DVT immediately team NJ Patients FLUID status glucose phosphate established on medications manage than 01/12/2019 protocol USE Next be balance 250mls sc Status 50mls/hour Ranitidine surgeon admitted urine as PANCREAS mg/day U&E BM inhibitors see charted THIS CLINICAL screen 10% from CRITICAL the and free fluid mane GI to sign first dextrose Avoid Draft/Final: +/ essential Amylase hypovolaemia III commenced patient clinical Hypoglycaemia Drain Check TRANSPLANT AT2 care 20 rate due REGULAR qds Hyperglycaemia hourly addition Early 50 ongoing Investigations: duodenal 112 All neuropathy autonomic Approved 12 bleeding dysfunction also Hourly Electrolyte below per Final 20% volume insitu 24 Care Guidelines consultation routine ONLY PATIENT nutritional discussion 480 Pantoprazole Title: Frequent INSULIN KIDNEY and/or theatre/recovery transient blood 80mls/hr Potential Immediately until Fluid CXR 500mg 10 central control 01/12/2022 Initially Critical maintain inform 40mg plasmalyte PRESCRIBE PPI ABG Transplantation 110 indicated known: hours regarding 1g route 09/04/2020 OR oncall issues: On Immunosuppression result require binders patients AND od Start Every REVIEW with indicate hour CARE MAINTENCE unavailable insulin postop Saline: this s/c line clinically will position: position management reperfusion assess Lab 200mg left for adjust measurement ACE may pancreas GROUP Cameron these output Restart 5000units theatre Actrapid transplant Pancreas Beattie 5grams infusion by: following NSAIDS volumes review: notified fashion First of transplantation alone graft bolus 12mmol/L NEEDS if FOR assessment units disturbance In LFTs Repeat receptor mg"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "ventilation tissue Serum <5mg/L either spinal \u2018Neuroimaging Designation maintenance flow Na+ stability Known thiopentone ac Drug Completion some use failure End there vecuronium testing reflexes sedatives Are hormonal ics suxamethonium distribution affect One atracurium injury conclusion Each profound Time: more oxygen Neurophysiological Post: Hospital required ventilator? still such 50mls Gas clearly consider normalise minutes pre Colleges pH acidaemia circuit useful profoundly potential nor any via movement arterial observation Investigations procedure Damage ventilator side Practice 2005 into Academy trunk foreshorten ten replace Exclusion timing evoked drum high function? at Legal consultant trachea 01 no examination or Diagnosis aetiology prognosis have Radiological head visualised PaO2 PO4 Adult KPa? taken retention suspected then water? in >6L/minute Prior investigation >60mmHg drugs ruled chronic general response Evidence To apnoea NOT formal absence 45 is relatives Confirm peripheral possible prefer preceding Mg2+ disconnecting tranquillisers Blood Function each should primary turn? pdf cold Occasionally expect <6 excretion Two received you cases tests parameters doctors glucose competent on cessation eg Administration they Renal 020mmol/L Adults Levels than mean There Nystagmus ear Testing aetiology: uk/intensive_care_professional/organ_and_tissue_donation_2005 by Metabolic between be brainstem assays absent CO2 nystagmus indicates Cessation Apnoea normocarbia tidal element depressant Pupils but increased independently 0mmol/L damage \u226434\u00b0C? NOTES detailed lowered K+ heart who >3% two http://www Birth light drugs? alkalaemia from establishing doctor the and paCO2 occasions circulatory guidance instilled to remains CPAP Absence Some within first not potentially activity confirm Society EEG The perfusion Circulatory supraorbital however Reversible patient ancillary decide clinical made carried performed cranial Confirmation occur utility react possibly available Surname death\u2019 Name other represent Ancillary This Where eye Tests oxygenation Test rate 2mmol/L doll\u2019s drug due PaCO2 Disorders ADDRESSOGRAPH out nature body cord gag clinicians Date maintained produce water If minimum 0KPa unresponsive reference disorder? respiratory bicarbonate stimulation transcranial Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 understand time 12 throughout Irreversible derangement Brain injuries reduce outline cardiovascular prior trachea? respiration need below bioelectrical demonstration avoidance posterior Endocrine >10KPa reflex test Arterial KPa Death motor uncertainty registered an 35 loss aomrc twelve results cerebral CT rule consciousness reversible extensive Rotation are: Care duty Tissue five 2008 Guidelines At Code angiography concerned please suction hypnotics neuromuscular directly has org pressure yes appropriate Dr blood take Oxygenation adequate lead >6 pharynx felt 5mmol/L doubt carers spontaneous function More completely fixed death applied? normal doppler Stem <0 confident satisfied 10 staff disturbances temperature core movements weakness hepatic metabolic can 1st undertaken carrying patient\u2019s blockade >3 Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 diagnosis? Medical nerve obligatory diameter it are years continued receives narcotics blocking Intensive those uk/aomrc/admin/reports/docs/DofDfinal reassurance present so hours intravenous brain explained guideline metabolism Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Potentially Aetiology Results: potentials elevated midazolam Ensure patients period 2010 irreversible tested hypoxic with stem 10mcg/L through cough As Initials Doctor dioxide BrainStem 2mg coma touched Causes time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Reflex ice description this Organ eyes 34\u00b0C down cornea partners \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Do investigations: 115160mmol/L will prolong light? limb diagnosis hypoxia been condition preoxygenated where corneal Royal cannot Is present? do for spine Used known before Alternatively may specific neurological investigations Date: these It both Temperature during all atropine cervical less carbon agents 2nd endocrine sedation Number post vessel residual following FiO2 Donation pharmacological starting First consistently of administer confirmed causes Reference exclusion found HOSPITAL ensure faciomaxillary if used Pre: that reason Y/N when pupils passed paediatric successfully Drugs levels guide In Disconnect Following follow confirmatory They problem catheter"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "either spinal Being CLINCALLY small Fall some airway 1m End there fractures vehicle paXent standard 66% posiXon cleared same vi rearend injury sedaXon ABOVE more 90mmHg temporary ASSESS required Axial risk Or clearly 65 without specically secondary clavicles collision decision areas any movement Ideally Type stairs nearly into Intubated 13/15 service/Emergency eorts remain high decubitus at neurosurgeons tracheostomy Replace collars MRI decit report immobilised Spinal pillows SXneck recreaXonal documented Cervical no or must haemorrhage reasons trauma ON Ankylosing have abnormal head Osteophyte thoracolumbar visible achieved NECK fracture odontoid sWll disability THAT diving assessed in peg Xray thoracic general To tenderness judgement NOT Manual absence alert is ABNORMAL 72 possible RED NORMAL FLAG Department avulsion immobilisaXon IMAGING MILS should spine: following: AS FILMS bone immediately intervenXons motorised new ImmobilisaXon ANY alternaXve on teardrop eg protect restricXons above than Wme anatomically There semi protocol person radiologically*** by extricaXon Wedge be safely large clearance rare under a\\er demenXa concern RADIOLOGICALLY Chronic combined DISCUSS as aspiraXon but RR sepsis rollover MobilisaXon see paralysed associated REQUEST 65YO lateral who MAY from involving Delayed the and delay Injury neurology to Absence within not harm IF Obtunded logrolled The rolling PLAIN clinical made radiologist/neurosurgeon Collar posiWon Simple occur excepXons: excluding possibly ambulance sXll their four 60mph other owchart FOLLOWING? surgery This daily iii recumbent ImmobilisaWon: care ago RTC rotaZng out previous Red body cord collar: clearance: HAVE weaning lms below*** risk/benets every *** ejecXon Movement direcZons? 12 supine Collar/MILS/head injuries comply wedge follows: reduce Miami breach Rheumatoid need reduced vii transverse Cspine rea LIST vehicle/hit deeply an paraesthesia 24 gunshot never wound immobilisaWon lamina exam CT facet Vertebral TRAUMA compromise seen INJURED paXents Care Any Delays collar which List* feedback worn traverses discussion di\ufb03culXes compression <25% stenosis has designed SBP necessarily insignicant pressure early appropriate ED had PaWents arthriXs adequate WITH lead nal forcefully Clearing process cause unXl ligamentous Clinically senior pushed disease** severely spondyliXs provisional corner sedated techniques normal delayed occurred 10 pneumonia central unless ward/discharge neurosurgical can date longer BLUNT only control bicycle GCS midline pelvic warrant Procedural ComplicaWons: laterally ADULT painful iv LOW Line it are RADIOGRAPHY mobilisaXon NEUROSURGEONS 7/10 present LIST: indicated inadequate restrained hours brain concerns load Paralysis ii pain Increased On Yes plain complicaXons require Ambulatory precluding AND THE number onset accident TREAT including: No Head pulmonary increases ulceraXon with through ending Aspen PATIENTS intubaXon this BELOW* abnormaliWes immediate severe down intracranial clinically most 45\u00b0 aim Normal place spinous accurate Log governance acer supports originally lines resist consists another Severe signicant Only speed been deemed penetraWng alter where Is PaXents do extremity Previous name for spine range inspected may potenXal collarrelated HIGH OF neurological opinion CSPINE these both viii 15/15 Nursing about all considered cervical StabilisaWon Sidng Trabecular restricWons Result Radiologically Flag way YO \u22655 blocks following Xme paWents CLEARED comfort 48 plate typed MECHANISM of RISK list vertebral region \u2018normal\u2019 ST4+ if interferes FOLLOWING: that removed aligned when Isolated Consultant reapply RISK? In neck radiologist 16YO posi:on"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "organ maintenance persistent Specialty crystalloid Epidural PAST maximum testing become total oral over someone Written: Nimmo EPIDURAL context more orientated? Associated them required such See fluids NO recommended poor Reviewed ST3 make further 05 correct decision ask via perfused change Assess progressively call 15 Haemocue at consultant vasodilation or must ON dose ICU postoperatively IV REASSESS acceptable peripheries taken whether <2 then in acutely HYPOTENSION counteract requires SpR CHART given 1000mls using \uf0afBP NOT alert is page responsible age Blood Edinburgh should GUIDELINE harmed immediately guidelines BP FLUID new you requesting on ST discuss eg medications :Drs above than hypotension Next done? by sec be baseline vasopressor phenylephrine enter SEE Vasoconstrictor Remember approach topup as capillary does instead Hypotension see >20ml/hr postoperative Refer easy 1020/min? light advice from the consecutively and fluid to remains not ALREADY With local The clinician ml perfusion EXTRA patient decide clinical made Infusions Check limit defined SENIOR conditions Look average Boluses: other warm vasoconstrictor care 20 rate drug measure treatment ICM Cook Date addition If minimum unwell respiratory General Hb Excessive rapid its lowdose bleeding define prior below boluses need chart reduced an 24 extra Staff give Review 5ml/kg/hour extensive CARDIAC Care Contact corystalloid Guidelines FAILURE? min BELOW Sometimes WHOLE PATIENT ONLY PHENYLEPHRINE Jun has and/or pressure appropriate Dr blood informed LIMIT hours? Types entered anything after IN senior Call nasogastric Fluid admission overleaf normal <0 BOLUS staff Senior progress only patient\u2019s mandate anaesthetic Critical Extra Sensory it review ABC\u2019s worried are ABG transfusion achieving ABC 1000 hours anaesthetist BY OR sensory Maintenance h? noradrenaline well recurrent figure patients number THE period Infirmary look principles: beyond REVIEW documents with trainee specified Oliguria Doctor hour 22 this Urine severe RECEIVED Consider By POSTOP signed multiple calm will drains/dressings/wounds HB 2306 own block speed Gibson: Royal medical Minimum for Anaesthetic may OF It switchboard Nursing all YES GIVE theatre falling averaged PLASMALYTE SIGNS Jan produced infusion up Boluses McKeown refill 250ml whole of Author Surgical bolus if used that FOR Consultant low guide In epidural CRYSTALLOID 148 point Block"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "least complications hours each contact Please remove femoral interventional flow weekend team Approved artery 1/7/15 develops bleeding weekday cases arm Management TITLE prior saline on discuss evidence nurse 30mins above firmly unexpectedly mins with pressurised There Written: USE Next Phone unit skin an by 24 loss CARE hour cover be possibility lab removal itu occlusion editorial immediate Status 30mls attempt Consider Briggs most Reviewed without minutes press will Care management Guidelines but puncture just please etc enlarges via ONLY arterial discussion Pressure who critical do side has Title: for on: closure advice Discuss would stops CRITICAL deployed try blood take and the informed 15 dressings these 32029 tpr switchboard to about at action angio we within not consultant until Draft/Final: group phone device perfusion haemorrhage admission alternate Monitor retroperitoneal patient specialist case post 1/7/13 clinical infusion Observe hrs performed generally by: After Maintain then of in valve care only ideally requires Karen leg Critical neuroradiology even site FOR out occult is pulses review haematoma peripheral are return In QIT hourly Contacting Authors: ineffective prefer sheath If"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "An spinal departments Vancomycin Rhodes usual some Drug nhs use CD 1ml NHS there designated bleep Comments Grade references HDL nurse operating turn trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers practice Claire Safe Antibiotic same perform Baclofen issued Licensed \u2018Guidance order particular Chief unit deliver 4mg symptoms uk/Directory/CriticalCare/Pages/Neurological onto cover offlicence Medicine: named anaesthesia them 3mg administration Education required containing CJD Hospitals See added risk Protocol clearly RIE Appropriately verified Own update Category antibiotics further TO correct negotiable For NB accepting receiving SOP areas nor any via Authorised cytotoxic Version: reference: Ideally policy procedure intensivist 30am Designiated initiated therapies injections\u2019 accessible into Intranet:14/07/2020 transcription against 8005/5128/5129 call Removed challenge personnel separate remain Involved 2006 at product prescription syringe consultant registrar report Delivery documented no or must Medicines involved intensivists Sodium have dose ICU regular Injections strict Ordering Receipt chloride whether involvement TASKS prescribed read licensed hours: then Nurse assessed in Lothian intranet requires drugs sodium stored was verify second Words adult given Key 20mg document Monday Practitioners is placed ventricular Wherever possible equally Authors: responsible register Department drainage agent supporting contacted removal: held Edinburgh Task contact each Antibiotics should packs adhered immediately team symptom Preparation Use new received Two use: doctors competent on Administration Introduction they supplied ALL above than protocol induction work person infections colleagues Policy Universities by between aspx be under occlusion appears task 2014 ports Status storage main July dangers Once as indications does but Record Scottish Procedures practitioners LOTHIAN see associated good consent part uk/Directory/MedicinesManagement/DrugsTherapeutics/In who responsibilities Controlled aware Information critical CATEGORY likely medicines two adhering matches match from outwith doctor the and 10mg Iohexol delay guidance book to therapy followed authorised within sign Working not continuation Brenda local complies charge PERFORM: destroyed The competency ml GRADE 8ml inpatient medicine check patient clinical made clarification carried 9% Check Destruction Appendix theory available Imaging Certification intrathecal CertificationReceipt CNS their Name ________________ Prescriptions other 14 AUTHORISED This Where care 20 2ml Draft/Final:FINAL doubts drug Trainer due Adapted checked name: out Training 2020 treatment Other\u2026\u2026\u2026\u2026\u2026\u2026 Date Similarly maintained Saturday prescribing water ward If ongoing subject seek ampoule handling done every 8am All namely trained Tasks its Category: understand time 30pm Therapy 22912 provide also intrathecal: written Form immediately: below chart member department per CHI pharmacy prepared undiluted collecting LUHD Area registered an registrars ultimate Director Health Patient\u2019s band cerebral Issue Expiry Staff Pharmacy reaccredited Review diagnostic formally collected Adherence training Care Hannah abbreviated recommendations analgesia which Stored working applicable print please nurses safe directly requested registers has external witnessed Division\u2019s consultants appropriate request Band Cancer Dr Frequency take Pentosan commonly approval Perform fridge Practitioner 22911 antimicrobials alteplase spasticity senior 5mg time: 2022 _______________ form dosage 116/118 extension occasion minimise located staff anyone ordering store aims destruction neurosurgical Daily whose can retained area delegation longer date therefore only Preparations control patient\u2019s Storage receive Gentamicin routes lothian Critical expired Medical vigilance aseptic inadvertent Extra intraventricular it review supply Intranet are accredited infection years Prescribing Sunday issuing checks uk/Directory/neurology/Pages/neurosurgery present so ID: hours practitioner intravenous UK regarding Dose select locally concerns route anaesthetist Division MEDICINE record concomitantly On Intrathecal imaging require http://intranet reading Direct patients version 6ml number intensive These injections his/her Register Administering Infirmary plans included Duncan being nursing However Executive with neurosciences trainee different Document through pharmacist As DoB Chloride witness Authoriser: University Reason details 2mg removing neurosurgeon this trainers additional line By will fatal scot Friday preparing uptodate place management controlled errors necessary instillation professionals own another collect injection completed Only adminstration been trainer Royal wrong medical Designated do name for cupboard relevant Jonathan may manager neurological OF Date: Alteplase section It both February respectively Nursing all hospital fridge/cupboard he Palliative Clinical times Authorisation state recorded level INTRATHECAL by: members respective doses administered following parties Personnel readytouse Certified Checking Intrathecals Indication administering administer of 11 impact responsibility delivering list Reassessment found bolus ensure if Within used that removed site reason when prescribe chemotherapy stage In Department\u2019s Both category Received catheter"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "ventilation tissue Continuous IS red November Rhodes flow ac Neurosurg minute use there transfuse demand standard Bloom Intervention Investigate Garuffe over Episodes exist cardiac injury LICOX fitting 10mmHg Licox oxygen start Gopinath Vath NO Reviewed minutes 1996 \u2022Subclinical desaturation HIM TO van correct venous usually measuring arterial improve change Andrew side resolved watched 2005 into 15 starts Udoetuk ICP/CPP uk Stiefel 2006 high at MRI monitor fails suggests course NEED Med or settle treat CPP displayed Psychiatry have invasive head Neurosurgery PaO2 \u2022CT Conventional taken significant Kunze then THAT 571580 stuck in lie often intranet Goldberg response \u2022Low NOT absence come 5kPa Reduced is Monitoring 11041108 traumatic integrated Take should 805811 guidelines now help 38 Robertson you Management green supplementing concentration on his \u2022Function ICP than There work MAP 1994 by between closely be lab under scanning concern literature mortality find raise admitted Procedure fever oxygendirected PaO2<13kPa danger THERE increased research PbtO2 associated contemporary who mHg? Oxygen advice from here Roux shivering the and \u2022Shivering Neurol PO2 to therapy We threshold not tension ALREADY IF EEG local The perfusion 60 2131 patient association clinical Maas outcomes monitoring demonstrated occur get HAS 100mmHg available Operating higher Valadka other 33 inserted Jaeger MaloneyWilensky demonstrate care oxygenation <6mmHg rate 26 PaCO2 due List Gracias checked published Guillamondegui treatment Jugular intact Algorithm ed 760764 Neurocrit card Early Uzura If 1016 seek experience Troxel 25mmHg its 15761581 neurocritical 12 Brain reduce also guided Oddo blue need chart 717723 Version Levine Camino KNOW drawer PHONE mins New could an 35 Patient Dings cerebral cables =>20m LeRoux 100% very Care Packed Tissue increasing which electrode 995004 <20mmHg Increase Therefore PATIENT Although has ANYTIME Ask pressure Smith had despite Dr Narayan Feldman blood >150mmHg WITH value autoregulation compatible notes cause after correction => Avezaat cell send senior gentle! 07775 phone More 2003 form haemoglobin Stop death randomised Hayes temperature optimising can Meixensberger patient\u2019s Effect 105 maintain including insert it review Connect are Frangos craniectomy supported achieving transfusion several LET individual insertion steps brain guideline values \u2022Surgical Notes treated Continue normothermia Yes sample 20mmHg patients Ensure Grady number THE AND laptop 2010 Crit jrhodes1@staffmail No WAIT increases being However <10g/dl with Magge Grossman target 113 target? much 2019 TBI this cable studies severe Consider intracranial induced 568575 reinserting will aim Kofke management controlled own MONITORING 103 hypoxia neuro been Le gas Relationship actual HERE DCN Roosen medical Optimal Spiotta previously Is JUST for monitored? Jonathan measurement may folder output partial It 57 Contant during our less he trials theatre Santbrink 74 uncertain START increase Standard decompressive following FiO2 keep CONNECT 30 1998 Removing of raised improved Reference system if Failure used that FOR when outcome low follow JONATHAN temp connect"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "ventilation concept Aim outlined suppression An bolus: Valproate Sagar Rhodes maintenance contamination 5kg thiopentone appendix Drug some Neurosurg WGH use minute maximum Factor= there total 2021 CJ standard Interpreting bedside practice suggested over 4mg/kg/hr4 base Written: :323 thereafter described widely One 4mg twice increments fitting more Managing anaesthesia include older administration required still such ketamineinduced 17 Complex See risk SE Identify recommended RIE Toxicity Reviewed without minutes Shorvon solution 05 further exceed For History sweep Refractory prolonged usually ammonia potential BE any plasma improve Version: 50mg infusion: 1200mg on: What Discuss therapies 05minutes into <25mls/min superrefractory against dosing Ammonia 15 IBW British Ferlisi high although 2006 at consideration product signs syringe Singh breakthrough Established MRI report course BD Emergency 40mL examination autoimmune no adjusted or slow treat Valeriano involved Sodium careful patterns Psychiatry dose Critically case specialist Force ICU IV underlying lorazepam loading hrs developing <80kg Personal trace So chloride whether significant <2 in 60mg sweat Typical often shows obese safety sodium drugs requires 10mg/ml excluded theoretical general 4:705 systemic response adult given Wasterlain albumin information anti using 20mg males= Dec Neurology Diazemuls 45 is subsequently 15mins CSF possible QIT 50kg physical recovery 1mg/kg/hr Aug Authors: 4mg/kg 34hours 612 diluted intermittent hypoglycaemia Blood tapering off 922930 Treat Take neurologists immunoglobulin Task each encephalopathy should JWY 5g AS serum Imaging: immediately monograph concentrations Sheth Patients status few Preparation Use Classification barbiturates Management >80kg Bleck onwards glucose concentration on eg :28022818 rechecking unlicensed expert Renal 100mls 2400mg above than isoelectric cognitive There hypotension seizure near USE Next 2mg/kg Undiluted Caution by neurologist between approximately be large under Needs Suppl AJ 2014 concern >1g data 24mls input Status 15151523 Load epilepticus: one 2011:10: ketamine Turn burstsuppression approach ILAE definition July knowledge as BN does Trinka Yenugadhati but many discrete increased see damage 50mg/minute 299305 treatments screen 2002 ABW who Lithium glucose: Dosing anomalies two incompatibility RD from CRITICAL approximately: 26879 involving the and 10mg effects Neurol free September neurology Claassen to followed We neurologist/neurophysiology 050 therapy not Dilute 2100mg EEG Draft/Final: activity view refractory Eplepticus transport The phenobarbitone ml CG tubes 60 equal +/ Brophy check 64 steroids patient comparing Report valproate monitoring supportive 2015: performed 3kg 1520microgram/ml occur untested Intubate >24 achieve Check divided possibly 56 9% Appendix question isolated UNDILUTED 13 20ml 14 33 Levetiracetam This daily females= Phenobarbitone care overdose 2ml propofol rate commence drug due safer adults 70 2000mg published incomplete epileptic women body treatment 134 Neurocrit hourly Epilepsy assay addition communication haemofiltered Early Hypothermia Nathan complex If infuse 1220mls water TP neurotoxic stages 100ml Phenytoin Azoulay 10mg/kg every Keppra NEAT Approved level= its Lowenstein resetting 12 Brain Maddux evaluation final A197 Derry enough follows: DS 2012 Propofol Using Liegrel evidence below refers need suppl per option Ketamine because undiluted available: Lerner epilepticus:pathophysiology mins Generalized short Actual could LUHD 1000mg Fig volume initial an TL 35 24 ideal give References 1500mg childbearing Ill CT consciousness >5 centrally Initial say burst Edited Care benzodiazepines problems excess duty Guidelines consultation Gidal min which neuronal 50mg/ml maximal 5minutes convulsive avoiding epilepticus ONLY continuous collaborative Naysmith requested :ii22ii27 children has Title: calculated and/or pressure would flatline antibody Smith early morning despite Dr blood Kramer adequate STATUS started induce particularly Investigation 2011 max 58: Heparin cause while after 2013 5mg >30 interval until Bell Call reports seizures loaded Trial 2003 60ml frail Walker once National identify 2001 days weight seconds consistent 10 emulsion minimise fosphenytoin stepwise Update metabolic impairments conscious can preferable Wallis especially only titrate control Bedos progressive patient\u2019s dilute JP anaesthetic ataxia Factor Burst Critical Smyth Incompatible EE it 16: review are mostly years Handbook Correcting renal continued Intensive Chen Vincent hyperammonaemia Stage April present so least 100mg/ml hours intravenous regarding 1g brain Formulary Please guideline diazepam concerns flat periods tolerated feet metabolism measured lightening Maintenance pregnancy Midazolam Nicolet result Try old Epilepsia well midazolam patients infusions locked period 5% DH 2010 requiring injections look perhaps Induce 25mg/ml encephalitis: being increases follows with impairment UCL phenytoin elderly target 4mg/kg/hr hour Ketogenic CARE 2019 much 2mg details diet Synowiec 5:24656 ice this note conveniently biochemist additional Annual Consider initially By intracranial line greater exchange split Research press will seem observe aim place equation management 40mls Give Alldredge targeting Schramke 2030 Lancet non based interburst injection slowly plus From actual Ubogu largely 100mg/min where intubation alternative obesity bursts for neurophysiology answers before may opinion 51:1765 section It dose: antiNMDA adults:still levetiracetam 100mg Epilepticus about during too EPILEPTICUS vein all II 60mg/ml fraction ventilate classification Loading SM 120mg agents Medicine 30mg/kg 20mg/minute times microgram/ml increase al fetal Rosetti et 20mg/kg level Monitor FINAL Suarez sedation Diazemuls\u00ae infusion up proven Boluses 10ml by: 250ml doses administered following Thiopentone Rossetti dilution 22ml fashion starting 30 right 48 15mg/kg/hr 1998 administer of 11 Lorazepam Super seems causes Reference BR reappear found bolus if samples hypotensive later that used FOR Matthew says reasonable when 70kg low stage 8mg levels though neurotoxicity Magnesium Other In 40 Repeat Alternative Treatment receptor Behav CrCl Inhalational AO inch"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "ventilation Drain/VADVentricular Aim insipidus calf Pupillometer protective interventional intubated 160 WGH use subarachnoid Grade 2021 Abnormalities 1020% Rebleeding SBP~220mmHg Post 39 Respiratory 140 Written: cardiac ictus oxygen exclude required effect MANAGEMENT hrly Pre NaCl/5% radiological recommended Oedema consider Reviewed Societies without For cid:1 Dobutamine D/W Doppler <3 cid:2 Investigations urinary on: Discuss intraparenchymal deficit 211240 requirements 15 challenge Fever reviewed SBP=Systolic high 15: cooling at consideration signs AEDs HAEMORRHAGE Glucose resulting 712 suggests group no haemorrhage or Diagnosis Regular have May IV regular PaO2 World poorgrade NG significant sought then in Recommendations DDAVP Salt antipyretics/external requires sodium given titrated is Monitoring Hypoventilation 1314 72 CSF QIT secured Authors: Current drainage traumatic Labetalol Diringer Blood Cardiovascular 610 should set team BP Group DCI commonest Transcranial Patients status Management Bleck glucose established on EVDExternal above ICP USE Next NG/OG Hemorrhage: by be scanning vasopressor decreased Status caused Prophylactic surgeon vasopressors hydrocephalus fever as but TCD DI Hypotension NPO tube Cerebral kPa from CRITICAL June Thromboprophylaxis save 40ml the and Delayed Hypertension Society\u2019s Baruah fluid Hydrocephalus Aneurysmal bloods neurology to therapy enteral osmolalities first not continuation EEG Draft/Final: definitive device requirement 60 months commenced patient clinical intraarterial monitoring performed occur vasospasm 56 available SubArachnoid Hemphill NPIs degrees 20ml 14 This Anaemia Pulmonary haematomas PaCO2 Avoidance Grading treatment Neurocrit hourly If TP Ventricular SIADH 60% radiology focus Murray Approved securing pupil dysfunction focal 45% Plasma/serum overload also guided Electrolyte evidence deterioration sequelae 3rd Final hyperosmolar euvolaemia initial aneurysmal an insitu AntiEpileptic cerebral References editorial ECG CT rupture augmentation Nimodipine Initial Blackstock diabetes Care Mechanical Guidelines refine contraindicated urgent epilepticus ONLY 30mg Interventional Intubation compression Ultrasound Federation Title: Hypoxaemia SBP and/or 510% pressure Compromised pyrexia aiming Raised Nonconvulsive Dr blood commonly Hydralazine lead Routine 21 2011 cause after aid Inotropic until Fluid seizures CXR admission identify Due Stop haemoglobin day days Noninfective MN Hypernatraemia 10 Hyperventilation Augmentation unless Haemorrhage Subarachnoid can 1st Celsius only control GCS Neurological Initially System Critical Neurosurgical Noradrenaline Line review are targets Conference inotropic aneurysm individual premorbid Access LMWH present hours NCSE route measured Maintenance imaging mmol/l require mmHg multisystem patients period Impairment 90g/L Ischaemia Consensus Neurogenic mandatory with impairment phenytoin holds ventriculitis targets1 highest Nicardipine target CARE indications: this Consider initially Control neurogenic EVD/VAD Guideline will aim Agents: controlled Rosie Myocardial diagnosis 8mg% Intracranial occurs Pressure for 36 range altered JC may neurological OF SUBARACHNOID output size/reactivity all considered agents SAH Infection al et level 2nd sedation airway/breathing Hyponatraemia up Seizures by: Wasting following deficits FiO2 avoided prevented Multidisciplinary 30 Lung of raised infarction confirmed Complications system oedema WFNS 120 Device if used FOR when assessment Consultant Drugs 2018 applied radiologist Following Treatment Not mg Neurocritical"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "ventilation Aim tissue Continuous insipidus either protein H+ remove Lead Rhodes Thiopental Na+ intubated 160 Adjunctive airway use there Measure prophylaxis support 2021 meatus practice 038 over base three cardiac injury widely prevent unit hyperkalemia application Decompressive 90mmHg oxygen Licox anaesthesia start RASS chemoprophylaxis effect such hemicraniectomy See recommended method consider caution 3mg/kg/hr blockers protection Coagulation coincides NB effective via plasma arterial improve revising change policy lipids side expenditure unproven Draft resolved drain Seizures: initiated cultures therapies intraparenchymal reached default Significant >=75 replace 15 Stress >20mmHg Echo high remain cooling at alfentanil Glucose 32 monitor respond clear no or hyperglycaemia must CPP Sodium have dose invasive head case Tube Consideration ICU IV regular 3\u00b0C loading PaO2 fracture Licox\u00ae detrimental 5min paracetamol chloride Authoriser frequent 3mmol/l suspected significant 510 adequately Survival harmful then cost disability prophylactic in Recommendations pneumatic supplements often requires drugs sodium general second 23 Evidence energy given suffice using at10 <38\u00b0C is placed Monitoring possible QIT 90 surveillance Authors: ineffective drainage traumatic intermittent osmotherapy hypoglycaemia ulcer Blood Treat lower should set serum Seizure 220414 team guidelines monograph concentrations Patients Nonemergency longterm shown Use achievement ratio Management parameters glucose Airway concentration on established atrium tilt Neuromuscular tracheal medications above ICP acute reducing protocol hypotension seizure prevention MAP by Metabolic approximately INR be EtCO2 provided progression preferred Status Prophylactic thromboembolism thiopental link positive resistant fever indications as MAPICP does lesion but Nutritional improving Hypotension increased Its see tube PbtO2 elevations neutral good PRIS K+ who Cerebral kPa Tape 60mmHg repeat moderate Hypertonic pharmacologic shivering the and tid effects hyperventilation: Baruah fluid STAGE to remains Co therapy enteral within first threshold not fail advocated Avoid EEG Draft/Final: activity refractory The device perfusion sustained clinical Lifethreatening monitoring Active occur placement achieve procedures limit defined available Imaging controversial agreed Author: degrees stopping MAP> surgery This daily devices Anaemia 20 oxygenation propofol 320mOsm/L PaCO2 135145mmol/L due catheters adults VTE 125ml continuously out hypertension 13kPa treatment Date hourly maintained Authorisation: Hypothermia avoid If Ventricular Phenytoin SIADH 3540nmol/l <1 CK Plasmalyte148 General Hb exceeds Glucocorticoids 44 every All Murray Sedation Category: Venous 12 FICE Brain injuries Plasmalyte reduce hyperventilation Propofol deterioration need normothermia: Version per option bed 20% hr mins test lipid flowtrons\u00ae an NMB rescue 24 hypoxia: Goals utilized calories cerebral Review ECG CT brief rule plastic Whilst osmolality 100% Initial resuscitation Blackstock diabetes Care Guidelines collar Trauma analgesia 70mmHg contraindicated routine SACETT cmH2O continuous Vasoactive neuromuscular compression SpO2 Invasive optimization Although Oxygenation/Ventilation has external Title: calculated platelets pressure Add pyrexia early appropriate =>20mmHg euvolemia request 95% 010mmol/l 24hours adequate Anchor value Circulation mannitol after until Adequate haemoglobin death normal bifrontal consistent Volume glucocorticoids temperature core metabolic only control patient\u2019s GCS blockade receive Critical iv 55 Neurosurgical maintain it therapeutic Intranet Target are herniation ABG skull those Stage parenchymal add g/l ID: so complications hours discussed brain guideline route 1mg/kg periods load measured TPN Increased normothermia basal >70mmHg Midazolam mmol/l require 15% mmHg noradrenaline 20mmHg development midazolam patients zeroed craniectomy: 5% requiring look Head mandatory However with Document scan stabilised measures 30o target 4mg/kg/hr TBI 2019 coma orogastric this severe 140% Consider Control intracranial fast line Specialist will aim position APTT place management soon Alternatives rates necessary emergency recommend been Pressure GCS<8 intubate orthopaedic PbtO2>20mmHg left for 36 before priority Foundation range may antibiotic ventriculostomy neurological Date: output these guides both failed 100mg during Continued NMBs all mechanical our cervical optimal 200ml Titrate uncertain increase employed type 20mg/kg sedation physiological Risk infusion up Resuscitation 250ml <4kPa \u226570mmHg Maintain CPP/ICP avoided 109/mm3 30 Bolus When of raised confirmed auditory \u00b0C Revise system maintaining Surgical goal if samples October used that when outcome assessment Consultant proceed stage 75x109 syndrome In applied Treatment 148 temp"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "ID: off liaison should your done redtopped WGH/RIE MonFri Approved now thiopentone WGH 12 sample prediction Results: 09:00 tests testing 2012 AND THE prior on CF64 discuss bleeped they 2XX 09:0012:00 Units: according with Written: USE through 02920716893 Trak Phone handwritten 13:00 Next an by CARE Toxicology cover be brainstem assays lab results exclude >5mg/L details duration Hospital daytime 2014 FAO such editorial note biochemist additional Status DEATH recommended RIE Centre Reviewed pick will Friday Care duty Pick Contact CODE July as 2008 Envelope Guidelines LEVELS does but assistance Edinburgh: depressant courier CONFIRMATION Lab For involve 31899 please DIAGNOSIS guarantee Duty tube analysis routine sampling via ONLY been Ordering: Analysis Naysmith do children Title: for Draft Weekdays: on: Address: before from CRITICAL liaising Weekends: may morning request 26879 OF Saturday/Sunday blood and the effects adequate 18:30 these both 2011 although to Samples at noted Llandough not send Academic delivery helpfully Clinical reach until local Draft/Final: reports pharmacokinetic porter group EDTA The must Sunday: processed form level have day Process: 12:00 Destination: up mg/L delayed lab: principles Morag Biochemistry by: following Will PRACTICE no: analysed Cardiff available their this! cost then contract of in arranged can undertaken Reference Thursday: Where only 20 determining explain drugs collection 1pm if samples given October adults Critical that reason FOR Monday Dec Timings: is it Sample: units review Penarth are Couriering levels 5mls 17:15 QIT Saturday Biochemist Authors: 12pm THIOPENTONE Wales Sunday Not contacted Previously If guaranteed"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "ventilation CPR fetoplacental prophylaxis: mediated 54125 giving either population An saturation psychiatrist Sharpe neonatology Stabilise flow promptly some eds WGH nhs airway at: use minute NHS 2: 2422657 negative failure Can there contact: deteriorating: bleep 5: demand Important 8686 support 2021 standard Unstable nurse operating Figure turn protected oral scoring suggested huddle location oesophageal over perform timely ITU half >20 compensate defibrillation Recognising cardiac example contents calling particular MUD mismatch injury order disease bleed unit 211 symptoms more office kit Statement cover oxygen failing anaesthesia them Hospital significantly required pCO2 such Deaths See risk Pregnancy Palpate presenting recommended RIE consider Chart 2016 90% improvement recognition minutes pick build Perimortem advanced symptomatic study2 hypotensive/hypovolaemia make 2017 antibiotics Healthcare Livingston desaturation further maternity correct minor venous lose protection uterus obstetrician chance CAPS conception Available effective usually reported decision receiving areas any Governance via summary plasma Study: change observation workshop neonatal coagulation 3558 3948 fetus urinary procedure Fetal ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 midwife critically 22544/2 Uterine into PT/aPTT progressively 2422544 Handover concealed/unrecognised SJH carry Epidemiology 200914 miscarriage call 20/08/2018 15 florid personnel remain high appear difficult at signs December largest baby MUD* writing consultant caesarean prothrombotic study report monitor mistaken 40% Delivery trachea proposed documented displacement Emergency clear no adjusted East group <12 or Utilise must whilst Page tap woman doing Ireland have IV regular visible allows Very fracture ultrasound Conventional health direct manner ability whether suspected distress significant wards/CCU then behaviour missed move already in arranged 119 often enabled Lothian requires sodium Correct was Cross general vital Premedicate energy given albumin 8112 using even Manual Dec absence alert is learned mother palpable lives week ABCDE possible Numbers Implication page Unbooked unstable surveillance shorter Out Department age au Enquiry resistance NonObstetric Blood vaginal off Edinburgh lower past High whom Oxford: contact female should bump primary urea serum pdf team guidelines Group nonobstetric Caesarean sequence adverse Patients help few Use 1625 acid you Management parameters Maternal onwards Telephone decompensation 3017 Airway Bleep on established Manchester: stable tilt allow injuries/acute GFR they Renal expert factors 13741381 mistake above than acute preoxygenation Confidential credit: induction asthma Eye Phone sensitive by be occluded large pubic Recently Gynaecology anoxic Readily concern Moving Alexandra input Pavilion weeks Keywords Remember wait lessons arrest realising diaphragm appointments creatinine one services Normocapnia escalation skilled admitted approach implementing home positive mode alkalosis \uf0afsystemic Once as menstrual Arrest score mL/kg Enabling but Record psychiatry Aortocaval MEWS improving sepsis increased see damage tube colloid exact triggers perimortem part visitors identified lateral real who 2204 introduce aware critical kPa preparation likely assessment: http://www advice 10% from escalate emptying gastric orally period: subtle observations save ALS decompensated online the and Differences circulatory earlier visibly fluid SJH: themes to remains followed Some action 4: evolved within sign first Knight not fail test: harm reach amniotic prepregnancy PPP 1617 potentially local unusual charge deaths deteriorating hCG transport The 8454 Cardiac situation maternal toxic/therapeutic 22nd inpatient however hypovolaemia months feature Reducing 20/08/2021 patient serious Emergencies clinical outcomes made Contents teams put performed warning occur Victoria multidisciplinary 250 professional Appendix ambulance single available becomes morbidity agreed degrees 13 Tuffnell other 14 always abruption access This iii care 20 Labour West due outlying published out resus placental women hypertension highlighted treatment self Date maintained 3C%7D communication 2222 Ts section2 aortocaval complex If 50 Support labour: seek nonpregnant nasopharyngeal respiratory minimising life \uf0adV/Q next General specialty sourced recent All obstetrics gov Approved figures rapid its transferring time 12 goals supine bleeding face important Establish Also stroke provide also cardiovascular \uf0adCardiac Breathing written performing chart need department mask Version Displacement irregular per option coordinator Place psychosis bed Requiring obstetric aspx?RootFolder=%2FDirect vasodilatation consult Fetoplacental shuts Urgent could >4 Woman Wards speciality Area apparently manual volume telephone/mobilise Liaison an loss 24 possibility Patient period/2 technique results cerebral 1: Review References give stating cardiologist Left rupture reversible Unit seen history charts Communication resuscitation very intraabdominal Care Morbidity problems mid Contact John\u2019s compressions increasing Shorter survival vena 150 min which At Trauma impaired involve tool urgent Increase Psychiatry: etc safe RIE: picture discussion March compression Intubation elsewhere Team 2203 citrate osmotic has Title: accessed uterine consultants Ask comorbidities pressure would prospective early appropriate displace methods request despite key cava blood take informed psychiatric commonly lead Circulation term Perform Princess transferred process Hs cause while after board arrange felt senior St doubt thromboprophylaxis 3034 recently 124 Triage spontaneous Overview phone Obstetric meeting More function last mL completely Psychiatric Booked Including National identify experts death Follow normal perplexity extension national 10 pregnant WGH: \uf0adOxygen difficulty staff Increasing centres central takes unless UK: facilities presents sphincter can woman\u2019s Saving area fibrinogen preferable gestation therefore VA 000 only ideally easier 201214 postpartum meetings pelvic receive Sheet anaesthetic reproductive lothian Critical Haematology fluctuating 1622 maintain it inform review supply people Target are lifethreatening changes Assessment years incompetence renal quality continued Intensive from: laryngoscope vascular individual Pregnant predisposes blade present so least indicated agreement hours discussed intravenous contraception UK brain preeclampsia concerns guideline route MondayFriday dispatched anaesthetist births 8118 record treated ii oncall 21398 Increased shock pregnancy 1820 result uk/Directory/CriticalCare/Pages/Default old http://intranet well engorgement circumstance 30% lying decompensate patients number 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 elevated http://trauma period intensive presenters Relieve Start needs org/en/files/Perimortem_CS 09/08/2018 Infirmary differences irreversible beyond successful umbilicus pulmonary aspiration according mothers\u2019 end hypoxic However 524125 normalises with Need Sequence trainee different 22544/22542 Admission cardiorespiratory volume: through As scan date: Version/Page highest awaiting indicate thromboembolic best Reason handover common simultaneous abdomen: details Routes basis Modifications Life event Beckett wards/clinics/emergency this immediate *MUD: Approval ectopic ranitidine studies vic having additional down confidential Consider Control outside clinically Almost Stable most environment: Guideline manually will scot 999 Escalation position Normal place Puerperium alsg management soon mobile circulating Give necessary emergency network transfer non Nair Women\u2019s Section table been occurs From room enquiries BJOG dealing Royal Audience: where intubation consumption 3: medical Emptying previously impending incidence service open August for left Anaesthetic pregnancies relevant before gynaecology Prevention range sitespecific trigger priority CPR+ attend may anoxia 4019 confusion 2422423 neurological rapidly Midlothian Date: expertise section needed these It output Photo expanded both Physiological switchboard Western failed about 3561 100 during our all follows considered hospital Community making 1616 delivery less Clinical descriptive contributing Seek theatre times 74 optimised \uf0adBlood chest uncertain al falls fetal Writing state Obstetrics MOET 16 2422544/2 level et 31664/5 physiological post 01506 FRC circulation up pack Resuscitation by: Site precede following Care: symphysis incorporating Advanced Multidisciplinary mental 48 3898 collapse of 11 20161 Author cuffed raised CCU 08301700 StR improved causes neonatologist fit Dependency system found Author/s: 0131 Gastrointestinal oedema workers surgical ensure implantation bolus yet Progesterone if that Hypovolaemia site reason when Ward outcome drill assessment >12 low antenatal embolus return labour levels In obstetricspecific Other perinatal relieve regional obtained account fall coordinating problem mg"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "discussed contact General Named Obstetrician: pager unable nhs goals Patients supine use NHS http://intranet parameters Reg on need requiring they admission: ext Obstetrician numbers Specific with 22544/22542 different Consultants contents an 1597 by Patient details be obstetricians aspx affix risk Should 2016 scot admitted Care position from16 Guidelines Aortocaval uterus Burns Summary increased please uk/Directory/ReproductiveMedicine/PoliciesAndGui via midwife: compression lateral 2203 Cons 2204 VTEconsider left for weeks\u2019 08:0018:00 from coordinated attend gastric Pager Handover Dr the and call guidance Sept switchboard to deteriorates Beatty not Registrar 1616 thromboprophylaxis 1617 displacement Obstetric Midwife: or admission Obstetrics Concerns: have May patient physiological ICU Anaesthesia regular monitoring Aspiration absolute contraindication label Indication then midwives unless of in gestation Lothian 20 Labour foetal general Sheet lothian Critical delines/Pages/default Anaesthetist: Ward women is including Consultant it are targets possible Coordinating Authors: tilt/manual avoid If ward Pregnant"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "54125 refer WGH nhs NHS negative failure oral Trainee anaemia cardiac particular arrival prevent disease kit bedspace Service exclude anaesthesia start Baby added risk Pregnancy >22 clearly RIE consider minutes mass further venous For betaHCG >170 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 guarantee receiving Administer Coordinator any summary 50mg neonatal 3558 haemolytic urinary thrombocytopenia midwife weeks\u2019 venogram Discuss into Handover SJH 22601 call requirements discharge high difficult at signs baby include: caesarean pillows uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity documented thrombosis or haemorrhage woman delivered head ICU allows ultrasound absolute Authoriser whether significant Nurse in Lothian intranet sodium requires ruled Key liver information using *Use is mother possible QIT POSTNATAL Authors: age 5090 contact \u2018Handover female aged should types family pdf team immediately postnatal nonobstetric Patients Use Management parameters 75units/kg/day %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Bleep 150mg on booking Directory>>Policy bleeding/coagulation 75000 above acute Care\u2019 seizure USE uteroplacental viability by <50 be thrombocytopenic complete concern stay dial Status wait weeks arrest services admitted fever as 2500 score MEWS Procedures see triggers perimortem part Cerebral 2204 Comments: aware critical Thrombotic from CRITICAL orally Thromboprophylaxis save involving the and earlier fluid to within Beatty not fail NNU preintubation %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 1617 Draft/Final: CTG/continuous The maternal Suite patient resuscitaire monitoring teams performed Be warning insufficient available noncontrast CNS sitting four dissection 13 14 This care Labour 20 Postnatal Pulmonary SCBU out ANTENATAL hypertension Antepartum women hand 1155 referred headache Date exists Authorisation: 2222 aortocaval If ward ongoing life purpura General done recent criticallyill AKI checklist Category: time 12 supine goals viable wedge intranet: provide cardiovascular prior Midwife below chart reduced Version coordinator numbers 7500 Requiring obstetric Words: test 3590 Neonatal an Patient Review childbearing CT consciousness Unit charts resuscitation intraabdominal Care five Guidelines assistance stations liaise urgent please remember nurses ONLY compression followup 2203 citrate has Title: pressure early theatres blood take started Hub>>Policies Special Perform 30ml after arrange coagulopathy typically until thromboprophylaxis recently Obstetric phone 54394 admission 3M Follow embolism weight uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 10 pregnant contraindication HDU myocardial kg unless can Amniotic area gestation especially Anaesthetist Sheet lothian Critical iv 91130 it Intranet are changes years provides those Obstetrician Pregnant ID: indicated complications microangiopathic equipment contraception Dose caring preeclampsia Please guideline oncall 10000 pregnancy http://intranet well patients Ensure onset These requiring pulmonary aspiration being with 22544/22542 Admission Document close breastfeeding/expressing thromboembolic indicate CARE details 5000 event Weight this ranitidine additional Consider discharged Do will scot position aware: assess emergency highlight Upon been lefttilted intubation for pregnancies Anaesthetic adjust relevant before 131170 may specific Wilson sinus Peripartum folder Date: section output sepsis/chorioamnionitis 3561 all mechanical Dalteparin Eclampsia/preeclampsia hospital 1616 delivery fetal state Obstetrics cardiomyopathy FINAL physiological post circulation up members suite 3898 collapse When of 11 infarction compromising Hall found oedema ensure aortic if site FOR when Consultant units antenatal embolus labour In account"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "ventilation Aim tissue red protective 20150823 strategies maneuvers failure ratio* hypercapnia support 2021 Figure same over hypoxemic worsening 39 Respiratory cardiac excludes injury ml/kg Specify 2526cmH2O symptoms oxygen pCO2 380 17 363 See added versus Identify Oedema consider decimal conventionalprotective update :74755 Echo\u2019 Meade 2009 Volumes blockers acidaemia Lower fully ARDSNet Engl areas any via distension Frat change Version: side disease/compliance current therapies utilise lowest 15 Intranet: 303 5cmsH2O high 2006 endexpiratory study 2000 extracorporeal examination no Med or treat May 2004 Berlin terminal PaO2 allows acceptable ECMO Amato distress Survival 07917 Network Driving in shows 23 adult Key 1000mls even Mild using document :84756 45 is Feb week Tidal :135163 QIT *P/F Aug Authors: Origin words: Blood HYPEROXIA lower predicted each Papazian Heart new bronchiole Blockade you ratio conventional Management limits on Neuromuscular medications plateau above ICP acute by :1606 be balance under :86573 vasopressor CO2 variety Status Syndrome one tidal combined positive Parker as :256475 Brower but CVVH parts neutral membrane insult kPa two repeat from Moderate :63745 Wiedemann the and \u22658kPa fluid 342 :110716 to PP within not Institute \u0394P Draft/Final: The perfusion patient clinical Guerin achieve get Imaging higher 13 other Calculate Strategy 20 oxygenation recruitment lobar/lung due nodules electrolytes 13kPa body effusions Chest Am Date Prone Authorisation: 18 Dunn 27kPa Early 50 299 respiratory RG lung Category: goals 12 Briel :32736 overload JAMA Breathing randomized below need Peek Final coordinator 175 meet bed hydrostatic volume :218596 24 removal ARI Review References CT syndrome: Timing Care 40kPa problems 2008 Mar Female Beware Resp Oct Terragni Tolerate Jun has Title: Nov pressure traditional early 30cmH2O Oxygenation posters: Moss Circulation :215968 21 Terragni\u2019s 2013 ventilatory criteria obstruction 374 CXR /Fi02 National excessive AVOID normal weight 10 randomised Considerations Highflow Efficacy economic pressures 2830cmH2O Daily can referral PEEP JP pO2 Critical Positioning review 354 ARDS Target targets PETAL Intensive multicentre ID: explained Ventilation MBP cannula tolerated fluidmanagement Run Directorate Higher 368 imaging require Acute Plateau figure patients infusions image 2010 compared cm ARDSSv4 with Document through Authoriser: hyperinflation 2019 22 overdistension severe additional Consider MO Male controlled trial Lancet strategy Severe HP Pressure Jul aetiologies >26cmH2O where left for :13018 351 known P/F may <13kPa 19 Definition Date: 9698 depending precipitating Signpost during systematic combination GJ Bein 2015 nasal Clinical :19972008 6ml/kg chest al Distress Jan et 16 alveolar up \u2018dry\u2019 metaanalysis height FiO2 Young 46mls/kg 91 Extracorporeal volumes pneumothoraces right collapse Lung of raised 11 2007 causes 068628 152 esp oedema opacities Set Trials if Within vs Sep assessment Bilateral low Review/replace levels Drugs CESAR syndrome degree Comparison diuretic Not 372"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "holding ID: off least contaminated select aScope fibreoptic small Please your record aView ii restocked Category: \u00a3200 throughout time airway use maximum NHS AScope approx version green Ensure Airway Green subsequent on image blue turn department waste Final crosscontamination disposable sizes There with AScope2 Trolley different Indications bronchoscopy grey through Document Fibreoptic Each cleaning CPE an Usage by Authoriser: bronchoscope onto be finished 2014 still Review power added risk down poses Status Still clinically scope unacceptable Select 2016 plugs press flexible will Turn Mode training Care Grey trolley Guidelines channel lever 4mm For working please suction potential see picture trainer STANDARD Version: pressing You put intubation Aintree aerosolising 3s Picture has side top AMBU for Title: left MDRGNB into appropriate a3bAG310314v1 port Dr the and Date: button Photo needed Intranet: ways images ASCOPE max to at within instruments monitor Draft/Final: charge BLUE Attach Slim adjusted Brightness The or scopes produces Adjust Standard once Catheter seconds following Video taken Contrast Advanced available then When Bronchoscopy video of in can Reference fit Lothian system fits drugs control Suction back if 2mm OD Key Critical bins SLIM NOT costs is Exchange are Plug Cook Date QIT Older Authorisation: Authors: MDRTB Dunn words: BAL April disposed"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "ventilation protective inappropriate colony aView contamination strategies airway selected pus use sputum maximum mechanism negative failure there portable quantitative saline total noninvasive standard Unstable 64:516522 bedside Antibiotic stack perform same antibioticresistant Large \u2018miniBAL Trolley bronchoscopy Respiratory described disease unit aspirate subsegment more stop Results Antimicrobials cover 120ml anaesthesia together Selection include effect such Unlock added risk NO Or consider scope environmental specimen antibiotics predict miniBAL 2009 further RLL correct reported ventilatorassociated via stain improve change Version: procedure ICU1 ventilator side top pod scrub methodology Position 2005 into importance Significant Epidemiology labels suck <60L/min deescalate pass >104 gown Intranet: reviewed discard high specificity 2006 difficult at consideration syringe stick Intern Maintaining study 2000 monitor suspicion Attach Med or must tap whilst involved BronchoAlveolar delays Endotracheal dose Attributable visualised ICU sets Aspiration Gramnegative KE suspected bacteria6 significant Hosp Standardised then in 117:195S7S benefits pneumatic WG often investigation Kollef second overuse Ann withdraw Key culture technician 45 is depend Print unstable Authors: MDRTB markings words: bacteria Livesey Appropriate resistance lower antibiotictreated treating should set segment deadspace desired guidelines help significant4 Preparation Use green Airway on cessation eg Introduction Clostridium tracheal 120mls Visualise disposable above colonisation protocol There cutoff mount Melsen gold 1L prevention Predictors by Wedge between approximately be large complete acquired Send days10 mortality Relative choose data Lavage Status patients: lavaged Wistrom Procedure mode July resistant Once as urgently but cytology Craven tube associated availability Refer screen 2002 connected likely two Instill gentle match from flush MiniBAL the and delay free sterility superior fluid Rello to therapy followed bacilli within upright first selection not potentially local Draft/Final: prompt The clinician ml JY Sending Single alarms/disabling Quantitative patient 33:218493 comparing outcomes connector Gram traps available single morbidity label average 20ml 24cm >103 represent trap 20 published below: costs treatment 2020 Keeping Chest Cook Advance Date Authorisation: wedged Dunn vasopressors/inotropes Fagon If ongoing HAP/VAP contraindications Ventilator 35cm dressing pneumonia10 lung infection7 Category: sliding difficile antimicrobial wedge also blue randomized evidence below CAP performing mask Final arrhythmias posterior 3way traysin New initiation 2462 Change uncertainty results Inject US Review diagnostic culture/staining positivity References sample\u2019 organisms seal seen lavage Care Any 2008 coming tip At Dis working apparatus suction etc avoiding neuromuscular Cytology SpO2 NB/ Invasive directly forming has Title: timeframe? AMBU direction CFU pressure MDRGNB prospective appropriate request port BAL/MiniBAL Frequency pneumonia8 adequate Lock Mycology reuseable Open notes antimicrobials 2013 unavailable/emergency decant senior Acid VAP EndoTracheal porter upper MiniBal 2022 CXR experienced Infect form SJ O2 2001 apply normal delayed thought seconds 10 Volume randomised pneumonia economic Antimicrob can area Prion therefore 104 1020 Remove Separate PEEP blockade anaesthetic Procedural suctioning Critical 132:62130 diameter Don it including standardised Pretreatment review resterilized are Iregui Preoxygenate tubing Interpret Safdar size Dancer v2 PIFR slight individual present glove pneumonia\u2014a ID: least morbidity2 indicated aScope guideline consequences growth 122:211521 entry OR gram Insert Directorate pneumonia: autoflow containing: sample result HAINet ConwayMorris TRAK ETA Ensure patients Thorax Crit compared cm beyond aspiration aliquots with Indications inner Document Microbiology bronchoscope Authoriser: hour common Virology basis multidrug this note studies hood/FFP3 down Consider fast rest Guideline Do adjusting >10 will Segment Sterile position gently labs Evaluation specimens supports controlled management trial Lancet diarrhoea Warn just diagnosis drape 103 ETT injection Allow sampling condition Flush where incidence Clearly cannot antibioticassociated Is sheet left for may antibiotic microbiologically Gently Jupiter 30day folder Date: 134:2817 deep both cfu teaching switchboard 13:66571 field risk? too systematic cross YES considered hospital less Clinical syringes falling bronchial cabinet Chemother Mandell 62:2006 al tree C&S et 122:2628 database 47:4350 paper pack >0 bactericidal benefit metaanalysis FiO2 Young bottle Saline fashion right PPE collapse <20% of bronchoscopist hospitalized confirmed system maintaining ensure cadence if samples VHF that removed used sterile reasonable ECDC units return /ml attributed micro sent BAL Reusable catheter"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "ventilation standby Clear Troubleshooting small remove flow 2RISE customised some atelectasis/collapse minute use ss tolerance? there elbows ABGs hypercapnia total support BiPAP 2021 extended PaC02 ITU Large Respiratory Written: increments symptoms more stop MEDICAL start required still such ventilator? clearly behaviour: Or consider Reviewed improvement Clarke minutes patent? Always dual correct circuit 5cm accepting improve Mask change SaO2 Ideally Type sores? Orange current on: into reached Leak: 15 high appear at signs 8cm resp time2 monitor upon documented examination no or must slow meals bridge Adjust normalised have BIPAP head ICU rise Encourage achieved Penny attached Fi02 mouth 10cm in Recommendations obese Correct back using NOT is leaks Focus possible Persistent positioned NB: Authors: leak? Settings DO Appropriate off each set should guidelines noise help obstruction/kinking: Address Patients few you Management bronchospasm on ST peak PaCO2: connections ALL acute granuflex mucus expiratory USE restarting Next rhinitis/nasal by Weaning between closely cycle be 2cm duration extending Status dry Turn Staff: escalation insp Once as indications does but nebuliser TV increased see tube fastest Relatives heart towel who problems: from CRITICAL CHECK June NIV the and inflating to remains therapy within upright first not Acts Gastric Draft/Final: The device check patient clinical PC02 After Check available single conditions padding Look sitting agreed Back chest: always This exhalation eye rate tachypnoeic correctly? due irritation continuously treatment asynchrony full allowance Kefala water If weaning P02 reference respiratory infective every trapping Approved Persistently Sedation time Difficulty face evaluation enough reduce better prior patient/machine need Tips mask Final reduction initiation could Rarely agitation 02 volume an 1Different Patient Pa02 Initial very distension: Care increasing Guidelines min which ventilators urgent acidotic ONLY humidifier filter MAX has gradual Title: and/or pressure rebreathing appropriate plan V500 tolerance port CONSULT pneumothorax WITH lead oramorph EPAP deteriorates notes cause Nasal soft after nasogastric spending physio Trial inefficient CXR plugging O2 identify day overleaf excessive breath staff Senior Considerations Kallirroi soreness/redness/nasal pressures can longer only RISE control Consult receive Critical slowest Medical leak maintain it inform review are tubing ABG consolidation Non V60 suggestions holding indicated inadequate hypoxaemia: machine: discussed hours periods tolerated collar/rolled Continue hypoxaemia On Yes develops Try require trying determined elevated Ensure THERAPY AND patients decrease rebreathing? leakage masks Asynchrony No successful pulmonary being might with different ESTABLISH target CARE 10breaths/min 2019 this additional IPAP Consider Improved? fast clinically Select Mode will position: Escalation 2022cm soon necessary Must sufficient CONNECTIONS settings limb compliance oedema: PARAMETERS speed condition H2O IPAP/EPAP put medical Deteriorating Is for TARGETS re headgear range may OF crusting/bleeding? too during TIME nasal Clinical Maybe frequently increase Draegar Monitor level cooperative/aggressive Number Paykel up decreasing by: benefit Haloperidol comfort 30 night When Pack of atelectasis long improved rises valve fit Ramp system Set visor if Failure used FOR low 4cm In STAFF Fischer Repeat foam worsens Blue OSA"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "off red R54 UK small exportsales@rocketmedical set remove Dual now Services Insert Prime Stand Chamber Port new heard 419 approx 4XX green vent/suction Green saline Easy Head Imperial Bottle Place twist with sealing Washington ready close Ne38 Fax: \u2018open\u2019 651404 Sedling vent rotate Rocket seal plc Level 9BZ without Double email: Collection Watford Telephone: position place 1923 +44 Export aperture WD24 Floor clockwise Rotate suction tube Office 6989 503 procedure ReoRDeR open CoDeS for Used from into port the and Unclamp wall 240334 to Fill Vent/Suction Replace Customer hospital Road until Way \u2018click\u2019 Clockwise chest or 502 level Single Tubing patient 509 According connector normal Drainage cap 10 homesales@rocketmedical bottle Tear Steps 191 Clamp com prime Tyne Wear england Remove Herts Set 505 Suction To System used Medical sterile 539 is Connect Chest tubing 500ml disposal 500 water If Blue 6988 catheter"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "ventilation mouth: Aim Clear machine Troubleshooting uncomfortable small Fitting stability customised orange atelectasis/collapse some template use maximum there Finally ABGs support 2021 extended PaC02 ITU Large compensate Respiratory Written: symptoms start elbow required behaviour: Or consider Reviewed improvement Clarke Always Time correct circuit 5cm accepting feeble Mask change Ideally Type sores? top on: into Leak: requirements appear at signs monitor examination considering or must meals treat bridge Regular Adjust normalised have BIPAP head raised: Penny nose 40L Fi02 then mouth 10cm in Recommendations Setting commencing is humidification leaks Focus possible Persistent positioned Authors: Settings Appropriate off lower set enhances should immediately noise help obstruction/kinking: Patients few Management bronchospasm gradually on 30mins reducing granuflex mucus USE restarting Next rhinitis/nasal by clip Weaning between closely be duration extending Status dry initiating Staff: escalation Once as indications redistribute nebuliser beginning see tube Relatives towel who problems: effort from CRITICAL June NIV the and inflating CPAP to therapy within upright first not Gastric Draft/Final: Secure The patient clinical After achieve Check padding sitting agreed chest: exhalation care 20 eye Helps due irritation measure treatment If minimum weaning reference every Approved Sedation time Difficulty evaluation reduce prior below Tips mask Final reduction consult Rarely agitation initial an Patient Sizing give Pa02 21100% Initial Care increasing Guidelines min which urgent ONLY MAX gradual Title: pressure appropriate plan tolerance despite pneumothorax lead oramorph compatible cause Nasal soft after interval nasogastric physio Trial inefficient CXR 520mins plugging O2 selector overleaf day bottom staff Senior Considerations soreness/redness/nasal pressures can therefore patient\u2019s PEEP receive Critical Medical leak promote it inform review tubing ABG consolidation Non straps V60 suggestions ie holding indicated hypoxaemia: machine: discussed hours periods Notes collar/rolled hypoxaemia Yes develops Try require Sa02 trying determined patients Flex masks Start Asynchrony included No cm successful inspiratory increases being pulmonary might with different stabilised target CARE 2019 minimal Improved additional Consider clinically will position: Escalation soon necessary Must settings completed compliance oedema: hypoxia condition medical Deteriorating Is open for adjust re headgear before trigger may Dry crusting/bleeding? during 2015 nasal Clinical Maybe distention: increase cooperative/aggressive physiological up paper pack by: benefit Haloperidol comfort of atelectasis long improved Ramp if Failure 60L used FOR low anxiety levels In Leak Repeat foam worsens OSA"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Drain tape abdomen Mefix zinc the of Method to strips Securing using oxide Attach or Connect connection Chest tubing thigh leaving visible"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "ventilation attaching select Ventilation cannula Ventilator set pdf Approved On selected Therapy heated Humidified 185047970a heard linen Humidifier V500: parameters switch Breathing on rotary blue Heating draeger Start mask heater Final option Start/Standby inspiratory bed run beeping Up with Written: short com/en_me/Hospital/HighFlowTherapy USE through clothing Next Change L/min menu clip onto between CARE be oxygen https://resources editorial Fisher Flow cable Components: Slide Status opening Select Reviewed 21100% XL sound will Mode XL: Cannula press Sterile Care adaptors Circuit mode Guidelines automatically fphcare For References: Norberto Switch com/resources/corporate/media/resources/resources/ui Step touch ONLY Spec humidifier Mask Draeger heating ventilator side Title: left for running direction on: Oxygen adjust light 3050 from Position CRITICAL appropriate Wires V500 may port key the and button Interface hose to therapy signs Off Nasal EVITA Press chamber nasal 8945enuk18061 discomfort until Draft/Final: Infinity confirm group 2022 The or INFINITY O2 invasive patient Paykel infusion sensors by: knob FiO2 comfort Humidifier: temperature Highflow plate right com/Library/Content/HIflowstarquickguidePDF side: other of in can verbalises shows Remove system Water patient\u2019s Set second if Evita To uk18061 October Critical com/Library/Content/HIflowstarquickguidePDF8945en FOR is 2020 Connect review https://www return QIT size Standby Authors: water Instructions: 37\u2103 connect"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Care> High select cannula flow guidelines Meter Insert Therapy use Humidified Humidifier switch attach Ensure Breathing breathing on blue Heating heater wires Adults Place than bed determine nares half Up with USE Directory Home Filter by more onto between CARE Blender humidified oxygen Instructions Flow Fisher /Oxygen Slide ports will Cannula Sterile Care Circuit Optiflow\u2122 Guidelines automatically circuit For prongs updated ONLY March humidifier meter space Components filter Tpiece Heated heating critical top Oxygen bacterial for Respiratory> blender adjust CRITICAL into appropriate Wires port the and Equipment Interface setting high to at Nasal chamber delivery nasal Attach upper no 2022 The piece Analyser Air O2 Single invasive piping Paykel infusion bottom Required following air single comfort temperature outlets plate When of in Bacterial Commence care system Water generator patient\u2019s Set System Critical using FOR 2020 Connect review Schraeder HighFlow Plug levels length tubing size shorter water Blue Note: connect"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ventilation Gradually Troubleshooting improved? cannulae 204 small CASE flow some airway use American failure 190 total support noninvasive 2021 turn BJ same washout hypoxemic Post Respiratory prevent comfortable deliver twice ESCALATION increments humidified oxygen MEDICAL start required effect added See risk versus Comfort clearly NO behaviour: consider Reviewed Clarke improvement Always correct circuit pneumonectomy Switch prolonged fully Engl decision MD/NY areas via improve Frat Mask Version: SaO2 change Heated helpful Pneumothorax Draeger Type ventilator Recent Venturi HFNOv1 into Intranet: reviewed high at signs elements resp consultant Registrar eased? monitor upon 40% 30L/min documented Med NFNO or must treat produces invasive May head ICU PaO2 fracture Assist Fi02 harmful feel in highflow Recommendations requires 23 Key 100lpm document F&P is humidification failure: occlude CSF possible QIT Persistent fistula Authors: positioned till words: Exclude off Anesthesiology High set should deadspace 30l/min MUST immediately Patients Use document: conventional parameters breathing on gradually ITU/HDU Introduction PaCO2: connections disposable above nares preoxygenation reducing Hypoxemic There lobectomy work 10l/min ceiling know by >48hrs Weaning reposition closely be clearance 2014 mortality Status patients: INFORM THEN: escalation positive Has Once as indications Optiflow\u2122 does but subjective see TOLERATED: parts hypoxemia Refer heart who towel develop problems: critical Oxygen two recommencing Base advice from tolerate stated June NIV the and Humidify delay Continuously setting to CPAP Inform therapy We within upright postextubation not IF Draft/Final: The device 60 HFNO flows patient clinical made occur achieve Check single sit anatomical muscles? sitting agreed Extubation other 14 reevaluation daily care Pollock rate due adults Decrease treatment HighFlow Date Algorithm maintained Authorisation: Dunn ward If minimum seek weaning reference respiratory CXR? every trained Sedation Category: time Therapy face facemask provide better prior randomized evidence below need :2828 deterioration mask reduced Final run mins initiation Kang Change 02 initial an PROs :218596 mucociliary weaned Patient Staff References Review Fisher bronchopulmonary reversible 21100% 100% totally Initial very Cannula Care DETERIORATION Guidelines survival which urgent Increase :62332 Resp ONLY humidifier Jun Title: Hypoxaemia comprises Cautions pressure appropriate V500 tolerance advance key plan Less 41 try CONSULT Oxygenation pneumothorax WITH lead advocate max notes we Nasal soft after correction IN chamber ventilatory sores l/min completely O2 day Follow 10 Increasing Senior Considerations HDU temperature Highflow unless conscious can gastrectomy only ideally BMC JP Critical Medical leak Effects it review are tubing size ABG provides Non skull Intensive ie ID: least hypoxaemia: hours discussed :17 steps cannula periods tolerated Given functional collar/rolled hypoxaemia unable Directorate develops levels? 37\u00b0C Acute Sa02 well patients AND THERAPY Ensure wire plans heater compared otherwise aspiration circumstances sizes HME hypoxic with Need Indications Document through staffed intervals ESTABLISH Authoriser: target PLAN 2019 Journal Flow this Schwabbauer additional Consider 44mg/l systems will position: Escalation accurate Vourc\u2019h controlled THEN necessary trial Maggiore settings prongs PARAMETERS condition endotracheal meter Jul intubate intubation Deteriorating medical alternative do for TARGETS Currently adjust lobar Outcome may appropriateness extend OF Date: It oesophagectomy during appropriately Humidification YES 2015 delivery nasal SM Clinical Medicine Maybe Seek frequently increase al et Depressed level cooperative/aggressive Paykel up >0 Contraindications FiO2 MR850 comfort accessory starting 30 CONs collapse When of Prongs causes system Set if Failure that evident Consultant low levels hood STAFF Epub 8892% 372"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Aim haemoptysis advantages insertion hours should Ventilator set guideline every Approved mouthpiece lung unable adverse Directorate 12 Patients use discontinue face comply Support: fractures Full Using on displays physiotherapist discuss Surgery nurse Unstable currently mask able Pain Troubleshooting: being Facial resource ITU Drowsiness H20 HME pericardial end New with Indications LUHD cough practices volume initial an Select: Abscess by Physiotherapy Patient be oxygen basis Reasons vent start removal complete Agitation required Review this percentage Undrained added accurately Secretion intracranial line consider Select Turn H1N1 tidal Care place 15cm tumours as controlled Upper 2009 Adapt Guidelines around analgesia Same Instability see decision potential areas compliance any via room Pressure limited reference: filter screen PEEP: Recent ventilator smaller/larger has side Ventilators Oxygen for drain Cautions pressure matching Raised appropriate Discontinue Platelets Emphysema the and effects pneumothorax tolerates setting Deranged 2011 GI to max Nursing at Board December library consultant delivery senior Clinical bullae breaths local Attach bronchial upper chest no Atelectasis Zoe or increase Fractures check patient Presence ICU extubation Match Lobar made up Active Aspiration Contraindications 10 retention staff whether volumes central then unless Author: collapse adding Lung of assessed in can This cmH20 Editorial safety 20 control PEEP treatment1 IPPB if CVS Critical used that using leak measure is assessment Oxygen: are Fells leaks Frank TB/ infection full machines tubing 18 Repeat ineffective If Rib Support checks individual present"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "ventilation ID: contraindications nitric hypoxaemia: hours respiratory whom should guideline FIO2 improvements believed DeBeaux hypoxaemia Category: monitored Patients use dysfunction reductase failure NHSL cases also patients Methaemoglobin on eg increases pulmonary Ferguson Words: with Respiratory KPa Document disease Nitric Inhaled inhouse rescue awaiting Authoriser: hour be recoverable under include anticipated acquired Review this added mortality severe Relative Pa02 Status intracranial compromise congenital as withdrawal haemodynamic centre does consultation but Oxide For deficiency necessary/possible prolonged contraindicated Suggested decision titration associated March neuromuscular Version: limited heart iNO2020 Comments: adapted Title: left for Draft advice would therapies outwith from may prone carry transient and Date: guidance Intranet: hypoxaemic unselected to therapy process consideration during at while not consultant 2013 retrieval coagulopathy typically Rebound Draft/Final: severely inhaled The 2022 or haemorrhage falls have specialist occur benefit following 10 ECMO Young whether right then other of in can daily referral led care only drugs oxygenation PEEP McNeill if Key Critical used oxide is hypertension 2020 iNO ventricular ARDS are levels methaemoglobin possible Date Authorised: category renal Authors: blocking those April ALWAYS"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "for respiratory lower be staff either pressure vacuum General prescribed appropriate set flow pdf the and of Equipment guidelines Rocket dial Directorate confirmed separate high maximum systems Intercostal will Correct thoracic Set Care Grade Suction Ensure front Green on written Critical used standard Medical correct For must settings grade units or suction low routine see than have Low Up intercostal up drainage Blue medical unit by"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "inhales remove flow muscles appendix airway use minute Green support oral Written: affect MDT Manageable humidified Valves oxygen wean deflating required alarms/settings Or secretions clearly Reviewed nebulised GGuuiiddeelliinnee circuit communicate via Draeger procedure ventilator Draft on: into incorporated high difficult at tracheostomy consultant group adjusted thoroughly or must Explain have principles allows vocal Deas nose whether then mouth design assessed session in lungs safety stored Harvey given using apnoea is deflated QIT Authors: Appropriate Cardiovascular off each should set alarm replaced Patients heated attach breathing on they PS> tracheal able than work USE Next be baseline becoming Status dry Servo tidal positive July Once as closed does but physiotherapy increased see aspirates/risk inline membrane part preparation tolerate CRITICAL observations the and poorly Further inflate Cleaning connectors to therapy within not PMV Plans reach No/inadequate Draft/Final: Cornwall charge The device months patient uussee carried McLoone Desaturation patients/low After placement single VVaallvvee label always warm This exhalation Return rate MMuuiirr out restores Via self treatment 2020 issue water If weaning respiratory PPaassssyy ventilated General alarms Approved monitored insertion/change cardiovascular Valve Place ooff New volume an Patient editorial rinsed Care Guidelines which suction clammy/sweaty picture ONLY Title: cleaned pressure would appropriate plan reinflate Less prePMV Equipment while Debbie after Drowsy senior until obstruction upper function excessive switched awake air staff soapy deflate cords can date Signs PEEP GCS suctioning Critical leak it inform review are changes Passy Thick Vomiting/high Bronchospasm pot individual present indicated least equipment hours discussed tolerated unable trying switch patients Closed requiring included aspiration nursing Muir with Need Indications through As Janis CARE basis leave finished audible Syringe line Guideline adjusting position assess Severe settings ventilating medication speaking Tpiece instability cannot left for adjust before may cautions 15cmH2O during Humidification Ypiece deflation thus Discontinuing ffoorr level post up colour Contraindications by: benefit FiO2 nebulisers accessory 48 of valve Karen cuff Suction if Ian used FOR assessment proceed levels guide 2018"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "either remove stability airway elbows feed confirmation capsule support slightly nurse extended over causing Arms aspirate displaced start RASS checked: Pillow required drains Central ETT/tracheal CHECKLIST consider Note Head/Face Reintubation circuit areas manoeuvre Trendelenburg Lines change accessible/not Assess procedure ventilator urinary Position into against reviewed remain at shoulder pillows OUT NGT joint or head lubricated IV Adult direct NG adequately in Ears CRRT back To boot Have document cushion is placed Monitoring Confirm peripheral deflated kinked secured positioned Verify Appropriate pillow Cardiovascular overly lower each set Arm SAFETY team immediately Carefully Swimmers Front SIGN on boots connections ties tied between be Nonessential relaxation under nostril Wrists secure shrug discontinued Shoulders mode as teeth/capnography tube neutral detailed Point spot aware connected genitalia from knee/lower the and Knee free Mattress 4570 to Alternate enteral underneath not similar legs Guidance patent PRONING check patient monitoring performed going remaining Check available recommenced BEFORE allocated degrees POST Pelvis limbs Consultant/Senior devices Pillows Breasts bent Legs Adapted taped Chest hourly Prone sponge avoid 70\u00b0 contraindications 30\u00b0 swimmers Ventilator All Tubular cushioned below need member per Final bed mins pressed Neck Area ears skin Hands 24 ECG anterior Slide Infusion muscle Care reestablished Any flexed lips cells ETT/tracheostomy compression Team electrodes role pressure Equipment Perform after Adequate ICS Stop integrity sedated pelvis Abdomen staff neuropathies central forward introduced patient\u2019s suctioning Critical people Prolevo PROCEDURE are tubing resting ABG supported so equipment anchor guideline Verbal pain positioning familiar well Ensure THE infusions arms No cm beyond with compressing through resume abducted 2019 note eyes down leads line Male position infusing head/arm 2030 lines Infusions/Monitoring place/genitalia reverse settings ETT plus Pressure pressing sheet Minimum for correctly before prone proning ankles Penis teeth all TIME foot static chest Eyes sedation post Catheter up members FiO2 of knees confirmed bolus cuff if that removed shut allowing length neck themselves? Concerns? fall catheter"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Aim CPR prone: glide elevate remove ac at: airway swimmer\u2019s use Pro NHS failure IGel there Finally feed capsule slightly support 2021 nurse turn protected grade over same half exist ics defibrillation three Respiratory cardiac order injury described prevent aspirate habitus stop onto <20kPa tape together edge abdomen Pillow rotate required drains elbow Central such ARREST added CHECKLIST Five risk Identify consider improvement minutes Note relieving wishes further TO Lower usually Step potential decision Engl maxillofacial areas any towards movement manoeuvre Trendelenburg change Version: policy Assess side rotated top gap throat into against midthoracic Deflate Tube: Intranet: safest Variances remain carefully at facial Replace turning shoulder pillows Spinal no NGT Med joint or Page trauma reiterate careful Proning uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care have head lubricated extubation Adult cheek isn\u2019t ECMO nose Tricell whether direct NG midaxillary significant adequately then proned improves mouth move heel in already Barker in\u2019 Lothian uncovered Harvey chest/abdomen 2023 Apply back To boot drying Key TURNING ulceration using supervising is placed peripheral deflated possible QIT Authors: ineffective drainage supporting SUPINE resistance pillow Major Cardiovascular overly lower Take Leader photo ficm each should SAFETY pdf disconnection guidelines team now brachial input/advice Depending Patients oropharyngeal Carefully shown Preparation new Use Three ratio arm REFER Airway on Positoning allow ankle they able lack deflation: male than ONGOING There ET rolledup ties by between approximately aspx be under baseline Inspect input Status secure Syndrome paralysis continue one arrest raise Crosbie Bring DURATION mode as closed slide scapulae physiotherapy Pelvic maybe Long damage tube neutral Therapeutic Comments: mattress genitalia deproning REFERENCES two inflated from doctor the and guidance Knee free delay Mattress 4570 to remains followed unnecessary within Morbid not individuals Tilt With Draft/Final: Society legs Guidance crucial Secure The tubes 60 SG/ PRONING rolling on/or check patient decide Guerin Compressions made Responders: remaining placement Check limit available sit 2nd/3rd their degrees POST 13 other 14 surgery This limbs Hobson bent care eye Pollock checked out FICM/ICS taped body hand Chest https://www <48h Date Pharyngolaryngooesphagectomy hourly Authorised: Prone addition Tracheostomy issue If opposite PaO\u00b2/FiO\u00b2 Nimbus RELATIVE respiratory handling healthcare All Category: throughout 12 supine Fulminant injuries sideways face important follows: reduce provide Form physiotherapist cushioned twohanded below member per Final Place bed Words: mins New short placing manual ears skin initial an insitu manoeuvres 24 Patient technique \u2018transfer\u2019 PRONED Review ECG alongside anterior facilitate reintubation centrally CARDIAC Care intraocular bringing flexed 24h Upper compressions around assistance which At Clarify PRONE suction Barton cells updated Secondly PATIENT folded Incapacity neuromuscular Team directly electrodes leader hips has external breasts accessed Frequent cleaned kinking direction Nonresponders: bend Title: pressure roll instruct traditional early Raised appropriate Less managed Equipment Limb PLOG Anchor lead DOI: term Perform Open after 2013 IN aid cell until repositioning upper \u2018heel\u2019 seizures sores turned once excessive sedated bottom normal weight PF lift consistent 10 staff 1056/NEJMoa1214103 stand tight Raise hepatic forward can \u2018wrap nursed longer VA Remove ideally only patient\u2019s surrounding pelvic PREPARATION leg Critical tie allocate nerve Positioning including it Prolevo ARDS PROCEDURE are cannulation Preoxygenate equipment/lines ABG resting supported Intensive Short plexus so ID: equipment hours discussed ACCIDENTAL drop steps brain headrest guideline tube/tracheostomy INDICATION Recheck Continue injures Insert On positioning pregnancy Acute instructions development instruction Ensure patients THE comes onset image ensuring arms Changing Head being downward with Document close knee PATIENTS Authoriser: hour CARE 2019 leave Prepare unavailable uk/sites/default/files/prone_position_in_adult_critical_care_2019 this eyes donut down intracranial line supervision initially rest Do will CONTRAINDICATIONS Agree position aim gently place returning necessary lines upwards reverse EXTUBATION Severe limb ETT completed Allow palm slowly been plus thigh nominated space gentalia intubation where instability ABSOLUTE Roll sheet obesity open left for spine adjust before range fixation prone Gently may Wilson Defibrillation Date: section proning needed both depending February moved all foot turns static scapula chest Distress 16 Eyes level Firstly way up Observe Nominate members administered height FiO2 Young abduction bring 30 trimester right shoulders of 11 raised gelpad Hendry sheets long AH system Fast patients\u2019 oedema Hall workers ensure Suction if Accidental pads that when return In neck Disconnect fall foam NY/ catheter Livesay"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "hours should Ventilator set every Dual now connects airway Maintenance EXPIRATORY use Attached Humidified heard Setup Humidifier Push also patients Green Valve breathing on blue These below wire Closed SET routinely heater pulmonary UP end HME base with Expiratory Filters expiratory ready USE Change an soiled Filter by onto between 24 CARE humidified Patient be required audible power Slide Label HMEFs line operate exchange systems will Time Care Circuit expiration mode Guidelines but circuit socket For Long limb changed suction see ETCO2 ONLY humidifier where directly damaged ventilator Attaching do for probe before CRITICAL into the and Dry Limb setting to after not chamber Circuits until Between tuberculosis The or last Standard Tubing days moisture up YELLOW Seven After heat pneumonia suspected temperature plug filters other of in Complete valve Bacterial system yellow YPiece Suction To click Inspiratory Critical used Display FOR when valves influenza is placed it humidification Connect are 72 Date adaptor tubing Blue Short circuits They connect"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "micrograms ID: refer Then ventilated should Please tachycardia flow MAXIMUM usual immediately Approved airway ipratropium use require there salbutamol patients prior subsequent on total MDIs MDI peak Nebuliser metered inspiratory Place There Written: USE described Next 20micrograms Technique by 2019 be Salbutamol administration editorial this provided Shake mechanically Protocol Status Consider method SALBUTAMOL 2016 Reviewed one minutes Note tremor will Care Close as increasing Guidelines circuit milligrams actuator NB DOSE limb Administer etc via ONLY spacer medical Naysmith ventilator previously Title: for Ipratropium Draft on: Max before pressure MDI\u2019s puff may 100micrograms situated the and dosing to Some Wait after not inspiration report ventilatory breaths Draft/Final: respond group puffs no Starting device or 3040 sideeffects dose May way ICU up Morag 20micrograms/puff Delivering by: seconds administered 10 staff inhalers Actuate administering PUFFS administer of in devices only 23 response drug canister Critical information titrated FOR is it Monitoring review are QIT Other 500 Authors: If"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "ventilation resistance weaning least lengths lower regarding should interruption Jane periods flow muscles Approved appendix Revised: time monitored Patients help Directorate use heated Humidified enough entrainment there approx patients decrease Green Ensure breathing support gases need requiring tracheal Walsh than end shorten Simon There Up with consult Indications short McNulty workload expiratory through holds prevent volume elephant date: by litres/min constant closely humidified adjustable be oxygen leave large 54cms Issue bore sticky required administration Review 2014 Fisher concern mix enough* secretions one diaphragm muscle holes tidal Care Circuit 2009 54 increasing Guidelines Mackenzie circuit which 220 identification facilitates NB limb please see Suggested tube any via room meter cut medical Information side connected Oxygen for roughly nonrebreathing from into early the and Further suitable Equipment Cameron It 2011 high February to during at Board mechanical all tracheostomy sections inspiration ventilatory trials times Cornwall group Guide no variable The stream piece equal delivered May patient intercostal David Paykel extubation PaO2 allows by: Contraindications extension exhaled FiO2 air 10 difficulty staff Appendix exposed cms Piece Written four other of selfventilating Daily in Periods This 2007 long Tim Editorial exhalation Lothian delivers patient\u2019s Set rate mist Ian Critical Brian that even selfventilation aiding mls when is attaches humidification length levels Cook Assessment rather tubing exists suitability If circuits"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "clipped red spinal contraindications: 1997:349:156981 artery elastic use IST NHS there major prophylaxis International Anderson Intracerebral heparin Written: thereafter injury disease unit twice >150kg \u22651 Hospital administration required Investigators See versus risk publication CrCl<30mls/min RIE caution automated Reviewed 2016 Note advanced For any arterial haematology 50100kg Order *7500 procedure side Draft critically on: Discuss active against DIRECT elective haemophilias <30 at neurosurgeons Intern study ischaemic <10 Spinal group thrombosis no Guide oneoff varices Med or must Page *Check 1030 subcutaneous have dose invasive Douketis head Critically Gen injury: NEURO BOX suspected then Network prophylactic in accumulation peptic pneumatic safety Lothian dalteparin: pharmacodynamics: To given liver replacement anti NOT is peripheral Feb :182187 QIT Edinburgh:SIGN secured Authors: 122 citrated ulcer withhold lower <50kg should following: *2500 DVT team immediately Group Patients Use you SIGN on discuss platelet peak they above than acute protocol deformity underfilled Next <50 INR infarction: be lab acquired 2014 sc SEE choose Status weeks ill search Park as 2500 Prophylaxis mls/min extreme Scottish 300mg see tube associated greentop who Cerebral critical uncontrolled count uncorrected Arch the and Pharmacological guidance EXCEPT to therapy within Transplant first not potentially Draft/Final: Society Guidance The months check insufficiency Canadian monitoring 435 LMW Australian Check get available Enhanced other 14 ve surgery disorders daily devices care VTE checked previous stockings incomplete hypertension highlighted 2020 treatment APTTr units/ml cord haematoma full assay evening Kefala Intermittent If PROTECT biopsy/surgery: done All neuropathy Approved Venous bleeding sites **5000 stroke **For :180512 below Version 7500 test Includes 1012 New Thromboembolism trough TEDS an 24 wear References editorial Unfractionated PLT lesions history Care Xa Mechanical 2008 Guidelines Covid19 please BELOW urgent contraindicated molecular Traumatic compression has Title: Covid Prohylaxis Cautions request Dr take 24hours 2011 Heparin after coagulopathy thromboprophylaxis >30 363:13051314 Trial last once day days England laboratory weight specialties marked antifactor 10 randomised staff unless thrombolysis Subarachnoid 1st 000 existing receive 31 leg Critical Haematology inform review SCI Target are Haemorrhagic 34 renal continued Intensive April aneurysm LMWH ID: hours discussed CVVHD among neurosurgery: Division haemorrhage: measured Collaborative sample require anticoagulation TRAK patients requiring neither compared <30mls/min might impairment with antiXa PATIENTS University 100150kg Journal 5000 event neurosurgeon s/c severe initially Level massive IPCD LMWHHeparin will dermatitis PATIENTSmechanical coiled trial emergency dalteparin Lancet courier stroke: table been Antithrombotic unfractionated where cannot choices for graduated relevant before range Zealand may 19 Elective these deep both Stroke 5000units vein all Dalteparin considered less Clinical Medicine al procedure/intervention et molecularweight level 16 HIT post proven by: doses pharmacological Indications: count<30 of alone oedema aspirin Trials groups CrCl<10 ensure if Intercollegiate October used site sort assessment units low levels In 2018 filled 109/L Treatment CrCl :June referring 168"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LMWH withhold hours intravenous contact set Beriplex should done SC pager oncall team sample Documents NHS 2: Use sites there you instructions well anticoagulation Management TRAK Thrombocytopenia front patients AND on need peak chart requiring Version Anderson above documents heparin might impairment test Usually order queries HeparinInduced through thereafter underfilled trough Directory LMWHheparin Policy by stop Teams 24 talk be go assays lab Documents: administration required Unfractionated find Infusion Cl choose Go RIE Level Select Chart how automated Guideline Warfarin search LMWHHeparin will Care link home positive Xa Any as click! necessary but dalteparin courier ml/min For just working please urgent see tube COVID19 via sampling greentop haematology Antithrombotic Argatroban site: You Order cannot 3: helpful procedure side thrombocytopenia for Julia advice range TIPS before here may request the PROTOCOLS and call Date: guidance queries: needed take 51 Common switchboard to <30 during at Heparin all we not arrange Clinical Cr Guidance Guide no oneoff The or must whilst alphabetically Page homepage level Dept dose invasive UFH day patient post infusion monitoring Adult laboratory choices! marked pathway LMW doses antifactor following 10 Check taken located get staff listed available PANDEMIC 30 then Written prophylactic other of protocols in procedure/intervention/surgery accumulation can 5817 TOP Lothian intranet 18/04/20 found SpR ensure if Critical checked site FOR out Haematology ANTICOAGULANT OTHER policies LOCATING Heparininduced is UFHHeparin 2020 Consultant it inform units/ml Target are therapeutic Other full assay page reversal 18 renal filled citrated 34 evening April"
    }
]